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ABSTRACT 
There is mounting experimental evidence demonstrating protection by free glycine 
against stress in several cell types. The glycine transporter type 1 (GlyT-1) mediates the 
high affinity supply of glycine, which together with cysteine is required for the synthesis 
of the antioxidant glutathione. Previous work in this laboratory has established that GlyT-
1 is expressed on the apical and basal membranes of intestinal epithelial cells and that its 
mRNA levels are regulated by stress. In the present study exactly how stress signals to 
transcriptional induction of GlyT-1 was investigated. Caco-2 cells transfected with 
reporter constructs of sequences of the GlyT-1a proximal promoter and 5’UTR cloned 
upstream of a β-galactosidase coding sequence, showed increased reporter activity 
following treatment with thapsigargin (Tg), tunicamycin (Tu), amino acid (AA) starvation, 
tert-Butylhydroquinone (tBHQ) or Diethyl maleate (DEM).  Despite no changes in Nrf-
2 mRNA levels, a significant increase in total Nrf-2 protein abundance was evident on 
western-blots following DEM treatment of Caco-2 cells. However, gel shift showed no 
protein-DNA complexes between Nrf-2 protein and a DNA probe sequence of the 
putative antioxidant response element (ARE) identified in the GlyT-1a 5’ flank. Despite 
a significant siRNA mediated knock-down of Nrf-2 mRNA and protein, there was no 
further effect on GlyT-1a expression. Unlike Nrf-2, the knock-down of Atf-4 diminished 
the basal and stressed induced expression of GlyT-1a. Atf-4 was detected bound to DNA 
probes containing a potential amino acid response element (AARE) located in the first 
exon of the GlyT-1a gene by gel shift and super shift assays. QPCR assays performed on 
DNA isolated from Caco-2 cells by chromatin immunoprecipitation (ChIP) using 
antibodies against Atf-4, demonstrated 9, 5 and 2-fold enrichment of the GlyT-1a AARE 
following Tu, AA starvation and DEM treatment respectively. Site directed mutation of 
the GlyT-1a AARE showed a 75% reduction in reporter activity as well as attenuated 
protein-DNA interaction with a representative probe. It is evident from the data 
presented in this thesis that the direct interaction of Atf-4 at the proposed GlyT-1a AARE 
contributes to its transcriptional up-regulation following endoplasmic reticulum stress, 
nutrient stress and oxidative stress.  
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PREFACE 
This PhD thesis is based on research into the transcriptional regulation of the high affinity 
glycine transporter (GlyT-1a) conducted by myself, L K F Fultang in the Epithelial 
Research Group (ERG) of the Institute for Cell and Molecular Biosciences (ICaMB), 
Newcastle University. Previous work conducted in this laboratory has demonstrated an 
important cytoprotective role of free glycine against perturbations to normal physiology 
in epithelial cells lining the human intestine. With an interest in cellular signalling 
pathways, I set out to investigate the underpinning molecular interactions which lead to 
the transcriptional regulation in GlyT-1 following physiological stress.  
This thesis is the first written account of the research conducted in the last three years. 
The text is divided into four chapters. In the first chapter (Chapter 1), I review existing 
knowledge on the importance of the synthesis and transport of free glycine, as well as 
what is known about its cytoprotective role. This is followed by a review of the multi-
faceted stress response pathways. This chapter lays the foundation and motivation for the 
work reported here. The next chapter (Chapter 2), contains a general description of all 
the methods used for the work carried out during this project. This includes experimental 
design for real time quantitative polymerase chain reaction, electrophoretic mobility shift 
and super-shift assays, chromatin immunoprecipitation (ChIP) assays, reporter assays and 
in silico methods. All experiments and associated protocols were approved by the 
appropriate departmental authorities and executed under the supervision of Dr Alison 
Howard and Prof Barry Hugo Hirst. The penultimate chapter (Chapter 3), provides a 
discussion of the key findings of this project. It begins by summarising observations on 
the expression of the glycine transporter (GlyT-1a) downstream of stress in Caco-2 cells. 
This is followed by novel evidence for the regulation of the resulting changes in 
expression by specific transcription factors. Some of the results described in this chapter 
have been presented at key international conferences (viz: the International Union of 
Physiological Sciences, IUPS Birmingham 2013, and Experimental Biology, EB San 
Diego 2014). In the final chapter (Chapter 4), I review and discuss the general implications 
of the findings from this project, whilst proposing future work that may further improve 
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our understanding of the regulation of the Glycine transporter and the pivotal role of the 
stress response in cytoprotection.       
The last four years have been a challenging journey of ups and downs. Fortunately, I have 
been accompanied by an extended team of sponsors, supervisors, friends and tutors 
whom I would like to thank.  I thank my supervisors: Prof Barry Hugo Hirst and Dr 
Alison Howard, as well as members of my progress review panel: Dr Judith Hall and Prof 
Barry Argent for their continued mentorship throughout this project. Many thanks to Mrs 
Maxine Geggie for advice and guidance with the tissue culture required for most of this 
work. I am also grateful to Dr Heath Murray for help with setting up the ChIP assays. I 
would also like to thank Dr Noel Carter (University of Sunderland) and Dr Anne 
Cunningham (previously University of Sunderland) for introducing me to the world of 
molecular biosciences during my undergraduate Biomedical Science studies and for 
encouraging me to continue in research. Thanks to all colleagues especially to members 
of Pearson lab for allowing me to use your equipment and office space. To my friend Dr 
Peter Chater, thank you for all the memorable moments.  
Special thanks to my family for sponsoring me to undertake this research. Your endless 
and unconditional support has seen me through several years of education, and has been 
motivational during the last four years. Finally I would also like to thank Tanya Vyland 
and the Vyland family for supporting me throughout these years. To you the reader, thank 
you for reading through the first two pages of my thesis. Hope you find the work 
described in the remainder of this text as interesting as it was to investigate. 
Livingstone Fultang 
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CHAPTER 1.  
INTRODUCTION 
 
Outline: This chapter details the theoretical framework and motivation for the study 
reported in this thesis. It provides a review of the importance of free glycine synthesis and 
transport. A discussion of the various proposed mechanisms for glycine cytoprotection is 
included. What is presently known about the supply and transport of glycine to cells is 
reviewed, detailing the various transporters involved. Facets of physiological stress in 
epithelial cells and the various evolutionary conserved adaptive stress response pathways 
are reviewed in this chapter. It concludes by defining the main hypothesis, aims and 
objectives of this project. 
Contents: 
1.1 Significance of glycine transport ................................................................. 2 
1.2 Defences of the human intestine ................................................................. 3 
1.3 Cyto-protection by glycine .......................................................................... 6 
1.4 Glycine synthesis and Metabolism............................................................. 13 
1.5 Glycine transporters ................................................................................... 15 
1.6 Regulation of Glycine transporters ............................................................ 24 
1.7 Stress induced gene regulation .................................................................. 30 
1.8 Hypothesis, Aims and Objectives .............................................................. 41 
 
 
In recent years, the metabolism and transport of glycine and one carbon units have been 
implicated in processes promoting epigenetic alterations, modification of redox status and 
genome maintenance (Amelio et al., 2014, Locasale, 2013). Studies conducted in this lab 
on cellular models of physiological stress reveal the rapid intracellular accumulation of 
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glycine in gut epithelia as a function of GlyT-1: the specific glycine transporter type 1 
(Howard and Hirst, 2011).  GlyT-1 (also known as SLC6A9 – where SLC6 stands for 
solute carrier family 6 member A9) has been identified as a downstream target of the 
integrated stress response (ISR) in mouse embryonic fibroblast cells (Dickhout et al., 
2012). Its mRNA levels are elevated in intestinal epithelial cell models following induction 
of the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress with 
tunicamycin and thapsigargin (Howard and Hirst, 2011). How various stresses amount to 
changes in GlyT-1 expression in intestinal epithelia is the subject of this thesis. 
1.1 Significance of glycine transport  
Glycine is a gluconeogenic, alpha-amino acetic acid with no stereoisomers. Its simplicity 
and size convene its function in beta-turn formation, linking the alpha helices to beta 
sheets in the secondary structure of various proteins. The structural implication of glycine 
availability for development is severe (Guay et al., 2002, Wu, 2010). A glycine residue 
occurs at almost every third position in the collagen chain (Lodish et al., 2000). Collagen, 
an insoluble structural protein accounts for about a quarter of all proteins in the human 
body.  The fact that very little of maternally fed labelled glycine is transported from 
mother to foetus is aggravating (Lewis et al., 2005). Only about 10% of maternal glycine 
is passed to the foetus, thus in preterm infants glycine is conditionally essential (Jackson 
et al., 1997). Offspring of rats feed a glycine free diet during pregnancy developed several 
complications in visceral organs at or before attaining adulthood (El Hafidi et al., 2004).  
Glycine transport across the intestine is necessary for the supply of amino acids to all 
tissues. In posterior areas of the central nervous system, the rapid re-uptake of glycine 
from synaptic clefts into the axon terminal or glycinergic neurones produces inhibitory 
post-synaptic potentials (Betz et al., 2006). Conversely, its binding to the N-methyl-D-
aspartate (NMDA) receptor co-agonises the effects of aspartate or glutamate; hence, 
potentiating excitatory transmissions and modulating synaptic plasticity (Viu et al., 1998). 
Glycine mediated transduction of action potentials is necessary for both sensory and 
motor control. Reduced plasma glycine and low glycine titre in cerebrospinal fluid has 
been associated with several neurological conditions (Altamura et al., 1995, Maes et al., 
1998). For this reason, several glycine transport inhibitors have been trialled, with the 
main purpose being to blunt its re-uptake from synapses in the central and peripheral 
nervous systems (Umbricht et al., 2014, Chue, 2013). 
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1.2 Defences of the human intestine 
With its distinctive high cell proliferation rate, the highly differentiated and complex 
gastrointestinal tract is an energetically expensive organ requiring an increased flow of 
nutrients. Despite accounting for less than 5% of whole body weight, about 20% of all 
body protein is synthesised in the intestine (Reeds et al., 2000). Although the gut wall is 
important for nutrient absorption and synthesis, it is precariously exposed to diverse 
microbes, toxins and xenobiotic compounds. In the absence of adequate defences 
dysbiosis in the luminal tract may result in adhesion to, and invasion of, the intestinal wall 
by micro-organisms. As such, a specialised two tier barrier comprising of primarily an 
intrinsic wall of glycocalyx coated continuous monolayer of epithelial cells with tight 
intracellular junctions serves as first line of defence (Figure 1.1). The intestinal epithelia 
are responsible for regulating the transit of micro and macromolecules between the 
interstitium and the underlying lamina propria. Specialised epithelial cells such as goblet 
cells, secrete mucus forming glycosylated proteins (including mucins) and other protective 
peptides for added mechanical resistance to injury. Others such as the microfold cell (M-
cells) found in Peyer’s patches of the ileum present pathogenic antigens to the immune 
cells of the lymphoid follicle for the induction of an immune response (Kucharzik et al., 
2000). The coat of mucus infused antimicrobial peptides (AMPs) is an important extrinsic 
defence protecting the epithelial barrier from changes in environmental variables such as 
pH, electrolyte balance and bacterial invasion (Agerberth and Gudmundsson, 2006). 
The integrity of the intrinsic barrier is subject to various physiological stresses including 
nutrient and oxidative stress (Soderholm and Perdue, 2001). Physiological stress 
represents the unfavourable effect of environmental factors (stressors) on the 
homeostasis and normal physiology of the cell (as defined in the directory of medical 
subject headings: MeSH ID 68013312; tree number G07.700.830). Prolonged barrier 
dysfunction (as depicted in Figure 1.2) and changes in epithelial permeability have been 
linked to the progression and complications of various intestinal diseases (Catalioto et al., 
2011, Ma, 1997, McGuckin et al., 2009). This includes the many diseases collectively 
known as inflammatory bowel disease (IBD). Generally, they result from the 
disproportionate and misguided response of the immune system to stressors from within 
the gut lumen (Geboes et al., 2014).  
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Crohn’s disease (CD; which affects any region of the gut) and Ulcerative colitis (UC; 
presenting only in the colon) are two of the most common forms of IBD with similar 
aetiology and progression but differing presentations. Genome wide analysis of 
expression quantitative trait loci (eQTL) for CD highlight associated gene variations in 
several loci such as those required for sensing pathogen or microbe associated molecular 
patterns (P/MAMP) and maintaining the microbial ecosystem (Barrett et al., 2008). 
Microbial endotoxins are effective stressors of the human intestine (Walker and 
Porvaznik, 1978). 
 
Figure 1.1: Defences within the healthy human intestine. Protection from injury is 
mediated by a specialised two tier barrier comprising of an extrinsic mucous layer with 
antimicrobial peptides, and an intrinsic network of epithelial cells forming a monolayer 
with tight intracellular junctions. Specialised cells such as the M-cells (or microfold cell) 
and dendritic cells detect pathogenic invasions and present specific antigens to 
lymphocytes within the lamina propria, resulting in the activation of an appropriate 
immune response.  
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Aside from IBD, several less severe forms of colitis such as Infectious Colitis are 
characterised by states of acute stress within the epithelial cells of the intestinal barrier. 
These often result from infection from parasites such as Shigella dysenteria. Chemical 
imbalance within the gut also represents a serious threat to luminal homeostasis. Stress 
resulting from the occurrence of free radicals may lead to chemical colitis. Brief periods 
of inadequate blood supply to the bowel have been linked to the occurrence of ischaemic 
colitis. Prolonged stress may ultimately lead to more severe CD. 
 
 
Figure 1.2: Effects of dysbiosis on gut barrier function. Toxins produced by invading 
pathobionts, upon accumulation in cells of the epithelial lining may lead to cell death, 
disruption of tight junctions and a leaky gut barrier. Dendritic and M cells present 
pathogen associated molecules to lymphocytes contained within the lamina propria. 
These lymphocytes mount an appropriate immune response against the invasion. 
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1.3 Cyto-protection by glycine 
Over the last 25 years the role of glycine as a cyto-protective agent has been extensively 
researched. It is now known that it can protect a number of cell types/organs against 
various stresses. Glycine has been shown to have cyto-protective effects in the 
hepatocytes of the liver (den Butter et al., 1993, den Butter et al., 1994), renal tubules of 
the kidney (Weinberg et al., 1987, Weinberg, 1990, Weinberg et al., 1990, Paller and Patten, 
1992), epithelia of the lung (Omasa et al., 2003, Gohrbandt et al., 2006), cardiocytes 
(fibroblasts and myoblasts) of the heart (Qi et al., 2007), and epithelial cells of the 
intestines (Mangino et al., 1996). That the accumulation of intracellular glycine retards 
stress induced damage in various cell types, prevents the depletion of cellular ATP levels 
or the accumulation of fatty acids, as well as prevents the onset of inflammation is an 
emerging theme.  
1.3.1 Immune regulation by glycine 
As glycine is one of the amino acids with the largest titre change in serum following septic 
shock (Vente et al., 1989), the hypothesis that glycine has an immune-regulatory role has 
been scrutinised (Wheeler et al., 1999, Zhong et al., 2003).  Glycine supplemented 
parenteral and enteral diets suppresses the immune responses resulting from intestinal 
ischemia/reperfusion (I/R) injury (Bower et al., 1995). Likewise dietary glycine is able to 
prevent the onset of ulcerative colitis in the gut by inhibiting the induction of various 
chemokines and cytokines (Stoffels et al., 2011, Tsune et al., 2003).   
The occurrence of glycine gated chloride channels on a variety of leukocytes, such as 
Kupffer cells, alveolar macrophages and neutrophils, has led to speculation on the role of 
glycine in blunting their activation (Wheeler et al., 1999). It is now understood that the 
binding of glycine to these chloride channels leads to rapid membrane depolarisation of 
the plasma membrane and an influx of extracellular calcium (eCa
2+) via voltage gated 
channels (Van den Eynden et al., 2009, Wheeler et al., 2000, McCarty et al., 2009, Ikejima 
et al., 1997, Schilling and Eder, 2004). Using a two hit model in rats combining an 
intravenous injection of a sub lethal endotoxin derived from Escherichia coli, together with 
partial hepatic I/R, Ikejima and colleagues reported that glycine feeding markedly 
improved survival (Ikejima et al., 1996). They propose from their results that the reduced 
hepatic necrosis is a consequence of blunting of intracellular calcium (iCa
2+) fluxes in 
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Kupffer cells preventing a cascade of eicosanoid and cytokine production which require 
intracellular iCa
2+ as second messenger. 
Canonical activation of leukocytes by external stimuli such as drugs, endotoxins, growth 
hormones or other stimuli invokes signal transduction via a G-protein coupled trans-
membrane receptor (Meng and Lowell, 1997). Activation of phospholipase C and the 
generation of inositol tri-phosphate (IP3) culminate at the release of iCa
2+ as secondary 
messenger from internal stores (Chow et al., 1995). The release of iCa
2+ from intracellular 
stores has for effect the rapid depolarisation of the plasma membrane and a further influx 
of extracellular eCa
2+. This massive change in intracellular iCa
2+ is believed to serve as 
message for the expression of key cytokines (Reilly et al., 2005). Thus, current 
understanding suggests that upon the binding of glycine to glycine gated chloride 
channels, hyper-polarisation of the plasma membrane shunts most (if not all) membrane 
voltage operated calcium gates. This renders the cell insensitive to external stimuli such 
as lipopolysaccharides (LPS), growth hormone or second messengers. 
1.3.2 Detoxification of xenobiotic compounds  
One of the earliest identified cyto-protective roles of glycine was its conjugation to 
xenobiotic compounds in the ‘glycination’ pathway (Quick and Cooper, 1931). The 
enzymatic conjugation of glycine to toxins and their metabolic intermediaries generates 
less toxic excretory derivatives. The two step amino acid conjugation to xenobiotic 
compounds comprises a key detoxification pathway (Figure 1.3). The first ATP-requiring 
step is the formation of a xenobiotic-co-enzyme A (CoA) intermediate (Schachter and 
Taggart, 1953, Gatley and Sherratt, 1977). The final step is the conjugation of the 
mitochondrial acyl-coA to glycine in a reaction catalysed by the enzyme glycine N 
acetyltransferase (GLYAT, EC 2.3.1.13). Although glycination is believed to take place 
predominantly in the mitochondria of the liver and kidney, the expression of acyl-coA by 
several other tissues (such as corneal and intestinal epithelium) point to the possibility of 
pre-systemic glycination of xenobiotic compounds (Kaminsky and Zhang, 2003). 
Benzoic acid is a naturally occurring aromatic acid in many plants and vegetables and 
widely used as common food preservative and anti-fungal agent. Additional benzoic acid 
is produced from microbial degradation of dietary aromatic acids such as purines and 
polyphenols in the gut. In the liver, benzoic acid is the end product of the catalytic 
conversion of Toluene - a widely used industrial solvent (van Duynhoven et al., 2011). 
 8 
Whilst dietary intake alone may be non-toxic, increased intracellular accumulation of 
benzoate can detrimentally alter cell physiology (Bas et al., 2014). In man, the conjugation 
of intracellular glycine to benzoic acid leads to excretion of hippurate (Graber et al., 2012).  
 
Figure 1.3: Glycination of xenobiotic compounds such as benzoic acid. 
Metabolic profiling of urine samples from patients presenting with IBD has shown to 
have significantly diminished hippurate (Williams et al., 2009), highlighting an apparent 
dysbiosis common in IBD patients. Whilst ruling out genetic causes for inadequate 
glycination, Williams and colleagues argue that it is this dysbiosis leading to excess 
accumulation of xenobiotic compounds in and around intestinal epithelial cells which 
elicits the ensuing auto-inflammatory response (Williams et al., 2010). Such dependency 
on glycine availability for detoxification was reported by Gregus and co-workers, where 
the administration of exogenous glycine increased the capacity of benzo-glycine 
formation at a rate much higher than permitted by endogenous glycine supply in the liver 
of anaesthetised rats (Gregus et al., 1996, Gregus et al., 1992, Gregus et al., 1993). 
For β-oxidation of esterified fatty acids, acyl-coA hydrolases in the mitochondria maintain 
a recycled pool of CoA (Reddy and Sambasiva Rao, 2006). In the absence of suitable 
conjugates like glycine, xenobiotic compounds conjugate to and sequester CoA in an 
ATP-dependent reaction forming xenobiotic acyl-coA compounds. Drugs such as 
sodium valproate (an anti-epileptic drug), aspirin and many other salicylates or phenyl 
acetic acids bind to CoA in this manner; reasons why glycine treatment is recommended 
following an overdose of these drugs (Patel et al., 1990). The depletion of CoA pools 
eventually disrupts oxidative phosphorylation (respiration) and β-oxidation of fatty acids 
(Knights et al., 2007).  This leads to the accumulation of long chain fatty acids, ATP 
depletion and an increased cascade of free radicals. The ensuing lipid-peroxidation is 
believed to result in necro-inflammation, fibrosis and cell death (Day and Saksena, 2002). 
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Such is the ‘double-hit’ pathogenesis in the progression from steatosis to steatohepatitis 
(Day and James, 1998)  in the livers of obese individuals, heavy alcoholic drinkers, and 
patients treated with some antiviral or some non-steroidal anti-inflammatory drugs 
(Gaemers et al., 2011). The alimentary inclusion of glycine significantly reduced the 
circulation of non-esterified fatty acid (NESFA) and reversed the high blood pressure in 
adult male Wistar rats previously fed a glycine-free diet (El Hafidi et al., 2004).  
1.3.3 Glutathione synthesis 
Like glycination, glutathione conjugation or ‘glutathionation’ is a crucial detoxification 
mechanism employed by several cell types (Pastore et al., 2003). The formation of thio-
ester bonds between glutathione (GSH) and compounds with an electrophilic centre 
represents a key antioxidant control. GSH is a tri-peptide consisting of a peptide link 
between the amino groups of cysteine and glycine, and unusually to the 𝛾-carboxyl group 
of the glutamate side chain (Figure 1.4). The terminal carboxyl moiety of the conjugated 
glycine of GSH prevents its degradation within the cell by 𝛾-glutamyl-cylo-transferase 
(GGCT, EC 2.3.2.4). For the synthesis of GSH, the conjugation of glycine to 𝛾-glutamyl-
cysteine by the action of glutathione synthetase (GSS, EC 6.3.2.3) is the final step in a 
two-step catalytic reaction; the first step being the conjugation of cysteine to glutamate 
by 𝛾-glutamyl-cysteine synthetase (𝛾-GCS, EC 6.3.2.2, also known as glutamate cysteine 
ligase). It has been suggested that microbial endotoxins such as LPS interfere with GSH 
synthesis by lowering the expression of the catalytic and modifier subunits of GCT 
(Tomasi et al., 2014). Using Caco-2 cells incubated with E. coli as a model for the intestinal 
micro-environments, He et al. report the activation of host defence response pathways 
associated with the intracellular accumulation of free radicals (He et al., 2013) . 
Free radicals are formed by the non-enzymatic autoxidation of surrounding molecules 
resulting in the breakup of electron pairs. The reactivity of ‘reactive’ oxygen species (ROS) 
is known to initiate or aggravate DNA-double strand breakage, lipid-peroxidation and 
oxidative stress; all of which are associated with ageing and other degenerative diseases 
(Ray et al., 2012). Whilst the toxicity of ROS is dependent on their reactivity, it is apparent 
that some free radicals are more potent than others. In recent years there has been an 
overwhelming focus on superoxides (O2
-), peroxides (H2O2), hydroxyl (OH) and hyroxy-
ethyl in the pathogenesis of disease and ageing (Ray et al., 2012, Tiganis, 2011, Alfadda 
and Sallam, 2012). Be they from the prolonged inhibition to oxidative phosphorylation, 
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alcohol induced, pathogenic sources, or the consequence of perturbed oxygen 
metabolism and cellular electrolyte balance, ROS are also essential in signalling to cellular 
adaptive responses such as in the stress response, pathogenic defences and cell death 
(Tiganis, 2011).  
 
Figure 1.4: Synthesis of the tri-peptide glutathione 
In extracellular space, the amino acid cysteine is often found in its oxidised form cystine 
(Banjac et al., 2008, Iyer et al., 2009). The cystine/glutamate antiporter System Xc
- mediates 
the high affinity import of cystine for GSH synthesis. Studies in rodents on GSH 
availability in states of oxidative stress highlight the cysteine/cystine redox cycle as rate 
limiting (Lyons et al., 2000, Bitensky, 1990). However, there is an equal importance in 
glycine availability for synthesis of GSH (Jackson, 1986). This is evident from the 
increases in downstream gene targets required for the intracellular accumulation of glycine 
following stress amongst which are GlyT-1 and other low affinity glycine transporters 
(Howard and Hirst, 2011). 
1.3.4 Osmo-protection by glycine 
Epithelial cells lining the intestinal wall and also the proximal tubules of the kidney are 
particularly susceptible to severe changes in cell volume resulting from acute osmotic 
imbalances (Burg et al., 2007, Brocker et al., 2012). The regulation of solute transport 
across the cell membrane comprises a prescribed response to the ensuing osmotic stress 
Glutamate 
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(Willem H Mager, 2000). To counter states of hyper- or hypo-tonicity, the opening of 
mechano-sensitive ion channels following changes in cell volume has for consequence 
the increased fluxes of predominantly inorganic ions across the membrane (Martinac, 
2004, Inoue et al., 2009). However, increased intracellular concentration of ionic 
compounds usually has for effect the disruption of biochemical process, build-up of free 
radicals, and alteration of protein structure and function.  To prevent the negative 
cascading effects of osmotic stress to oxidative stress, and ER stress resulting from altered 
intracellular biochemistry, small neutral organic amino acids like glycine (or tri-methyl 
glycine [betaine], taurine; amongst many others) are preferred osmolytes in many animal 
cells (Dawson and Baltz, 1997, Yancey, 2005, Dawson et al., 1998). In the kidney and 
intestinal cells, glycine is a potent inducer of ornithine decarboxylase (ODC; EC 4.1.1.17) 
required for the synthesis of polyamines from ornithine (a by-product of urea), which if 
accumulated may elicit osmotic stress (Chen and Canellakis, 1977, Minami et al., 1985). 
Work done by Steeves and associates using mouse embryo shows that the intracellular 
accumulation of glycine in hypertonic states results from increased direct activity of GlyT-
1 (Steeves et al., 2003, Steeves and Baltz, 2005).   
Gene expression levels of many organic osmolyte-transporters (such as members of the 
System A amino acid transport family), and enzymes facilitating their intracellular 
synthesis are known to be regulated by hyper-tonicity (Burg et al., 2007, Burg et al., 1997). 
The minimal essential osmotic response element (ORE) – a 12 bp sequence 
(GGAAANN(C/T)N(C/T)) first identified in the 5’ flanking region of the gene encoding 
aldose reductase (AR, an enzyme required for the synthesis of the osmo-protectant 
sorbitol), has also been identified in the promoter regions of the betaine/GABA 
transporter (BGT-1), Sodium/myo-inositol co-transporter (SMIT), the taurine 
transporter (TauT) and HSP70 (Ferraris and Garcia-Perez, 2001, Ito et al., 2009, Burg et 
al., 2007, Miyakawa et al., 1999). Amino acid limitation combined with hyper-tonicity has 
been shown to increase the binding and activity of the Tonicity responsive Enhancer 
Binding Protein or Osmotic Response Element Binding protein (TonEBP/OREBP) at 
the SNAT-2 ORE (Franchi-Gazzola et al., 2004, Franchi-Gazzola et al., 2001). 
TonEBP/ORE-BP a member of the rel family of transcription factors was first identified 
in cells of the renal medulla (Miyakawa et al., 1999). Due to its very close ancestry and 
similar function to members of the Nuclear factor of activated T-cells  (NFAT) family of 
transcription factors that regulate gene expression in response to osmotic stress it is has 
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now been reclassified as NFAT-5 or NFAT-L1 (NFAT-like protein type 1) (López-
Rodríguez et al., 1999, Trama et al., 2000). NFAT-5, an ubiquitously expressed 
transcription factor, has been shown to regulate expression of the taurine transporter 
(TauT/SLC6A6) as well as the betaine (N, N, N-tri-methyl-glycine) solute exchanger 
(BGT-1/SLC6A12) (Hsin et al., 2011, Ito et al., 2005, Lopez-Rodriguez et al., 2004) 
As to whether NFAT-5 or other tonic response transcription factor directly regulates 
GlyT-1 like other members of the SLC6 family remains speculative. But with widespread 
acceptance on the osmolytic properties of glycine (Baltz and Zhou, 2012, Steeves and 
Baltz, 2005, Steeves et al., 2003) and given that GlyT-1 activity increases in hypertonic 
states (Steeves et al., 2003), it is a reasonable assumption that the transporters of glycine 
like those for other osmolytes such as taurine, may be regulated by osmotic stress at a 
transcriptional level.    
1.3.5 Stimulation of Heat Shock Proteins 
It has been demonstrated both in vivo and in vitro that changes in temperature lead to a 
well-orchestrated heat stress response (Nowak, 1990, Pelham, 1986). The transcriptional 
regulation of downstream heat shock proteins (HSP) occurs early following heat stress, 
but also following ischemia, anoxia, nutrient deprivation and other forms of stress 
(Morimoto, 1998, Morimoto et al., 1992, Tonkiss and Calderwood, 2005). Using opossum 
kidney (OK) cell line, Nissim and colleagues demonstrated that when glycine or alanine 
was supplemented in culture media the mRNA levels of the 70, 72 and 73 kDa heat shock 
proteins (HSP70, HSP72 and HSP73) were significantly increased following heat stress 
(Nissim et al., 1992). In the same experiment, treatment with glutamate, leucine, arginine 
or aspartate had no such effects. Similarly, supplementation of Caco-2 culture medium 
with 8 mmol/L glycine significantly increased the protein expression of HSP72 following 
heat stress (Lindemann et al., 2001). In both studies the effect of glycine supplementation 
alone under basal conditions (no stress) had no effect on the transcription of these 
proteins. That glycine and not just any amino acid resulted in transcriptional regulation 
of HSPs points to a specific role for glycine in cellular resistance to heat stress, although 
a mechanism is as of yet unknown. 
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1.4 Glycine synthesis and Metabolism 
Previously, glycine had been considered nutritionally dispensable on the foundation that 
its endogenous supply and metabolism provided sufficient recycling capacity for 
intracellular needs. Now, it is better described as conditionally essential, with periods of 
glycine insufficiency due to inadequate intracellular synthesis or increased requirement, 
for instance during periods of stress. Amino acid metabolism in the intestine accounts for 
over 60% of all metabolism in the portally-drained viscera or PDV (Yu et al., 1992, Yu et 
al., 1995). Studies with stable isotopic tracers reveal that glycine is important in 
gluconeogenesis, the biosynthesis of pophyrins such as heme, the production of 
creatinine and the synthesis of purines for nucleic acid synthesis (Locasale, 2013). Nucleic 
acid synthesis in the intestine relies predominantly on de novo synthesis of nucleotides from 
intestinal amino acids (Berthold et al., 1995). An intact glycine residue is incorporated into 
the purines of mucosal RNA (Boza et al., 1996).  In addition to direct synthesis from 
carbon-dioxide and ammonium salts by the reverse action of the glycine synthetase 
complex (or glycine cleavage system GCS), glycine can also be generated from many 
sources (Wang et al., 2013b). This includes from the amino acids threonine and serine or 
from glyoxylate, the ammonium salts choline, betaine (tri-methyl glycine) and sarcosine 
(mono-methyl glycine).   
The breakdown of glycine by mitochondrial GCS serves as a source of one carbon units 
to many important metabolic processes. GCS comprises a concert of four proteins (T-
protein, P-Protein, L-Protein and H-protein) which together catalyse the oxidative 
decarboxylation of glycine to carbon-dioxide. The lipoyl group of the H-protein (also 
known as GCSH) mediates the shuttling of moieties between the three other enzymes in 
the system. The methylamine moiety, resulting from glycine decarboxylation by the action 
of P-protein (also known as Glycine dehydrogenase, GLDC: EC 1.4.4.2) is transferred to 
the H-protein. T-protein (GCST: EC 2.1.2.10) an amino-methyl-transferase, catalyses the 
release of the methylamine from and reduction of H-protein, and transfers a methyl group 
to tetra-hydro folate. This yields ammonia and 5,-10-methylenetetrahydrofolate (5, 10-
MTHF). The reduced H-protein is oxidised by L-protein (GCSL: EC 1.8.1.4) which uses 
NAD+ as cofactor.  
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Figure 1.5: Glycine synthesis and metabolism. Enzymes are denoted in purple; 1: di-hydro 
folate reductase (DHFR); 2: Serine hydroxylmetyltransferase (SHMT); 3: 5, 10-methylene 
THF reductase (MTHFR); 4: methionine synthase (MS), 5: methionine synthase reductase 
(MTRR); 6: betaine-homocysteine methyltransferase (BHMT); 7,8,9: methionine adenosyl 
transferase 1a (MAT-1A), 2A (MAT-2A) and 2B (MAT-2B) respectively; 10: S-adenosyl-
homocysteine (SAH) hydrolase (SAHH); SAM: S-adenosyl-methionine; TMG: 
Trimethylglycine (Betaine); DMG: Dimethyl glycine (Sarcosine); 
5, 10-MTHF is an important cofactor in the synthesis of serine from glycine by the action 
of serine hydroxyl methyl transferase (SHMT). It is an important source of methyl groups 
used for DNA methylation patterns (hence gene silencing) associated with several 
cancers. It is reduced by the action of Methylenetetrahydrofolate reductase (MTHFR, EC 
1.5.1.20) to 5-MTHF and eventually demethylated to THF or re-methylated to 5-10-
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MTHF in a series of steps termed the folate cycle.  The one-carbon (methyl) output from 
the folate cycle is donated to the methionine cycle via methylation of homocysteine by 
the action of methionine synthase (MS, EC 2.1.1.13) and its co-factor vitamin B12.  
1.5 Glycine transporters 
Owing to its importance in cyto-protection as described above, during periods of 
physiological stress there is an increased intracellular requirement for glycine. This may 
result in significant shortfall between the supply of glycine from intracellular biosynthesis 
and metabolic demands, hence requiring added glycine transport from external sources. 
Most dietary amino acid and peptide absorption occurs in the early two thirds of the small 
intestine, predominantly in the duodenum, proximal jejunum and ileum (Freeman and 
Kim, 1978, Silk et al., 1985). This usually involves active uptake across the apical 
membrane of absorptive cells, simple diffusion across the cytoplasm and transport 
through the basolateral membrane into the blood stream. In humans, systemic availability 
of amino acids represents less than half of dietary intake, with the remainder sequestered 
by tissues comprising the PDV (stomach, intestine, pancreas and spleen) which have a 
heightened energy expenditure and metabolic rate (Yu et al., 1992, Yu et al., 1995). In pigs, 
first-pass extraction accounts for up to 40% of dietary glycine and 60% of cysteine 
retention in absorptive cells (Reeds et al., 2000). This is in contrast with the systemic 
availability of absorbed monosaccharide of almost all of enteral intake. In the human 
intestine, glycine can be transported by a multiplicity of SLC proteins summarised in 
Table 1.1 and described below. 
1.5.1 Imino and proton driven glycine transporters 
Initially identified as the lysosomal amino acid transporter (LAAT) in brain neurones, the 
proton assisted amino acid transporter (PAT-1; SLC36A1) is known to mediate electro 
genic transport of the imino acid proline, glycine, alanine, betaine (N, N, N-tri-methyl 
glycine) and sarcosine (N-methyl glycine) (Chen et al., 2002, Boll et al., 2003a, Boll et al., 
2003b, Boll et al., 2004, Broberg et al., 2012). PAT-1 activity is absent at neutral pH but 
highest at low pH with no enantiomer discrimination and relatively low substrate affinity 
(Km 3 - 7mM) (Inigo et al., 2006). The order of substrate preference for PAT-1 is highest 
for compounds containing an imine group within three carbon units of a carboxyl group 
such as proline or hydroxyproline, and lowest for amino acids such as glycine (Metzner et 
al., 2006). Like most proton driven transporters, PAT-1 co-transports (symport) one 
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amino acid and one proton (H+) sourced from the H+/ATPase, H+/K+/ATPase (or V-
type H+/ATPase on lysosomes) or the immediate acidic surroundings of the cell. 
Evidence points to an apparent ambiguity in requirement for Na+ by PAT-1 in rat 
intestine (Inigo et al., 2006). This is possibly due to the Na+ dependence of the membrane 
H+/Na+ anti-porters from whence H+ required for its activity may be sourced. 
Subcellular PAT-1, expressed on lysosomal membranes in human embryonic kidney 
(HEK293) cells is known to enable the amino acid dependent recruitment of the 
mammalian target of rapamycin (mTORC1) to the lysosome by virtue of its physical 
interaction with Rag/GTPases (Ogmundsdottir et al., 2012).  In mammalian tissue, PAT-
1 mRNA is differentially expressed from the gene locus 5q33.1 in cells of the kidney, 
neuronal cells in the brain and cells of the spleen, but predominantly on the apical 
membrane of epithelial cells lining the stomach, small intestines and colon (Boll et al., 
2004). Due to the pH neutral environment of the kidney proximal tubular cells, PAT-1 is 
inefficient in the re-absorption of glycine at the apical membrane. This together with a 
moderate substrate specificity for imino compounds has let to doubts of its association 
with the morbidity of iminoglycinuria (Broer et al., 2006).  
Iminoglycinuria (IG; OMIM 242600) and hyperglycinuria (HG; OMIM 138500) are 
autosomal recessive errors of glycine and imino acid transport, resulting from complex 
mutations in glycine and imino acid transporters. Despite its low capacity for glycine, 
PAT-1 mutations have been associated with the prevalence of IG with impaired intestinal 
transport. It is believed that an IG phenotype is associated with the inheritance of two 
non-functional alleles within genes encoding for the low to medium affinity imino and 
glycine transport such as PAT-1 (Broer, 2008a, Broer et al., 2008). An HG phenotype, 
whilst common in neonates with a burgeoning glycine transport, is thought to be 
associated with inheritance of a single non-functional allele within the genes encoding 
medium to high affinity glycine transporters.  
Like PAT-1, PAT-2 (SLC36A2) is a proton (H+) dependent amino acid transporter. It has 
thus far been identified in mouse, rat and human (Boll et al., 2003a, Boll et al., 2003b, 
Bermingham and Pennington, 2004). Although PAT-2 is less distributed in humans than 
PAT-1, PAT-2 mRNA expression has been detected in cells of the kidney, skeletal muscle 
(Bermingham and Pennington, 2004, Nishimura and Naito, 2005) and intestine (Foltz et 
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al., 2004). PAT-2 mediates the high affinity transport (Km 100 – 200µM) of glycine, proline 
and other L-alpha amino acids with small aliphatic side chains (Kennedy et al., 2005).  
1.5.2 Neutral amino acid transporters 
Like PAT-1, the first sodium coupled neutral amino acid transporters (SNAT-
3/SLC38A3 and SNAT-1/SLC38A1) were cloned on the basis of their sequence 
homology to the vesicular inhibitory or GABA amino acid transporter (VIAAT or 
VGAT; SLC32A1) of inhibitory neurones (Sagne et al., 2001). Despite an apparent Na+ 
dependence, it was subsequently suggested that there exists functional similarities 
between members of the SLC38, SLC36 and SLC32 families in terms of substrate 
specificity (Schioth et al., 2013). Indeed like PAT-1, two members of the System N 
subfamily, SNAT-3 (SLC38A3) and SNAT-5 (SLC38A5), which share up to 22% 
sequence similarity to VGAT, counter-transport one H+ ion for the co-import or export 
of one Na+ with either one of glutamine, histidine, asparagine and sometimes glycine 
(Broer et al., 2002). Amongst the System N transporters, SNAT-3 does not transport 
glycine, whilst SNAT-5 has very low substrate selectivity (Km 1 – 2mM) (Fei et al., 2000, 
Nakanishi et al., 2001). SNAT-5 substrates (in order of preference) are: asparagine, serine, 
histidine, glutamine, glycine and alanine (Nakanishi et al., 2001). Unlike PAT-1 and despite 
diminished transport at low extracellular pH, SNAT-5 transporters are differentially 
expressed on plasma membranes in the brain, liver, lung and intestinal tract (Mackenzie 
and Erickson, 2004).  
SNAT-1, SNAT-2/SLC38A2 and SNAT-4/SLC38A4 (members of the System A 
subfamily) share up to 60% sequence similarity to System N transporters. System A 
transporters do not require the counter transport of the H+ ion, but are solely dependent 
on a Na+ gradient for substrate co-transport (Hatanaka et al., 2000, Albers et al., 2001, 
Hatanaka et al., 2001). Whilst no transport of glycine has been demonstrated for SNAT-
1 – which is mostly expressed in the brain (Albers et al., 2001), SNAT-2 and SNAT-4 
mediate efficient low affinity glycine transport (Hatanaka et al., 2001, Hatanaka et al., 
2000). SNAT-2 mRNA levels increase as a consequence of activation of osmo-sensitive 
transcription factor NFAT-5/TonEBP (See section 1.3.4) in response to osmotic stress 
in cultured human fibroblast cells (Franchi-Gazzola et al., 2001, Franchi-Gazzola et al., 
2004).  
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Other members of the neutral amino acid subfamily of transporters such as the B0 neutral 
amino acid transporter B0AT-1(SLC6A19) are expressed on the apical epithelial surface 
in the intestine (Broer, 2008a, Broer, 2008b). B0AT-1 is expressed on epithelial cells of 
the duodenum, jejunum and ileum, and also mediates reabsorption in the proximal tubule 
of the nephron (Seow et al., 2004). Like members of the System N subfamily (described 
above), B0AT-1 is very dependent on the availability of a Na+ gradient for the transport 
of its substrates. Although B0AT-1 has a high preference for leucine, it is able to transport 
several other non-aromatic L-amino acids with low selectivity (Km 1 – 12mM) (Bohmer 
et al., 2005). This includes methionine, valine, asparagine, alanine, serine, threonine, 
glycine and proline, listed here in order of preference. Like B0AT-1, NTT-4 (SLC6A17) 
is another neutral amino acid transporter which is expressed solely in the central nervous 
system. NTT4 is Na+ dependent and mediates low affinity transporter of glycine (Zaia 
and Reimer, 2009). 
B0AT-3 (SLC6A18) transports glycine with higher affinity than B0AT-1(Km 0.9 – 
2.3mM)(Broer and Gether, 2012). However unlike B0AT-1 it is expressed in the kidney 
but not expressed in the intestine, and is dependent on both a Na+ and Cl- ion gradient 
(Singer et al., 2009). Another neutral and basic transporter ATB0+ (SLC6A14) has similar 
transporter affinities for glycine as B0AT-3. It is expressed at its highest levels in the adult 
and foetal lung as well as trachea and salivary glands, although very low levels have been 
detected in the stomach and colon (Sloan and Mager, 1999). This transporter (ATB0+) like 
B0AT-3, is Na+ and Cl- dependent; with transport stoichiometry of 2-3 Na+ for 1 Cl- and 
1 amino acid. 
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Table 1.1: List of SLC transporters with glycine affinities; assembled with data curated in the database of SLC transporters by Alexander et al. (2013). 
System cDNA SLC Affinity Mechanism  
A SNAT-1 SLC38A1 Medium Symport Na
+ 
 SNAT-2 SLC38A2 Medium Symport Na
+ 
 SNAT-4 SLC38A4 Medium Symport Na
+ 
N SNAT-5 SLC38A5 Low Symport H
+ 
asc 4F2 hc/asc1 SLC3A2/SLC7A10 Low Antiport 
 
B0 B
0AT-1 SLC6A19 Low Symport Na
+ 
 B
0AT-3 SLC6A18 Medium Symport Na
+ 
B0,+ ATB
0,+ SLC6A14 High Symport Na
+, Cl- 
PAT PAT1 SLC36A1 Low Symport H
+ 
 PAT2 SLC36A2 Medium Symport H
+ 
Gly GlyT-1 SLC6A9 High Symport 2 Na
+ : 1 Cl- : 1 Gly 
 GlyT-2 SLC6A5 High  3 Na
+ : 1 Cl- : 1 Gly 
 B
0AT3 (XT2) SLC6A18 High Symport Na
+ 
PepT PepT1 SLC15A1 Low Symport H
+ 
 PepT2 SLC15A2 Low Symport H
+ 
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1.5.3 Peptide transporters 
Additional glycine supply may be achieved by the catabolism of di- and tri-peptides 
transported into the cell by the high-capacity, low-affinity (Km 0.2 – 10 mM) peptide 
transporters PepT-1 (SLC15A1) and PepT-2 (SLC15A2) (Doring et al., 1998, Daniel and 
Kottra, 2004). PepT-1 is a sodium-independent, proton-dependent transporter 
predominantly expressed on the apical membranes of the small intestine but also epithelial 
cells of the proximal tubules in the kidney, the epithelial cells of the bile duct and vascular 
smooth muscle cells. It mediates the proton coupled transport of preferentially dipeptides 
(2H+ co transported with one zwitterionic peptide). PepT-2 is predominantly expressed 
in the kidney and cells of the nervous system. In RNA-seq of coding RNA from the tissue 
samples of 95 human individuals, two of the seven possible PepT-2 transcripts were 
detected in the colon and duodenum (Fagerberg et al., 2014; array data visualised in 
ArrayExpress). 
1.5.4 High affinity specific glycine transporters (GlyTs) 
GlyT-1 (SLC6A9) and GlyT-2 (SLC6A5) mediate the high affinity active uptake of glycine 
across the plasma membrane of absorptive cells and synaptic ends of neuronal cells 
(Borowsky et al., 1993).  GlyT-1 and GlyT-2 share up to 50% sequence homology but 
differ in tissue distribution and function. The basolateral uptake of glycine across the 
human intestine was characterised as a single high affinity transport system sensitive to 
sarcosine (Christie et al., 2001) and with transport kinetics consistent with those previously 
published for system Gly transporters (Hillman et al., 1968, Narkewicz et al., 2000). Both 
GlyT-1 and GlyT-2 are significantly expressed in the white and grey matter of the central 
nervous system of developing mice and rats (Jursky and Nelson, 2002, Cubelos et al., 
2005) where they facilitate inhibitory potentials at glycinergic synapses (Betz et al., 2006). 
Whilst GlyT-2 is mostly detected in the spinal and spinothalamic white matter, expression 
of GlyT-1 is detectable predominantly in the grey matter in regions rich with NMDA (N-
methyl-D-aspartate) receptor-containing synapses including significant subpopulations of 
glutamatergic neurons (Adams et al., 1995, Cubelos et al., 2005, Betz and Eulenburg, 2012). 
GlyT-1 antibodies also detected expression in the liver, intestines and kidney (Jursky and 
Nelson, 2002). Homozygous mice lacking GlyT-1 were reported to die within one day 
after birth from severe motor and respiratory complications (Gomeza et al., 2003a, 
Gomeza et al., 2003b, Tsai et al., 2004). GlyT-2 deletions in mice resulted in significant 
weight gain and the development of a fatal hypertonia and hyperekplexia (an exaggerated 
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startle reflex characterised by touch induced seizures and muscle stiffness) within two 
postnatal weeks (Rousseau et al., 2008). Correspondingly, autosomal dominant inheritance 
of homozygous, heterozygous or compound heterozygous mutations within the GlyT-2 
gene has been associated to hyperekplexia type 3 (HKPX-3, OMIM-614618) and 
proposed as causative or contributory to sudden infant death syndrome (OMIM 272120).  
Glycine transporters (GlyTs) are strictly dependent on extracellular Na+ and Cl- ion fluxes. 
By combining electrophysiological and radiological techniques, Roux and Supplisson 
(2000) confirmed a requirement for 3 Na+ and 1 Cl- by GlyT-2 (Km  27 µM) and 2 Na
+ 
and 1 Cl- for GlyT-1 (Km 72 µM). It is believed that this difference in stoichiometry results 
from varying constraints of glycine transport (such as rate of transport required) at site of 
transporter localisation (Roux and Supplisson, 2000, Supplisson and Roux, 2002). From 
N-glycosylation and cysteine scanning mutagenesis assays it is understood that GlyT-1 
and GlyT-2 have twelve trans-membrane domains (TMD) connected by six extra- and 
five intra-cellular loops functioning in nutrient sensing and selectivity (Olivares et al., 1994, 
Olivares et al., 1995). The coupling of GlyTs to their extracellular substrates leads to a 
conformational change favouring an inwardly open over an outwardly open topology 
(Zafra and Gimenez, 2008, Perez-Siles et al., 2011). Whilst the exact substrate pockets or 
glycine binding sites of GlyTs are yet to be deciphered, substitution of the tyrosine 289 
residue located in TMD3 to a tryptophan or serine residue significantly reduces transport 
kinetics (Ponce et al., 2000). Comparative modelling to the Aquifex aeolicus leucine 
transporter (LeuTaa) suggests the glycine 305 residue in TMD6 of GlyT-1 and serine 481 
of GlyT1 may also be important to glycine selectivity (Zafra and Gimenez, 2008). The 
Drosophila disc large (Dlg) homologous region (DHR; or PDZ) domain located on the 
intracellular carboxyl (C) terminal is supposed to function in protein trafficking and 
regulation of protein density at the cell surface or synaptic interface (Adams et al., 1995, 
Betz et al., 2006). It has been suggested that removal or modification of the C-terminal 
during states of elevated calcium comprise a well-defined control in glycine homeostasis 
(Baliova and Jursky, 2010).  
Several isoforms for both GlyT-1 and GlyT-2 have been described. GlyT-1 isoforms are 
expressed in the brain, kidney, pancreases, lung, placenta, liver and intestine, whilst GlyT-
2 is mostly found in the brain (Lopez-Corcuera et al., 2001a, Lopez-Corcuera et al., 2001b). 
Three isoforms of GlyT-2 have been defined (GlyT-2A, GlyT-2B and GlyT-2C); which 
differ in their N-terminal regions (Liu et al., 1993, Ponce et al., 1998). By convention, the 
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protein isoforms a labelled with uppercase letters A, B, C etc., whilst the DNA transcripts 
a labelled with the corresponding lowercase alphabet i.e. a, b, c etc.  Variations at both 
the N- and C-termini are evident amongst the isoforms of both GlyT-1 and GlyT-2; with 
GlyT-2A having an unusually long N-terminus (about 200aa residues) when compared to 
other members of SLC transporters (usually 30-45aa).  
Alternative promoter usage at the same gene loci 1p33 spanning 44.1 Mb, as well as 
variations in splicing of the coding exons may result in up to twelve transcript variants of 
GlyT-1 (Borowsky et al., 1993, Borowsky and Hoffman, 1998). Of the twelve ‘predicted’ 
variants, mRNA from the expression of three GlyT-1 variants has been detected in 
humans (Kim et al., 1994, Borowsky and Hoffman, 1998). These are: variant 3 or GlyT-
1a (NM_001024845, 3236bp), variant 1 or GlyT-1b (NM_006934.3, 3228pb) and variant 
2 or GlyT-1c (NM_201649.3, 3390bp).  GlyT-1a, b and c are identical in their 3’ end and 
have been identified in a number of mammals including rat, mice, human and cattle. Of 
the three transcripts, GlyT-1a – a 14 exon (out of the possible 17 exons) transcript, has 
been shown in rats to be under the control of a promoter upstream of exon 1. With exon 
3 out of transcriptional frame and exon 1 completely untranslated, GlyT-1a mRNA 
encodes the shortest protein (with only 633 amino acid  residues) from a translational 
start site in exon 2. Variations in the large 5’-UTR region of GlyT-1a convey a distinctive 
N-terminus when compared to GlyT-1B and GlyT-1C.  
Transcription of GlyT-1b is (in rats) under the control of an alternate promoter located 
between exons 2 and 3 (Borowsky and Hoffman, 1998). Despite a shorter transcript, 
GlyT-1b codes for an isoform 19 AA residues longer than GlyT-1a. Exons 1 and 2 are 
completely excluded from GlyT-1b and its translation starts from the alternate exon 3, 
but maintains the same subsequent exon usage as GlyT-1a. Hence, GlyT-1B differs from 
GlyT-1A only at the 5’-terminus in that, the first 10 amino acid residues of GlyT-1A 
which result from the translated region of exon 2 are swapped for 29 amino acid residues 
from the translated region of exon 3. Like GlyT-1b, GlyT-1c is under the control of an 
alternate promoter between exon 2 and 3. Whilst the N and C termini of their 
corresponding protein isoforms are identical, the GlyT-1C isoform is 54 amino acid 
residues longer than GlyT-1B. This is due to the inclusion of an additional in-frame exon 
(exon 4 of the gene) into the GlyT-1c sequence.  
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To date GlyT-1c mRNA has only been identified in human cells or tissues (Kim et al., 
1994, Herdon et al., 2001). GlyT-1b and GlyT-1c mRNAs are expressed predominantly 
in neuronal tissues whereas GlyT-1a is found in the brain and peripheral organs. GlyT-1a 
mRNA is the prevalent transcript detectable in human intestinal cells, based on PCR 
evidence from work done in this lab, although low amounts of GlyT-1b and GlyT-1c 
mRNAs are also detected in these cells. Attempts at identifying the cellular localisation of 
the different isoforms of GlyT-1 proteins have remained futile, hindered in part by the 
lack of specific antibodies to the various isoforms. Characterisation of GlyT-1 in Caco-2 
cells revealed greater localisation to the basolateral membrane (Christie et al., 2001). Four 
times more glycine is transported by GlyT-1 at the basolateral membrane of intestinal 
epithelia as opposed to the apical membrane. Such transport polarity lays further 
emphasis on the importance of glycine transport to the epithelial barrier lining the gut.  
Despite its classification as ‘protein coding’ in the genome assembly, no mRNA level 
evidence has been demonstrated for the fourth transcript variant 4 (NM_001261380.1, 
3183bp) annotated by the NEDO human cDNA sequencing project (Japan). 
Additionally, Hanley et al. by yeast 2 hybrid assays identified two potential bovine GlyT-
1 isoforms with C-terminal variations (GlyT-1D and GlyT-1E) which specifically interact 
with the rho-1 subunit of the GABA receptor and have significantly different transport 
kinetics (Hanley et al., 2000). However these isoforms are yet to be described in human 
species. Of the remaining seven, two transcripts, variant 5 (NR_048584.1) and variant 6 
(NR_048549.1), are long non protein coding RNAs in human. Evidence of the existence 
of five more transcripts are inferred based on locus specific information determined by 
homology analysis from Sanger’s HAVANA project but have never been confirmed in 
humans.   
In this and other labs, recent and on-going functional characterisation of GlyT-1 provide 
hints into the extent at which intrinsic and extrinsic factors modulate GlyT-1 availability, 
localisation and function in various cellular physiological states. Factors such as pH 
changes, metal binding, nutrient availability and calcium fluxes within the cell have all 
been postulated to regulate the localisation and activity of the protein. The transcriptional 
regulation and expression of GlyTs have been largely studied in their capacity as 
facilitators of neurotransmission across glycinergic synapses. Most of what is known 
stems from studies in neuronal and renal transport systems. Whilst it is now accepted that 
the intracellular accumulation of glycine is important to the viability of the cell, the 
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molecular events leading to the expression, localisation and activity of GlyTs following 
stress are yet to be understood. Amino acid availability, metabolism and transport have 
been demonstrated to regulate gene expression at key dogmatic points; from nucleic acid 
to mRNA to protein levels. It remains unknown as to whether GlyT-1 expression control 
involves specific coordinated regulatory networks during epigenetic, transcriptional, 
translational or post-translation processing. 
1.6 Regulation of Glycine transporters  
As with most members of the SLC6 family, transporter regulation include epigenetic, 
transcriptional and translational modulation, as well as post-translational effects. A 
complexity of multiple protein-protein and protein-DNA interactions oversee processes 
such as acetylation and methylation, phosphorylation, SUMOylation, glycosylation and 
ubiquitination, which together regulate cell surface density and activity of the transporter 
by 1) altering the accessibility of chromatin domains to transcription factors, 2) 
transcription factor and cofactor recruitment and specificity at the promoter and enhancer 
regions of the transporter gene, 3) promoting transcription of the transporter gene, RNA 
stability and translation of the protein, 4) localisation and trafficking of the protein to the 
cell surface,  5) fusion of the protein trafficking vesicles to the plasma membrane mediated 
by the numerous SNAP (Soluble N-ethylmaleimide sensitive factor (NSF) Attachment 
Protein) Receptor proteins or SNARE and 6) internationalisation and removal of 
unneeded transporter by phosphorylation of the N or C-terminus of the transporter, or 
Ca2+ mediated modification of the PDZ domains. Work done to understand regulation 
of a variety of SLC6 transporters along the above avenues is extensive and beyond the 
scope of this thesis Broer and Gether (2012), (Kristensen et al., 2011, Pramod et al., 2013). 
However, but for a few conclusive reports on GlyTs regulation (reviewed in this section) 
most of what is known is inferred or implied.  
1.6.1 Epigenetic regulation 
Trans-generational inheritance of an epigenome conveys environmentally induced 
adaptation to changes in gene expression via processes of DNA methylation, histone 
modifications, RNA silencing amongst many others (Jaenisch and Bird, 2003, Portela and 
Esteller, 2010). Research into epigenetic regulation of GlyT-1 has focused on two key 
epigenetic processes, histone methylation and acetylation. These epigenetic modifications 
have the ability to regulate the level of GlyT-1 expression by altering chromatin 
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accessibility to polymerases and transcription  factors (Jaenisch and Bird, 2003). The 
nuclear localisation of the chromosomal high mobility group nucleosome binding protein 
HMGN3a has been reported to facilitate unravelling of the chromatin to reveal the GlyT-
1 promoter (Barkess et al., 2012). Unlike HMGN-3b, the bi-partite nuclear localisation 
and nuclear binding domain together with the regulatory domain of HMGN3a improved 
the ability of the CREB binding protein co-associated factor (p300/pCAF, also known as 
the Lysine (K) acetyl-transferase 2B or KAT-2B), a member of the GCNC-5/pCAF 
nuclear histone acetyl-transferases (HATs) to acetylate histone 3 (H3Ac) at lysine 14 
residue (H3K14) along the body of SLC6A9 gene locus promoting chromatin unravelling 
(West, 2004). pCAF is a known cofactor of activating transcription factor 4 (Atf-4) and 
other ATF/CREB factors, for the expression of genes downstream of the amino acid 
starvation response (Cherasse et al., 2007). Acetylation of histone 3 at lysines 9 and 14 as 
well as at lysine 5, 8, 12 and 16 of histone 4 constitute a primer for transcriptional 
activation whilst di- and tri-methylation at lysine 27 of histone 3 are markers for 
transcriptional repression (Kouzarides, 2007). The significance of the HMGN proteins to 
GlyT1 expression was emphasised in an experiment by Shan and colleagues where 
expression of the Jumonji domain-containing protein 3 (JMJD3; a histone 3 lysine 27 de-
methylase known to be up-regulated by Atf-4 following amino acid starvation) was 
rescued in Atf-4 knockout HepG2 and MEF cells (Shan et al., 2012).  
The role of activating transcription factor 2 (Atf-2) a member of the BZIP family of 
activating transcription factors in the epigenetic control of genes regulated by amino acid 
availability has been studied (Gibney and Nolan, 2010, Feil and Fraga, 2011, Seong et al., 
2011). Reporter and gel shift assays demonstrate Atf-2 and Atf-4 are crucial components 
for immediate/early expression of target genes of the amino acid response, such as the 
neutral amino acid transporter ATB0 (SLC1A5), the cell-surface antigen heavy chain 4F2 
(SLC3A2; also known as CD98) which when associated with xCT/SLC7A11 comprise 
the cysteine/glutamate exchanger (System Xc
-) or with LAT-2/SLC7A8, transports 
leucine and glycine with low affinity (System Y+) (Averous et al., 2004).  
Following nutrient stress, phosphorylation of Atf-2 at threonine 71 precedes acetylation 
of histone H4 and H2B (Waas et al., 2001, Bruhat et al., 2007). This results in the 
modification of chromatin structure to enhance transcription of multiple genes potentially 
including GlyT-1 by Atf-4. In the early events leading to the recruitment and activity of 
Atf-4, phosphorylation of pre-bound Atf-2 by mitogen activated protein kinase (MAPK), 
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extracellular signal regulated kinase (ERK) and the MAPK/ERK kinase (MEKK1-p38) 
is regarded as an absolute requirement (Livingstone et al., 1995, van Dam et al., 1995, Waas 
et al., 2001, Turjanski et al., 2007). In drosophila, it has been demonstrated that the non-
Mendelian inheritance of disrupted heterochromatin resulting from a similar 
phosphorylation of the analogous Atf-2 protein (dAtf-2) conveyed resistance to heat and 
osmotic stress across multiple generations (Seong et al., 2011).  
1.6.2 Post-translational regulation 
The regulation of cell surface density of amino acid transporter in lieu of modulating 
transporter activity provides control on how much substrate transits across the cell 
membrane. This is particularly true for neuro-transmission where a rapid turnover of the 
transporter by either endocytosis or exocytosis is required to maintain the cadence of an 
action potential across the synapse (Geerlings et al., 2000, Geerlings et al., 2001, Horton 
and Quick, 2001). Extracellular levels of Calcium ions (eCa
2+) have been shown to 
modulate GlyT-2 and GlyT-1 numbers on the cell surface of neuronal cells in synaptic 
junctions. This was demonstrated by Baliova et al. in two separate studies first for GlyT-
2 and subsequently for GlyT-1A and GlyT-1B protein turnover in rat spinal cord 
synaptosomes (Baliova and Jursky, 2004a, Baliova and Jursky, 2004b, Baliova and Jursky, 
2005). From their work, increased synaptic Ca2+ mediated the proteolytic cleavage of the 
N-terminal of both GlyT-1 and GlyT-2 at distinct sites which could be blocked by 
phosphatases. Fairly recently Baliova and colleagues showed a Ca2+ dependent cleavage 
of the last 12 amino acids comprising the PDZ domain in the distal C-terminus of GlyT-
1C, preventing its trafficking to the membrane (Baliova and Jursky, 2010). 
1.6.2.1 Regulation of transporter trafficking 
GlyT-1 function is dependent on localisation of the properly folded protein at membranes 
across which it transports glycine. Glycine transporter trafficking by the SNARE system 
is a tightly controlled process. Most of what is known of this system comes from 
investigations on neuronal GlyTs interactions with SNARE proteins; predominantly with 
the synaptobrevin or vesicle associated membrane protein (VAMP), the synapse specific 
Syntaxin-1A and synaptosomes associated protein 25 (SNAP-25).  The conjugation of 
Syntaxin-1A to SNAP-25 provides a docking port for VAMP on membranes of 
trafficking vesicles allowing for membrane fusion at cell surface membrane.  When 
expressed alone or in combination with Syntaxin-1A in COS cells SNAP-25 had no 
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additional functional effects on glycine transport (Lopez-Corcuera et al., 2001a). However 
it was observed that the direct physical interaction between Syntaxin-1A and either both 
GlyT-1 or GlyT-2 decreased plasma membrane concentrations without any changes in 
transporter expression (Geerlings et al., 2000). Whilst no such investigations on GlyTs 
trafficking and docking have been carried out on epithelial tissues of the intestine, 
investigations of the SNARE system in Caco-2 cells highlight a complex network of over 
60 proteins, notably Syntaxin-3 and SNAP-23 which regulate the docking of trafficking 
vesicles at either the apical or basal membrane (Riento et al., 1998), This could form the 
basis of an investigation into GlyTs trafficking and docking at membranes of intestinal 
epithelial cells. 
1.6.3 Regulation of transporter surface density 
Protein kinase C (PKC) is considered a major player in transporter trafficking to the 
membrane by modulating the physical interaction between the transporters and the 
SNARE proteins (Beckman et al., 1998). Activation of PKC isoforms by phorbol esters 
has been reported to inhibit transport by glycine transporters in glioblastoma C6 cells 
(Gomeza et al., 1995, Morioka et al., 2008) as well as L-arginine transport in cultured 
pulmonary endothelial cells (Krotova et al., 2003). This appears to be due to an increase 
in internalisation rate of the transporters from the membrane (Fornes et al., 2008). Similar 
effects of PMA have been demonstrated for GlyT-2 in transfected COS cells (Fornes et 
al., 2004).  Several PKC sites common to all GlyTs and indeed other Na+ and Cl- 
dependent transporters have been proposed. In GlyT-2, substitution of the charged lysine 
422 residue and the polar threonine 419 and serine 420 residues of the second intracellular 
loop with acidic residues blocks internalisation of the transporter (Fornes et al., 2004). In 
line with the above observation, it was determined from work done in this lab that 
phorbol 12-myristate 13-acetate (PMA) an activator of PKC significantly reduced the 
basolateral glycine uptake via the basolateral GlyT-1 transporter in Caco-2 cells after 4 
hours treatment (Christie et al., 2001). For GlyT-1, it has been suggested that a reduction 
in maximal transport rate by PMA treatment might result from indirect phosphorylation 
mechanisms (Sato et al., 2002). Work has identified the cysteine 159 residue close to the 
putative substrate pocket of GlyT-1C (Vargas-Medrano, 2010) and the lysine 619, 577 
and 581 residues in the N-terminal of GlyT-1b as phosphorylation sensitive sites (Vargas-
Medrano et al., 2011, Fernandez-Sanchez et al., 2009). However, unlike GlyT-2, there is as 
of yet no confirmatory evidence of phosphorylation, neither at the above sites or the 
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many studied polar threonine and serine residues of the intracellular loop regions of either 
GlyT-1a, GlyT-1b or GlyT-1c (Vargas-Medrano et al., 2011). 
1.6.4 Regulation of transporter distribution across membranes 
Aside from phosphorylation, protein N-terminal glycosylation represents an important 
sorting mechanism for transporter localisation to either the apical or basolateral 
membrane of polarized epithelial cells (Vagin et al., 2009, Martinez-Maza et al., 2001, 
Poyatos et al., 2000, Olivares et al., 1995). There is significant membrane polarity in 
localisation of GlyT-1 in human intestinal epithelia; with higher surface density on the 
basolateral membrane when compared to the apical membrane (Christie et al., 2001). 
Oliveras and co-workers describe four putative glycosylation sites in the N-terminal of 
GlyT-1 used in surface targeting of the transporter (Olivares et al., 1995).  Though 
treatment with tunicamycin (a glycosylation inhibitor) and the mutation of these sites 
significantly reduced transporter activity GlyT-1 in transfected COS cells, enzymatic de-
glycosylation of localised GlyT-1 protein did not alter transporter activity. In contrast to 
GlyT-1, enzymatic de-glycosylation of GlyT-2 reduced transporter activity by up to 40% 
in COS cells whilst mutation of putative glycosylation sites in the large second 
extracellular loop (EL2) completely blocked localisation of the transporter to the apical 
surface of Madin-Darby canine kidney (MDCK) cells (Martinez-Maza et al., 2001). 
1.6.5 Modulators of transporter activity 
The association of glycine signalling to several neuro-psychotic disorders has resulted in 
extensive research into molecular means of directly affecting transporter activity. Several 
extrinsic as well as intrinsic inhibitors of glycine transport have been proposed. Ju and 
colleagues reported on the ability of Zn2+ at low doses to inhibit GlyT-1b at glycinergic 
synapses in the central nervous system (Ju et al., 2004) by binding to two histidine residues 
(His-410 and His-421) of the large second and fourth loop extracellular loop respectively 
and inhibiting conformational changes crucial to glycine transport. Amongst the many 
other classes of glycine inhibitors, substitute sarcosine based compounds such as 3H-(R)-
NTPS or (R)-N-[3-phenyl-3-(4′-(4-toluoyl)-phenoxy)-propyl]-Sarcosine irreversibly block 
glycine transport. It appears Sarcosine based inhibitors block glycine in a concentration 
independent, non-competitive manner, whilst non-Sarcosine based glycine analogues are 
mostly reversible and very much dependent on glycine concentration (Mezler et al., 2008). 
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1.6.6 Transcriptional regulation 
Given that most studies on regulation of glycine transport thus far has dwelled on post-
transcriptional aspects, very little is known of the transcriptional regulatory networks 
modulating transporter expression. Transcriptional regulation of gene expression 
provides a unique mechanism for cellular adaptations to specific environmental events.  
Gene transcription is facilitated by the presence of core promoter sequences characterised 
by an array of tissue-specific and/or development-specific and even event-specific cis- 
and trans-acting regulatory transcription factor binding sites (TFBS). An assembly of 
transcriptional factors (TF), scaffolding proteins, cofactors and DNA polymerases at the 
promoter form the pre transcriptional complex and promote expression of the gene in 
response to specific cytosolic events. Experimental analysis and characterisation of the 
promoter regions of several amino acid transporters confirm a characteristic use of 
specific TF combinations at multiple promoters and transcriptional start sites (TSS) (Palii 
et al., 2004, Fafournoux et al., 2000). Which factors regulate the expression of GlyTs in 
the human intestinal cells following stress is the subject of the work presented here. 
Although the resulting transcripts from alternate promoter usage in the GlyT-1 gene are 
known to result in several distinct and possibly functionally diverse GlyT-1 transporter 
isoforms, little is known about cellular events leading to the preferential usage of one 
promoter over the other. An advantage of alternate promoter usage and multiple reading 
frames in target genes may be to improve mRNA stability by favouring different 3’ post-
transcriptional processing and alternative splicing (Ayoubi and Van De Ven, 1996). Such 
is believed to boost protein translation and mRNA turnover of tissue restricted and event-
specific protein isoforms during a targeted response to specific physiological events such 
as stress. It is however unlikely that alternate promoter usage in GlyT-1 expression in 
human intestinal cell serves a similar purpose.  
Aside from multiple promoter usage, the regulation of gene expression by long-range 
enhancers, repressors, silencers and insulators within distal promoters, intronic regions 
and even within 3’ flanking regions is now better appreciated with evidence from projects 
such as the ENCODE (Skipper et al., 2012). Indeed, amino acid limitation or starvation 
controls the expression of CCAAT enhancer box binding protein (C/EBPβ) via elements 
located downstream of the coding sequence (Chen et al., 2005). What remains outstanding 
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is linking these elements to modules within specific regulatory networks in response to 
specific events such as physiological stress. 
In eukaryotic cells, extremes of both intracellular or extracellular environmental variables 
and changes in cellular homeostasis can alter gene expression of proteins required for 
withstanding the effects of the stressor.  Depending on the nature of the stress and the 
cell type, a manifold response ensues ranging from the activation of survival pathways to 
the initiation of programmed cell death. A conserved adaptive signalling pathway 
involving several membrane receptors, kinases and transcription factors, link the cellular 
stress induced events to target genes and proteins. In the next section aspects of the 
cellular response to shortfalls in nutrient availability, to unfolded proteins, endoplasmic 
reticulum stress and oxidative stress are reviewed; specifically discussing how such events 
may link to up-regulation in transcription of the glycine transporters. 
1.7 Stress induced gene regulation 
Cellular stress defines a physiological disturbance to intracellular homeostasis. These 
include states of protein wasting in disease or inflammation, states of uncontrolled or 
compromised protein synthesis, poor nutrient availability, increased metabolic toxicity, 
physical or mechanical injury etc. The cellular stressor can be defined as any compound 
or event resulting in the disruption of homeostasis. Such disruptions can alter various 
cellular processes, including by interfering with protein glycosylation, as well as tampering 
with ionic and metabolite balance. To maintain homeostasis, the epithelium must adapt 
at a molecular and cellular level to changes in its environment. Elaborate mechanisms for 
sensing and responding to specific cellular stresses have evolved to enable the cell to 
maintain its viability, or in cases where the former is unachievable the activation of 
programmed cell death.  
1.7.1 The amino acid response (AAR) 
Amino acid (AA) depletion can have severe consequences on cellular metabolism; from 
resulting in biosynthetic and metabolic alterations to epigenetic changes and up regulation 
of gene expression of specific transporters. All mammalian cells possess evolutionary 
conserved adaptive pathways to sense and efficiently respond to specific changes in amino 
acid availability (Berlanga et al., 1999). First identified in yeast, the mammalian general 
control nonderepressible 2 (GCN-2) protein kinase – a member of the pancreatic 
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eukaryotic initiation factor-2alpha kinase (PEK) family, is capable of sensing single amino 
acid deficiencies during protein elongation (Austin et al., 1986). Under normal conditions, 
the binding of GTP to the eukaryotic translation initiation factor 2α (eIF-2α) mediates 
the delivery of a methionine charged t-RNA to the 40S ribosome. The accumulation of 
uncharged t-RNA as a result of amino acid unavailability for protein elongation leads to 
the direct phosphorylation of eIF-2α at its serine 51 residue (Gietzen et al., 2004). 
Phosphorylated eIF-2α effectively blocks the required catalytic conversion of GDP to 
GTP by eIF-2β with net effect being the general suppression of protein translation. This 
marks the start of the AAR.  
The initiation of the AAR is greatly conserved from yeast to mammalian cells. Following 
eIF-2α phosphorylation, the up regulation of some members of the activating factor 
family (Atf) of transcription factors, notably Atf-4 is ubiquitous across all cell types. 
Whilst Atf-4 mediated gene regulation appears to be the central pathway for AAR (more 
on this later), accessory pathways are understood to confer specificity to the response. 
For instance, blockade of the interdependent mitogen activated protein kinase (MAPKK 
or MEK; a tyrosine/threonine kinase) has been shown to prevent phosphorylation of 
eIF-2α by GCN-2 as well as block transcriptional induction of downstream Atf-4 target 
genes in human hepatoma cell lines (Thiaville et al., 2008a, Thiaville et al., 2008b, Thiaville 
et al., 2008c). In line with this observation, Lopez-Fontanals and colleagues demonstrated 
that the increase in SNAT-2/SLC38A2 mRNA abundance following amino acid 
limitation was dependent on a MAPKK/MEK pathway whilst transporter activation by 
hyper-tonicity was not (Lopez-Fontanals et al., 2003). Likewise activation of 
MAPKK/MEK pathway by amino acid signals is believed to mediate the phosphorylation 
of existing Atf-2 required for epigenetic modulation of Atf-4 target genes.  
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Figure 1.6: Illustration showing pathways of the amino acid response (AAR). In periods 
of amino acid insufficiency the mammalian general control nonderepressible 2 (GCN-2) 
phosphorylates the 2α subunit of the eukaryotic elongation factor (eIF-2α) a consequence 
of which is the down regulation of protein synthesis and activation of specific 
transcription factors such as Atf-4. Complementary to the AAR is activation of MAP 
kinase (MEKK) pathways which may activate other BZIP factors such as Atf-2 and cJUN 
required for transcriptional regulation of the target genes; GPRC: G-Protein coupled 
receptor; Rac1: Ras-related C3 botulinum toxin substrate 1, a RhoA GTPase; ERK: 
Extracellular signal regulated kinase. JNK: c-Jun N-terminal kinase. 
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A large group of amino acid transporters are regulated by Atf-4 following induction of 
the AAR. These include the cationic arginine and lysine amino acid transporter gene (Cat-
1), SNAT-2, the excitatory amino-acid transporter (EAAT) and xCT – the light chain of 
the System XC
- cystine/glutamate exchanger (Lopez et al., 2007, Palii et al., 2004, Sato et 
al., 2004). Whilst an increase in Atf-4 mRNA following AAR is documented, its primary 
mode of activation downstream of phosphorylated eIF-2α is by translation control of 
existing mRNA. There are two upstream open reading frames (uORF) within Atf-4 
mRNA. The 5’ translation start site used in normal conditions is out of frame with the 
Atf-4 coding sequence negatively regulating it. Following stress, ribosomal 5’-cap 
scanning overlooks the first uORF in favour of a second, in-frame with the coding 
sequence; resulting in translation of a functional transcription factor. Activated Atf-4 
promotes transcriptional induction of target genes within 30 minutes of AAR initiation. 
From transcription factors to transporters and more, the repertoire of Atf-4 target genes 
is large. Sequence analysis of the 5’-flanking regions of these genes revealed characteristic 
short nine base pair sequences collectively termed the amino acid response element or 
AARE (Averous et al., 2004, Kilberg et al., 2009).  
First identified in the promoter region of the human C/EBP homologous protein 
(CHOP), AAREs are short 8-9bp composite cAMP response element and Atf-binding 
sites (CRE/ATF) with consensus 5’-TGATG/(N)AA(N)-3’ (Bruhat et al., 2002, Kilberg 
et al., 2009). AAREs have been characterised within several amino acid transporters. In 
Cat-1, the binding of Atf-4 to the AARE in the 5’-UTR of the gene between nucleotides 
+45 and +53 relative to the transcription start site (TSS) mediates its up-regulation in 
response to amino acid limitation (Fernandez et al., 2003). In many cell types, xCT is 
required for the supply of cysteine for use in glutathione synthesis. Sato et al. 
demonstrated using gel super shift and reporter assays that Atf-4 complexes with amino 
acid response elements in the 5’ flanking region of the murine xCT gene (Sato et al., 2004), 
and that the expression of this gene was induced by deprivation of not only cysteine, but 
shortages in other amino acids. Two AAREs were subsequently described in the 5’-
flanking regions between nucleotides -94 and -86 relative to the TSS, one in a forward 
orientation on the sense strand, and the other 9bp further on the same strand in a reverse 
orientation (Sato et al., 2004). Although cysteine availability is considered to be the rate-
limiting step in the synthesis of glutathione, other experimental evidence suggests an equal 
importance for the supply of glycine to the final step of glutathione synthesis (Jackson et 
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al., 2004). As such, it is possible that the GlyT-1 transporter is regulated in a similar way 
to xCT.  Interestingly, the coupling of Atf-4 to the single AARE in the SNAT-2 promoter 
decreases its mRNA abundance in liver cells but increases SNAT-2 mRNA following 
amino acid limitation in skeletal muscle or 3T3-L1 mouse adipocytes (Gaccioli et al., 2006, 
Alfieri et al., 2005, Luo et al., 2013). Whilst it is not clear whether the former is a result of 
Atf-4 or other transcription factors, it may be that regulation of these transporters at their 
AARE is highly tissue specific. 
Permutations in dimerisation of members of the BZIP and other superfamily of TFs such 
as nuclear factor kappa light chain enhancer protein (NF-κB) are important to modulating 
the calibre and tenure of the AAR.  Phosphorylation of eIF-2α by GCN-2 is also believed 
to promote dissociation of the inhibitory kappa B protein (IκB), mimicking the effects of 
the active IκB kinase (IKK) in up-regulating NF-κB within an hour of AA starvation 
(Jiang et al., 2003). Micro-array analysis of several NF-κB target genes has shown several 
to be up-regulated following amino acid starvation in HepG2 cells (Shan et al., 2010); 
amongst which are the amino acid transporters SNAT-2/SLC38A2, the transcription 
factors C/EBPβ, Atf-3, Atf-5 and CHOP (also known as DNA damage-inducible 
transcript factor 3 [DDIT3] or GADD153) amongst many.  CHOP is a negative repressor 
of the AAR by promoting the de-phosphorylation of eIF-2α 
1.7.2 The unfolded protein response (UPR) and ER stress 
The endoplasmic reticulum (ER) is a versatile organelle important to several cellular 
functions, including for calcium storage and providing a site for protein folding. 
Perturbations in ER function have been linked to the pathogenesis of several disease 
states, including many neuro-pathological conditions like Alzheimer’s and Parkinson’s 
diseases (Schroder and Kaufman, 2005). Inhibition of protein glycosylation or disruption 
in Ca2+ homeostasis as well as oxygen deprivation elicits a well prescribed ER stress 
response (Bailey and O'Hare, 2007, Takayanagi et al., 2013, Vaughn et al., 2014). Where 
the stressor is the accumulated unfolded proteins, the ensuing ER stress pathways are 
collectively termed the unfolded protein response (UPR). The accumulation of unfolded 
client protein within the ER leads to the dissociation of chaperon Immunoglobulin heavy 
chain binding protein (BIP) from its ER membrane dock (Sommer and Jarosch, 2002). 
The result is the initiation of multifaceted signalling pathways of the UPR. 
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Three adaptive pathways comprise the UPR. First and predominantly, the dissociation of 
BIP from its ER membrane-docking site activates the double stranded RNA-activated 
protein kinase R (PKR)-like ER kinase (PERK) (Harding et al., 2003, Avivar-Valderas et 
al., 2011). As with GCN-2 in the AAR response, PERK mediates the phosphorylation of 
eIF-2α. This leads to the translational activation of Atf-4 and a response similar in kind 
to the AAR (Harding et al., 2000, Harding et al., 2003). Second to and independent of the 
PERK/Atf-4 pathway, phosphorylation of the inositol requiring endonuclease (IRE-1) 
follows activation of the UPR (Xu et al., 2014). In brief periods of stress IRE-1α actuates 
pro-survival pathways by splicing of the basic leucine zipper factor x-box binding protein 
type 1 (XBP-1). Upon translocation to the nucleus, spliced XBP-1 (XBP-1s) regulates 
gene expression of proteins of the ER degradation systems (ERAD) via cis-acting UPR 
response elements or UPREs (consensus: 5’-CAGCGTG-3’) in their promoter regions 
(Wang et al., 2009). In states of prolonged ER stress IRE-1 overseas the Regulated IRE-
1 dependent decay (RIDD) of anti-apoptotic pre-miRNAs such as the pre-miRNA of the 
pro-apoptotic protease caspase-2 (CASP-2) (Sano and Reed, 2013, Maurel et al., 2014). 
IRE-1α also mediates the activation of the Jun N-terminal kinase (JNK) pro-apoptotic 
pathways (Kato et al., 2012, Cheng et al., 2014).  
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Figure 1.7: Illustration showing pathways of the UPR and ER stress response. The 
accumulation of unfolded proteins in the ER, and ER stress leads to the activation of 
several ER kinases, amongst which is the protein kinase R (PKR)-like ER kinase (PERK). 
As in the AAR PERK phosphorylates eIF2a and leads to the activation of Atf-4. Along 
with the PERK pathway is the activation of the x-box binding protein (XBP-1) by the 
Inositol requiring endonuclease IRE-1 which is a serine/threonine protein kinase resident 
at the ER membrane. Upon activation XBP-1 binds to unfolded protein response 
elements in the promoters of target genes. The proteolytic cleavage of Atf-6 in the Golgi 
following ER stress leads to the release of an active transcription factor able to regulate 
target genes via ER stress response elements (ESRE) in target gene promoters. 
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In later phases of ER stress, a negative feedback mechanism emanating from the 
accumulation of stable C/EBP-β LIP (liver-enriched inhibitory protein) isoforms 
previously minimised by proteolytic degradation and eIF-2α phosphorylation, supresses 
gene expression (Nakajima et al., 2011). Lastly, the accumulation of unfolded proteins 
within the ER promotes trans-localisation of Atf-6 to the Golgi apparatus where in 
proteolytic cleavages activates the transcription factor (Yoshida et al., 2000, Yoshida et al., 
2001, Sommer and Jarosch, 2002). Upon translocation to the nucleus Atf-6, alongside 
Atf-4, regulate the expression of response genes via a cis-acting endoplasmic reticulum 
stress element or ERSE with consensus 5’-CCAAN-N9-CCACG-3’. 
The overlapping nature of the three ER stress response pathways has led to ambiguity in 
nomenclature in the literature of the characteristic response elements. As originally 
identified, UPRE only describes elements to which the spliced XBP-1s binds, whilst 
ERSE corresponds to Atf-6 binding sites. A third response element with consensus 5’-
ATTGG-N-CCACG-3’ has been characterised and termed ERSE-II to which either 
XBP-1s or Atf-6 bind. Complicating further, is the understanding that the activation of 
PERK-Atf-4 pathway by ER stress can lead to gene regulation by elements identical to 
the consensus AAREs described above.  
Recently, our understanding of the damaging effects of prolonged accumulation of 
unfolded proteins has highlighted additional facets of ER stress, notably disruption in 
oxygen metabolism and the accumulation of reactive oxygen species. Closer investigations 
of the interrelationship between ER stress and oxidative stress reveal highly specialised 
signalling pathways leading to the accumulation of ROS. ER-stress induced Ca2+ release: 
a) activates the calcium dependent protease m-Calpain which b) activates the ER 
procaspase 12. This in turn leads to c) the depolarisation of the inner mitochondrial 
membrane and activation of procaspase-9 mediated apoptosis as well as d) direct ROS 
release from the respiratory chain in response to Ca2+.  
1.7.3 Response to reactive oxygen species (ROS) 
Despite advances in understanding ROS signalling in mammalian cells, puzzling questions 
remain on its role in several cellular processes. However it is evident that ROS 
accumulation from toxins, imbalanced oxygen metabolism or pre-existing ER stress leads 
to altered cellular biochemical processes and cell physiology.  
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As the primary sites for oxygen metabolism within the cell, the matrix and inner 
membrane of the mitochondrion are an important sources of ROS. Superoxides (O2
-) 
produced in the mitochondria by the respiratory chain are impermeable to the 
mitochondrial membrane. O2
- fluxes appear to be dependent on the availability of electron 
donors in the respiratory chain, oxygen concentration and NADH/NAD+ ratios in the 
mitochondrial matrix. Dismutation† of the elevated O2
- in the mitochondria is catalysed 
by the mitochondrial specific enzyme superoxide dismutase (SOD, EC 1.15.1.1). 
Hydrogen peroxide, the resulting by product of this reaction is membrane permeable and 
upon interaction with iron forms highly reactive hydroxyl specie (OH-).  Several redox 
homeostatic systems respond to specific threats from ROS within the cell, these include 
turnover of NADH/NAD+ and glutathione conjugation. In fact, increased expression of 
anti-oxidant genes is characteristic of a target response to ROS accumulation. 
For the transcriptional regulation of antioxidant genes, nuclear factor of the erythroid 
derived 2 like factor 2 (NFE2-L2 or Nuclear factor related factor 2, Nrf-2), another BZIP 
factor has garnered significant attention as an important mediator. Nrf-2 has been shown 
to regulate the expression of xCT via electrophile response (EpRE) cis-elements in its 
promoter region, as well as mediating the expression of a host of enzymes including the 
two electron reductase NADPH/Quinone oxido-reductase 1 (NQO1, EC 1.6.5.2) and 
glutathione S-transferases (GST, EC 2.5.1.18). In neuronal cells where xCT is not 
expressed, Nrf-2 up regulates the expression of excitatory amino acid transporter 3 
(EAAT3) which transports cysteine required to facilitate glutathione synthesis in these 
cells. Miyamoto and colleagues describe a regulatory arm of the oxidative stress response 
in corneal epithelium where the phosphorylation of Nrf-2 by PERK increases Atf-4 
expression following stress (Miyamoto et al., 2011). This together with reports on possible 
Nrf-2/Atf-4 co-regulation and interactions supports a crossover in target response to 
ROS. 
The modulation of gene expression by Nrf-2 is achieved at a post-transcriptional and 
possibly post-translational level. Under normal physiological states, Nrf-2 is sequestered 
within the cytoplasm by its association with the Kelch domain of the Kelch-like erythroid 
CNC-homologue (ECH) associated protein KEAP-1, pending ubiquitination and 
                                                 
† A disproportionation reaction in which both oxidised and reduced products are generated 
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degradation in a Culicin-3 (Cul3) dependent pathway (Gan et al., 2010). Several models 
have been postulated as to how Nrf-2 escapes its association with KEAP-1 following 
stress. Clements et al, propose the involvement of DJ-1/PARK-7 (A cancer associated 
protein first identified in Parkinson’s disease) (Clements et al., 2006). Other radical 
explanations propose the phosphorylation of Nrf-2 by upstream activated protein kinases, 
such as MAPKK/MEK, phosphatidyl inositol kinase (PI3K) and even Protein Kinase C 
(PKC) facilitating escape from KEAP-1 and nuclear trans localisation. Zipper and 
Mulcahy suggest that the modification of the reactive cysteine residues of KEAP-1 
enables the dissociation of Nrf-2, hence proposing KEAP-1 and not Nrf-2 as the sensor 
of oxidative stress (Zipper and Mulcahy, 2003). In Contrast, Li et. al. identified a canonical 
redox sensitive nuclear export signal in the transactivation domain of the Nrf-2 protein 
and a redox sensitive leucine zipper domain of the Nrf-2 protein, suggesting that the Nrf-
2 protein itself is sensitive to oxidative stress (Li et al., 2010).  The observations that 
phosphorylation of Nrf-2 by PERK kinase facilitates its nuclear localisation and that Nrf-
2 up regulates the expression of genes involved in the anti-oxidant response including 
Atf-4, provides insights into the possible link between phosphorylation events similar to 
those of both AAR, ER stress and redox homeostasis. 
1.7.4 The Integrated Stress Response (ISR) 
GCN-2 for AAR and PERK for UPR/ER stress response are only two of four known 
ER resident kinases capable of sensing changes in cellular homeostasis. Another, the 
Heme regulated inhibitor (HRI or EIF2αK1), is activated in response to heme deprivation 
as well as oxidative and heat stress in erythroid tissues.  The accumulation of idiogenic 
double-stranded DNA (dsDNA, such as from bacteria) or severe inflammation activates 
the Protein kinase R (PKR or EIF2AK2). Regardless of the stressor, phosphorylation of 
eIF-2α converges several distinct stress sensing pathways to the termination of unneeded 
translation and the up-regulation of specific mRNA required in a targeted response; 
notably that for Atf-4. This has led to the proposal of a single central integrated stress 
response (ISR) pathway with Atf-4 transcription at its core and presiding over distinct 
and appropriate cellular responses to specific stress types. Harding and colleagues 
observed a rapid and sustained accumulation of Atf-4 protein and downstream genes such 
as GlyT-1 in wild-type mouse fibroblasts following ER stress or amino acid removal 
(Harding et al., 2000). This observation was reversed in PERK and Atf-4 mutants.  
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Figure 1.8: Illustration of the main pathway of the integrated stress response (ISR); A 
convergence point of several stress response pathways in the phosphorylation of eIF2a. 
That Atf-4 is activated after eIF2a has led to investigations in its role in several stress 
responses; this includes in response to unfolded protein, heme deprivation, viral infection, 
amino acid starvation and oxidative stress. It has been suggested that Nrf-2 another stress 
response BZIP factor may be activated by PERK although exactly how is not fully 
understood. Upon activation, both Atf-4 and Nrf-2 may regulate the expression of target 
genes via specific response elements in the promoters. 
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1.8 Hypothesis, Aims and Objectives 
Given that stress plays an important role in the pathogenesis of several diseases, it is 
important to understand the gene regulatory modules and networks thereof, mediating 
the cellular adaptations to environmental changes.  Several glycine transporters are 
responsible for the high affinity supply of glycine; and in the human intestine, GlyT-1a is 
the predominant isoform. The supply of glycine to epithelial cells of the human intestine, 
together with cysteine serves as an important precursor to the production of glutathione, 
bolstering cellular defences against oxidative stress, as well as protecting against other 
types of stress. Thus motivated, the molecular events involved in the transcriptional 
regulation of GlyT-1a, downstream of the stress response as contributory to glycine cyto-
protection were investigated.  
Using cellular models of the human intestinal epithelium and stress initiating agents, I 
aimed to explore the role of components of the integrated stress response in the 
regulation of the human GlyT-1a gene, examine key players involved in the stress 
response and amino acid transport control as potential transcriptional regulators of GlyT-
1a and to propose a model network for the regulation of GlyT-1a during stress 
To achieve these aims, a number of hypotheses have been developed based on a present 
understanding: 
1) That the transcriptional up-regulation of GlyT-1a is mediated by the action of Atf-4, 
downstream of amino acid starvation, oxidative stress and endoplasmic reticulum 
stress;  
2) The transcription of GlyT-1a is controlled by specific stress response elements and 
other regulatory motifs; and  
3) Permutations of binding partners amongst the various members of the basic leucine 
zipper (BZIP) family of transcription factors such as Atf-4 and Nrf-2 modulate the 
specificity of the response to stress.  
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MATERIALS AND METHODS 
 
Outline: This chapter describes the experimental procedures used throughout this project. 
All protocols described here were validated and approved by respective administrative 
bodies and conducted under defined safety precautions.  
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2.1 Intestinal cellular model 
In the work described here, two intestinal cellular models were used. These are the human 
colonic carcinoma cell-line (Caco-2), and the human illeo-caecal carcinoma cell-line 
(HCT-8).  
2.1.1 Caco-2, The Human colonic carcinoma cell line  
Originally described by Fogh et al. (1977), colonic carcinoma cell lines like SW480, T-84, 
HT-29 and Caco-2, have extensively been used as in vitro models to investigate various 
intestinal properties (Sambuy et al., 2005). These include for the study of gut physiology, 
barrier permeability, amino acid transport, nutrient absorption and metabolic regulation.  
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When grown in culture, Caco-2 cells show striking structural and biochemical similarities 
to human colonocytes but differentiate to small intestinal-like cells (Engle et al., 1998). 
Their desirability as intestinal models over other human colonic carcinoma cell lines stems 
from the fact that, in addition to better representing several in vivo properties, they 
spontaneously differentiate in culture after confluence (Delie and Rubas, 1997, Engle et 
al., 1998, Sambuy et al., 2005).  
When grown in culture, Caco-2 monolayers exhibit high cell functional polarity with well 
differentiated microvilli on the apical side, tight junctions between adjacent cells and 
characteristic expression of enzymes and membrane transporters (Hilgers et al., 1990, 
Mariadason et al., 2000). Most colonic carcinoma cells lines show varying degrees of 
differentiation when grown in culture (Bolte et al., 1997). Some such as T-84 cell lines 
unlike Caco-2, exhibit uncharacteristic protein expression profiles. HT-29 on the other 
hand, does not differentiate in culture unless induced under specific conditions to form 
some enterocyte-like cells (Rousset, 1986). Subpopulations of Caco-2 cells have 
heterogeneity of properties, with satellites of microvilli, tight junction formation, and 
distinct morphologies post confluence. 
The suitability of cultured Caco-2 cell line as an intestinal model has ushered its rapid 
propagation across many laboratories. Several groups have attempted to develop specific 
homogenous clones for specific applications. Culture conditions, supplements, etc. are all 
effective selective pressures that can significantly alter results from Caco-2 modelled 
studies; making the interpretation and correlation of data more difficult. For this purpose, 
the work described here used the parental Caco-2 cells (ATCC no. HTB-37TM) which was 
routinely cultured under the same conditions as described in Section 2.1.3.  
2.1.2 HCT-8, The Human illeo-caecal carcinoma cell line 
HCT-8 is a human illeo-caecal colorectal adenocarcinoma derived cell line (Tompkins et 
al., 1974). It is now known to be the same as the parental HRT-18 cell line (Vermeulen et 
al., 1998, Vermeulen et al., 1997). Their distinctive high proliferation rate and increased 
migration provides a low passage model for the study of intestinal physiology on 
phenotypically characteristic human colonocytes. When compared to Caco-2 cells, their 
characteristic invasive phenotype is associated with a smaller cell size and rounded 
morphology which is believed to be the result of the loss of an α-catenin gene (Vermeulen 
et al., 1997).  α-catenin is a crucial requirement for the formation of the E-cadherin-catenin 
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complex which when linked to the cytoskeleton enables cell-cell adhesion and retention 
of an epithelioid morphology (Wijnhoven et al., 2000).   
Like Caco-2 cell lines, several HCT-8 clones have been developed, notably the many α-
catenin positive HCT-8 clones which despite their reduced invasion in vitro, have very 
similar tumorigenic behaviour as that of α-catenin negative clones when transplanted to 
nude mice (Van Hoorde et al., 2000). Such similarities in in vivo characteristics have led to 
their interchangeable use with Caco-2 cells to study colonic parameters. Unlike Caco-2 
which undergo spontaneous enterocytic differentiation and polarization (and can also de-
differentiate), HCT-8 despite their ability to form a polarized monolayer, when grown on 
micro-porous filters do not differentiate in in vitro culture no matter the conditions; 
However, some differentiation markers such as the actin binding protein Villin, are 
expressed, all be it at a much lower level when compared to Caco-2 (Chantret et al., 1988). 
Some of the work described here used the parental HCT-8 cell line (ATCC no. CCL-224) 
obtained from the American Type Culture Collection (ATCC) routinely cultured under 
the same conditions as described in Section 2.1.3 
2.1.3 Routine cell culture 
To minimize contamination from infectious splashes, all tissue culture was performed 
using aseptic techniques in a SafeFlow® 1.2 laminar flow hood (Class II). Caco-2 cells 
(passage number 91-96) and/or HCT-8 cells (passage number 30-40) were routinely 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 4.5 g/L glucose, 
supplemented with 10% (v/v) foetal calf serum, 1.2% (w/v) non-essential amino acids, 100 
units/mL penicillin and 100 µg/mL streptomycin. Unless otherwise stated all reagents 
were obtained from Sigma UK. Cells were grown to 90-100% confluence under 
conditions of 5% CO2, 95% air and 37°C in a CO2 cell culture incubator (Sanyo). The 
culture medium was replaced every 48-72 hours. Confluent cells were ‘passaged’ for either 
experimentation or routine culture with seeding densities as shown in Table 2.1. To 
passage cells, the confluent monolayers were washed once with sterile phosphate-
buffered-saline (PBS: pH7.3, 137 mM NaCl2, 2.7mM KCL, 4.3 mM Na2HPO4, 1.4 mM 
KH2PO4). Cells were then incubated with 5 mL of trypsin-EDTA solution (containing 
0.25% trypsin and 0.03% EDTA) for either 5 minutes (Caco-2) or 2 minutes (HCT-8) at 
37oC to enzymatically disrupt and detach the monolayer. 10 mL of routine culture 
medium (containing 10% foetal calf serum) was added to stop trypsinisation. The 
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dissociated cell suspensions were then transferred to a 25 mL universal and centrifuged 
for 3 minutes at 1500 rpm to pellet the cells. The resulting supernatant containing 
neutralized trypsin was discarded and cell pellet re-suspended in 10 mL of routine culture 
medium. The cells were counted on an automated T4 cellometer (Nexcelcom) and seeded 
onto new culture vessels as shown in Table 2.1. Cells were often inspected under a light 
microscope and/or tested for mycoplasma infection. 
Table 2.1: Cell seeding densities for varying culture vessels. The amount of culture 
medium required for routine culture is indicated as well as volume of trypsin required to 
detach the monolayer from culture vessel following 5 minute incubation at 37°C. Caco-2 
or HCT-8 cells were routinely cultured in T-175 flasks. Transfections for reporter assays 
and gene knockdown experiments were performed on cells grown on 12-well plates. 
Nuclear protein extracts were from Caco-2 cells grown on 6-well plates. All culture vessels 
were from Corning, UK. 
 
Surface 
Area 
(mm2) 
Caco-2 
Seeding 
Density  
HCT-8 
Seeding 
Density 
Trypsin (mL 
of 0.25% 
trypsin, 
0.03% 
EDTA 
Volume 
Growth 
Medium 
(mL) 
12-well plate 401 0.3 x 106 0.25 x 106 1 1 
6-well plate 962  0.5 x 106  0.3 x 106 2 3 
T-175 flask 1750 3.0 x 106 0.5 x 106 5 30 
 
2.1.4 Stress treatment 
Regimes for stress treatments were maintained as used previously in this lab (Howard and 
Hirst, 2011). Prior to stress treatment, cells were grown under optimal conditions in 
complete medium for an extended period to ensure there was no exertion of either 
nutrient or other physiological stresses. For consistency, the morphology and confluence 
of cells were noted and maintained across all experiments. No foetal calf serum was added 
to stress medium 
2.1.4.1 Amino acid and Glycine starvation 
For amino acid starvation assays, cells were incubated for the desired length of time in 
freshly made amino acid free stress medium with formulation shown in Table 2.2. For 
glycine starvation, freshly made glycine free stress medium as per the formulation shown 
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in Table 2.2, supplemented with all other amino acids except glycine. Whilst antibiotics, 
and Glucose and Phenol Red were added to amino acid and glycine starvation media, no 
foetal calf serum was used in this medium. Given that the medium used for routine cell 
culture contained 30 mg/L of glycine, for Glycine supplementation assays twice as much 
glycine (60 mg/L) was used.  
2.1.4.2 Oxidative Stress treatment 
For the induction of oxidative stress response, either 0.2 mM diethyl-maleate (DEM) for 
4 hours or 60 µM tert-Butyl Hydroquinone (tBHQ) for 16 hours was added to serum free 
stress medium. DEM – an electrophilic agent is widely used in models for oxidative stress. 
DEM effectively depletes glutathione levels within the cell, by binding to and oxidising 
its free sulfhydryl (thiol) groups, leading to the build-up of free radicals and other reactive 
oxygen species within the cell. These are able to cause oxidative modifications to proteins, 
leading to their fragmentation, or proteolytic degradation, or increase intracellular 
accumulation of oxidised protein.  
Table 2.2: Formulation of base medium for nutrient availability studies. 
Component For Amino acid 
Starvation 
For Glycine 
Starvation 
For Glycine 
Supplement. 
Calcium Chloride (CaCl2) 265 mg/L 
Ferric Nitrate (FeNO3) 0.100 mg/L 
Potassium Chloride 400 mg/L 
Magnesium Sulphate 97.72 mg/L 
Sodium Bicarbonate 3700 mg/L 
Sodium Chloride 6400 mg/L 
Sodium Phosphate Dibasic 141 mg/L 
Penicillin 100 U/mL 
Streptomycin 100 µg/mL 
Glycine‡ 0 mg/L 0 mg/L 60 mg/L 
L-Arginine 0 mg/L 84 mg/L 
L-Alanine 0 mg/L 66 mg/L 
L-Histidine 0 mg/L 42 mg/L 
L-Glutamine 0 mg/L 584.4 mg/L 
L-Leucine 0 mg/L 105 mg/L 
L-Cystine 0 mg/L 62.6 mg/L 
                                                 
‡ According to Documenta Giegy Scientific tables, the physiological concentrations of glycine in blood serum is 17.7mg/L.  
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L-Lysine 0 mg/L 146 mg/L 
L-Methionine 0 mg/L 30 mg/L 
L-Serine 0 mg/L 42 mg/L 
L-Threonine 0 mg/L 95 mg/L 
L-Tryptophan 0 mg/L 16mg/L 
L-Tyrosine disodium Salt 0 mg/L 103 mg/L 
L-Valine 0 mg/L 94 mg/L 
Glucose 4500 mg/L 
Phenol Red 15.9 mg/L 
MEM Vitamin Solution§ 1 % v/v of 100x Stock. (See footnotes)  
 
Evidence points to an ER-independent redox regulatory mechanism with many cell types. 
tBHQ promotes the oxidative stress response by preventing the degradation of key 
antioxidant transcription factors such as Nrf-2. Peroxide formation in the mitochondria 
may be a consequence of mitochondrial calcium overload induced which is induced by 
tBHQ (Peng and Jou, 2010). 
2.1.4.3 Induction of UPR and ER stress  
For comparison between an UPR specific response and ER stress, thapsigargin was used 
to elicit a Ca2+ ER stress response whilst Tunicamycin was used to mimic an UPR 
response. Cultured Caco-2 cells were incubated in serum free DMEM medium containing 
50nM thapsigargin for 16 hours or alternatively in serum free DMEM medium containing 
1μM tunicamycin for 16 hours.  
Tunicamycin and Thapsigargin, two stress agents known to elicit the UPR and ER stress 
in several cell types were used. Derived from Streptomyces, the glucosamine-containing 
antibiotic Tunicamycin is a potent inducer of the UPR. By specifically inhibiting, dolichol 
pyro phosphatase mediated N-linked glycosylation of asparaginyl residues, it facilitates 
the formation of N-glycosidic protein-carbohydrates, inducing ER stress. Toxico-
genomic analysis of tunicamycin stress in the cells of liver and small intestinal tract of 
C57BL/6J mice have revealed activation of a host of several downstream genes; these 
include chaperones, proteins involved in ubiquitination and proteolysis, electron and 
amino acid transporters and detoxification enzymes and other proteins required for cell 
                                                 
§ MEM Vitamin solution from Gibcco® (Catalogue Number 11120). 100x Stock Contains: D-Ca panthothenate (100 mg/L), Choline chloride (100 
mg/L), Folic acid (100 mg/L), i-Inositiol (200 mg/L), Nicotinamide (100 mg/L), Pyridoxal HCl (100 mg/L), Ribovflavin (10 mg/L), and Thiamine HCl 
(100 mg/L). 
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growth, apoptosis and the cell cycle (Nair et al.). Thapsigargin is a Thapsia garganica (also 
known as ‘deadly carrots’) plant derived lactone built from three isoprene units. It binds 
tightly to (and only to) the unique carboxyl tail of the intracellular sarcoplasmic or ER 
Ca2+-dependent ATPase (SERCA) pump of the ER membrane. This leads to a rapid 
release of Ca2+ from these stores and ER stress.  It is believed that the ensuing 
multifaceted stress response following Ca2+ signalling results from changes in ionic 
balance within the ER. The uncontrolled calcium influx to the mitochondrion is believed 
to play an important role in inducing the apoptotic machinery (See section 1.7.2).  
2.2 In Silico Identification of GlyT-1 transcriptional regulatory network 
Modern computer algorithms used in the identification of gene regulatory networks can 
be classified into three main categories. This includes 1) those which perform a 
comparative promoter analysis of co-regulated genes from micro-array expression or 
other expression profiling data sets, to identify regulatory sequences of known 
transcription factors,  and/or 2) where there is limited expression data for the given 
genome or genes of interest, comparative genomic (mostly phylogenetic foot-printing) 
analysis using orthologous promoter sequences from multiple species allows for 
identification of both putative TFBS and their corresponding TFs. 3) Lastly, a 
combinatorial approach as shown in Figure 2.1, consisting of approaches 1) and 2) to 
build a refined promoter dataset to which detailed composite element analysis is 
performed for identification of known TFBS. A combination of all of the above was used 
for the identification of conserved regulatory motifs within the GlyT-1a promoter as 
described below. 
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Figure 2.1: Strategy for the identification of GlyT-1a regulatory modules 
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2.2.1 Identification of GlyT-1a co-regulated promoters   
In recent years, the use of high throughput expression profiling to identify gene 
expression changes following specific cellular stresses simplifies the task of identifying 
probable gene regulatory modules (regulatory and co-regulated protein networks). 
Computational clustering algorithms on the available genome wide expression profiles 
from microarray datasets in public databases such as the Gene expression omnibus 
NCBI-GEO(Edgar et al., 2002) and GEO2R – an R-based web application for analysing 
GEO data (Barrett et al., 2013) are widely used to this effect. There is presently no 
comprehensive expression dataset for the integrated stress response (ISR) in epithelial 
cells of the human intestine. However, using the CO-Regulation database (CORD), genes 
with similar factor dependent expression profiles to GlyT-1a/SLC6A9 were catalogued 
from public micro-array datasets. Analysis was performed on the promoters of the co-
regulated genes using the TRANSFAC F-MATCH algorithm to identify enriched TFBS. 
From the list of enriched TFBS, composite models were built using the TRANSFAC 
composite model analysis tool to detect the arrangement of TFBS within putative 
Composite regulatory modules (CRMs) 
2.2.2 Conservation analysis of the putative GlyT-1a CRM 
Combining phylogenetic analysis with detailed analysis of promoters of co-regulated and 
co-expressed genes, to ascertain the occurrence of similar motifs provides added evidence 
to possible biological function of such putative sites (Wang and Stormo, 2003). For 
phylogenetic analysis of the GlyT1-a promoter, sequence spanning 2000 bases upstream 
of the transcription start site (TSS) of 56 orthologous transcripts (Appendix A.3), 
catalogued in the database of orthologous groups (OrthoDB) were obtained from 
corresponding species-specific ENSEMBL databases using the BioMart Perl API. All Perl 
scripts used are documented in Appendix A.  Sequences were aligned using the MAFFT 
plugin of the Geneious Bioinformatics suite version R7 (Kearse et al., 2012). Arbitrary 
conservation scores for putative TFBS (regulatory motifs) were calculated using a similar 
method as described by (Hestand et al., 2008); briefly the percentile conservation score is 
calculated as the sum of the percentage alignment at each position of the TFBS motif, 
divided by the motif length. 
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2.3 Endpoint Polymerase Chain Reaction (PCR)  
2.3.1 Genomic DNA extraction for endpoint-PCR 
Genomic DNA from 2 x 106 – 3 x 106 Caco-2  or HCT-8 cells was extracted using the 
GenElute® Mammalian genomic DNA Miniprep kit (Sigma) according to the 
manufacturer’s instructions.  DNA content of the final 50 µL eluent was quantified on a 
Biomate TM 3 spectrophotometer from Thermofisher. 2 μL extracted genomic DNA was 
also electrophoresed for 1 hour with 5V per cm on a 0.5x TBE agarose horizontal gel and 
visualized under UV in a Bio-Rad Gel Documentation System. Genomic DNA was stored 
at 4oC and used as template for amplification of the GlyT-1a 5’flanking region by endpoint 
PCR. 
2.3.2 Primer design for endpoint-PCR 
Primer pairs for endpoint-PCR were designed using the NCBI Primer3 portal, and 
synthesised by Integrated DNA Technologies (IDT, Belgium). Corresponding sense and 
antisense oligonucleotide primers for endpoint-PCR were designed to be at least 19 bases 
in length, GC content within a 45-60% range. In addition to these, care was taken to avoid 
the tendency of secondary structure (hairpins, self-dimers, cross-dimers) formation. 
Where possible GC clamps were included at the 3’ primer end. Primer melting 
temperature (Tm) of between 55
oC and 65oC were preferred. All primer Tm  were re-
calculated using the base-stacking nearest neighbour thermodynamic algorithms 
(SantaLucia, 1998). These calculations allow for salt correction of melting temperatures 
as shown in Equation 1 below.  
 
 
Equation 1: Calculation of PCR primer melting temperature (Tm). Where ΔH (kcal/mole): 
Change in enthalpy obtained by adding all dinucleotide enthalpy values of each nearest 
neighbour base pair adjusted for helix initiation factors (Peyret et al., 1999, SantaLucia, 
1998); ΔS (kcal/mole): Change in entropy adjusted for the contribution of Mg2+ salts used 
to the entropy of the system; R is the universal gas constant (1.987 cal/oC Mol); [primer] 
is the final concentration of the primer. Where primers have a high tendency for self-
complementarity [primer]/4 is used (SantaLucia, 1998). 
Tmprimer =
DH
DS +R ln([primer])
-273.15
 52 
Tm values calculated using this formula did not vary significantly from values calculated 
using the GC content formula (Equation 2) for sequences longer than 14 bases. To 
estimate the optimal annealing temperatures (Ta) for effective DNA-primer hybrid 
stability during amplification used Tm values of both the primers and the anticipated 
product were considered as shown in Equation 3 above as originally described by (Rychlik 
et al., 1990).  
 
 
Equation 2: Salt adjusted formula for calculation of melting temperatures (Tm) For DNA 
sequences of length N longer than 14 bases and assumes the presence of monovalent ions 
in the PCR reaction.  
 
 
Equation 3: Annealing temperature (Ta) calculation for endpoint PCR. Where,  is 
the melting temperature of the primers and   is the melting temperatures of the 
target sequence or amplicon. As the nearest neighbour thermodynamic model is only 
applicable to short oligonucleotides  was calculated based on GC content as shown 
in Equation 2.   
 
2.3.3 Endpoint-PCR using a Thermo Scientific Px2 Thermal Cycler 
Amplification of genomic DNA target sequences by PCR was performed on a Px2 
thermal cycler (Thermo Scientific) using 1.25 U of GoTaq® DNA polymerase (Promega) 
per reaction.  Briefly for each reaction, a 50 μL volume was used. This consisted of 10 μL 
of 5x GoTaq® Green PCR buffer (pH 8.5, 1X contains 1.5 mM Mg2+) from Promega, 5 
μL each of 10 μM forward and reverse primers (final concentration of each primer 0.5 
μM), 5 μL of a 10 x dNTP mix (final concentration of each dATP, dTTP, dCTP, dGTP 
in reaction mix was 0.2 mM), 2.5 μL of the template DNA (less than 0.5μg final 
Tmtarget =81.5
oC + 0.41oC ´ (%G+%C)+16.6oC ´ (log10[Na
+]+[K+])-675 / N
Ta = 0.3
oC´Tmprimer +0.7
oC´Tmtarget -14.9
Tmprimer
Tmtarget
Tmtarget
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concentration), 1.25 U of GoTaq® polymerase enzyme and nuclease free water. A 
standard temperature program was used for amplification which included a single initial 
2 minute activation step at 95oC followed by 35 cycles of denaturing at 95oC for 1 minute, 
annealing at the calculated Ta (as described in Section 2.3.2 for each primer set) for 90 
seconds and a final extension step at 72oC for S seconds depending on the size of the 
expected product, where S is equal to 60 seconds per each kilo base of the expected 
product length. A final extension cycle of 8 minutes was added to the program before 
final incubation at 4oC. 
2.3.4 Electrophoresis, Imaging and Purification of endpoint-PCR products 
10 μL of endpoint-PCR products were analysed on a 1% agarose/1x Tris-borate EDTA 
(TBE) horizontal gel by electrophoresis. Samples were electrophoresed for 1 hour with 
5V per cm of gel length and visualized under UV and imaged on a Bio-Rad™ Gel Doc 
XR system. Endpoint-PCR products were extracted from the excised gel bands using 
either the GenElute™ Gel extraction Kit (Sigma) or the Montage™ gel extraction kit 
(Millipore) according to their respective manufacturer’s specifications. PCR products 
were assayed for contaminants and quantified on a Biomate 3 spectrophotometer. 
Samples were stored at -20oC until required for cloning or use as a secondary template in 
ligation-mediated PCR (see Section 2.5.1). 
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2.4 Quantification of gene expression by real time PCR (QPCR) assays 
Real time quantitative PCR (QPCR) was used to quantify gene expression or gene signal 
enrichment. All QPCR procedures were conducted and data obtained for presentation in 
accordance with the revised MIQE (Minimum Information for the publication of 
Quantitative Real-Time  PCR Experiments) guidelines (Taylor et al., 2010).  
2.4.1 Transfection of mammalian cells with short interfering RNA (siRNA) 
Caco-2 or HCT-8 cells were seeded onto 12-well plates (Corning) and grown for 24 hours 
in complete medium at optimal conditions as described in Section 2.1.3. Transfection was 
only performed on cell monolayers with confluency between 60-80%. For gene 
knockdown analysis, mammalian cells were transfected with at least two siRNAs targeting 
the transcription factors Atf-4 (s1702 and s1704 (Silencer Select, Life Technologies); 
sc35112 (Santa Cruz)), ATF6 (s223543 and s223544 (Life Technologies)), XBP-1 (s14913 
and s14915 (Life Technologies)) and Nrf2 (s9491 and s9492 (Life Technologies)). 5 ρmol 
of each siRNA, diluted in 200 µL of OPTIMEM® (Life Technologies) was complexed 
to 2 µL of Lipofectamine RNAi MAX transfection reagent (Life Technologies) for 20 
minutes at room temperature. The transfection complex was then added to cells pre-
incubated in 1 mL of antibiotic free medium for 24 or 48 hours. This was then followed 
by stress treatment with tunicamycin, thapsigargin, amino acid starvation, or DEM as 
described in Section 2.1.4 
2.4.2 Total RNA isolation  
Following transfections, total RNA was extracted from cells using the SV Total™ RNA 
extraction system (Promega, Southampton UK) according to the manufacturers 
specification. Adherent cells were lysed in a 10 mM Tris-HCl (pH 7.5) based lysis buffer 
containing 4 M guanidine thiocyanate (GTC), and 0.97% β-mercaptoethanol to inactivate 
the ribonucleases present in the cell extracts.  Cell lysates were aspirated through a 20-
gauge syringe needle to shear genomic DNA and diluted further in a dilution buffer 
containing excess GTC and incubated at 70oC for 3 minutes to selectively precipitate 
proteins from solution. Samples were then filtered by vacuum through SV Total spin 
baskets to allow for binding of RNA to the silica surface of the component glass fibres. 
RNA samples were then treated for 15 minutes with DNAseI enzyme to cleave any 
contaminating DNA and the reaction stopped with a DNAseI stop solution (final 
concentrations: 2M GTC, 4mM Tris HCl [pH7.5], 57% ethanol). A single filtration pass 
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of wash solution (final concentrations: 60 mM Potassium acetate, 10mM Tris HCl [pH 
7.5, RTP], 60% ethanol) through the RNA-bound glass fibres of the spin baskets under 
vacuum was used to precipitate out the resulting RNA. Isolated RNA was then eluted in 
50 μL of nuclease free water.  The SV Total™ offers purer DNA-free RNA due to an 
additional DNAseI-I treatment step. The concentration of the extracted RNA was 
quantified by measuring the absorbance at 260 nm on a Biomate 3 spectrophotometer. 
RNA integrity was determined on an Agilent™ Bio Analyser (Agilent). A RNA integrity 
Number (RiN) greater than 8 was required for use of the sample. RNA samples were 
stored at -80oC until required for reverse transcription as described in the next section 
(Section 2.4.3) 
2.4.3 Reverse transcription reaction 
First strand complimentary DNA (cDNA) synthesis from isolated total RNA was 
performed by incubating 0.5 μg of extracted total RNA, 500 ng of random hexamers (GE 
Biosciences), 0.5 mM of each dNTP (Promega, Southampton UK), 1x reaction buffer (50 
nM Tris HCl [pH 8.3, RTP], 75 mM KCl, 3 mM MgCl2, 10 mM DTT), 20 U RNAsin 
(Promega, Southampton UK) and 100 U of M-MLV RNAse H+ Reverse Transcriptase 
(Promega, Southampton UK) in a final volume of 20 μL for 120 minutes at 42oC. Two 
controls were included with each sample batch; these included a no RNA control and a 
no reverse transcriptase enzyme control. The samples where then incubated at 70oC for 
a further 1 minute to inactivate the enzymes. The resulting cDNA was diluted by a factor 
of one in five. Both undiluted and diluted cDNA samples were stored at -20oC until 
required for QPCR. 
2.4.4 Primer design for QPCR 
Primers for QPCR shown in Table 2.3 were designed with considerations as described in 
Section 2.3.2. Additionally to dissuade amplification from possible contaminating 
genomic DNA primers were designed – where possible, to span an exon-exon boundary, 
and preferentially for both the upstream and downstream primers to be at least 1000 bases 
apart on different exons on the same genome. Primers amplifying products not greater 
than 250 bp were preferred.  
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Table 2.3: Primer pairs used for quantification by QPCR. Annealing temperatures (Ta) 
used for QPCR amplification from genomic DNA are indicated. Primers for QPCR were 
synthesised and HPLC purified by Integrated DNA technologies (IDT, Belgium). 
Sequences are listed in the 5’ to 3’ orientation. 
Primer 
Pair 
Target 
template 
accession 
number 
Primer Sequences 
Temp. 
(Ta) 
Product 
Size 
Atf-4** NM_001675 
CTTCAAACCTCATGGGTTCTCCA
G 60 171 
AACAGGGCATCCAAGTCGAACTC 
Atf-6 NM_007348.3 
TCTCGTCTCCTGCCTCAGTG 
60 151 TTATCTTCCTTCAGTGGCTCC 
XBP-1** NM_005080 
GACAGCGCTTGGGGATGGATG 
60 149 GAGGGGTGACAACTGGGCCTG 
Nrf-2** NM_006164 
CAGCCAGCCCAGCACATCCA 
60 120 TGTCTGCGCCAAAAGCTGCA 
Transporters 
xCT NM_014331 
GTTTTGCACCCTTTGACAATGA 
55 120 GTTCATCCCAGCTTTGTTTTCC 
GlyT-1 NM_001024845 
TCGGGAGGCTGATGCAACTTTC 
55 220 GGCACAGCACCATTCAGCATC 
PepT-1 NM_005073 
TTCCACAATCATCACACC 
50 192 GGTTACGAGGGTGATGTT 
 
2.4.5 Preparation of QPCR standards and normalisation 
For QPCR assays a relative standard curve method was used (Larionov et al., 2005). 
Endpoint-PCR (as described in Section 2.3) was used for the amplification of 
corresponding sequences from cDNA templates. Products from endpoint PCR were 
electrophoresed on a 1x TBE agarose gel and visualised under UV light. Gel bands 
corresponding to the expected product size were excised and purified as described in 
Section 2.3.4 . Purified PCR products were cloned into the TA insertion site of a pGEM-
T-Easy plasmid vector (Promega, Southampton UK, plasmid map illustrated in Appendix 
A.4). E. coli strain JM109 (Promega, Southampton UK) were transformed with the 
recombinant plasmid. 20 hours post transformation and incubation on ampicillin infused 
Luria Bertani (LB) agar plates at 37oC, a single positive colony was exponentially grown 
for a further 18hours in LB broth. The cloned plasmids were extracted from JM109 using 
                                                 
** Primers used detect all transcript variants (Atf-4 NM_001675 or NM_182810; Nrf-2 NM_001145412,  NM_001145413 or NM_006164; XBP-1: 
NM_005080.3 and [NM_001079539.1 with product size 123bp]) 
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the GenElute™ Plasmid Miniprep kit (Sigma). Plasmids were then sequenced using the 
common M13 20-mer forward sequencing primer (5’-GTAAAACGACGGCCAGT-3’) 
by GeneVision (Newcastle, UK). A BLAST search of the sequencing result was also 
carried out to confirm accuracy of amplicon and sequence integrity. Plasmid DNA 
samples containing identical full length target sequence for each gene of interest were 
stored at -20oC, and a 1/100 or 1/1000 dilution series to cover appropriate cycle threshold 
ranges, was used as QPCR standards as described below. 
2.4.6 QPCR using Roche Light Cycler 480 
Relative quantification of expressed mRNA message for the genes of interest was 
completed on a Roche Light Cycler 480 using the SyBR-Green I technique. Briefly, 
sample duplicates of 10 µL QPCR reaction volume were used. Each consisted of 5 μL of 
2X SyBR Green mix (Roche UK), 0.5 μL of a 10 µM primer pair mix, 2.0 μL of the 
template DNA and 2.5 µL of nuclease free water. The thermo cycling program consisted 
of an initial denaturing step at 95oC for 5 minutes followed by 45 cycles of a further 
denaturing step at 95oC for 5 seconds, annealing at the optimal Ta for each primer set as 
shown in Table 2.3 for 10 seconds, and an extension step at 72oC for a further 10 seconds. 
This was followed by melt curve analysis and a cooling step to 4oC.  The No RNA control 
and No Reverse transcriptase controls generated during cDNA synthesis (Section 2.4.3) 
together with a no-template-control (NTC) were used as negative controls of PCR 
amplification. 
2.4.7 Data Normalisation and Analysis of QPCR assay 
In QPCR, the crossover point (CP also known as the cycle threshold CT value) represents 
the cycle at which the measured fluorescence from the SyBR-Green I dye intercalated in 
the grooves of a nascent DNA amplicon exceeds a predefined threshold. CT values are 
proportional to the accumulating concentration of amplicon from the PCR reaction. 
Owing to the logarithmic kinetics of the PCR amplification process, CT values are 
calculated in the exponential phase of the reaction. Intra sample duplicate variations in 
CT values of more than 1% were flanked as pipetting errors and the sample omitted from 
relative quantification calculations. Arbitrary concentrations of amplicon are determined 
from the standard curve of known concentration. The QPCR efficiency and coefficient 
of variability was calculated from the standard curve and recorded for an assay of intra-
experimental consistency. Data are represented as the relative arbitrary concentration of 
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experimental group ± standard error of the mean (SEM). All statistical analysis was 
performed using the commercially available software package GraphPad (InStat, USA). 
Analytical tests used and inferences are highlighted in the data figure legends in the results 
chapter (Chapter 3). 
For data normalisation against intra-sample expression variations, arbitrary 
concentrations calculated from a standard curve of CT values from QPCR of three 
housekeeping genes: GAPDH, ATP-5B and TOP-1 are used. The suitability for these 
genes to be used as internal control was determined as per the GENorm algorithm 
(Guenin et al., 2009). All data were normalised to a geometric mean (normalisation factor) 
derived from the arbitrary concentrations of these three housekeeping genes. For stress 
treated samples, relative messenger RNA (mRNA) abundance was reported as a 
percentage of the unstressed control sample average.  A One-way analysis of variance 
(ANOVA) was used for comparisons between experimental groups. 
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2.5 Reporter gene Assays 
To identify potential regulatory motifs, in silico analysis of the sequence upstream from 
the TSS to the translational start codon in exon 2 of the GlyT-1a nucleotide sequence was 
performed. Analysis of the first intronic sequence between exons 1 and 2 was carried out 
(as outlined in Section 2.2). Five β-galactosidase reporter plasmid constructs were 
designed containing sequences of the GlyT-1a corresponding to the promoter and the 
entirety of exon 1 (pG1PromE1); the promoter and 5-UTR (pG1Prom5U, excluding 
intronic sequence); the promoter, exon 1, intron 1, and the UTR of Exon 2 
(pG1PromInt15U), the UTR sequence of exon 2 (pG1E2) and last a construct with just 
the GlyT-1a 5UTR (pG15U). In this section I describe how these constructs were 
generated and used (Sequence maps are included in the results section). 
Table 2.4: Primer for reporter plasmid construction, All primers were synthesised and de-
salted by Integrated DNA technologies (IDT, Belgium) 
Product Target  Primer Sequences 
Primer 1 GlyT1-Prom S 5’-TGCAGCCCTCCCAGGAAATAGC-3’ 
Primer 2 GlyT1-Exon 1 AS 5’-GCGGCGGTGGGTTGGGGCTC-3’ 
Primer 3 GlyT1-Exon 1 S 5’-GAAGGAATTGGACTCCATCC-3’ 
Primer 4 GlyT1-Exon 2 AS 5’-GCGGCGGTGGGTTGGGGCTC-3’ 
Primer 5 GlyT1-Exon 2 S 5’-GAAGGAATTGGACTCCATCC-3’ 
Primer 5b GlyT1-Exon 2 S (ext) 5’-aggcccccGAAGGAATTGGACTCCATCC-3’ 
Primer 6 GlyT1-Intron 1 AS 5’-TTGCGGCGAGACAGACATCC-3’ 
Primer 7 GlyT1-Intron 1 S (ext) 
5’-tcgccgcaaGGGCACCGGTTTCCTCCCAC-
3’ 
Primer 8 GlyT1-Intron 1 AS 5’-GGGGGCCTGGCCTTGTGTAAG-3’ 
 
2.5.1 Preparation of reporter plasmids constructs. 
End point PCR as described in Section 2.3 was used to amplify a 1346bp amplicon from 
Caco-2 genomic DNA template, corresponding to the promoter and exon 1 of GlyT-1a 
(G1PromE1) between nucleotides -1159 and +187 (relative to transcription start site TSS 
of NM_001024845). For this amplification, Primer 1 (a forward primer with annealing 
site in the promoter region of GlyT-1a) and Primer 2 (a reverse primer in exon 1 of GlyT-
1a) was used. Primer sequences are indicated in Table 2.4. 
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Amplification by endpoint PCR (using Primer 3 and Primer 4) of the full 272bp GlyT-1a 
5’UTR (G15U) was carried out using Caco-2 cDNA as template to exclude the large 6.9kb 
intronic sequence between exon 1 and exon 2 (Figure 2.2). To obtain a full length 1431bp 
promoter and 5’UTR sequence (G1Prom5U), ligation mediated PCR (LM-PCR) was used 
to ligate the G1PromE1 and Gl5U amplicons via their overlapping ends of exon 1 
sequence.  
The resulting endpoint PCR and LM-PCR products were purified as described in Section 
2.3.4. To confirm the sequence accuracy of amplification and sequence integrity, the 
G1PromE1, G15U and G1Prom5U products were cloned into the TA insertion site of a 
pGEM-T-Easy plasmid vector (Promega, Southampton UK, plasmid map illustrated 
Appendix A.4). The cloned plasmids were replicated in E. Coli strain JM109 (Promega, 
Southampton UK) and sequenced using the common M13 20-mer forward sequencing 
primer (5’-GTAAAACGACGGCCAGT-3’) by GeneVision (Newcastle, UK). Exact 
sequences were then sub cloned into the TA sites of a pBlueTOPO-TA vector (Life 
Technologies) or between the EcoR1 endonuclease sites, upstream of the β-galactosidase 
(LacZ) reporter gene sequence of pSF-PromMCS-BetaGal reporter vector from Oxford 
Genetics.  
 
Figure 2.2: GlyT-1a Sequence map for the generation of reporter constructs. G1PromE1 
was generated using Primer 1 and Primer 2. The G1PromE1 amplicon was ligated to an 
amplicon representing the GlyT-1a 5UTR (E1 UTR + E2 UTR) amplified from cDNA 
using Primer 3 and Primer 4. The locations of the putative composite regulatory modules 
(CRM) are shown in yellow. Numbering is relative to the Transcription start site (TSS) in 
Exon 1. All Primer sequences are indicated in Table 2.4.  
All plasmid inserts were designed such that the transcription start sites within the proximal 
promoters were in the same frame with the reporter gene. The resulting β-galactosidase 
constructs were named correspondingly, pG1PromE1, pG15U and pG1Prom5U. 
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Reconstituted reporter plasmids were replicated in E. coli strain JM109, grown and 
selected on an antibiotic infused LB agar plates. Following a further 18 hour incubation 
of antibiotic selected positive colony in LB broth, amplified reporter plasmids were 
extracted using the QIAGEN Plasmid Maxi Kit (Qiagen) and sequenced to confirm 
sequence integrity. All reporter plasmids were stored at -20oC until required for 
transfection as described below.  
2.5.2 Transient transfection of reporter plasmids and stress treatment 
Prior to transfection cells were grown under optimal conditions as described above 
(Section 2.1.3). Reporter plasmid constructs were transfected into Caco-2 cells grown on 
a 12 well plate. 2µg of reporter plasmid diluted in 200 µL JetPrime™ Buffer (Polypus) 
was complexed to 2µL JetPrime™ reagent (PolyPlus) for 20 minutes at RTP. 75 µL of 
the DNA/Reagent complex was added together with 1mL of complete DMEM growth 
medium to each sample well of Caco-2 cells (40-50% confluent). The “no-transfection” 
control cells were incubated with only JetPrime™ buffer. Cells were then incubated under 
conditions of 5% CO2, 95% air and 37°C in a CO2 cell culture incubator (Sanyo). The 
transfection medium was replaced 4 hours post transfection to minimise any adverse 
stress effects of the transfection reagents.  After a further 20 hour incubation and growth 
phase, cells were treated with tunicamycin, thapsigargin, amino acid Starvation, tBHQ or 
DEM as described in Section 2.1.4. To investigate the influence of polyphenols on the 
response activity at the transfected GlyT-1a promoter, cells transfected as described 
above were treated with either 50 µM Resveratrol for 24 hours, 10 µM Genistein for 24 
hours or a polyphenol soup from alcoholic brown seaweed extract (generously donated 
by Dr Peter Chater) for 30 minutes before stress treatment.  
2.5.3 Extraction and quantification of total protein 
Following stress-treatment, Caco-2 cells were washed with 1 mL PBS per well. Cells were 
then lysed by a single freeze-thaw cycle in the presence of 100 µL/well of lysis buffer (250 
mM Tris [pH6.4], 0.25% (v/v) Nonindent P-40, 2.5 mM EDTA).  Cell lysates were 
transferred to a 1.5 mL micro-centrifuge tube and centrifuged at 13000 G for 5 minutes 
at 4oC. The cleared supernatant, containing total protein was transferred to a new micro-
centrifuge tube, quantified, and sampled for β-galactosidase activity or stored at -80oC 
until required. The protein concentrations of the cell lysates were determined using the 
Thermo Scientific Pierce 660 nm Protein assay in micro plate format. A standard curve 
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generated using bovine serum albumin (BSA) samples of known amounts was used to 
quantify sample protein concentration. Duplicate absorbance readings at 660 nm 
wavelengths were obtained for each sample 10 minutes after addition of Pierce reagent 
using a FLUOstar Omega spectrophotometer (BMG LabTech). 
2.5.4 Beta-Galactosidase activity assay 
Reporter gene activity was determined using the galactosidase analogue chlorophenol red-
β-D-galactopyranoisde (CPRG) (Sigma). β-galactosidase enzyme catalyses the hydrolysis 
of the galactosidase analogue converting it from a yellowish-orange substrate to 
chlorophenol red chromophore.  To quantify specific enzymatic activity, 20 µL of the 
cleared cell lysate from each sample (Section 2.5.3) was incubated for 60 minutes at 37oC 
with 130 µL of 1 mg/mL of CPRG diluted in buffer containing 25 mM MOPs, 100 mM 
NaCl, 10 mM MgCl2 at pH 7.5.  The enzymatic reaction was stopped by the addition of 
80 µL of 0.5M Na2CO3. Absorbance was measured at 575 nm using a FLUOstar Omega 
spectrophotometer (BMG LabTech). 
2.5.5 Data Analysis 
β-galactosidase specific activity (U/min/mg) was calculated as the amount of 
chlorophenol red formed per minute of incubation time, and corrected to the total protein 
in each individual cell lysate sample. Repeated experimental data was expressed as mean 
± standard error of the mean (SEM) and relative to the background β-galactosidase 
activity of the un-transfected control cells. Statistical differences between experimental 
groups were calculated using the commercially available software package GraphPad 
(InStat, USA) and outlined in the corresponding data figure legends.  
 
 
 
 
 
 63 
2.6 Electrophoretic gel mobility shift assays (EMSA) 
To investigate specific TF interaction at putative regulatory motifs within the GlyT-1a 
proximal promoter identified by in silico analysis (Section 2.2), gel shift assays of crude 
nuclear extract and representative synthetic labelled GlyT-1a DNA probes were used as 
described below. 
2.6.1 Preparation of crude nuclear extracts 
Following stress treatment of routinely cultured Caco-2 cells on 6 well plates (as described 
in Section 2.1.3 and 2.1.4), adherent cells were briefly washed with 1ml of ice cold PBS, 
scraped and transferred to a micro-centrifuge tube. Stress treated, as well as untreated 
control cells were then pelleted by centrifuging at 4°C at 1500 G for 5 minutes. The cell 
pellet was re-suspended in ice cold cell lysis buffer (10 mM HEPES at pH 7.9, 1.5mM 
MgCl2, 10 mM KCl, 0.5 mM DTT, 25% v/v glycerol, 0.1% v/v NP-40) for 15 minutes at 
4oC and centrifuged for a further 5 minutes at 4°C and 1500 G. The supernatant 
containing the cytosolic components was discarded. The remaining pellet was re-
suspended in nuclei lysis buffer (20mM HEPES at pH 7.9, 1.5 mM MgCl2, 400mM KCl, 
0.5 mM DTT, 25% v/v glycerol, 1 complete mini EDTA-free protease inhibitor cocktail 
table [Roche]) and incubated for 30 minutes on ice. The crude nuclear extract was 
centrifuged at 4°C and 1500 G for 15 minutes and the supernatant collected. The protein 
concentration from each sample was determined using the Thermo Scientific Pierce 660 
nm Protein assay in micro plate format. Protein samples were stored in aliquots at -80oC 
until required for binding assays.  Buffers and protein extracts were stored in ice at all 
times and sample aliquots subject to more than one freeze thaw cycle were discarded. 
2.6.2 Preparation of Infrared labelled DNA Probes and competitors 
For investigations into Atf-4 or Nrf2 and GlyT-1a interactions two Infrared dye (IRD) 
labelled DNA probes were designed. /5IRD700/G1Exon1, an 88bp DNA probe 
spanning +97 to +185 downstream of the GlyT-1a TSS of the GlyT-1a gene transcript 
was designed to investigate Atf-4/GlyT-1a interactions at predicted regulatory elements. 
For investigations into Nrf-2/GlyT-1a interactions, /5IRD800/G1Prom, a 50bp probe 
spanning between 559 and 509 bases upstream of the GlyT1a TSS was synthetically 
generated (IdtDNA, Belgium). Previous attempts to generate these probes by endpoint 
PCR using IRD-700 5’end-labelled PCR primers proved time consuming and impractical. 
As such, the full length single stranded oligonucleotide was eventually synthetically 
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generated by IdtDNA to include an IRD-700 or IRD-800 dye at the 5’ end. Synthetically 
generated oligonucleotides were HPLC purified to separate truncated or incomplete 
sequences from the full length labelled probes. Double-stranded DNA (dsDNA) probes 
were generated by incubating equimolar amounts of the single stranded probes at 95oC 
and allowed to cool to room temperature.  A third probe – /IRD700/G1Exon1/Mut, 
was designed and synthesised by IdtDNA as above, to include a double mutation in the 
identified AARE and was used to investigate the specificity of Atf-4 interactions at the 
putative AARE.  
To demonstrate affinity of the Atf-4/GlyT-1a at the putative AARE, competition assays 
using an unlabelled competitor probe were performed. A 23bp oligonucleotide probe 
containing the specific amino acid response element (AARE) of the CHOP (also known 
as C/EBP-ζ) promoter was used as binding competitor to the /5IRD700/G1Exon1 and 
/5IRD700/G1Exon1/Mut probes. Excess amounts of the unlabelled representative 
GlyT-1a probe was used to ‘out-compete’ positively identified complexes with either of 
these probes. All single stranded competitor oligos were synthetically generated by 
IdtDNA, HPLC purified and annealed as described above. All labelled oligonucleotide 
probes were kept under minimal light and stored at -20oC until required for binding 
reactions as described below. 
2.6.3 Binding reactions and gel shift assay 
Binding reactions were performed using the Odyssey EMSA buffer kit (Licor, Cambridge 
UK) according to the guidelines. For each binding reaction, 1 ρmol of the labelled probe 
was incubated with either 5 μg of crude nuclear protein extract, competitor sequence or 
both, in a 20 μL binding reaction. Final binding reaction solution in addition to the probes 
and DNA, consisted of 200mM EDTA, 1M KCl, 1% NP-40, 1 μg/μL DNA polymer 
dI.dC, 2.5% Tween-20, 1x Binding buffer. To ascertain observed complexes resulted 
from specific protein-DNA interactions, incubations with BSA as opposed to crude 
nuclear extracts or no protein were used in binding reactions. The reaction was incubated 
at 4oC for at least 60 minutes and at most 16 hours in the dark. Following the addition of 
2 µL of 10x orange loading dye (Licor, Cambridge UK) binding reaction samples were 
electrophoresed on a mini-PROTEAN TGX precast 7.5% poly-acrylamide gel (PAGE) 
(Bio-Rad Laboratories, Hemel Hempstead UK) in 0.5% TBE at 5 mV per cm of gel for 
60 minutes in the dark.  
 65 
Gels were imaged using a Licor® Odyssey™ Infra-red Scanner. Scanning resolution was 
set at 169 µM with a focus offset of 1.5 mm (i.e. the thickness of the plate plus half the 
thickness of the PAGE gel). Scanning intensities were tweaked per gel to obtain the best 
possible complex image for each channel (700nm or 800nm) scanned.  
2.6.4 Gel super-shift assays 
For super-shift assays, an Atf-4 specific antibody (#sc200x, Santa Cruz), was added to the 
binding reactions described above, prior to the addition of the IRD probe. Reaction 
conditions for super-shift assays were identical to those described above. A smaller 
binding reaction volume of 10 µL was used.  Super-shift samples were electrophoresed 
on a 26-well 7.5% Criterion™  TGX Precast PAGE gel (Bio-Rad Laboratories, UK) and 
imaged on a Licor® Odyssey™ Infra-red Scanner. 
2.6.5 Data Analysis 
The resulting intensities (I) of the complex bands and their relative migration (M) down 
the PAGE provide two exact variables for characterising the protein-DNA interaction 
forming the said complex. With the molecular weight of the IRD probe used being 
constant, the mobility of the observed complex is proportional to the molecular weight 
of the interacting protein, whilst the intensity of the complex band quantifies the 
interaction to provide an estimate of protein affinity to the DNA probe. Comparative 
lane by lane analysis was performed between lanes using the Licor® Odyssey™ Software 
suite (version 3.0) to determine the relative mobility factor (RF) – defined as a percentage 
migration of the complex band from the top of the lane (0%) to the bottom of the lane 
(100%); Lane profiles from which an automatically defined background intensity 
threshold had been deducted were used to identify fainter band complex non-evident by 
visual inspection of the gel image.  
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2.7 Chromatin Immunoprecipitation (ChIP) Assays 
ChIP assays were performed using a modified protocol originally described by (Carey et 
al., 2009) and adapted in (Johnson et al., 2007). The ChIP work-flow described here is 
outlined in Figure 2.3. Assays were performed on a total of 100 million Caco-2 cells per 
stress treated sample cultured as described above in Section 2.1.3.  
2.7.1 Cross-linking, nuclei isolation and Sonication 
Routinely cultured Caco-2 cells in a T-175 flask were stressed as described in section 2.1.4. 
Cells were transferred to 10 mL of serum free medium in a universal macro-centrifuge 
tube. Total protein bound DNA was cross-linked by adding formaldehyde to a final 
concentration of 1% (v/v) then stopped 10 minutes later by the addition of glycine to a 
final concentration of 0.125M. The cells were pelleted at 15000g for 5 minutes at 4oC and 
washed in ice cold PBS and incubated in RIPA buffer (1% NP-40, 0.1% SDS, 50 mM 
Tris-HCl [pH 7.4], 150 mM NaCl, 0.5% Sodium Deoxycholate, 1 mM EDTA) for 20 
minutes at 4oC. Pelleting at 15000g for 10 minutes retrieved the intact nuclei.  
The intact Caco-2 nuclei containing cross-linked chromatin were incubated in 5 mL of 
freshly prepared nuclei lysis buffer (50 mM NaCl, 10 mM Tris [pH 7], 20% Sucrose, 10 
mM EDTA, 1 complete Roche protease inhibitor table) and sonicated using a U300H 
ultrasonic bench top cell sonicator (Ultrawave) for 15s at full power with 1-min cooling 
intervals on ice between each burst. Sonicated DNA was electrophoresed on a 1% 
agarose/TBE horizontal gel, to confirm the obtained DNA fragments were of length less 
than 500bp.  
2.7.2 Immunoprecipitation (IP) and DNA Extraction 
Complexed protein-DNA aliquots, representing nuclei extracts from about 1x106 cells 
were incubated overnight at 4oC with 0.5μg/mL of Atf-4 antibody (SC-200x, Santa Cruz). 
The antibody-bound complex was then precipitated using protein-A magnetic Dynabeads 
(Life Technologies) according to the manufacturers’ specification. Dynabeads bound 
protein-DNA complexes were washed five times with ice cold IP wash buffer (100 mM 
Tris-HCl [pH 7.5], 500 mM LiCl, 1% NP-40, 1% sodium deoxycholate, 4°C) followed by 
a single wash in 1 x Tris/EDTA (TE) buffer (10 mM Tris-HCl pH 7.5 + 0.1 mM EDTA). 
The immune-precipitate was then eluted in 200 μL of IP elution buffer (1% SDS, 0.1 M 
NaHCO3). The DNA fragments bound to the antibody complexed protein in the 
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immuno-precipitate was released by reversing the cross-linking overnight at 65o C and 
purified using a phenol/chloroform/isoamyl extraction. To determine total DNA input, 
control total DNA was purified from sonicated chromatin. Total DNA concentration of 
each sample was measured on a Biomate3 Nano cell (Thermofisher scientific) prior 
quantification by real-time QPCR. 
2.7.3 Quantification of ChIP signal enrichment by quantitative QPCR 
The relative abundance of DNA sequence containing the putative regulatory motif was 
measured by real-time QPCR. Products from preliminary PCR amplifications for the 
corresponding sequences were characterised by cloning and sequencing as described 
elsewhere.  A sense primer 5’-CTGTGGAAGAGCTGCGAGC-3’ and reverse primer    
5’-CCAGGTGGCTTTCTTAAAGGG-3’ were used to quantify the enrichment of a 100 
bp sequence spanning the putative GlyT-1a AARE in input and no-input DNA samples. 
All reactions were optimised to generate a single PCR product from the region of interest 
and to avoid primer-dimer formation. Real-time quantitative PCR reaction mixes 
consisted of 0.5 µL of 10mM each ChIP primer set, 2 µL purified ChIP DNA fragments, 
5.0µL of 2x Light Cycler 480 SYBR Green 1 Master Mix in a total reaction volume of 10 
µL.  PCR was performed over 45 cycles and included an initial hot start activation at 95oC 
for 5 minutes, denaturation at 95oC for 5 seconds, annealing at 55oC for 15 seconds and 
extension at 72oC for 20 seconds. Fluorescence was measured at the end of the extension 
step in each cycle. After PCR, melting curves were acquired by stepwise increases in the 
temperature from 65 to 90oC to ensure that a single product was amplified in the reaction. 
PCR analyses were performed in duplicate for each sample. The immunoprecipitated 
material was quantified relative to a standard curve of genomic DNA.  
2.7.4 Data Analysis 
The results are expressed as the relative amounts of quantified AARE in the “input” 
(precipitated chromatin) of stress treated Caco-2 cells versus the control un-stressed 
group.   
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Figure 2.3: ChIP experimental workflow 
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CHAPTER 3.  
RESULTS & DISCUSSIONS 
 
Outline: In this chapter I discuss the project results. This chapter begins by providing RT-
QPCR evidence that the expression of GlyT-1a is increased in response to stress, and that 
similar changes in expression are observed with other potentially co-regulated SLC 
transporters. Outcomes of a detailed bioinformatics analysis of the GlyT-1a flanking 
sequence are reviewed. In this chapter I review the interactions of two potential regulatory 
transcription factors (Nrf-2 and Atf-4) at their respective identified putative regulatory 
elements as experimentally ascertained by electrophoretic mobility shift (EMSA), 
chromatin immune-precipitation (ChIP-PCR), and reporter assays. Where indicated, n 
represents sample replicates while N represents experimental replicates, such that the total 
number of samples included in each data graph is N * n. 
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3.1 GlyT-1a mRNA abundance is increased by stress 
It had previously been established in this lab that the intracellular accumulation of glycine 
resulting from the activity of GlyT-1, confers protection from various insults to the cell. 
To determine if Caco-2 cells increased expression of the GlyT-1a transporter to mitigate 
an added requirement for glycine during periods of stress, mRNA level of the specific 
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GlyT-1a variant was quantified in total RNA extracted from stress treated confluent 
Caco-2 monolayers (as described in Chapter 2). As shown in Figure 3.1, GlyT-1a mRNA 
levels were significantly increased by approximately 6-fold following treatment with 1 µM 
tunicamycin for 16 hours. Consistent with these findings, work by Lecca and colleagues 
show that primary fibroblast cells from patients with type-1 congenital disorders of 
glycosylation (CDG-1) treated with tunicamycin or grown in glucose-deprived medium 
resulted in an 8.7 and 2.6 fold increase in GlyT-1a expression respectively (See Table 2 in 
Lecca et al., 2005). 
Likewise a significant 3-fold increase in GlyT-1a mRNA was observed with 16 hour 
treatment of 50 nM thapsigargin. Increases in GlyT-1a mRNA were observed following 
4 hours of 0.2 mM DEM and also following 8 hours of amino acid starvation (Figure 3.1).  
To establish whether these changes in expression of the high affinity GlyT-1 transporter 
were indeed a preferred specific response to the added requirement for the intracellular 
accumulation of glycine during periods of stress, the mRNA level of the peptide 
transporter PepT-1 was quantified. In intestinal epithelia, PepT-1, expressed solely on the 
apical membrane mediates the absorption of short di and tri- dietary peptides (See Section 
1.5.3). As shown in Figure 3.2, no statistically significant change in PepT-1 expression 
between stress treated and unstressed Caco-2 cells was observed following amino acid 
starvation, tunicamycin, thapsigargin or DEM treatment. 
Our initial hypothesis predicted that increased glycine transport to intestinal epithelium 
during states of physiological stress contributed to glycine supply for the synthesis of the 
intracellular antioxidant glutathione (GSH), hence cyto-protection from antioxidants. 
Another required component for the two step synthesis of GSH is the amino acid 
cysteine. Cysteine is unstable in the extracellular environment and is rapidly oxidised to 
form cystine. Cellular cystine fluxes are generally considered rate-limiting to the 
intracellular provision of cystine required for the production of glutamyl-cystine, which 
is subsequently conjugated to glycine in the final step of the reaction to produce GSH 
(Section 1.3.3).  In epithelial cells of the peripherally drained viscera (PDV), cystine is 
transported across cellular plasma membranes by the dimeric cystine-glutamate anti-
porter (System Xc
-). In cells of the central nervous system cysteine transport is by the 
excitatory amino acid transporter 3 (EAAT-3/SLC1A3). There is extensive work in the 
literature detailing the importance of system Xc
- or EAAT-3 in oxidative protection, as 
well as chemo sensitivity and chemo resistance. The expression of xCT/SLC7A11, the 
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light-chain of System Xc
-, has been shown to be increased downstream of amino acid 
starvation in mouse fibroblast cells (Sato et al., 2004) and downstream of DEM treatment 
(Hosoya et al., 2002) or oxidative stress. Indeed, littermates of C57BL/6 mice deficient in 
xCT had decreased plasma concentrations of GSH and a characteristic redox imbalance, 
whilst fibroblast cells derived from these mice required addition of the antioxidant 2-
mercaptoethanol to the culture medium for survival in routine culture (Sato et al., 2005).  
To determine if the expression of GlyT-1 was regulated by similar regulatory modules to 
that of xCT (discussed here and also in Section 1.7 above), xCT mRNA abundance was 
quantified in total RNA extracted from stress treated Caco-2. As shown in Figure 3.3, like 
GlyT-1a, xCT mRNA expression was significantly increased by approximately 4-fold 
following treatment with 1 µM tunicamycin for 16 hours. Also a significant 3-fold increase 
in xCT mRNA was observed with 8 hours of amino acid starvation whilst a doubling was 
observed following either a 16 hour treatment with 50nM thapsigargin or 4 hours 
treatment with 0.2 mM DEM. This data is consistent with observations made in this lab 
using the same stress conditions on HCT-8 cells (data not included) 
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Figure 3.1:  GlyT1a mRNA abundance is increased following stress in Caco-2 cells with 
either tunicamycin (Tu) or thapsigargin (Tg) for 16 hours, 8 hours of amino acid starvation 
(No AA) or 4 hours of diethyl maleate (DEM). Values are pooled from multiple 
experiments and represent a percentage mean of the untreated control sample displayed 
as mean ± SEM, n=2-3 (N = 2 for each treatment). Sample data is consistent with further 
experiments performed in this laboratory. One-way (non-parametric) analysis of variance 
(ANOVA) was performed. For comparison of each treatment to the control Dunnett’s 
multiple comparison tests with pooled variance for each treatment was used. **** 
represents a P-value of less than 0.001. 
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Figure 3.2:  PepT-1 mRNA abundance is unchanged following stress in Caco-2 cells. Cells 
were treated with either tunicamycin (Tu) or thapsigargin (Tg) for 16 hours, 8 hours of 
amino acid starvation (No AA) or 4 hours of DEM. Values are pooled from multiple 
stress treatment experiments and represent a percentage mean of the untreated control 
sample displayed as mean ± SEM, n=2-3 (N = 3 for each treatment). One-way (non-
parametric) analysis of variance (ANOVA) was performed. Dunnett’s multiple 
comparison tests with pooled variance for each treatment was used for comparison of 
each treatment to the control. ns: not significant  
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Figure 3.3:  xCT mRNA abundance is increased following stress in Caco-2 cells with 
either tunicamycin (Tu) or thapsigargin (Tg) for 16 hours, 8 hours of amino acid starvation 
(No AA) or 4 hours of diethyl maleate (DEM). Values are pooled from multiple stress 
treatment experiments and represent a percentage mean of the untreated control sample 
displayed as mean ± SEM, n=2-3 (N = 2 for each treatment). One-way (non-parametric) 
analysis of variance (ANOVA) was performed. For comparison of each treatment to the 
control, Dunnett’s multiple comparison tests with pooled variance for each treatment was 
used. *** and **** represents a P-value of less than 0.005 and 0.001 respectively 
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Taken together, the fact that mRNA levels of both xCT and GlyT-1 are increased in a 
similar pattern downstream of stress unlike PepT-1 suggest that these adaptive changes 
in expression are part of a specific response to stress and not a result of a global increase 
in requirements for amino acids for protein synthesis or energy production. Whilst our 
data shows no change in PepT-1 expression following stress, impairment in transport 
(measured as the uptake of [14C]glycine-sarcosine) by the PepT-1 transporter in Caco-2 
cells pre-treated with hydrogen peroxide for 24 hours has previously been reported and 
associated with decreased expression of the transporter; as well as reduced Vmax  of the 
transporter (Alteheld et al., 2005). Such a decrease in expression of PepT-1 has also 
recently been reported in mouse models of Crohn’s disease-like ileitis or colitis as well as 
in tissue samples collected from IBD patients during endoscopy (Wuensch et al., 2014). 
Altheheld et al. showed that uptake by PepT-1 in stressed Caco-2 cells, as well as 
intracellular GSH level and redox potential can be maintained by simultaneously treating 
cells with growth hormone (GH) or the dipeptide alanine-glutamine (Alteheld et al., 2005). 
Recently the regulation of PepT-1 by the transcription factor Nrf-2 has been 
demonstrated following Sulforaphane treatment of Caco-2 (Geillinger et al., 2014). 
Most cellular functions and adaptive processes are characterised by modular, interactive 
networks of regulator proteins (including transcription factors, co-factors, modifying 
enzymes) and regulated genes. These modular components acting in concert produce a 
characteristic functional activating or repressing response by means of protein expression, 
silencing or modification. The work described here set out on the assumption that specific 
gene regulatory modules, largely comprised of key members of the integrated stress 
response (ISR), regulate the transcriptional expression of the GlyT-1a and xCT 
downstream of stress stimuli such as oxidative stress.  
Canonical methods for the identification of probabilistic regulatory networks begin with 
large expression array datasets and rely on specific clustering algorithms to elucidate any 
functional meaning. From existing literature and published data, it is possible to catalogue 
potential regulator proteins active in states of oxidative stress, amino acid starvation, the 
unfolded protein response, or ER stress. Our approach, entailed detailed computational 
analysis of the GlyT-1 flanking sequence in search for candidate binding sites and motifs 
for the catalogued potential regulatory proteins, followed by experimental validation of 
their DNA/Protein interaction following stress treatment in Caco-2 cells.    
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3.2 Identification of regulatory motifs of GlyT-1a 
 
 
Figure 3.4: Flow chart showing the workflow and outcomes of bioinformatic analysis of 
the GlyT-1a Promoter as discussed in Section 3.2 
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Be they transcription factors (TFs) responsible for driving gene expression or cofactors 
required for epigenetic modifications of the chromatin at specific sites, the binding of 
proteins to nucleic materials provides an interface for the regulation of several cellular 
processes. Understanding the site specificity of protein-DNA interactions is an important 
challenge to deciphering gene regulatory modules and networks. The short sequence-
specific transcription factor binding sites (TFBS) within flanking regions of stress 
responding genes confers varying degrees of trans-repressive or trans-activating activity 
upon binding of a TF.  Despite the absence of ambiguity in a well-prescribed stress 
response, the degeneracy of TFBS poses a significant problem to the accurate in silico 
identification of factors involved in the regulation of a gene.  
In-lieu of time-consuming and often expensive wet-lab methods, combinatorial and 
enumerative methods are used on previously identified sequences of probabilistic protein 
occupancy to describe TFBS consensus for applicability to the remainder of the genome.  
Most of what is known of TFBS is based on a limited amount of experimental evidence 
from assays such as ChIP on ‘chip’ followed by sequencing (ChIP-seq), DNase I foot-
printing, electrophoretic mobility gel-shift assays (EMSA), south-western blots and 
promoter reporter assays (Neph et al., 2012). For determining the function of specific TF 
at a gene promoter, newer methodologies such as protein-binding microarrays (PBM) 
provide comprehensive and high throughput datasets for the characterisation of binding 
sites (Bulyk, 2007). Databases such as UniPROBE catalogues PBM array data for a limited 
number of transcription factors (Newburger and Bulyk, 2009). Algorithms combining 
protein-specific binding data to functional expression data are emerging as a suitable 
computational strategy for identifying gene modules within regulatory networks (Bar-
Joseph et al., 2003). 
Several of such consensus TFBS for eukaryotic TFs are catalogued as positional weight 
matrices (PWMs) or position specific score matrices (PSSM)  in databases such as 
TRANSFAC® (Matys et al., 2003) and JASPAR (Sandelin et al., 2004). PWMs represent a 
mathematical representation of multiple sequences identified from the wet-lab methods 
described above and to which a given transcription factor is believed to bind. In effect, 
they are an L by four matrix (where L is the sequence length of the postulated TFBS, 
usually between 5 and 20) which describe the frequency of occurrence any of the four 
nucleotide bases (A, C, G, T) at any one point along L. PWMs, together with their 
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graphical representations known as Tom Schneider sequence logos depict the DNA 
binding preferences of a TF at a TFBS. 
Importantly, does the occurrence of a probabilistic TFBS within the promoter region of 
a gene imply its specific activity at that site? Despite the many approaches and algorithms 
used to identify TFBS in silico, minimising false positives and negatives from 
computational prediction remains an important challenge. The use of TFBS consensus 
matrices in identifying putative regulatory motifs at other genomic sites ignores the issues 
of TF redundancy, co-binding (transcription factor tethering), tissue specificity of 
TF/DNA interactions as well as the regulatory context (Kuntz et al., 2012). The 
understanding that several proteins or heterodimers of transcription factors may interact 
at a particular TFBS further complicates the notion of one TF to one TFBS.  
For the identification of the transcriptional modules involved in the regulation of human 
GlyT-1a a combination of several methods and workflows were used as described in 
(Wasserman and Fahl, 1997, Wasserman and Sandelin, 2004). To begin, the GlyT-1a 
promoter sequence was characterised to identify regions of important regulatory 
significance. Next, using the database of co-ordinately regulated genes (CORD), several 
promoters from genes with significant regulatory correlation to GlyT-1a were catalogued. 
This was followed by detailed analysis of the promoter collection to reveal significantly 
enriched (frequently occurring) TFBS using the TRANSFAC Explain tool. To minimize 
false positives from TFBS identification, the TRANSFAC Composite Model Analyst tool 
was used to identify composite sites. In the following section, the results from this 
bioinformatic analysis of Glyt-1a are discussed. 
3.2.1 Characterisation of the GlyT-1a promoter 
The human GlyT-1a gene transcript (Accession numbers RefSeq: NM_001024845, 
Ensembl: ENST00000372310) is encoded from 16 out of a possible 17 exons (Figure 
3.5), which span a 44.1 kb sequence on the reverse strand of chromosome 1 between 
nucleotides 44462155 and 44497164 (unless otherwise stated, all genomic coordinates 
noted in this section are with respect to the GlyT-1a NM_001024845 transcription of 
GRCh37/hg19 assembly obtained from NCBI). Exon 1 and the first 86 bases of exon 2 
are completely untranslated and form the 5’UTR of the mRNA. On the genome the first 
and second exons are separated by a 6943bp genomic intron. The last 1062 bases of exon 
16 are untranslated and form the 3’UTR.   
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The human GlyT-1a gene transcript sequence was studied to determine a characteristic 
‘core’ promoter and basal regulatory elements (BRE). The core promoter is defined as 
the minimum essential neighbouring DNA sequence required for accurate binding and 
initiation of gene transcription by RNA polymerase II (RNAPII) and other co-factors 
(Butler and Kadonaga, 2002).  Typically the core promoter extends ~50 bases either 
upstream or downstream of the transcription start site (TSS or A+1) and may contain 
specific sequence motifs such as a TATA-box required for anchoring RNAPII (as 
illustrated in Figure 3.6), an initiator motif (INR) functionally similar to TATA-box in 
facilitating binding of the TATA-box binding protein (TBP, TFIID) complex, CpG 
islands (CGI), and sometimes downstream core promoter elements (DCE or DPE) 
(Kadonaga, 2002).  
Analysis of the GC content of the GlyT-1a flanking sequence (chr1:44499164-44489948) 
suggest that its core lies within an extensive CGI as indicated in (Figure 3.7; page84). 
CGIs were calculated as regions where over an average of 10 sliding windows of size at 
least 100 nucleotides (or a region spanning no less than 1000 nucleotides, whichever is 
greater) the percentage G+C content is over 50 and the calculated observed/expected 
ratio for the occurrence of a CpG (i.e. a cytosine base immediately linked by a phosphate 
backbone to a guanine base) is over a threshold of 60%. 
In mammalian genomes, about 70% of gene core promoters reside within CGIs. CGIs 
have a strong correlation with gene regulatory sites and are pronouncedly GC-rich, CpG 
rich and non-methylated when they occur in active promoters (Deaton and Bird, 2011). 
Whilst it is impossible to computationally determine the methylated status of CGIs, 
biochemical analysis reveals an association between methylation of the cytosine of the 
CpGs and gene silencing. The methylated cytosine can spontaneously de-aminate to a 
thymine to form TpG sites. TpG are up to 50 times more frequent than other types of 
transitional mutations in cancer cells. In humans, the enzyme thymine-DNA glycosylase 
(TDG, EC 3.2.2.29) upon interaction with several TFs and co-factors such as the 
pCAF/p300, is tethered to the DNA and catalyses the removal of the C/T mismatch.  
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Figure 3.5: Arrangement of the human GlyT-1a/SLC6A9 gene. The human GlyT-1a 
transcript (NM_001024845 or ENST00000372310) is encoded from 16 out of a possible 
17 exons (numbered rectangles) spanning a 44kb region of chromosome 1 between 
nucleotides 44497164 and 4446215 –  as numbered in the latest  release of the human 
genome assembly (GRCh37/hg19, Released 1st Feb 2009). The exon excluded from 
GlyT-1a lies between exons 2 and 3 (all translated exons are indicated by dark boxes). 
Exon 1 and the first 86 bases of exon 2 are completely un-translated (forming the 5’UTR) 
and on the genome are separated by a 6943 base intron (Intron 1). Likewise, the last 1062 
bases of exon 16 are un-translated and define the 3’UTR. In work reported here, 
bioinformatic analysis was performed on key promoter regions (core, proximal and distal 
promoters) to identify regulatory motifs important to the transcriptional regulation of the 
gene. All identified motifs within these regions are reported and discussed in the text. 
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In addition to the methylated status of the cytosine in CGIs histone modifications are 
believed to be involved in controlling gene expression or repression. Whilst direct 
methylation of the cytosine may lead to permanent or long term gene silencing, reversible 
methylation of some histones such as di-methylation of histone 3 at lysine 9 (H3k9me2) 
may provide short term gene inactivation. The specific methylation status of histone 3 at 
lysine 4 is generally considered a characteristic signature of CGIs, and has previously been 
used to experimentally determine cell type-specific gene regions rich in regulatory 
enhancers. Work by Creyghton and colleagues on H3k4me1 histone marks identified by 
ChIP-Seq using murine ES cell revealed that, when co-associated with H3k27ac histone 
acetylation marks, they highlight important gene regulatory enhancer sites (Creyghton et 
al., 2010). These sites actively promote gene expression by negating the silencing effect 
of methylation. Another conclusion from the later study is that enhancers associated with 
only the H3k4me1 mark often require additional external stimulus for gene activation. 
Analysis of the GlyT-1a sequence in h1-hESC, HUVEC and GM128787 cells from data 
outputs of the ENCODE project show that it correlates to significant H3k27ac marks 
(Figure 3.7), positing that it lies in a transcriptionally permissive region. Results of this 
analysis, depicted in Figure 3.7 demonstrate an important overlap of the Glyt-1a core 
promoter with the predicted CGI, high PhastCons†† conservation scores, high GC 
content and high H3k27ac marks. Based on these observations, this sequence region was 
searched further for the occurrence of specific regulatory sites.  
In a study by Suzuki et al., analysis of core promoters of 1031 human genes revealed only 
32% contained a TATA box, whilst 80% contained an INR motif (Suzuki et al., 2001). A 
detailed understanding of the occurrence of general transcriptional regulatory elements 
around and afar from a given TSS (Figure 3.6) provides insights to the combinatorial 
relationship between these elements in regulating gene transcription (Smale, 2001). For 
instance it has been suggested that some TFs such as SP-1 exhibit differences in activity 
at TATA-containing versus TATA-less promoters, with TATA-less promoters requiring 
an additional INR motif for activity of upstream enhancers such as SP-1 (Lo and Smale, 
1996).  
                                                 
†† Scores representing the predicted base-by-base conservation in multi-aligned sequences determined 
using the PhastCons algorithm developed by Siepel, A., Bejerano, G., Pedersen, J. S., Hinrichs, A. S., Hou, 
M., Rosenbloom, K., Clawson, H., Spieth, J., Hillier, L. W., Richards, S., Weinstock, G. M., Wilson, R. K., 
Gibbs, R. A., Kent, W. J., Miller, W. & Haussler, D. 2005. Evolutionarily conserved elements in vertebrate, 
insect, worm, and yeast genomes. Genome Res, 15, 1034-50.  
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Figure 3.6: Hypothetical TFBS architecture at gene promoters The core promoter (shaded 
green), defines the minimum essential sequence required for assembly of the pre-
transcription complex. The occurrence and arrangements of BRE, TATA boxes with 
respect to the INR, as well as downstream DPE and MTEs modulate RNA Polymerase 
II and cofactor assembly. Core promoters are characterised by CpG islands and flanked 
by extensive methylation sites in the proximal promoter. The proximal promoter (shaded 
orange) contains additional enhancer or repressor motifs capable of modulating event 
specific transcription. Additional insulators or silencers modulate access to the core 
promoter by elements at long range regulatory sites (LRREs).  
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In humans the occurrence of SP-1 and CCAAT-enhancer boxes (C/EB) within TATA-
less promoters has been postulated to replace the requirement for TATA-boxes in 
recruitment of transcriptional initiator proteins and interaction with conventional TBP-
associated factors such as transcription factor IID (Emami et al., 1998, Butler and 
Kadonaga, 2002). CGI promoters often lack characteristic TATA boxes, BRE, DPE, or 
DCE elements, show diverse initiation patterns and can have multiple TSS (Juven-
Gershon and Kadonaga, 2010). It may be for this reason that genome build algorithms 
(such as Sanger’s Eponine algorithm) used by various online assembly databases have 
resulted in differing TSS annotated for the same GlyT-1a transcript (the GlyT1a TSS on 
Ensembl (ENST00000372310) is 100 bases upstream of that for the same transcript on 
NCBI (NM_001024845)). In the post genomics era, the identification of gene TSSs or 
INRs is generally achieved by mapping sequenced RNA or cDNA ends to genomic DNA 
and noted on several genome assemblies (Cullen and Barton, 2007, Pelechano et al., 2014).  
The GlyT-1a core promoter which resides in an extensive CGI, is TATA-less, but 
contains a characteristic INR motif (5’- TGA+1GAATC-3’) at its TSS (in this case that of 
the NCBI entry). The GlyT-1a INR motif is similar to the originally defined INR 
consensus sequence for vertebrates (C/T)(C/T)A+1N(A/T)(C/T)(C/T) (Smale and 
Baltimore, 1989), but differs in that the bases preceding the A+1 and at +3 are non-
pyrimidine (Javahery et al., 1994).   
It has been suggested that TATA-less core promoters which have an INR domain usually 
contain an additional DPE element with the suggested consensus 
(A/G)G(A/T)(C/T)(G/A/C) (Burke and Kadonaga, 1996) within the first 30 bases 
downstream of A+1 (Yang et al., 2007); however, no such DPE was identified within +50 
bases from A+1 of GlyT-1a. The absence of a characteristic TBP motif and other BRE 
elements within the GlyT-1a core promoter heightens the significance of additional 
enhancers and other regulatory elements for its transcription. 
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Figure 3.7: Co-occurrence in the human GlyT-1a promoter of CpG islands (CGIs),  and correlation to a highly conserved region and one of high 
levels of H3k27ac. CGIs were predicted in a region spanning -2000 bases upstream the TSS of GlyT-1a to include the full 6.9kb of intron 1 and the 
85 un-translated bases of exon 2 (Panels A and B). For comparative analysis of conservation, PhastCons scores from a Multi-z  alignment of the 
genome regions of 100 vertebrate species (multi-100-way, Panel C) was downloaded from UCSC browser table and charted. Based on the assumption 
that non-coding sequences of functional significance are under heightened selective pressure, regions of high conservation represent potential sites 
for gene regulatory elements. Whilst CGIs are characteristic of transcriptionally permissive promoters, histone acetylation marks are representative of 
active promoter regions and usually coincide with enhancer elements and other regulatory motifs. H3K27ac marks (Panel D) are from three cells lines 
(h1-HESC, HUVEC and GM12878) studied by the ENCODE project.  
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3.2.2 Identification of putative GlyT-1 regulatory TFBS 
A 2.2kb flanking sequence of the GlyT-1a gene transcript was analysed for the occurrence 
of TFBS. This sequence consisted of 2000 bases upstream of the GlyT1a TSS, the first 
exon (187 bases) and the first 85 un-translated (UTR) bases of the second exon.  Using 
the MATCH algorithm with cut-off scores set to minimise false positives (minFP), 2481 
sites were highlighted as potential binding sites using high quality PWMs from the 
TRANSFAC Matrix Table (data not included). Cut-off scores define the minimal 
similarity to the PWM for a given TFBS to be assumed biologically ‘real’ (minFP) or 
‘functional’ (minFN). An important disadvantage of cut-off scores and in fact a limitation 
to the MATCH algorithm is that higher similarity to the PWM does not always imply a 
given site is biologically relevant. For instance TFs such as C/EBP, Sp-1 and Ap-1 all 
bind to functional biological sites with considerable sequence variation, as such a 
significantly lower similarity score (minFN of as low as 40% similarity to the core matrix) 
are required to computationally detect all of such sites in an input sequence. This could 
eventually result in numerous false negatives. On the flip-side, with high cut-off scores to 
minimise false positives (minFP), it is possible to miss biologically ‘functional’ sites which 
may differ significantly from the information content (IC‡‡) of a given PWM. The authors 
of the MATCH algorithm suggest using cut-off scores which minimise the sum 
(minSUM) of both error rates i.e. false-positives and false-negatives. Using minSUM cut-
off scores, 28510 sites were identified in the GlyT-1a flanking sequence under 
investigation (data not included). Given that the biological specificity of any one TF is 
attained by a combinatorial relationship between several factors and co-factors (modules), 
determining the biological significance from a very large list of TFBS returned from 
computer algorithms such as this is best achieved by contextual analysis of the occurrence 
of these sites within specified sequence windows. One such approach is to determine 
which TFBS are overrepresented in co-regulated genes, and then study their arrangements 
within composite cis-regulatory modules (CRMs) 
As originally pioneered by Spellman et al, the meta-analysis of large scale micro-array data 
to identify differentially co-expressed genes followed by promoter analysis to identify 
                                                 
‡‡ The information content (IC) or a PWM is the sum of the expected self-information. Self-information is a numerical measure of the information 
content associated with the unique outcome of a random occurrence. It is the negative log of the probability of observing a particular base at a particular 
position as defined in a PWM. 
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common (or highly represented) TFBS is a useful and popular strategy for the 
identification of CRMs (Spellman et al., 1998). The hypothesis that genes with similar 
expression patterns are indicative of co-regulation overly simplifies the multi-faceted 
nature of gene regulation, which often may include other epigenetic and post-
transcriptional, and protein modification modules. However, work done by Alloco and 
colleagues using 611 microarray datasets to quantify the relationship between co-
expression, co-regulation and co-functionality, showed that for two genes to have a 
greater than 50% chance of being regulated by the same TF they must have a greater than 
84% correlation in their factor-specific expression profiles (Allocco et al., 2004). When 
the correlation in expression is condition or factor dependent it is more often than not 
consequential of similar regulatory modules. Hence, meaningful prediction of regulatory 
modules can be achieved from analysis of the promoter regions of genes sharing a strong 
correlation in expression under similar conditions. Based on these assumptions, an 
analysis of the promoter region of genes potentially co-regulated with GlyT-1a (identified 
by high correlation in their factor specific expression profiles) was performed to identify 
frequently occurring TFBS.  
The Co-regulation Database (CORD) was searched to identify genes with high factor 
dependent co-relation in expression to GlyT-1a. Using 9490 public microarray datasets 
from the Gene Expression Omnibus (GEO) database and ArrayExpress database, the 
curators of CORD analysed over 120000 group by group comparisons of 
factor/condition dependent correlation in gene expression. CORD query parameters 
where set to allow a minimum fold change of greater than 2 in more than 3 experiments 
and a threshold p-value (correlation coefficient significance) of less than 0.01. Only genes 
with correlation of expression greater than or equal to 84% were retained for subsequent 
analysis. To identify co-regulated genes, CORD uses a gene ranking algorithm. Briefly, all 
microarray datasets in which the target gene (GlyT-1a) is differentially expressed are 
collected and grouped using one of two methods viz: ‘grouped factor method’ or 
‘individual factor method’. The Pearson correlation coefficient of the log2 fold change in 
expression between the target gene and each gene in the above datasets are then calculated 
and compared across each group. 185 potentially co-regulated genes were returned from 
the above query (data not shown).  
Using the TRANSFAC Explain tool, the returned gene list was classified based on gene 
ontology (GO) of terms describing the biological processes they are involved in 
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(Appendix A.1).  The list of co-regulated genes returned from CORD includes those 
involved in similar biological processes as is GlyT-1; such as in the transport of amino 
acids, nitrogenous and other organic compounds,  neuro-transmission, cell cycle and 
development, anti-apoptotic genes,  immune response and stress response genes. As most 
of these functions overlap postulated GlyT-1 function, the above list of co-regulated gene 
was deemed informative enough to proceed with promoter analysis for the identification 
of overrepresented TFBS. 
Using the TRANSFAC F-MATCH algorithm, analysis of the promoter regions (spanning 
2000 bases upstream to 1000 bases downstream of the TSS) of co-regulated genes 
identified by CORD was performed. F-MATCH uses an algorithm similar to MATCH 
but can simultaneously scan multiple promoters to identify over-represented TFBS as 
potential ‘causes’ for differential gene expressions. F-MATCH compares the occurrence 
of these over-represented TFBS in the ‘test’ or ‘YES’ list of differentially expressed gene 
promoters to a ‘control’ or ‘NO’ list of housekeeping genes to correct for multiplicity 
(errors in inference, i.e. where the frequency of a given TFBS is higher in the NO set than 
the YES set it is omitted from the result). For genes in the YES set of co-ordinately 
expressed genes with multiple promoters, only the promoters annotated in the 
TRANSPRO database with the best support were used. P-value cut-offs of 0.01 were used 
for F-MATCH. Only TFBS with significant enrichment in the promoter regions of the 
YES genes were studied. From this list, only TFBS present in the GlyT-1a promoter were 
retained for subsequent analysis. A complete list of the 131 enriched TFBS, P-values, and 
the TF which bind them is included in Appendix A.2. 
Amongst the 131 TFBS identified as enriched were sites for some TFs known to be 
involved in the regulation of the stress response. These included, amongst many, sites for 
the activator protein 1 and 2 transcription factors (AP-1, 2); sites for the C/EBP proteins 
(C/EBP-α, β, δ, and γ); several E-box binding motifs, CREB/ATF; small MAF proteins 
(MAF-A, G and Z; which are known to interact with Nrf-2 in the regulation of oxidative 
stress), sites for NFAT (involved in the response to osmotic stress), the POU class of 
transcription factors involved in the regulation of cell cycle and sites for hypoxia inducible 
factor (HIF). Although such an analysis may provide an exhaustive list of TFBS enriched 
within a given set of promoters, very little can be garnered as to which are biologically 
relevant. Moreover, the above analysis does not discriminate between which of the 
promoters in the collection are actually involved downstream of the stress response 
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pathways under investigation here. As such, the significant enrichment of a given TFBS 
in the promoter set only provides a possible indication to its significance in the regulation 
of GlyT-1a downstream of stress. Thus, the arrangement of each of these TFBS on the 
GlyT-1a sequence was studied to identify possible composite regulatory modules (CRMs).  
3.2.3 Composite regulatory modules (CRMs) of the GlyT-1a promoter  
Simply defined, CRMs are a combination of cis- or trans-regulatory elements whose 
combinatorial effect on neighbouring gene expression is dependent on the individual 
factors bound to each regulatory site in the module. As several TFs and co-factors may 
be involved in the control of the spatial and temporal expression of any one gene, it is 
axiomatic that the outcome of any gene transcriptional regulatory network is dependent 
on the functioning of its constituent CRMs. CRMs offer important logic-like switches to 
molecular transcriptional events downstream of intracellular and extracellular stimuli such 
as stress (discussed later). They exert their transcriptional control on gene expression by 
exactly computing the titres of active nuclear localised transcription factors at any one 
time to satisfy maximum occupancy and function of individual TFBS in the module.  
CRMs can be classified into two main groups based on the architecture and functioning 
of their constituent TFBS (Jeziorska et al., 2009). Where the rigid arrangement of the 
individual TFBS within a given CRM allows for coordinated information processing of 
all the bound factors to generate a unified coordinated output, it is termed an 
‘enhanceosome’. Enhanceosomes are particularly sensitive to mutations or changes in any 
one of their constituent TFBS. Unlike enhanceosomes, there is a much greater flexibility 
in the arrangements of TFBS and occupancy of these sites by individual TF within 
‘billboard’ CRMs. The transcriptional output of billboard CRMs is generally the sum of 
the competing effects of every factor in the module (Arnosti and Kulkarni, 2005).  
Detecting CRMs in the promoters of responsive genes usually results in fewer false 
positives and better biological meaning over analysis of isolated individual TFBS (Guturu 
et al., 2013). Whilst several computer algorithms exist for the detection of CRMs, the 
TRANSFAC Composite Model Analysis tool was used as it allows for the ability to define 
custom composite models. A composite model defines pairs of PWMs used for searching 
DNA sequences for TFBS located within a specified sequence window. In the absence 
of effective models for combinatorial interactions of TFs downstream of the stress 
response, composite models were designed to capture potential structural arrangement of 
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sites conducive to previously described protein-protein interactions of several stress 
response transcription factors (Table 3.1). For instance, the direct physical interaction 
between E-twenty-six (Ets-1 a transcription factor with several roles in cell development 
and tumour progression) and activator protein type 1 (Ap-1) has been previously 
described and associated with regulation of gene transcription in stress and cancer 
progression (Yordy and Muise-Helmericks, 2000). Using a composite Ap-1/Ets model of 
the vertebrate Ap-1 TRANSFAC matrix V$AP1_Q6_01 and Ets matrix V$ETS_Q6 
(Figure 3.8), 28 Ap-1/Ets motifs were identified in the GlyT-1a flanking sequences (data 
not shown) where the two sites either overlap or are not separated by more than 30 
nucleotides and have at least 80% similarity to their respective core PWM. Closer 
inspection of these motifs to identify which overlap with other TFBS for other proteins 
known to interact with either Ets-1 or Ap-1 can significantly improve the quality of such 
in silico predictions. 
As discussed in Section 1.7, a plethora of BZIP factors control the temporal and 
differential transcriptional response to various stresses. BZIPs are characterised by a 
dimerisation ‘zipper’ domain of heptad repeats of hydrophobic and leucine residues as 
well as a basic region required for sequence specific DNA binding (Figure 3.9). Based on 
their originally characterised DNA binding specificity, BZIP transcription factors are 
classified into three subfamilies. This includes the classic AP-1 sub-family comprising 
factors that bind to a characteristic 12-o-tetradeconyphorbol-13-acetate (TPA) response 
element (also known as TRE; consensus TGACTCA; (Mitchell and Tjian, 1989)), the 
CREB/ATF subfamily which bind to a composite and often palindromic cAMP response 
element (CRE; consensus TGACGTCA; (Montminy et al., 1986)) and the 
CCAAT/enhancer box binding protein (C/EBP) subfamily. Inter and intra family 
dimerisation of these BZIP factors with other protein super families is reported to 
regulate specific functional gene expression. All of the information required for 
dimerisation specificity to external stimuli is contained within the BZIP dimerisation 
domain, although other determinants such as the nature and calibre of external stimuli 
may favour one dimerisation partner over another. 
 
 90 
 
Figure 3.8: Creating custom TFBS composite models using the TRANSFAC Composite 
Model tool. Composite models define two PWM used to search a DNA sequence to 
identify contextual occurrence of TFBS conducive to the interaction of the two factors. 
Using the Model definition form of the tool it is possible to define the similarity cut-off 
scores and orientation of each site, as well as the minimum overlap distance between the 
components and the maximum permissible distance of separation. 
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Figure 3.9: 3D Structure and dimerization of BZIP factors (A). Schematic of the BZIP 
heterodimer of mouse activating transcription factor 4 (ATF4) and CCAT/enhancer box 
binding protein beta (C/EBPβ) (MMDB ID: 15196, (Podust et al., 2000)) demonstrating 
a characteristic BZIP coil-coil structure with homodimers of parallel alpha helices forming 
an inter-helix coiled-coil region via the leucine zipper and the two N-terminal basic 
regions (B). Schematic of human C/EBP-β homodimers showing ternary interaction of 
the basic domain of the protein with the major grooves of the half sites on opposite sides 
of a DNA helix (MMDB ID: 61310, Tahirov et. al. 2006). (C). A BZIP tetrad of two 
human c-Fos/c-Jun heterodimers tethered together by additional residues within the 
zipper domain (MMDB ID: 72084, (Glover and Harrison, 1995, Glover et al., 1995)). 
 
 
Leucine zipper 
domain 
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Figure 3.10: Illustration showing possible BZIP functional dimerisation patterns and the 
resulting DNA binding composite sites. Dimerisation is crucial for BZIP transcription 
factor activity and regulates the state of inducible genes. The AARE identified in GlyT-
1a exon 1 is a composite ATF/CRE site with a characteristic C/EBP half site. Under 
normal physiological conditions homotypic dimers of two C/EBP proteins functionally 
interact at this site either as a repressor or an activator of gene expression. Following 
stress and the early induction of Atf-4, dimers of C/EBP-β/Atf-4 maintain the gene in 
an “ON” state. A feedback loop described at least in the transcriptional regulation of Cat-
1 gene expression involves a monomer exchange at the same or similar binding site where 
in Atf-3 (a downstream target of ATF4) replaces Atf-4, turning “OFF” gene expression 
(Adapted from Tsukada et al., 2011).    
  
 
 
 
 
 
 
OR 
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Of the 56 known human BZIPs, only a few self dimerise, with the rest forming and 
functioning as heterodimers with proteins from other families. The subset of BZIP 
factors investigated in the work described here was limited to those known to be active 
during stress. Careful consideration was given to the physical interactions of these factors 
downstream of stress as reported in the literature in the creation of composite models 
(Table 3.1).  
Evidence of protein-protein interaction of these TFs was obtained from BioGrid – a 
database of experimentally validated protein-protein interactions (Stark et al., 2006). 
BioGrid was preferred over other interaction databases such as StringDB (Franceschini 
et al., 2013), as it appears to be the most actively curated with most of the interactions 
recorded in StringDB better documented in BioGrid.  Composite models of factor pairs 
of Atf-4, C/EBPα, C/EBPβ, C/EBPε, C/EBPγ, c-Fos, Fos-L1, Jun and Nrf-2 were built 
in this manner and used to search the GlyT-1a sequence for putative CRMs.  Sites not 
being part of a paired module, i.e. isolated TFBS for single BZIP with good matrix 
similarity scores, were still considered as it is understood that whilst dimerisation may be 
crucial to the activity of the resulting complexes, individual factors may bind to their 
respective sites and recruit or swap partners depending on the nature and duration of the 
stimuli (Figure 3.10).  
As there are several PWMs of varying qualities and informational content in the 
TRANSFAC matrix table, deciding on which matrices to use was on a case by case basis. 
Assumptions were made on the theoretical permissible distance between each TFBS core 
in the composite model. A maximum separating distance of 9 was used as it’s the longest 
know distance between the two halves in the ER stress response element (ERSE-I) 
consensus. Close or overlapping core motifs are not a stringent requirement for CRMs 
(Leung et al., 2010). The stepwise binding of each subunit of the BZIP dimer complex to 
DNA could result in bending of the DNA helix to allow for co-binding of the 
dimerisation partner at near or distant regulatory motifs (Coulombe and Burton, 1999, 
Gustafson et al., 1989, Kim et al., 1989, Lorenz et al., 1999). Nonetheless, as a key 
hypothesis in the computational detection of CRMs is the nearness of the core domains, 
a minimum overlap of five nucleotides and maximum separating distance of the individual 
TFBS of nine nucleotides was used.  
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Table 3.1: Stress response BZIP factors and their dimerisation partners involved in the 
stress response. Composite models of BZIP factors and their interacting partners were 
built to detect stress response motifs in the GlyT-1a sequence. Interacting partners were 
determined using the BioGrid database. (+) or (-) denote activating or repressive 
transcriptional activity. Typical stress response CRMs include the Amino Acid Response 
Element (AARE), the Nutrient Stress Response Element (NSRE-1), the ER stress 
response element (ESRE), the MAF recognition element (MARE), the antioxidant 
response element (ARE) and the Unfolded protein response element (UPRE). Shown in 
bold are factor pairs used to build composite models (Table adapted from Schroder and 
Kaufman, 2005).  
Transcription 
factor 
Cis-regulatory motif to 
which factor binds 
Confirmed interacting partners at these 
sites 
Atf-3 AARE 
Atf-2 (-/+),  Atf-3 (-), Atf-4, Atf-7, 
C/EBPξ, C/EBPγ, C/EBPα, c-JUN (-
/+), NF-κBp50, CREBA 
Atf-4 
AARE, ARE, UPRE, 
ERSE, NSRE 
Atf-3 (-/+), Atf-7, B-Atf, C/EBP-β, 
C/EBP-γ, C/EBP-α, C/EBP-δ, 
C/EBP-ε, C/EBP-ξ, c-Fos, Fos-L1, 
FosB,  HLF, Jun, JunD, c-Maf, Nrf-1, 
Nrf-2 (+ on ARE, - on AARE) 
Atf-6α 
ATF/CRE, ERSE-I, 
ERSE-II 
Atf-6α (+), Atf-6β, XBP-1(+), NF-Y(+), 
SRF 
Atf-6β ERSE-I Atf-6α (-), Atf-6β 
XBP-1 CRE, ERSE Atf-6 
XBP-1S CRE, ERSE Atf-6 (+) 
Nrf-2 ARE, MARE 
Atf-4 (+), c-Jun (+), JunB(+), cMaf, 
Maf-G, Maf-K (+) 
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3.2.3.1 CRMs with binding sites for Atf-4 in the GlyT-1a Promoter 
BZIP dimers with at least one Atf-4 subunit have been shown to interact at several stress 
response CRMs. These includes the amino acid response element (AARE), the 
antioxidant response element (ARE; consensus: G/CTGAC/T-N3-GC (A/G), the 
unfolded protein response element (UPRE), the ER stress response elements (ERSE-I, 
consensus: CCAAT-N9-CCACG and ERSE-II, consensus: AATTGG-N-CCACG) and 
the nutrient stress response elements. Hence, Atf-4 is widely accepted as an early regulator 
of downstream targets of the integrated stress response (ISR). As discussed earlier 
(Section 1.7), it is known to regulate the expression of several amino acid transporters and 
other genes downstream of amino acid limitation, unfolded protein accumulation, 
nutrient stress and ER stress.  
At the time of analysis 94 experimental observations of 66 unique physical interactions of 
human Atf-4 with other proteins were documented in the BioGrid database of protein 
interactions. Reported interactions include with zinc finger proteins, various enzymes, 
other transcription factors, including the subunit 2α of the eukaryotic elongation factor 
(eIF-2α), subunit 3 of RNA polymerase II (RNAPII-B3), pCAF/KAT-2B, polyubiquitin-
C and SUMO-3 all of which can facilitate Atf-4 activation and activity or its repression. 
Of the 66 unique interactions, 21 (~30%) are interactions between Atf-4 and other 
proteins containing a BZIP domain. For the analysis described here, only Atf-4 
interactions documented in the literature to be involved in stress responses were 
considered (Table 3.1). 
Ten putative CRMs including at least one site for Atf-4 were identified in the GlyT-1a 
sequence spanning 2000 bases upstream and 200 bases downstream of the TSS. (Figure 
3.11a CRMs are numbered 1 to 10 for convenience). Furthest from the GlyT-1a TSS, 
CRM 1 spans a 21 base pair region (-1975 to -1955), but includes a sense site for Atf-4 
(agCCTCAga) with 82.9% similarity to the V$ATF4_Q6 matrix. Overlapping the Atf-4 
TFBS in this module are an antisense site for C/EBPα, antisense sites for small Maf 
proteins and Nrf-2 and sense sites for c-FOS and JUN which together form the classic 
Ap-1 complex (See Figure 3.11a for matrix sequences and similarity scores).  
The significance if any, of the orientation of these TFBS within the putative CRMs is 
unknown. The approach used here relies solely on the assumption that the probability of 
occurrence of a TFBS in a given module relates to its probable biological function, i.e. in 
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the regulation of GlyT-1a. Crystal structures of the interaction of TF at symmetrical, 
asymmetrical or other composite DNA motifs reveal that interacting TFs within a 
complex may bind to opposite strands of the DNA (Guturu et al., 2013). This may explain 
the possible functioning of modules with significantly overlapping binding sites.  
A common feature across the ten identified CRMs is the sequence TGAC which is 
common to both the TRE (TGACTCA) and CRE (TGACgTCA) motifs. The only 
difference between the TRE and CRE consensus is the addition of a single guanine 
nucleotide between the first TGCA and the last TCA. Within CRM1 is the extended 
CRE/TRE like 12bp sequence TGACGgagccTCA, which differs from the originally 
defined CRE consensus by the intercalation of the pentamer GAGCC between the first 
TGACG and the last TCA halves. The ability for BZIP factors to resolve these differences 
and bind in response to external stimulus appears to be conserved throughout evolution 
(Jones and Jones, 1989). Near exact CRE/TRE-like elements like the one identified in 
this CRM are known to bind several BZIP factor configurations. These include binding 
sites for the proto-oncogenic factors FOS and JUN, and members of the CREB/ATF 
subfamily of BZIP factors (Busch and Sassonecorsi, 1990). 
Derivatives of the CRE and TRE have also been characterised as sites for the binding of 
Maf factors downstream of oxidative stress (Motohashi et al., 2004, Motohashi et al., 
2002). The extended antioxidant response element consensus (G/C)TGA(C/T)-N3-
GC(A/G) is believed to be a mash-up of several Maf recognition sites (Erickson et al., 
2002). The palindromic Maf recognition element or MARE is further divided into two 
kinds: the C-MARE (CRE-like) of consensus TGCTGA(GC/CG)TCAGCA and the T-
MARE (TRE-like) which has the consensus TGCTGAC(G/C)TCAGCA (Kurokawa et 
al., 2009). The core of the consensus MARE sequences bear striking similarity to the 
CRE/TRE-like element identified in CRM1 of the GlyT-1a sequence 
(TGACGGAGCCTCA). As this CRM contains binding sites for both Maf 
(cTGACGgagcc) with 75.6% similarity to the matrix V$MAF_Q6_01 and Nrf-2 
(CTGACggagcc) with 90.4% similarity to the matrix V$NFE2L2_01, we hypothesise that 
CRM1 may be important in the regulation of GlyT-1a downstream of oxidative stress.  
Between nucleotide positions 1900 and 1100 upstream from the GlyT1a TSS, five CRMS 
(CRM2, 3, 4, 5, and 6; Figure 3.11a, b) contain TFBS that may favour the binding of BZIP 
dimers between Atf-4 and members of the C/EBP subfamily (C/EBPα, C/EBPβ, 
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C/EBPε and C/EBPγ).  Whilst none of the respective sites overlap in either of these 
CRMs, the individual sites for either Atf-4 or C/EBP are all within a window not spanning 
more than seven bases. Closer inspection of the sequences within these modules 
highlights the occurrence of several TRE-like, CRE-like and CRE/Atf-like half sites 
(TGAGCCAT in CRM2; TCAGGAAG and TGATGCCTG in CRM6). Moreover the 
sequence similarity scores of the individual TFBS for the C/EBP proteins are greater than 
90% in most of these modules.  
Sequences identified in CRM4 (CCAGC-N7-CCAAG), CRM5 (GGAAT-GGACC) and 
CRM6 (GGAAT-G-CCTGG) bear some resemblance to the ERSE-I consensus 
(CCAAT-N9-CCACG; (Roy and Lee, 1999)). Repeats of the sequence GGAAN as seen 
in CRM5 (GGAAGgTTgtGGAAT) and CRM6 have been proposed to be required for 
the regulation of genes downstream of heat stress (Amin et al., 1988). The consensus 
CNGGAAN2TTCN2G defines the heat shock response element (HSRE; (Xiao and Lis, 
1988)). Such HSRE have been identified in the human and rat human oxygenase 1 (HO-
1) gene, as well as heat shock protein 70 (HSP70) and have been shown to regulate HO-
1 expression downstream of thermal stress (Okinaga et al., 1996). Hence, these CRMs may 
warrant further experimental attention for validation of their possible involvement in the 
regulation of the transcription of GlyT-1a. 
As illustrated in Figure 3.11b, CRM7 (ggTGAGGACTCAgg) is a short palindromic 
sequence of two TGAG halves, separated by an extra adenine (A) and guanine (G) base 
and flanked on either 3’ and 5’ ends by double guanine bases. Within these sequences is 
a reversed Atf-4 TFBS (ggTGAGGac) with 82.9% similarity to the V$ATF4_Q6 PWM 
as well as sites for cJUN and cFOS (see illustration for matrix similarity scores). Indeed 
this sequence resembles an extended TRE/Ap-1 consensus (TGA[G/C]TCA) and has 
been linked to the regulation of gene transcripts downstream of prolonged stress. Ap-1 
TFBS often feature in the gene promoter region of several genes activated in response to 
external stimuli.  
While studying the frequency distribution of Ap-1 TFBS in the human genome, Zhou 
and colleagues documented that although multiple genes had multiple sites for Ap-1 in 
their promoters there exist significant variations from the consensus (Zhou et al., 2005). 
Two such variations include the A-TRE (TGAATCA), which differs from the TRE in 
that the fourth cytosine in the consensus is substituted for an adenine and the AA-TRE 
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(TGACTAA). Frilling et al., reported on the occurrence of two adjacent TRE/Ap-1-like 
sites (TGACATTGC and TGACAAAGC) in the promoter region of glutathione s-
transferase (Friling et al., 1992). In the later study, these Ap-1 like sites, when cloned 
upstream of the chloramphenicol acetyltransferase (CAT) coding sequence and 
transfected into HepG2 cells, generated significant reporter activity following 24 hours of 
either 30µM tert-Butylhydroquinone (tBHQ) or 50µM β-napthoflavone treatment. The 
authors concluded that these two sites may constitute a CRM required in the response to 
oxidative stress and labelled these sites as electrophile or antioxidant response elements.   
An AA-TRE/Ap-1-like site of sequence (TGACCAA) was identified in the putative 
CRM8 of the GlyT-1a promoter (Figure 3.11c). This site overlaps a sense Nrf-2 binding 
site of sequence CTGAccaagcc with 91% similarity to the V$NFE2L2_01 matrix. 
Likewise within CRM8 are sites for Maf, cFOS and cJUN. Seven bases upstream from 
the Nrf-2 consensus is a sense binding site for Atf-4 (caCCTCAaa) which has 90.09% 
similarity to the Atf-4 matrix used. 
Two additional modules CRM9 (between -21 and +2 from the TSS) and CRM10 (in exon 
1 between +104 and +134) within the Glyt-1a promoter contain sites for the C/EBP 
proteins (C/EBP-α, C/EBP-β, C/EBP-ε and C/EBP-γ) all with more than 90% similarity 
to the consensus sequence. Data from the ENCODE project suggest that the C/EBP-β 
site identified here in CRM10 by computational means is indeed a true binding site. Using 
a specific antibody to C/EBP-β (sc-150; Santa Cruz) ChIP-seq peaks revealed significant 
enrichment of the transcription factor at the sequence AAGAAAGCCACC of GlyT-1a 
from human embryonic stem cells (H1-hESC). There is no data to suggest that Atf-4 may 
interact at the other half site as at the time of analysis only 116 TF not including Atf-4 
had been analysed in the ENCODE project. Nonetheless such validation of the C/EBP-
β site identified here by computational means offers additional confidence to the 
possibility of biological significance of the other CRMs. Within CRM 10 is an antisense 
Atf-4 binding (gcTGATCa) site with 89.5% similarity to V$ATF4_Q6. 
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  -2000 CCCTAGGTTA GTCCCCAAGC CTTCCTCTTT CTGACGGAGC CTCAGAGGGC 
  -1950 TGGCCCCTGA GCACCCATCC TCCTCTCTTC TAACAGCCCA GGCCCCAAGC 
 
  -1900 CCCTAGGCCT GAGGGCATCC TGGAAGTCTG GCTTGCAGCA CCCTACACCT 
 
 
 
 
 
 
 
  -1850 GCCTCCCTTC ATATGGATTC CCTGAGCCAT GAAAACTCTC GGAATCTTCA 
  -1800 CTGAGTGTTC TTAGCGCTCA GTGCCCTCTT CTAGGCCTGT CCCCACCCCA 
 
 
 
  -1750 GCCTACTGCT GGAAGGGAGA AGGAGGGAGG CCTTTTCCCC TTCATACTCT 
 
 
 
  -1700 TCCTTGTCCG CCTTCCTCTA CTTGGGGGCC TCTTCGACAT CCTCCATCTG 
 
 
 
 
  -1650 CCTTCCCTGG GGTGGTATCC CTTTTGATGA GCCCCAGCGA GGAGGCAAGG 
  -1600 AGGAAGATCC TAAAAAAAAC TTATGGAGGA AGTTACGTCC TGGCAGGAGA 
  -1550 GATATAGAGG GCTTGGACCC CATCTGCCCA GTCCCAGGAA TTGAGCACAC  
  -1500 ACATAACTAC ACAGACCTGC TGCAGTGCAC ACAATCAGTC TTCCACAGAT 
  -1450 GTACCTACAC AAATACACAA TCGGGGCTCA GGTGTCTGGG GGCACAGACA 
  -1400 CAACAGGTTG CCTAGATCCA GGTGTGTGTG CACACAACTC ACGCAAGAAA 
  -1350 CACCTGCACT TGGCTTGTAG GAGACTAAAA ATCCCAAACA TGCTATACCT 
 
 
Figure 3.11a: Predicted CRMs with Atf-4 TFBS between 1300 and 2000 bases upstream 
of the GlyT-1a transcriptional start site (TSS). In this region of the GlyT-1a flanking 
sequence, four putative CRMs were identified using the TRANSFAC Composite 
Module Analyst Tool. Composite models were designed to capture sequences with at 
least 80% similarity to PWMs for Atf-4 and one other known interacting partner. 
Matrix-similarity scores are shown on the annotations together with the matching 
sequences included in brackets. Matrix core sequences are capitalised. Numbering is 
with respect to the transcriptional start site of GlyT-1a. 
 
 
0.816 (cccTTCAta) 
+CEBPb (+) 
 
 
 
 
 
0.919 (tcTTTCTgacgga) 0.829 (agCCTCAga) 
0.829 (agCCTCAga) 0.896 (TGACGgag) 
0.904 (gCTTGCagcacc) +ATF4 (+) 
0.816 (cccTTCAta) 0.926 (gATTCCctga) 
0.829 (agCCTCAga) 0.934 (TGACGg) 
0.816 (cccTTCAta) +CEBPG (-) 
0.829 (agCCTCAga) 0.756 (cTGACGgagcc) 
0.816 (cccTTCAta) 0.926 (gATTCCctgagc) 
0.816 (cccTTCAta) 
0.828 (cTGCCTccctt) 
0.829 (agCCTCAga) 0.904 (CTGACggagcc) 
ATF4_Q6 
CEBPA_Q6 
FOSL1_01 
CEBPB_Q6 
CEBPE_Q6 
CEBPG_Q6_01 
CFOS_Q6 
CJUN_Q6 
MAF_Q6_01 
NFE2L2_01 
0.816 (cccTTCAta) 0.880 (ccctgAGCCAt) 
+Atf-4 (+) 0.924 (cCTTCCtcta) 
CRM 1 
0.816 (cccTTCAta) +CEBPE (+) 
+Atf-4 (+) 0.853(ccgcCTTCCtctac) 
0.822 (ttTGATGag) 0.925 (cgaggaGGCAAgg) 
0.822 (ttTGATGag) 0.866 (ggaGGCAAGg) 
0.822 (ttTGATGag) 0.863 (cgaggAGGCAa) 
CRM 2 
CRM 3 
CRM 4 
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  -1300 ACTAGGTTTG GGGACAAAGT AAAAGTGAAA ATAATCTCGC TGATAAGACT 
  -1250 AAGGTGTCTT CCCAGATCTG ATCAGGAGTC CAATGTGAAT AGGAGACAAC 
 
 
 
 
 
  -1200 AGAGAGCTGT CTTTGTACTT TGGCTCTGAG GAAGGTTTGT GGAATGGACC 
 
 
 
 
 
 
  -1150 GCGTGTGGCC TGAGAGAGCT CGCATTTCAG GGAATGCCTG GGCTTGATGC 
  -1100 CTGTTATCTT GTTCAGTGCC TCTGATAAAT TAATAAACTG GAATCTCACT 
  -1050 CAACAATTGG TTTCACGTGA GTTTGGCATG TGTGCACTCG CTTCTTGGAG 
  -1000 GCTGACTGTC CCAAGGAAAA AAATTAAACT GTTTCCTGGC CAGAAAATGG 
 
 
 
 
 
   -950 TGAGGACTCA GGGTCCAAAG TAGAAATTGC CTCTGTGGGC TGGGCCCCTT 
   -900 CCCTGAGCAG ATGCCCTACT CAGGTTGGGG CAAAAACCAG TTCCTCTGAC 
   -850 AGAACTAACT GGCCACTCTC CATGAAAGGT GGTGGCTCTC ACAAGGTATG 
   -800 CAAATGTGGG AGGCTCATTC CAAATGCCAG CCACCACTCC CCAGAGGCAG 
   -750 CCTGGAGCAA TGGGCTTTAT ATACACACAC ATGCATTTCC TTAGCCCCTT 
   -700 CTCTCTGTTT CACAGAGGAG GAAACCGAGG CTCACCATGC TCCTTTTGGC 
   -650 AAAGACTCTT TTTTAGCTGA GATTGTAACC CAGGTCTGTC TCACCATGGA 
 
 
Figure 3.11b: Predicted CRMs with Atf-4 TFBS between 1300 and 650 bases upstream 
from the transcriptional start site (TSS). In this region of the GlyT-1a flanking sequence, 
four putative CRMs were identified using the TRANSFAC Composite Module Analyst 
Tool. Composite models were designed to capture sequences with at least 80% 
similarity to PWMs for Atf-4 and one other known interacting partner. Matrix-similarity 
scores are shown on the annotations together with the matching sequences. PWM core 
sequences are capitalised. Numbering is with respect to the transcriptional start site of 
GlyT-1a. 
 
 
 
 
 
 
0.836 (tcTGAGGaa) 0.977 (ggtttgTGGAAtg 
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0.829 (ggTGAGGac) 
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CEBPA_Q6 
FOSL1_01 
CEBPB_Q6 
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CEBPG_Q6_01 
CFOS_Q6 
CJUN_Q6 
MAF_Q6_01 
NFE2L2_01 
CRM 7 
CRM 6 
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   -600 AGGAGGAGGG ATCCCAGGTT GGTGTCTGCA GCCCCTGTAA CACCACCTCA 
    
 
 
 
 
   -550 AAAGTAGAGC TGACCAAGCC GGTGGTCCAG GAGGGAAATT TGAGAAAGGG 
   -500 CTACCCCGAG CCCTCCAGTT CCAAGGAGTA GGACCTAGGC CTTACCCAGC 
   -450 AATGCCCACA GTCTCTAGCG GCTCTGCTCC AAAGGGAATG GAATTTGCTC 
   -400 TGACTTCTCT CTAGGGGAAA CGCAGGCGCA GAAGGCCAGG GGCCTGGAGG 
 
   -350 GCTAACTCCA GCCTCAGCCC CCCATAGTGC CCCAGGCCTT CTGGCTTCAT 
   -300 TCCAGCCTAG CCCGAAGGGG CCCACATCTG CTTGCTCAAG GGCCCCAGCT 
   -250 GGAGGGCAGC GAGGCAGGGG CGGAGAAGGG GACTCCTTTG TGGCGCTCAC 
   -200 TCCCAGGGGT TCGTGGGGAT CAATCATCTG AAAGCTGGAG AGACTTGTAA 
   -150 TTTTATTCCC TGGGAGGAGG AGCCTGAGAA GTCGGCACGG GAGGAGGGGA 
   -100 TGGGATGGAG AGGGGAGGAC GGCCAGGGGA GCCGTTCGGG TAGGGGAGGG 
 
 
 
 
 
    -50 ACTTGGCTAG ATCTCCCAAG CCTTCTCCAC TCTTCAAACT TTCACCAAAC 
     +1 TCTTAGCCCC CGCCTCCCCG AAACCAAAAC ACAACAGGCT GTGGAAGAGC 
    +51 TGCGAGCGGC GCGGCGGGGC GGGCGAACTC GGCGCGGCAC AGAGCCTCGG 
 
 
 
 
 
   +101 GAGGCTGATG CAACTTTCCC TTTAAGAAAG CCACCTGGGC GCACCGCGGT 
   +151 GCGGACCCAG CACGCCTGGG CCGGGGGCTG CAGCATGGTA AGGGGGCTGG 
 
 
Figure 3.11c: Predicted CRMs with Atf-4 TFBS between 600 bases upstream to 200 
bases downstream from the GlyT-1a TSS. In this region of the GlyT-1a flanking 
sequence, four putative CRMs were identified using the TRANSFAC Composite 
Module Analyst Tool. Composite models were designed to capture sequences with at 
least 80% similarity to PWMs for Atf-4 and one other known interacting partner. 
Matrix-similarity scores are shown on the annotations together with the matching 
sequences included in brackets. PWM core sequences are capitalised. Numbering is with 
respect to the transcriptional start site of GlyT-1a. 
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0.807 ctCTTCAaa) 0.915 (aCTTTCaccaaa) 
0.887 (gatctcCCAAGc) 0.807 ctCTTCAaa) 
0.895 (gcTGATGca) 0.931 (ctttaaGAAAGc) 
0.909 (caCCTCAaa) 
0.909 (caCCTCAaa) 
+Atf-4(+) 0.929 (TGACCa) 
0.909 (caCCTCAaa) 
0.864 (ggCTTCAtt) 0.794 (gTGCCcaggc) 
0.909 (caCCTCAaa) 
+Atf-4(+) 0.910 (CTGACcaagcc) 
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CRM 10 
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3.2.3.2 CRMs with binding sites for Nrf-2 in the GlyT-1a Promoter 
At the time of analysis 189 experimental observations of 56 unique direct physical 
interactions of human Nrf-2 (NFE2L2) with other proteins were documented in the 
BioGrid database. These include, as expected, interactions with KEAP-1 and Cullin-3 
which are known to sequester the protein in the cytoplasm and mediate its degradation 
via ubiquitination. Interactions with Atf-4, Maf-G and Maf-F amongst many other BZIPs 
are catalogued. Physical interactions between Nrf-2 and several kinases have also been 
reported leading to the speculation that Nrf-2 may directly be activated by the same 
kinases which result in the phosphorylation of eIF2 and the activation of Atf-4. In this 
analysis, only interactions documented in the literature to be involved in the stress 
response were considered (Table 3.1). 
In the computational search for CRMs involving Atf-4, two sites for possible Atf-4 and 
Nrf-2 interaction were identified (CRM1 and CRM8; Section 3.2.3.1). To determine if 
additional modules with binding sites for Nrf-2 and other dimerisation partners existed 
in the sequence, composite models of Nrf-2 and six other BZIP factors (Table 3.1) were 
used to scan the GlyT-1a flanking sequence under investigation. Aside from CRM1 and 
CRM8 which contain binding sites for both Nrf-2, Atf-4 and small Maf proteins 
(discussed above), no additional CRMs with binding sites for Nrf-2 were identified either 
in the 2000 bases upstream of the TSS, the first exon, or the untranslated region of the 
second exon of GlyT-1a. 
3.2.4 Phylogenetic foot-printing of putative GlyT-1a CRMs  
Although occurring within relatively conserved regions, the putative GlyT-1a CRMs 2-7 
and 9 showed significant variations within the primate phylogenetic scope (Data not 
included). These variations suggest a faster evolution of these sequences when compared 
to other putative functional regions such as CRM1, CRM8 and CRM10. The observation 
that functional regulatory motifs within the promoter regions evolve at much slower rate 
than background sequences, elevates the usefulness of cross-species comparative 
genomic analysis (Wasserman and Sandelin, 2004). Given that highly conserved non-
coding sequences within homologous genes represent areas of significant selective 
pressure, analysis beginning or ending with phylogenetic foot-printing of homologous 
promoter sequences by means of local and global alignment algorithms can lead to fewer 
false positive when identifying regulatory motifs solely from the use of PWMs. Several 
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multiple sequence alignment (MSA) programs like the classic command line (CLI) library 
CLUSTAL software family including CLUSTAL X, CLUSTAL W and more recent 
CLUSTAL Ω, MUSCLE (Multiple Sequence Comparison by Log-Expectation), MAFFT 
(Multiple Sequence Alignment based on Fast Fourier Transform) and T-COFFEE (Tree-
based Consistency Objective Function for alignment Evaluation), enable the discovery of 
conserved motifs based on the evolutionary biological relationships between multi-
aligned input sequences. Practicality, for instance in terms of speed of execution or 
biological accuracy determines the suitability of any one of these alignment programs, 
each of which employs distinct progressive or iterative statistical evaluations to determine 
the most biologically relevant relationship with maximum parsimony (maximum 
likelihood or simplest assumption) between two or more sequences. Biological accuracy, 
whilst unrelated to speed of execution is dependent on several factors, including the 
number of sequences being aligned, sequence lengths and method specific parametric 
differences. Given that phylogenetic footprinting analysis are based on the assumption of 
similarities in conserved sequences across assumed orthologous species, any overlooked 
differences in base-wise conservation do not necessarily mean a non-functional regulatory 
motif. In a clustering analysis of such highly degenerate yet experimentally validated 
TFBSs in the mammalian genome, Zhang et al observed a non-random distribution of 
mismatches, conserved across orthologs in a manner that was significantly more than 
expected by chance (Zhang et al., 2006). Based on the very statistical nature of 
phylogenetic analysis it is possible that regulatory motifs go unidentified where there is 
no sufficient ancestrally relevant input data or over-reliance on base-wise conservation. 
False negatives from phylogenetic footprinting analyses could result from a large 
evolutionary separation (across multiple speciation events) between input sequences.  
Several attempts have been made to qualify and quantify the relationships between 
sequence conservation and function (Duret et al., 1993, Roy et al., 2013); Reviewed in 
(Cooper and Brown, 2008). To date, there exists no exact measure of correlation between 
these two variables (a measure of the strength and efficacy of natural selection). In fact 
one of the highlights of the ENCODE project was the discovery of several regulatory 
modules not within highly conserved regions. Cooper et al argue that the false discovery 
rate (FDR) from comparative genomic approaches may be down to several technical 
challenges as well as the phylogenetic scope used in such analysis (Cooper and Brown, 
2008). In this study, orthologous GlyT-1a sequences from 56 vertebrate species (as listed 
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in appendix A.3) were aligned using the MAFFT algorithm to assay the conservation of 
the CRMs identified as described in section 3.2.3.  
3.2.4.1 Conservation of putative GlyT-1a CRM1 across vertebrate species 
As illustrated in Figure 3.12, the CRM1 sequence is highly conserved within the primate 
subset of the phylogenetic scope analysed. Using a similar method as described by 
(Hestand et al., 2008) the calculated conservation score of primate CRM1 amounts to 
95.21%. Fourteen of the twenty-one bases of CRM1 have 100% conservation across the 
12 primates analysed. The least conserved base in the primate subgroup is the guanine at 
position 11 of the CRM sequence, where it is substituted for an adenine in four out of 
the 12 species (i.e. 66.6% conservation). The preceding cytosine at position 10 of the 
CRM is also substituted for a thymine in three of the 12 primate species analysed (i.e. 
75% conservation score). The Atf-4 binding half site within this module of sequence 
(agCCTCTGAga) is extensively conserved, suggesting it may be an important functional 
region in primates. Including other divergent species to the phylogenetic analysis suggest 
that this composite module might have evolved under relaxed structural and evolutionary 
constraints in a manner that is consistent with billboard CRMs (See Figure 1 in Meireles-
Filho and Stark (2009)). The flexibility in function of billboard CRMs often coincides with 
characteristic flexibility in structural conservation of the individual TFBS. In CRM1 
despite the absence of the full motif in the guinea pig sequence, some of the marsupials 
and Sarcopteryggi species, a CRE/ATF-like binding sequence (in the second half of the 
module) has been maintained throughout a larger evolutionary timespan. As argued by 
Miereles-Filho et al, billboard motifs such as CRM1 gain other TFBS which often are sites 
for interacting partners to proteins which bind at the maintained site (Meireles-Filho and 
Stark, 2009). Such CRMs may appear ‘shuffled’ over large evolutionary timespans. Such 
shuffling of TFBS for BZIP factors coincides with the fact that most metazoan BZIP 
factors are able to recognise composite sites with either CRE-like, TRE-like, MARE-like 
sequences and CCAAT half sites whilst ancestral BZIPs only recognise either CRE and 
TRE motifs (Deppmann et al., 2006, Amoutzias et al., 2007). Reinke et al. (2013) show that 
interactions between Atf-4, Mafs, and cap and collar (CNC) factors like NFE2 have only 
‘recently’ been acquired. 
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Figure 3.12: Conservation of the putative CRM1 across 56 vertebrate species. Spaces in 
the sequence represent gaps whilst adjacent bases are indicated with a dash (-). See text 
for discussion (section 3.2.4.1 page 104) 
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3.2.4.2 Conservation of putative GlyT-1a CRM8 across vertebrate species 
As illustrated in Figure 3.13, there is extensive conservation of the CRM8 sequence over 
a much larger phylogenetic scope, when compared to CRM1. The 28bp GlyT-1a CRM8 
sequence has a conservation score of 93.72% across the twelve primate subgroups 
studied. When just the individual TFBS in the module are considered, the identified Atf-
4 binding sequence in this putative module (caCCTCAaa; which has a 90.9% similarity to 
the V$ATF4_Q6 PWM) has 95.41% conservation, whilst the Nrf-2 binding sequence 
(CTGACcaagcc; which has a 91.01% similarity to the V$NFE2L2_01 PWM) has 89.34% 
conservation rate amongst primates. The heptamer AGTAGAG which separates the 
putative Atf-4 binding site from the Nrf-2 half site in this module has a 97.6% 
conservation rate across the twelve primate species studied.  
Extending the conservation analysis to include 31 species diverging from the 
supraprimate (euarchontoglires) and placental mammal (laurasiatheria) clades, reveals that 
the TFBS for the Nrf-2 sequence is maintained over these phylogenetic scopes (77.77% 
conservation). Conservation for the Atf-4 site in this sub-scope is only 27.24%. The 
significance of the seven base pair region separating the Atf-4 site from the Nrf-2 site in 
this module is unknown given that no factor which binds it was found in the CRM 
analysis. This heptamer sequence has a conservation score of 67.28% across the scope of 
these 31 species (59.69% across all 56 species analysed). 
The human GlyT-1a putative CRM8 sequence was not detected in rat, wallaby, platypus, 
American alligator or lamprey. As is the case with CRM1, the conservation pattern of 
CRM8 across vertebrate speciation events suggests that the binding site for Nrf-2 may 
have been maintained whilst a binding site for Atf-4 was gained only late in evolution and 
found only in primates. Three ways by which regulatory modules might gain TFBS include 
via the insertion of transposable elements, chromosomal rearrangement and de novo 
mutations (Rubinstein and de Souza, 2013). Rubinstein et al argue that whilst these events 
may lead to TFBS shuffling within the module without altering ancestral expression 
patterns, the acquisition of novel TFBS to a module might provide an additional spatio-
temporal domain for gene regulation. For instance the gaining of a silencer site for the 
binding of a repressor protein by a CRM might enable a feedback opportunity to switch-
off the expression of the regulated gene from an already present activating TFBS (Ochi 
et al., 2012).  
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Figure 3.13: Conservation of the putative CRM8 across 56 vertebrate species. MAFFT 
alignment of 56 orthologous species reveals extensive conservation from small mammals 
to primates. Spaces in the sequence represent gaps whilst adjacent bases are indicated with 
a dash (-). Note the complete absence of this module in rat GlyT-1a, as well as the absence 
in Sarcopteryggi and small mammals. See text for discussion  
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3.2.4.3 Conservation of putative GlyT-1a CRM-10 across vertebrate species 
The 32 bases of the putative GlyT-1a CRM10 are within the first non-coding exon of 
GlyT-1a and as shown above contains binding sites for Atf-4 and several C/EBP BZIP 
factors. Conservation of this CRM was analysed across 56 orthologous GlyT-1a species.  
Amongst the primate phylogenetic scope it has a conservation score of 98.44% (Figure 
3.14). With the exception of the American lizard and the lamprey, the CRM10 sequence 
is extensively conserved in the remaining 54 GlyT-1a orthologs analysed (96.37% 
conservation). The Atf-4 half site of the sequence (gcTCATGca) is unchanged in 51 of 
the 56 species. The first guanine of the Atf-4 site is substituted for an adenine in sheep 
and a cytosine in the GlyT-1a sequence from American alligator and lamprey. It is 
completely missing in the gibbon (primate) and platypus. A similar conservation pattern 
is noted in the C/EBP (AAGAAA--GCCACC) sites. 
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Figure 3.14: Conservation of the putative CRM10 across 56 vertebrate species. MAFFT 
alignment of 56 orthologous species reveals extensive conservation from small mammals 
to primates. Spaces in the sequence represent gaps whilst adjacent bases are indicated with 
a dash (-). Note the American alligator TGCCCG sequence which separates the first two 
halves and the insert “AA” in the hedgehog sequence.  
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3.3 Stress Induced Regulation of GlyT-1a gene 
Ten putative composite regulatory modules (CRMs) have been identified in the GlyT-1a 
flanking sequence and 5’UTR by bioinformatics analysis (Section 3.2.3). These include a 
potential amino acid response element (AARE; of sequence TGACTGCAAC) in CRM10 
of the first exon and an electrophile or antioxidant response element (EpRE/ARE; of 
sequence CTGACCAAGCC) in CRM8. To determine if these and other CRMs of the 
GlyT-1a promoter respond to various stress treatments in vitro, reporter constructs of 
representative GlyT-1a sequences cloned upstream of the β-galactosidase coding 
sequence in a reporter plasmid were generated as discussed in Section 2.5.1 (Page 59).  
A reporter construct (pG1PromE1) that contained 1159 bases of GlyT-1a genomic 
sequence upstream of the TSS and the whole of the 187 base first exon of GlyT-1a linked 
to a β-galactosidase reporter gene was generated and validated by sequencing (Figure 
3.15). As the first exon of GlyT-1a contains the translation start codon (ATG) of an 
upstream open reading frame (uORF), the sequences were cloned in frame so as to allow 
for the expression of β-galactosidase only from its start codon. Despite the presence of 
the predicted AARE in this construct, no significant difference in β-galactosidase activity 
was noted between Caco-2 cells transfected with this construct (pG1PromE1), those 
transfected with a promoter-less, ‘empty’ β-galactosidase vector (pNoPromLacZ) or in 
un-transfected control cells. Treatment of transfected Caco-2 cells for 16 hours with 1µM 
tunicamycin had no additional potentiating effect on the β-galactosidase activity (Figure 
3.16). 
A possible explanation for the lack of activity of this construct is that the AARE functions 
as a ‘billboard’ type CRM requiring a collection of other TFBS working in concert to 
produce the desired transcriptional outcome. In other words, additional sequences not 
included in the promoter construct may be required for effective functioning of the 
AARE of exon 1. Indeed, such an observation has been previously reported for the 
AARE elements of Cat-1 (Fernandez et al., 2003). In the latter study, Fernandez and 
colleagues showed that although the Cat-1 gene contains an AARE downstream of its 
TSS (precisely, in its first exon) when C6 glioma cells were transfected with a Cat-
1/luciferase reporter construct spanning 1.4kb upstream of the TSS and including exon 
1, no difference in activity was observed between stressed and unstressed states. Results 
from the same study showed that replacing the exon 1 sequence with the complete Cat-1 
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5’-UTR which consists of exons 1, 2 and part of exon 3 (which contains the Cat-1 
translational start codon) resulted in significant increases in expression from this 
construct in starved over fed states. 
 
 
 
 
Figure 3.15: Illustration of the flanking region of the GlyT-1a gene(upper), showing the 
locations of the identified composite regulatory modules (CRMs). The GlyT-1a first and 
second exons are interrupted by a 6.9kb intron. The derived reporter construct 
pG1PromE1 (lower) was obtained from cloning the GlyT-1a flanking sequence amplified 
from genomic DNA using a sense primer (Primer 1) and reverse primer (Primer 2). 
Features are numbered relative to the transcription start site (TSS) and the position of a 
putative amino acid response element (AARE; TGATGCAAC) and electrophile or 
antioxidant response elements (EpRE/ARE) are given. Primers 3 and 4 were used for 
generation of a second construct as discussed below. 
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Figure 3.16: No activity is observed with construct pG1PromE1. Bars show the relative 
basal and stressed induced β-galactosidase activity from Caco-2 cells transfected with the 
pG1PromE1 that contains a sequence representative of the GlyT-1a promoter (-1159 
bases upstream of the transcription start site and exon 1 only). In the absence of stress, 
cells transfected with the pG1PromE1 construct had comparable β-galactosidase activity 
to the untransfected cells this was not increased following the induction of stress with 
tunicamycin. No difference in β-galactosidase activity was observed between 
pG1PromE1 and the promoter-less ‘empty’ plasmid (pNoPromLacZ). Data are pooled 
from two experiments each of three experimental replicates (N=2, n=6) and shown here 
as percentage mean ± SEM relative to the average activity from the un-transfected 
unstressed control (No Plasmid). Reporter activity was determined by CPRG assay as 
described in the Section 2.5.4  
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The stochastic model for the arrangement of sites in a given CRM postulates that the 
occurrence of TFBS only increases the probability that the gene may be regulated by 
factors which bind to them (Walters et al., 1995). This model also suggests there is no 
correlation between the binding of a TF to its binding site and the calibre (rate or 
intensity) of expression. The rheostatic response model on the other hand postulates that 
TFBS in a given CRM work in concert to produce an outcome with calibre that is 
dependent on TF occupancy of all the required sites. Indeed Sato and colleagues 
demonstrated that mutation of one of the two AAREs (which are separated by just nine 
bases) in the flanking sequence of the mouse xCT gene, resulted in a reduction in reporter 
activity from luciferase constructs (Sato et al., 2004).   
Motivated by the Cat-1 observations described above, and on the assumption that 
additional TFBS, possibly located in the UTR of the second exon of GlyT-1a might be 
required for optimal functioning of the predicted AARE in the GlyT-1a first exon, a 
second reporter construct (pG1Prom5U) was generated. As described in section 2.5.1, 
the insert cloned to pG1Prom5U was generated using ligated mediated PCR (LMPCR) to 
join two PCR products. The first product, containing a sequence spanning 1159 bases 
upstream of the GlyT-1a TSS plus the entirety of exon 1 (187 bases) was generated from 
genomic DNA (Figure 3.17). This was ligated to a second PCR product amplified from 
cDNA to include the GlyT-1a exon 1 and first 86 bases of exon 2 (Figure 3.18). The 
resulting 1431 base pair product was cloned upstream and in frame of the β-galactosidase 
coding sequence and the resulting pG1Prom5U validated by sequencing.   
Transfecting Caco-2 cells with the pG1Prom5U reporter construct resulted in β-
galactosidase activity that was significantly increased when cells were treated with 1µM 
tunicamycin for 16 hours when compared to the transfected unstressed control, but also 
to the activity measured when cells were transfected with the construct pG1PromE1 
(Figure 3.19). Whilst it is impossible to ascertain from this experiment if the additional 86 
bases of the UTR of exon 2 of GlyT-1a contain all the TFBS required for effective 
functioning of CRM10 these data suggest that an element or elements in this sequence 
are required for its activity. Taken together, this suggests that downstream of ER and 
UPR stress TF occupancy possibly at both the AARE of exon 1 and at least one other 
TFBS in the UTR of exon 2 are sufficient to enhance transcription of GlyT-1a.  
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Figure 3.17: Illustration showing the features of the pG1Prom5U reporter (lower) 
amplified from the GlyT-1a flanking sequence (upper). Primers 1 and 2 were used to 
amplify the promoter region from genomic DNA while primers 3 and 4 were used to 
amplify the UTR of exons 1 and 2 from cDNA. The resulting PCR products were joined 
by ligation mediated PCR to generate an insert which was cloned upstream of the β-
galactosidase coding sequence (lacZ). Features are numbered relative to the TSS and the 
position of a putative amino acid response element (AARE) and electrophile or 
antioxidant response elements (EpRE/ARE) are given. 
L 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  
 
 
 
 
 
Figure 3.18: Gel image showing individual PCR products and the pG1Prom5U insert  
Band sizes were determined using the 1kB O’Gene Ruler ladder in lane 1. A 272 bp band 
(lanes 3-6) represents the uninterrupted UTR of the first and second exons amplified 
from GlyT-1a cDNA. Lanes 8, 9 and 10 show a 1346bp product representing the GlyT-
1a flanking sequence amplified from genomic DNA. The two PCR products were ligated 
by LMPCR and cloned upstream of the β-galactosidase coding sequence. Lanes 12 and 
14 show the resulting recombinant pG1Prom5U plasmid. Lanes 13 and 15 show the insert 
cut from the pG1Prom5U using endonucleases flanking each side of the cloned insert on 
the plasmid. 
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Figure 3.19: The full GlyT-1 5’UTR is required for stress induced reporter activity. Bars 
show the relative unstressed (open bars) and stressed (closed bars) induced activity of 
GlyT-1a promoter reporter constructs when transfected into Caco-2 cells. A reporter 
construct containing the GlyT-1a flanking promoter sequence (1159 bases upstream of 
the TSS) and the full 5’UTR (i.e. the whole of exon 1 and the first 86 bases of exon 2), 
but excluding intron 1 (pG1Prom5U) shows a significant increase in relative β-
galactosidase activity in tunicamycin stressed Caco-2 cells; this when compared to the 
unstressed and un-transfected control samples but also when compared to a construct 
containing just the flanking promoter and exon 1 (pG1PromE1). Data are pooled from 
two experiments each with three experimental replicates (N=2, n=6) and shown here as 
percentage mean ± SEM relative to the average activity from the un-transfected and 
unstressed control (no plasmid). Reporter activity was measured by CPRG assay as 
described in Section 2.5.4. One-way ANOVA was used for multiple comparisons. *** 
indicates a P-value of < 0.005. 
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It is important to note that the sequence arrangement of the pG1Prom5U excludes the 
large 6.9kb intron which interrupts the first and second exon of GlyT-1a on the genome. 
Whilst introns have previously been considered to be part of ‘junk’ DNA their 
significance as important sites for gene regulation are recently being elucidated. From 
work by Li et al. (2012), it was concluded that the first introns of eukaryotic genes are 
generally larger, richer in CGIs and contain more basal regulatory elements (BREs) such 
as TATA boxes and CCAAT boxes than other intron locations. The functionality of 
additional AARE elements identified in the GlyT-1a first intron is assayed and discussed 
later (Section 3.4, page147). To determine if the arrangement of TFBS contained in the 
pG1Prom5U construct were sufficient for transcriptional induction of GlyT-1a following 
other stress types including oxidative stress and nutrient stress, Caco-2 cells were 
transfected with this reporter construct and subjected to DEM, tBHQ, and thapsigargin 
challenge and amino acid and or glycine starvation.  
3.3.1 Glyt-1a Promoter activity in response to oxidative stress 
The doubling of GlyT-1a mRNA abundance in Caco-2 cells following DEM treatment is 
evident from QPCR analysis of RNA extracted from stressed Caco-2 cells (Figure 3.1, 
page72). The pattern of changes in GlyT-1a mRNA expression following DEM treatment 
is consistent with that for xCT. A founding hypothesis for the work discussed here 
proposed that the transcription of GlyT-1a downstream of oxidative stress, like that for 
xCT is mediated by Nrf-2. Therefore we sought to determine if downstream of oxidative 
stress GlyT-1a mRNA expression is regulated via elements contained in the CRMs 
included in the reporter construct pG1Prom5U. 
3.3.1.1 Regulation by Di-ethylene Maleate (DEM) 
Treating Caco-2 cells transfected with the pG1Prom5U reporter construct with 0.2mM 
DEM for four hours resulted in a doubling of reporter activity when compared to the 
transfected and unstressed control, but also to cells transfected with the promoter-less 
construct pNoPromLacZ (Figure 3.20). DEM has been shown to effectively deplete 
glutathione levels resulting in heightened predisposition to oxidative stress (Mitchell et al., 
1983). As discussed elsewhere in this text, a knock on effect of increased oxidative stress 
is the expression of typically antioxidant transcription factors such as Nrf-2. Whilst the 
subsets of target genes for both Nrf-2 and Atf-4 may overlap, it is possible that as to 
whether these transcription factors result in activation or repression of the target depends 
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on the nature of the stressor. For instance, CHOP, a gene known to be regulated by 
amino acid availability via multiple AAREs in its promoter is known to be activated by 
Atf-4 but also potentially repressed by Nrf-2 activation (Zong et al., 2012).  
Nrf-2/Atf-4 dimers have been described in the literature (He et al., 2001, Reinke et al., 
2013). As to whether the interaction of these BZIP dimers at distinct TFBS mediates 
activation or repression of the given gene transcript is arguable. That Nrf-2, upon 
activation, binds to and sequesters Atf-4 from interaction at functional AARE or other 
functional sites of a given CRM is a possible explanation to the ‘competitive’ repressive 
properties of Nrf-2. Downstream of oxidative stress, Nrf-2 is most frequently known to 
dimerise with small Maf proteins for the transcriptional activation of genes via ARE (Li 
et al., 2008). However, He and colleagues, showed that hepatoma cells derived from 
dominant negative mouse mutants of either Nrf-2 or Atf-4, and transfected with a 
luciferase fusion construct of ARE containing sequence from the haem oxygenase (HO-
1) gene, had reduced reporter activity following CdCl2 treatment (He et al., 2001). This 
suggests that there may be an equally important requirement for both Atf-4 and Nrf-2 in 
regulating HO-1 expression from this ARE. As to whether the two interact at the same 
ARE as a heterodimer cannot be determined from the above study. There is no published 
evidence that Nrf-2 and Atf-4 dimers interact at AARE.  
Although the reporter activity observed from pG1Prom5U is significantly increased with 
DEM treatment, the magnitude of increase is less than that observed in tunicamycin 
treated cells. This is possibly due to the differing mode of actions of these stress inducing 
compounds. Given that DEM and not tunicamycin induces Nrf-2, could this be a specific 
effect of Nrf-2 at particular antioxidant response elements in the GlyT-1a sequence?  
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Figure 3.20: GlyT-1a promoter activity after DEM treatment in Caco-2 cells Confluent 
monolayers of cells were exposed to 0.2 mM DEM for 4 hours, 24 hours after transfection 
with the appropriate construct and assayed for β-galactosidase activity. Bars show the 
relative β-galactosidase activity in unstressed (open bars) and stressed (closed bars) Caco-
2 cells. pG1Prom5U shows a relative β-galactosidase reporter activity in DEM stressed 
Caco-2 cells that is 55% higher than that observed in the stressed cells transfected with 
the promoter-less ‘empty’ plasmid (pNoPromLacZ). However when compared to activity 
from unstressed cells transfected with pG1Prom5U shows 100% more activity. Data are 
pooled from three experiments each with three experimental replicates (N=3, n=9) and 
shown here as percentage mean ± SEM relative to the average activity of the un-
transfected and unstressed control. One-way ANOVA was used for multiple 
comparisons. *** indicates a P-value of < 0.005. 
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3.3.1.2 Regulation by Polyphenols 
Despite the controversy surrounding the efficacy or modes of action of dietary 
antioxidants such as vitamin C and carotenoids, epidemiological studies in populations 
consuming large amounts of plant derived polyphenols show a significantly lower 
prevalence of degenerative diseases (Arts and Hollman, 2005, Vauzour et al., 2010). In 
recent years, dietary phenolic compounds have extensively been studied and generally 
accepted to play important roles in the prevention of cancers and other degenerative 
diseases such as Alzheimer’s and cardiovascular disease (Vita, 2005, Choi et al., 2012). By 
their direct and indirect regulation of TFs and consequential modulation of expression of 
cytokines, growth factors and nutrient transporter genes, polyphenols can have profound 
effects on several biological processes. It is believed that the antioxidant scavenging 
capacity of a phenolic compound is dependent on its molecular structure, particularly the 
positions of hydroxyl groups in relation to the other chemical moieties in its structure 
(Pandey and Rizvi, 2009, Kurek-Gorecka et al., 2013, Malik and Mukherjee, 2014). This is 
particularly true for flavonoids, a ubiquitous group of polyphenols found in fruits and 
vegetables and often added to other food substances and drinks. Several thousand 
flavonoids (previously referred to as Vitamin P) have now been identified and are 
classified based on their structure as flavonols, flavonones, isoflavones, catechins, 
anthocyanidins and chalcones, which have varying anti-oxidative or pro-oxidative activity 
(Cos et al., 1998, Nijveldt et al., 2001, Heim et al., 2002).  
It has been shown that the treatment of Caco-2 cells with anti-oxidative flavonoids such 
as genistein, an isoflavone found in soy, attenuated H2O2-induced peroxide formation by 
boosting the expression of phase II detoxification enzymes such as haem oxygenase 1 
(HO-1) and the glutamate-L-cysteine ligase catalytic subunit (GCLC) (Zhai et al., 2013). 
Pre-treating Caco-2 cells with specific siRNA to Nrf-2 specifically blocked the effects of 
genistein. Zhai and colleagues proposed that genistein activates ERK and PKC which in 
turn facilitate the dissociation of Nrf-2 from the cytosolic KEAP-1 and encourages its 
nuclear translocation (Zhai et al., 2013). In another study by Maher, pre-treatment of rat 
phaechromocytoma cells (PC12) with the isoflavone fisetin not only increased glutathione 
(GSH) levels but maintained GSH under conditions of oxidative stress via an ERK 
dependent pathway (Maher, 2006). Work following on from this showed that the effects 
of fisetin in maintaining GSH levels downstream of oxidative stress were reversed by 
transfecting the cells with siRNA to either Nrf-2 and/or Atf-4 (Ehren and Maher, 2013). 
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A conclusion from the latter study was that the concurrent regulation of both TFs (Atf-4 
and Nrf-2) by fisetin is required for maintaining GSH levels. Like genistein, resveratrol, a 
polyphenol found in red wine has been shown to up-regulate the expression and 
activation of Nrf-2 by similar pathways downstream of oxidative stress (Cheng et al., 
2012).    
In the work described here, a possible potentiating effect of genistein and other 
polyphenols on the transcription of GlyT-1a in Caco-2 cells was investigated. No change 
in reporter activity was observed in Caco-2 cells transfected with the reporter construct 
pG1Prom5U and treated with 10 µM genistein or 50 µM Resveratrol for 24 hours (Figure 
3.21 and Figure 3.22). Given that the rationale in this case is that treatment with genistein 
or resveratrol may promote expression of GlyT-1a as part of an anti-oxidative response, 
this observation is in line with that by Maher and Ehren whose data showed an underlying 
oxidative state is required for the potentiating effect of the flavonoid fisetin on anti-
oxidative genes, (Ehren and Maher, 2013, Maher and Hanneken, 2005).  
To test if an underlying oxidative state may be required for flavonoid regulation of GlyT-
1a expression, Caco-2 cells transfected with the pG1Prom5U construct were pre-treated 
with either resveratrol or genistein as above before the induction of oxidative stress. No 
differences in promoter activity were noticed following 4 hours of 0.2mM DEM 
treatment of transfected Caco-2 cells either with or without genistein (Figure 3.23) or 
resveratrol (Figure 3.24) pre-treatment. 
Extracts from several seaweeds are an important source of anti-oxidative phenolic 
compounds (Chojnacka et al., 2012). These extracts, often used as dietary supplements, 
have been shown to protect against oxidative stress in several cell models (Linares et al., 
2004, Raghavendran et al., 2004, Matanjun et al., 2008). They regulate the expression of 
detoxification enzymes via an Nrf-2 ARE dependent pathway (Wang et al., 2013a). To 
determine if these may result in changes in expression of GlyT-1a, Caco-2 cells transfected 
with the pG1Prom5U reporter construct were subjected to a 30 minute pre-treatment 
with brown seaweed alcoholic extract prior to DEM treatment. Although it was 
impossible to determine the total phenolic content of the extract or what components 
may be involved, it had been shown that treating 3T3-L1 adipocytes in this way resulted 
in the attenuation of oxidative damage via an Nrf-2 dependent pathway (Lee et al., 2011). 
The incubation of pG1Prom5U transfected Caco-2 cells, with seaweed alcoholic extract 
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for 30 minutes did not change promoter activity either without (Figure 3.25) or with 
oxidative stress induced by 4hours of 0.2mM DEM treatment (Figure 3.26).  
 
 
Figure 3.21: Genistein has no effect on GlyT-1a promoter activity. Genistein, a dietary 
polyphenol is known to potentiate the activity of the anti-oxidative factors Atf-4 and Nrf-
2 as described in the text. Bars show the relative β-galactosidase activity measured in total 
protein extract from unstressed (open bars) and stressed (closed bars) Caco-2 cells by 
CPRG assay as described in the Section 2.5.4. Cells transfected with the construct 
pG1Prom5U showed no increase in β-galactosidase when compared to those transfected 
with pNoPromLacZ or untransfected cells. Stimulating the cells with genistein for 24 
hours had no additional effect. Data are pooled from two experiments (N=2, n=6) and 
values represent the percentage mean ± SEM relative to the average activity of the 
untransfected and unstressed control (No Plasmid).  
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Figure 3.22: Resveratrol treatment has no effect on GlyT-1a promoter activity. 
Resveratrol, a dietary polyphenol found in red wine is known to potentiate the activity of 
the anti-oxidative transcription factors Atf-4 and Nrf-2 as described in the text. Bars show 
the relative β-galactosidase activity measured in total protein extract from untreated (open 
bars) and treated (closed bars) Caco-2 cells by CPRG assay as described in the Section 
2.5.4. Cells transfected with the construct pG1Prom5U showed no increase in β-
galactosidase when compared to those transfected with pNoPromLacZ or untransfected 
cells. Stimulating the cells with resveratrol for 24 hours had no additional effect. Data are 
pooled from two experiments (N=2, n=5-6) and values represent the percentage mean ± 
SEM relative to the average activity of the untransfected and unstressed control (No 
Plasmid). 
 
 123 
 
Figure 3.23: Genistein pre-treatment has no effect on DEM induced activity. 
pG1Prom5U, when transfected into Caco-2 cells results in β-galactosidase reporter 
activity that is not affected by pre-incubating the cells with genistein for 24 hours prior to 
4h treatment with DEM. Bars show the relative β-galactosidase activity measured in total 
protein extract of Caco-2 cells relative to the untransfected and untreated control (open 
bars). DEM only treated samples are shown as closed bars, whilst samples pre-treated 
with genistein prior to DEM treatment are shown as hatched bars. Data are pooled from 
two experiments (N=2, n=6). Bar values are the percentage mean ± SEM for each sample 
group relative to the average activity of the untransfected and unstressed control (No 
plasmid). One-way ANOVA was used for comparisons.  
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Figure 3.24: Resveratrol pre-treatment has no effect on DEM induced activity. β-
galactosidase reporter activity from Caco-2 cells transfected with the construct 
pG1Prom5U was not affected by pre-incubating these cells with resveratrol for 24 hours 
prior to 4 hour treatment with DEM. Bars show the beta-galactosidase activity measured 
in total protein extract of Caco-2 cells relative to the untreated and untransfected control 
(no plasmid). Untreated samples are shown as open bars; DEM only treated samples are 
shown as closed bars, whilst samples pre-treated with resveratrol prior to DEM treatment 
are shown as hatched bars. Data are pooled from two experiments (N=2, n=6). Bar values 
are the percentage mean ± SEM for each sample group relative to the average activity of 
the un-transfected and unstressed control. One-way ANOVA was used for comparisons. 
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Figure 3.25: Seaweed extract has no effect on GlyT-1a promoter activity. Alcoholic brown 
seaweed extract containing un-quantified and un-determined polyphenols was added to 
the Caco-2 cell culture medium for 30 minutes. This had no effect on β-galactosidase 
activity from cells transfected with the construct pG1Prom5U.  Bars show the β-
galactosidase activity in total protein extract for untreated (open bars) and treated (closed 
bars) Caco-2 cells relative to the untransfected controls (No Plasmid). Bar values are the 
percentage mean ± SEM for each sample group relative to the average activity of the un-
transfected and unstressed control (N=2, n=6).  
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Figure 3.26: Seaweed extract pre-treatment has no effect on DEM induced activity. β-
galactosidase reporter activity from Caco-2 cells transfected with the construct 
pG1Prom5U was not affected by pre-incubating these cells with alcoholic brown seaweed 
extracts for 30 minutes prior to 4h treatment with 0.2mM DEM. Bars show the β-
galactosidase activity measured in total protein extract of Caco-2 cells relative to the 
unstressed and untransfected control (No plasmid). Untreated samples are shown as open 
bars; DEM only treated samples are shown as closed bars, whilst samples pre-treated with 
seaweed extract prior to DEM treatment are shown as hatched bars. Data are pooled 
from two experiments (N=2, n=6). Bar values are the percentage mean ± SEM for each 
sample group. One-way ANOVA was used for comparisons. 
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3.3.1.3 Regulation by tert-Butylhydroquinone (tBHQ) 
2, 5-di-(tert-butyl)-1, 4-hydroquinone (tBHQ) is used as a preservative in several packaged 
foods.  As it is often used in combination with the antioxidant butylated hydroxyanisole 
(BHA), which is itself metabolised to tBHQ, some have argued that tBHQ possesses 
some “antioxidant” properties. Imhoff et al demonstrated that in HeLa cells, the induction 
of Nrf-2 by tBHQ is a result of increased oxidation of the mitochondrial thioredoxin-2 
(Trx-2) and unlike DEM, has no effect on glutathione (GSH) levels (Imhoff and Hansen, 
2010).  
It appears that expression of Nrf-2 target genes following tBHQ treatment is largely 
dependent on calcium fluxes (Cheung et al., 2011). Pre-treating human platelets with a 
calcium chelating agent such as ethylene glycol tetra-acetic acid (EGTA) significantly 
attenuated tBHQ induced expression of HO-1 by Nrf-2 (Redondo et al., 2008). Like 
thapsigargin, tBHQ is known to effectively inhibit endomembrane Ca2+/ATPase and can 
alter the intracellular chemical balance by causing the rapid depletion of intracellular 
calcium stores, normally sensitive to inositol triphosphate (IP3) (Mason et al., 1991). 
Unlike thapsigargin, changes in intracellular calcium fluxes induced by tBHQ do not lead 
to the rapid intracellular influx of extracellular calcium. This is because tBHQ may also 
block L-type channel activity and calcium exchange at the cellular plasma membrane 
(Nelson et al., 1994). Such L-type voltage activated channel activity typical in skeletal, 
smooth and cardiac muscles, as well as neuronal cells, has also been characterised in 
epithelial cells (Zhang and O'Neil, 1996). The relationship between intracellular and 
extracellular calcium fluxes and oxidative stress is still being elucidated. It is understood 
that the additional metabolic requirement for the ATP-dependent extrusion of the 
accumulated cytosolic calcium may significantly alter cellular biochemical properties 
leading to the formation of free radicals (Guzman et al., 2010). The added oxidative 
phosphorylation required for the production of ATP may lead to a significant increase in 
the formation of superoxide and reactive oxygen species (ROS) by-products in the 
mitochondrion. Moreover, most of the calcium handling proteins such as calmodulin that 
contain disulphide linkages of cysteine residues are particularly susceptible to oxidative 
damage, further exacerbating the emergency.   
With the above understanding of tBHQ mode of action, it is possible to navigate the 
ambiguity in existing literature. It appears that in studies where tBHQ is administered at 
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dosage low enough to illicit only mitochondrial oxidative stress and the induction of Nrf-
2 (or other TFs), tBHQ is considered ‘cytoprotective’ or as an anti-oxidant. For instance, 
incubating the neuronal NT2N cell line with 10 µM tBHQ effectively protected the cells 
from H2O2 induced oxidative damage and the formation of amyloid proteins 
(Eftekharzadeh et al., 2010). The same is true for human neural stem cells (hNSCs) where 
20 µM tBHQ treatment for 24 hours protected against oxidative damage (Li et al., 2005). 
On the contrary, doses of tBHQ in the millimolar range resulted in significant cell death 
(Okubo et al., 2003). In this study, Caco-2 cells transfected with the pG1Prom5U reporter 
construct were treated with 60 µM tBHQ for 16 hours to determine if this may lead to 
regulation of the GlyT-1a promoter. As shown in (Figure 3.27), a ~3 fold increase in 
promoter activity was observed in Caco-2 cells transfected with the pG1Prom5U 
promoter and treated with tBHQ.  
Reports of Atf-4 induction by tBHQ exist in the literature (Lewerenz and Maher, 2009, 
Li and Johnson, 2002). Western blot analysis of proteins from tBHQ treated urinary 
bladder T24 carcinoma cells, suggest an increase of both Atf-4 and Nrf-2 protein titres, 
which are required for the up regulation of xCT (Ye et al., 2014). It is therefore possible 
that the effect seen here with tBHQ treatment of pG1Prom5U transfected Caco-2 cells 
is a result of action of Atf-4 activity at the AARE contained within this construct.  
The effects of polyphenols such as genistein, or resveratrol on the promoter activity 
induced by 60 µM tBHQ were also studied. If the increases in promoter activity induced 
by tBHQ were via an Nrf-2 independent mechanism, it was expected that potentiating 
nuclear translocation of Nrf-2 with polyphenols may result in sequestration of Atf-4 and 
a reduction in the amounts available to regulate GlyT-1a via the AARE in exon 1. No 
statistically significant reduction in promoter reporter activity was observed in a single 
experiment with either genistein (Figure 3.28) or resveratrol (Figure 3.29). Genistein pre-
treatment slightly increased tBHQ induced promoter activity. In contrast to the 
observations with genistein and resveratrol pre-treatment, Caco-2 cells transfected with 
the construct pG1Prom5U and treated with seaweed extracts for 30 minutes prior to 
stress resulted in a 25% reduction in tBHQ induced promoter activity (Figure 3.30).  
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Figure 3.27: GlyT-1a promoter activity after tBHQ treatment of Caco-2 cells. Bars show 
the relative β-galactosidase activity in unstressed (open bars) and stressed (closed bars) 
Caco-2 cells. Transfecting cells with the construct pG1Prom5U followed by 16 hour 
treatment with 60µM tBHQ showed a relative β-galactosidase reporter activity 200% 
higher than that observed in cells transfected with the promoter-less ‘empty’ plasmid 
(pNoPromLacZ) and stressed with tBHQ. Data are pooled from three experiments each 
with three experimental replicates (N=3, n=9) and shown here as percentage mean ± 
SEM relative to the average activity of the un-transfected and unstressed control. One-
way ANOVA was used for multiple comparisons. *** indicates a P-value of < 0.001. 
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Figure 3.28: Genistein may potentiate tBHQ induced pG1Prom5U activity. In a single 
experiment, pG1Prom5U, when transfected into Caco-2 cells resulted in β-galactosidase 
activity that was greater when the cells were pre-incubated with genistein for 24 hours 
prior to a 16 hour incubation with tBHQ. Data are from a single experiment with three 
experimental replicates (N=1, n=3) and shown here as percentage mean ± SEM relative 
to the average activity of the un-transfected and unstressed control (No Plasmid). One-
way ANOVA was used for multiple comparisons. ** indicates a P-value of < 0.05. 
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Figure 3.29: Resveratrol has no effect on tBHQ induced GlyT-1a promoter activity. The 
pG1Prom5U construct when transfected into Caco-2 cells resulted in β-galactosidase 
activity that was no different either with or without resveratrol treatment prior to 
incubation for 16 hours with tBHQ. Bars show the β-galactosidase activity measured in 
total protein extracts from transfected Caco-2 cells relative to the un-transfected and 
untreated control (No Plasmid). Untreated samples are shown as open bars; samples 
treated with tBHQ only are shown as closed bars, whilst samples pre-treated with 
resveratrol prior to tBHQ incubation are shown as hatched bars. Data are from a single 
experiment with three experimental replicates for each sample group (N=1, n=3). Bars 
represent the percentage mean ± SEM for each sample group relative to the average 
activity of the un-transfected and unstressed control. One-way ANOVA was used for 
multiple comparisons 
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Figure 3.30: Seaweed extract pre-treatment reduced tBHQ induced promoter activity. 
Caco-2 cells transfected with the GlyT-1a promoter reporter construct pG1Prom5U 
resulted in β-galactosidase activity that was significantly lower in samples pre-treated with 
brown seaweed alcoholic extract for 30 minutes prior to tBHQ treatment when compared 
to samples not pre-treated with seaweed extract. Bars show the β-galactosidase activity 
measured in total protein extracts from transfected Caco-2 cells relative to the un-
transfected and untreated control (No Plasmid). Untreated samples are shown as open 
bars; samples treated with tBHQ only are shown as closed bars, whilst samples pre-treated 
with seaweed extracts prior to tBHQ treatment are shown as hatched bars. Data are from 
a single experiment with three experiment replicates for each sample group (N=1, n=6). 
Bars represent the percentage mean ± SEM for each sample group relative to the average 
activity of the un-transfected and unstressed control. One-way ANOVA was used for 
multiple comparisons. ** indicates a P-value of < 0.05. 
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To understand this result, closer consideration was given to the phenolic content of 
alcoholic extracts from the brown algae Fucus vesiculosus used here. Characterisation of 
these seaweeds in the lab of Prof Jeff Pearson (ICAMB, Newcastle University) suggested 
that their total polyphenol content, steadily released by an in vitro digestion method, 
demonstrated significant dose dependent antioxidant capability as determined by the 
ferrous ion-chelating assay (data not shown). Whilst flavonoids have thus far not been 
found in any brown algae, the phenolic content of Fucus vesiculosus is composed 
predominantly of phlorotannins (Wang et al., 2012), which are fucol-type tannin with a 
heavily hydroxylated and polymerised phenolic structure. The treatment of lung fibroblast 
V79-4 cell lines with a phlorotannin compound increased the expression and activity of 
Nrf-2 and subsequently HO-1 enzyme in a dose dependent manner (Kim et al., 2010). In 
the latter study, the authors also demonstrated that phlorotannins lead to the direct 
activation of Nrf-2 following the phosphorylation of ERK and Akt. Phlorotannins from 
Fucus vesiculosus extracted using 70% acetone have been shown to prevent the 
accumulation of advanced protein glycated end (AGEs) products by scavenging reactive 
carbonyl species (Liu and Gu, 2012). AGEs are non-enzymatically glycated and oxidized 
proteins formed from the reaction between reducing sugars and the amine residues on 
proteins, lipids and nucleic acids. AGEs are implicated in the pathogenesis of several 
degenerative diseases including Alzheimer’s, ischemic heart disease and inflammatory 
bowel disease (Ciccocioppo et al., 2013, Takeuchi et al., 2004, Sasaki et al., 1998). The 
accumulation of endogenous AGEs in the ER, during hyperglycaemic states or oxidative 
or hypoxic stress induces ER stress and injury and lead to an ER stress (Adamopoulos et 
al., 2014, Yamabe et al., 2013). AGE induced ER stress is very dependent on an underlying 
oxidative state and in prolonged stress is believed to result in the activation of apoptotic 
mechanisms via MAPK/ERK dependent pathways (Alikhani et al., 2007). 
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3.3.2 GlyT-1a Promoter activity in response to the ER Stress 
As the ER is the major site for protein folding within cells, perturbations in environmental 
conditions conducive to protein folding have profound effects on cell viability. The 
accumulation of unfolded or misfolded proteins within the ER leads to ER stress and 
activates the unfolded protein response (UPR) as discussed in Section 1.7.2. Downstream 
of the UPR are genes that are ultimately required for effective protein folding, trafficking 
and degradation. The relationship between ER and oxidative stress is extensively 
researched. Current understanding suggests unresolved ER stress or prolonged UPR 
often leads to further accumulation of ROS through oxidative protein folding by 
eukaryotic protein disulphide isomerase (PDI; EC 5.3.4.1) an ER resident enzyme (Tu 
and Weissman, 2004, Simmen et al., 2010).  
 
 
Figure 3.31: The relationship between ER stress and oxidative stress. Prolonged ER stress 
caused by the accumulation of unfolded proteins in the ER leads to the onset of oxidative 
stress via the shuttling of electrons between protein disulphide isomerase (PDI), the 
cysteine residues of unfolded proteins or peptides and the flavoenzyme ER oxidoreductin 
1 (Ero-1), which are important controls for protein folding in the ER. See main text 
(Section 3.3.2 above) for description. 
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The relay of electrons between Protein disulphide isomerase (PDI), the cysteine residues 
of unfolded proteins or peptides and the ER oxidoreductin 1 (Ero-1; EC 1.8.3.2) 
flavoenzyme mediates oxidative protein folding in the ER. Reduced PDI mediates the 
formation of disulphide linkages between intramolecular cysteine residues of unfolded 
proteins (Wang and Tsou, 1993). In its oxidized form, PDI mediates the rearrangement 
of mispaired disulphide bridges. PDI is able to perform both oxidation and reduction by 
virtue of two distinct redox active thioreductin domains. Free electrons resulting from 
such oxidative folding by PDI are relayed to Ero-1 (Figure 3.31). Together with the 
cofactor Flavin adenine dinucleotide (FAD), Ero-1 transfers the relayed electron from 
PDI to molecular oxygen resulting in the formation of superoxide species. With time, 
unfolded protein accumulation leads to the build-up of ROS within the ER. ROS 
accumulation in the ER may signal to key antioxidant pathways or apoptotic pathways 
resulting in controlled cell death. 
3.3.2.1 Regulation by Tunicamycin  
One of the hypothesis for this project posited that for the supply of glutathione to 
scavenge ROS, glycine supply via the specific transporter GlyT-1 is required. To test if 
prolonged ER stress may lead to the transcriptional induction of GlyT-1, Caco-2 cells 
transfected with the GlyT-1a promoter reporter construct pG1Prom5U were treated with 
1 µM tunicamycin for 16 hours. As shown in Figure 3.32, in stressed cells promoter 
activity was significantly increased by approximate fivefold when compared to the 
promoter-less vector control. When compared to the transfected unstressed control, the 
difference in activity was ~8 fold. This observation is consistent with the change in GlyT-
1a mRNA levels downstream of tunicamycin treatment in these cells. 
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Figure 3.32: GlyT-1a promoter activity is increased by tunicamycin treatment. Bars show 
the relative β-galactosidase activity in unstressed (open bars) and stressed (closed bars) 
Caco-2 cells. Transfecting cells with the construct pG1Prom5U followed by 16 hour 
treatment with 1 µM tunicamycin treatment shows a relative β-galactosidase reporter 
activity that is ~5 fold higher than that observed in cells transfected with the promoter-
less ‘empty’ plasmid (pNoPromLacZ) and stressed with tunicamycin. When compared to 
the transfected and unstressed control the difference in pG1Prom5U activity is ~8 fold. 
Data are pooled from multiple experiments (N=6, n=2-3 per experiment) and shown 
here as percentage mean ± SEM relative to the average activity of the un-transfected and 
unstressed control (No Plasmid). One-way ANOVA was used for multiple comparisons. 
*** indicates a P-value of < 0.001. 
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3.3.2.2 Regulation by Thapsigargin 
ER stress caused by the accumulation of unfolded proteins may lead to the production 
of ROS and the formation of ER-localised peroxides and/or superoxide. ROS mediated 
inactivation of the sarco/endoplasmic reticulum Ca2+/ATPase (or SERCA pumps) by 
cysteine S-glutathionylation and activation of the inositol triphosphate receptor (IP3R) 
leads to the rapid flooding of the cytosol with calcium (Lock et al., 2011). Such increases 
in intracellular calcium lead to its rapid uptake to the mitochondrial matrix via 
mitochondrial calcium uniporters (MCUs) and H+/Ca2+ exchanges on the ER 
mitochondrial associated membranes (MAMs). The consequences of elevated calcium in 
the mitochondrial matrix are diverse and generally end in more oxidative stress from 
impaired function and the activation of cell death.  
Thapsigargin selectively blocks the SERCA pumps leading to calcium overload in both 
the cytosol and mitochondria as described above. In addition to increased ROS 
accumulation, thapsigargin treatment also induces a characteristic ER stress response 
(Samali et al., 2010). To determine if the induction of ER stress via alternative means 
(other than N-glycosylation induction by tunicamycin) resulted in similar effects on GlyT-
1a promoter activity, Caco-2 cells were transfected with the pG1Prom5U construct and 
subject to 50µM thapsigargin challenge for 16 hours.  As shown in Figure 3.33, Glyt-1 
promoter activity was ~3 times greater following thapsigargin treatment and consistent 
with findings of GlyT-1 mRNA expression downstream of thapsigargin treatment (see 
Figure 3.1, page72).  
That both tunicamycin and thapsigargin resulted in significant transcriptional induction 
of the GlyT-1a promoter suggest that the up-regulation of the glycine transporter 
downstream of the ER stress is part of a targeted response. Interestingly, the fold change 
in activity is consistent with that observed with tBHQ. Although both thapsigargin and 
tBHQ result in increased cytosolic calcium and ER stress, there are significant differences 
in their downstream effects owing to the differing extent at which they deplete 
intracellular calcium stores (Scamps et al., 2000).  
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Figure 3.33: GlyT-1a promoter activity is increased by thapsigargin treatment. Bars show 
the relative β-galactosidase activity in unstressed (open bars) and stressed (closed bars) 
Caco-2 cells. Transfecting cells with the construct pG1Prom5U followed by 16 hour 
treatment with 50µM thapsigargin shows a relative β-galactosidase reporter activity that 
is ~2.5 fold higher than that observed in cells transfected with the promoter-less ‘empty’ 
plasmid (pNoPromLacZ) and stressed with tunicamycin. Data are pooled from multiple 
experiments (N=3, n=9) and shown here as percentage mean ± SEM relative to the 
average activity of the un-transfected and unstressed control (No Plasmid). One-way 
ANOVA was used for multiple comparisons. *** indicates a P-value of < 0.001. 
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3.3.3 GlyT-1a Promoter activity in response to nutrient availability 
In previous work carried out in this laboratory, removing amino acids from culture 
medium had a time dependent effect on the expression of GlyT-1 mRNA in both Caco-
2 and HCT-8 cells (Data not included).  Amino acid starvation may have a cascading 
effect on several cellular functions ultimately leading to the induction of core stress 
regulatory pathways. To determine if amino acid availability affected Glyt-1a promoter 
reporter activity, Caco-2 cells were transfected with the pG1Prom5U and subject to states 
of either complete amino acid starvation or amino acid supplementation.  
3.3.3.1 Regulation by amino acid starvation 
Whilst no significant changes in promoter activity were observed in Caco-2 after 4 hours 
amino acid deprivation (Figure 3.34), there was a doubling of promoter activity after 8 
hours (Figure 3.35) when compared to the control. Such a timed program in the 
expression of human genes downstream of nutrient availability has been reported 
previously (Kilberg et al., 2009, Lopez et al., 2007); this is believed to be consequential to 
the temporal changes in regulatory transcription factors (Thiaville et al., 2008a). There 
appears to be a temporal correlation between the titres of Atf-4, Atf-3-FL (the longest 
protein isoform of Atf-3, believed to be a repressor of transcription) and C/EBP-β and 
the expression of the human asparagine synthetase gene (ASNS) downstream of nutrient 
limitation (Chen et al., 2004). In that study, Chen and colleagues noted a peak of Atf-4 
protein (a 20-fold increase) in total cell extract after 2 hours of histidine limitation which 
coincided with the point at which the protein isoforms of ASNS, Atf-3-FL and the LAP 
isoform of C/EBP-β are first detected by Western blots. With time, as the protein titres 
of Atf-3 and C/EBP-β, and the mRNA abundance of ASNS steadily rose to a peak at 
between 8 and 12 hours after the onset of amino acid limitation there was a corresponding 
decrease in the expression of ASNS as well the protein titre of Atf-4. The authors 
concluded that a regulatory module involving the interaction of Atf-4 at nutrient stress 
response elements (NSRE) in the ASNS promoter leads to its expression shortly after 
nutrient stress. With time, as the stress burden is reduced interactions at the same NSRE 
by Atf-3-FL or dimers of Atf-3/C/EBP-β function as a negative feedback control loop. 
It is also possible that in cases of prolonged stress, a similar mechanism is used to switch 
the ensuing response from pro-survival to pro-apoptosis. 
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Figure 3.34: Effect of amino acid starvation on GlyT-1a promoter activity. Bars show the 
relative β-galactosidase activity in unstressed (open bars) and stressed (closed bars) Caco-
2 cells. Transfecting cells with the construct pG1Prom5U followed by 4 hours of amino 
acid starvation resulted in β-galactosidase activity that was not different from that seen in 
cells transfected with the promoter-less ‘empty’ plasmid (pNoPromLacZ) and subject to 
amino acid starvation in a similar way. Data are pooled from two experiments (N=2, n=6) 
and shown here as percentage mean ± SEM relative to the average activity of the un-
transfected and unstressed control (No Plasmid). One-way ANOVA was used for 
multiple comparisons. 
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Figure 3.35: Effect of prolonged amino acid starvation on GlyT-1a promoter activity. 
Bars show the relative β-galactosidase activity in unstressed (open bars) and stressed 
(closed bars) Caco-2 cells. Transfecting cells with the construct pG1Prom5U followed by 
8 hours of amino acid starvation resulted in β-galactosidase activity that was higher than 
that seen in cells transfected with the promoter-less ‘empty’ plasmid (pNoPromLacZ) and 
subject to amino acid starvation in a similar way. This significant increase in activity was 
also apparent when comparing unstressed cells transfected with the pG1Prom5U 
construct. Data are pooled from two experiments (N=2, n=6) and shown here as 
percentage mean ± SEM relative to the average activity of the un-transfected and 
unstressed control (No Plasmid). One-way ANOVA was used for multiple comparisons. 
*** indicates a P-value of < 0.001.  
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A similar temporal program in expression from the arginine/lysine transporter (Cat-1) 
was observed by Lopez and colleagues (Fernandez et al., 2003, Lopez et al., 2007). Atf-4 
protein titres peaked 1 hour after the removal of cysteine, methionine and glutamine from 
the culture medium of C6 glioma cells. The subsequent increase in both Atf-3 and 
C/EBP-β protein corresponded to a steady decrease in Cat-1 mRNA expression. As 
proposed for GlyT-1, Cat-1 has an AARE in the first exon of the gene to which Atf-4 
has been shown to bind (Fernandez et al., 2003). There is therefore a possibility for the 
temporal regulation of GlyT-1 by similar TFs.   
3.3.3.2 Regulation by glycine availability 
GlyT-1a promoter activity in response to glycine starvation or supplementation was 
determined. No significant difference in promoter activity between test and control 
samples was observed after incubating transfected Caco-2 cells in glycine free culture 
medium for four hours (data not included). Eight hours after the removal of glycine from 
culture medium a 75% increase in promoter activity from pG1Prom5U was observed 
(Figure 3.36). Although the increase in promoter activity following glycine starvation is 
four times less than that observed when all amino acids are removed from the culture 
medium the resulting activity at the GlyT-1a promoter is evidence for a specific response 
to glycine shortages and not just part of an overall response to the added requirement for 
amino acids. Certainly, intracellular shortages in amino acids may have profound effects 
on the synthesis of crucial proteins required by the cell. However, it is likely that regulation 
of GlyT-1a by TF modules involving Atf-4 interaction at the AARE is not just a random 
consequence of the underlying stresses for two main reasons.  Firstly, an important 
consequence of stress is the overall reduction in protein synthesis via phosphorylation of 
the eukaryotic eIF-2a implying an overall decrease in amino acids required for protein 
synthesis. Secondly, that some amino acids like glycine have added functions beyond 
being mere components for protein synthesis points to the requirement for adaptive 
regulation.   
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Figure 3.36: Effect of glycine starvation on pG1Prom5U.  Bars shown here represent the 
relative unstressed (open bars) and glycine starvation (closed bars) induced activity of 
GlyT-1a promoter reporter construct pG1Prom5U when transfected into Caco-2 cells. 
Compared to the transfected unstressed control, 8hours of amino acid starvation resulted 
in a 75% increase in reporter activity from the pG1Prom5U construct. When compared 
to activity from cells transfected with the pNoPromLacZ constructed and starved of 
Glycine, the pG1Prom5U generates 50% more activity. Data shown as percentage mean 
± SEM relative to the average activity of the un-transfected and unstressed control (N=2, 
n=6). One-way ANOVA was used for comparisons. *** represents P-values of less than 
0.001  
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In all human cells, signalling to the mammalian target of rapamycin (mTOR) is an 
important regulatory pathway downstream of nutrient availability. The mTOR protein is 
a highly conserved serine-threonine kinase present in two distinct complexes, mTOR-C1 
and mTOR-C2 which have very differing functions. Whilst mTOR-C2 signals to the 
structural dynamics and survival of the cell via the activation of protein kinase B (PKB, 
also known as Akt), mTOR-C1 predominantly regulates cell growth and proliferation. 
mTOR-C1 is essential for the phosphorylation and activation of the ribosomal protein S6 
kinase (S6K) which in turn regulates protein translation via eIF-3. mTOR-C1 also directly 
controls mRNA translation by its ability to phosphorylate eIF-4E. It is unclear how 
mTOR-C1 senses amino acid sufficiency. From current understanding, in states of 
increased amino acid availability, the physical interaction between mTOR-C1 with the Ras 
related GTPases (or Rag) tethers it to the lysosome. At the lysosome mTOR-C1 is 
activated by the Ras homolog enriched in the brain (or Rheb) G protein. The observation 
that growth factors had no effect on mTOR-C1 signalling in the absence of amino acids 
suggested the requirement for an upstream gated mechanism to control mTOR-C1 
interaction with Rag and Rheb (Jewell et al., 2013). Bar-Peled et al suggest two GTPase 
activators of mTOR-C1 (GATOR 1 and 2) which specifically block the interaction 
between mTOR-C1 and Rag downstream of amino acid starvation (Bar-Peled et al., 2013). 
Likewise the tuberous sclerosis protein complexes TSC 1 and 2, inactive in states of amino 
acid sufficiency, block mTOR-C1 interaction with Rheb in amino acid starvation 
(Carracedo et al., 2008).  
There is extensive evidence for the activation of Atf-4 following amino acid starvation 
(some of which are discussed earlier). Although mTOR-C1 activation is known to regulate 
protein translation via phosphorylation of various eIF proteins, there is no evidence to 
suggest that mTOR-C1 is responsible for Atf-4 activation following amino acid 
starvation. Double knockout TSC mutants of mouse embryonic fibroblast (MEF) cells 
were associated with increased mTOR-C1 and decreased Atf-4, Atf-6 and CHOP despite 
the extensive eIF-2α phosphorylation (Kang et al., 2011). No promoter activity was 
observed either after four or eight hour incubation of Caco-2 cells transfected with 
pG1Prom5U in glycine supplemented culture medium (Figure 3.37). Atf-4 activation 
itself is believed to block mTOR by up regulating TSC via the Regulated in development 
and DNA damage response 1 gene (REDD-1 or DDIT-4) – an Atf-4 target gene (Ait 
Ghezala et al., 2012).  
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Figure 3.37: Effect of glycine supplementation on GlyT-1a promoter activity. Bars show 
the relative β-galactosidase activity in unstressed (open bars) and stressed (closed bars) 
Caco-2 cells. Transfecting cells with the construct pG1Prom5U followed by incubation 
for 4 hours in glycine supplemented medium resulted in β-galactosidase activity that was 
not different from that seen in cells transfected with the promoter-less ‘empty’ plasmid 
(pNoPromLacZ) and incubated in glycine supplemented medium. Data are pooled from 
three experiments (N=3, n=9) and shown as percentage mean ± SEM relative to the 
average activity of the un-transfected and unstressed control (No Plasmid). One-way 
ANOVA was used for multiple comparisons. 
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Figure 3.38: Effect of prolonged glycine supplementation on GlyT-1a promoter activity. 
Bars show the relative β-galactosidase activity in unstressed (open bars) and stressed 
(closed bars) Caco-2 cells. Transfecting cells with the construct pG1Prom5U followed by 
incubation for 8 hours in glycine supplemented medium resulted in β-galactosidase 
activity that was not different from that seen in cells transfected with the promoter-less 
‘empty’ plasmid (pNoPromLacZ) and incubated in glycine supplemented medium. Data 
are pooled from three experiments (N=3, n=9) and shown here as percentage mean ± 
SEM relative to the average activity of the un-transfected and unstressed control (No 
Plasmid). One-way ANOVA was used for multiple comparisons. 
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3.4 Additional motifs may be necessary for GlyT-1a transcription 
Data discussed in section 3.3 showed that a reporter construct (pG1Prom5U) inclusive 
of the predicted CRMs 6, 7, 8 and 10 contains elements sufficient for transcriptional 
induction of GlyT-1a by various stress treatments. Previously, Caco-2 cells transfected 
with another construct pG1PromE1 (which also contains all the aforementioned CRMS 
but unlike pG1Prom5U excludes the UTR of the second exon) did not generate 
significant reporter activity when stressed (Figure 3.16, page112). This observation was 
puzzling given that both constructs pG1PromE1 and pG1Prom5U contained a predicted 
ARE of the GlyT-1a flanking sequence (CRM8) and a predicted AARE in the GlyT-1a 
first exon (CRM10). Therefore a new hypothesis was proposed that although these 
sequence motifs may indeed be necessary for transcription downstream of stress other as 
of yet unidentified motifs, probably contained in the exon 2 UTR, are also required for 
effective or enhanced transcription. 
3.4.1 Mutation of the GlyT-1a AARE sequence reduces reporter activity 
To begin testing this hypothesis the importance of the AARE in pG1Prom5U was 
investigated. The first and last adenines in this AARE were mutated by site directed 
mutagenesis to thymine and guanine respectively (TGATGCAAC reverse complement 
ACTACGTTG to TGTTGCAGC reverse complement ACAACGTCG). The mutated 
bases were selected on the basis that they had the highest base-wise conservation scores 
in the Atf-4 binding consensus described in the TRANSFAC database. The resulting 
mutated construct pG1Prom5U(mut) was validated by sequencing. As can be seen in 
Figure 3.39a, the double mutation of the AARE resulted in β-galactosidase activity that 
was about 30% less than that with pG1Prom5U in transfected cells stressed by 1 µM 
tunicamycin for 16 hours; this relative to the background activity from untransfected and 
transfected cells. Although the activity from pG1Prom5U in these experiments was less 
than that seen previously, correcting for background activity shows that the mutations 
result in a ~75% reduction in promoter activity (Figure 3.39). Comparing the β-
galactosidase activity in cells transfected with the promoter-less control plasmid 
pNoPromLacZ to those transfected with pG1Prom5U(mut) shows a small but significant 
increase. In all, this suggests that although the AARE may be necessary for GlyT-1a 
transcription additional elements elsewhere in the GlyT-1a sequence are indeed required. 
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Figure 3.39: Mutation of the putative GlyT1a AARE reduces promoter activity. a) Caco-2 cells transfected with pG1Prom5U and treated with 
tunicamycin showed ~1.5 fold induction of β-galactosidase activity; in cells transfected with pG1Prom5U (mut) a small but significant increase in 
activity was observed when compared to the No Plasmid control. b) Correction for background activity from the No Plasmid control showed  that 
in tunicamycin treated cells transfected with pG1Prom5U(mut) results in β-galactosidase activity that is 75% less when compared to the un-mutated 
probe. Note that in these experiments tunicamycin induced reporter activity of the pG1Prom5U construct was less than that observed previously. 
Data are pooled from three experiments each with three experimental replicates (N=3, n=9) and shown here as a percentage mean ± SEM relative 
to the average activity of the control. One-way ANOVA was used for comparisons. *** indicates a P-value of < 0.001.  
a b 
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3.4.2 Reporter constructs of the second exon UTR lack activity. 
The challenge therefore was to identify which additional cis-regulatory motifs other than 
those shown to bind Atf-4 above may be necessary for GlyT-1a regulation. To begin, in 
silico analysis of the 86 untranslated bases of the second exon of GlyT-1a was performed 
to detect any additional binding sites. Using the TRANSFAC Composite Module Analyst 
Tool, a 21 base pair region of sequence TGTGAGTGTggtCCCCGTCACCA contained 
a possible sense site for Atf-4 binding (Sequence: ccCGTCAcc with 85.4% similarity to 
the V$ATF4_Q6 matrix). Additionally, C/EBP-β and C/EBP-α were also predicted to 
bind this sequence, however their matching matrix similarity scores were much lower than 
the 85% threshold score imposed by the analysis to minimise false negatives.  
To determine if the UTR of the second exon of GlyT-1a (G1E2) contained all the binding 
sites required for transcriptional regulation of GlyT-1a, PCR with forward primer 5 and 
reverse primer 4 (Primer sequences are shown in Table 2.4, page59) was used to amplify 
the first 86 bases of exon 2 from cDNA. The resulting G1E2 amplicon was cloned 
upstream of the β-galactosidase coding sequence. No additional β-galactosidase activity 
was detected in total protein extracts from Caco-2 cells transfected with the pG1E2 
reporter construct and stressed with tunicamycin (Figure 3.40); this when compared to 
activity from cells transfected with pNoPromLacZ or untransfected cells. Based on the 
fact that significant activity was observed in simultaneous control experiments using the 
pG1Prom5U construct,  this result suggests that the sequence of the untranslated region 
of exon 2 does not contain motifs capable of independently regulating GlyT-1a 
transcription.  Why then is this sequence required for activity of the pG1Prom5U 
construct? A possible explanation is that even if this sequence contained motifs necessary 
for transcription, additional distant TFBS are required in a billboard-like CRM  for the 
optimal transcription of GlyT-1a following tunicamycin stress. 
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Figure 3.40: GlyT-1a exon 2 UTR alone does generate promoter activity No additional β-
galactosidase activity was seen in Caco-2 cells transfected with pG1E2, a reporter 
construct of the first 86 bases of exon 2; this when compared to cells transfected with the 
pNoPromLacZ. Bars show the relative unstressed (open bars) and stressed (closed bars) 
activity in Caco-2 cell relative to the untransfected and unstressed (No Plasmid) control. 
Data are pooled from two experiments each with three experimental replicates (N=2, 
n=6) and shown here as percentage mean ± SEM relative to the average activity from the 
untransfected and unstressed control. One-way ANOVA was used for sample group 
comparisons. *** indicates a P-value of < 0.001; ns indicates a P-value > 0.05. 
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3.4.3 Activity from constructs of just the GlyT-1 5’UTR 
A further reporter construct (pG15U) was developed to include the UTRs of both the 
first and second exons of GlyT-1a without the interrupting large intron sequence (Figure 
3.41). pG15U was designed to assess if the GlyT-1a UTR alone was sufficient for 
transcription or if TFBS in the promoter region are also required.  When pG15U was 
transfected into Caco-2 cells which were subsequently stressed with 1µM tunicamycin for 
16 hours, the β-galactosidase activity detected in total extracts from these cells was three 
times higher than that from cells transfected with the pNoPromLacZ (Figure 3.42). 
However, when compared to cells transfected with pG1Prom5U and stressed in the same 
way the activity from pG15U was half that seen with pG1Prom5U.  This suggests that 
whilst elements in the GlyT-1a 5’-UTR found on both the first and second exon are 
capable of driving transcription, additional motifs in the 1159 bases of sequence upstream 
of the TSS enhance it. Three additional CRMs with binding sites for Atf-4 and several of 
its dimerisation partners were predicted in this region by bioinformatic analysis (See 
CRM6, CRM7 and CRM8 discussed in Section 3.2). 
 
 
 
Figure 3.41: Illustration showing the features of the pG15U reporter. Primers 3 and 4 
were used to amplify the UTR of exons 1 and 2 from cDNA. The resulting PCR product 
was cloned upstream of the β-galactosidase coding sequence (lacZ). Features are 
numbered relative to the TSS and the position of a putative amino acid response element 
(AARE) and electrophile or antioxidant response elements (EpRE/ARE) are given. 
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Figure 3.42: Reporter activity from the GlyT-1a UTR sequence. Caco-2 cells transfected 
with pG15U, a reporter construct of the 5’UTR of exon 1 and 2 showed β-galactosidase 
activity three times that from cells transfected with pNoPromLacZ. However, the activity 
from pG15U is approximately half that from pG1Prom5U. Bars show the relative 
unstressed (open bars) and stressed (closed bars) induced activity in Caco-2 cell relative 
to the untransfected and unstressed (No Plasmid) control. Data are pooled from two 
experiments each with three experimental replicates (N=2, n=6) and shown here as 
percentage mean ± SEM relative to the average activity from the untransfected and 
unstressed control. One-way ANOVA was used for sample group comparisons. *** 
indicates a P-value of < 0.001. 
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3.4.4 Activity from constructs including additional intronic elements 
The role of intronic elements (INE) in the direct regulation of gene transcription is 
increasingly being elucidated. Functional AARE-like motifs have been described in the 
intronic sequence of the Atf-4 regulated Cat-1 gene (Huang et al., 2009). Analysis of the 
large 6.9kb first intron of GlyT-1a revealed two additional AARE-like motifs. The two 
intronic AAREs are labelled INE-1 and INE-2 for convenience. INE-1 is located on the 
antisense strand between nucleotides 2551 and 2559 downstream from the GlyT-1a TSS. 
The INE-1 (reverse complement sequence TGATGAAT) differs from the AARE of the 
first exon (TGATGCAAC) in the occurrence of a thymine in place of the most 3’ cytosine 
and lacks the cytosine at position 6. INE-2 of sequence TGATGAAC is located in the 
reverse orientation on the sense strand. INE-2 is identical to that described in the first 
intron of the Cat-1 gene shown to bind the Purine-rich Element Binding Protein A (Purα) 
(Huang et al., 2009).  
To determine if these sequences had any additional effect on the activity already observed 
with the pG1Prom5U, a new reporter construct (pG1PromInt15U) which is similar to 
pG1Prom5U but contained an additional 964bp intronic sequence inserted between 
exons 1 and 2 was made (Figure 3.43). pG1PromInt15U was generated in four steps. In 
the first step, the GlyT-1a promoter sequence starting 1159 upstream from the TSS, exon 
1 and 209 bases of intronic donor sequence were amplified using forward primer 1 and 
reverse primer 6 (G1PromE1_). In the second step, the 964bp intronic sequence 
(_G1Int1_; between bases 2472 and 3436 downstream from the GlyT-1a TSS) was 
amplified using sense primer 7 and reverse primer 8. Primer 7 was designed to include a 
5’-overhang sequence complementary to the 3’ end of Primer 6. This allowed for ligation 
of these two fragments (G1PromE1_ and _G1Int1_) by LM-PCR in the next step to 
generate G1PromInt1_. A variant of primer 5 (primer 5b) was designed, identical to 
primer 5 in the 3’ region, but including a 5’-overhang sequence complementary to the 3’ 
end of primer 8. Primer 5b and primer 4 were then used to amplify the first 86 bases of 
GlyT-1 exon 2 (_G1E2). _G1E2 was subsequently joined to the G1PromIn1_ by LMPCR 
to generate a 1445bp product (G1PromInt5U). G1PromInt5U was cloned upstream of 
the β-galactosidase coding sequence as described earlier to generate the construct 
pG1PromInt5U.  
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When Caco-2 cells were transfected with this construct (pG1PromInt5U) and stressed 
with 1µM tunicamycin for 16 hours, the resulting reporter activity (from a single 
experiment) was no different than that observed with pG1Prom5U (Figure 3.44); 
suggesting that INE-1 and INE-2 did not have any additive effect on GlyT-1a 
transcription. 
 
 
 
 
 
 
Figure 3.43: Illustrations showing features of the pG1PromInt15U reporter (bottom); 
The pG1PromInt15U construct which contains additional AARE-like sequences was 
generate by ligating three PCR products as described in the text. The resulting 1445 bp 
sequence was cloned upstream of the β-galactosidase coding sequence and the resulting 
construct validated by sequencing. 
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Figure 3.44: Activity of GlyT-1a constructs incorporating AAREs of intron 1. Bars 
represent the relative unstressed (open bars) and stressed (closed bars) induced β-
galactosidase activity of constructs transfected into Caco-2 cells. The pG1PromInt15U 
construct (which is designed to incorporate two additional AAREs identified in intron 1) 
resulted in β-galactosidase activity that is comparable to that observed with pG1Prom5U 
and significantly higher than the unstressed control in tunicamycin treated cells. Data are 
from a single experiment with three experimental replicates (N=1, n=3) and shown here 
as percentage mean ± SEM relative to the average activity from the untransfected and 
unstressed control (No Plasmid). *** indicates a P-value of < 0.001 while ns represents a 
P-value > 0.05. 
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3.5 Regulation of GlyT-1a transcription by Nrf-2  
Nrf-2, a cap-n-collar (CNC) BZIP factor, is an important transcriptional regulator of cyto-
protective genes in response to several cellular insults. It was first identified by Moi et al. 
(1994) when screening for proteins which bound to a tandem Ap-1-like repeat in the β-
globin gene. The Nrf-2 protein has since been found in several cell types and tissues (Lee 
et al., 2005).  Nrf-2 double knock-out mice show increased tumour growth in the intestinal 
tract when treated with the tar derived carcinogen benzo(a)pyrene (Ramos-Gomez et al., 
2001, Ramos-Gomez et al., 2003). In the studies by Ramos-Gomez and colleagues, 
treating Nrf-2-/- mice with the tumour preventing drug oltipraz had little effect on 
benzo(a)pyrene induced tumour growth when compared to the wild type controls. Nrf-2 
repression and the subsequent down-regulation of antioxidant genes correlates to 
significant accumulation of reactive oxygen species (ROS) in human mesenchymal stem 
cells (MSC) and breast cancer cell lines (Tsai et al., 2013, Funes et al., 2014). The 
constitutive activation of the Nrf-2 pathway is an effective chemo resistance and evasion 
strategy for several cancer types (Kwak et al., 2002, Kwak et al., 2003, Sporn and Liby, 
2012). There are indications that Nrf-2 may be a direct PERK substrate (Cullinan et al., 
2003, Cullinan and Diehl, 2004, Cullinan and Diehl, 2006). The phosphorylation of eIF-
2α by PERK and other ER bound kinases followed by the activation of Atf-4 marks a 
convergence point in the intergrated stress response (ISR) pathway. Thus, it is possible 
that the ISR pathway might result in Nrf-2 activation irrespective of the stress type. 
Together Nrf-2 and Atf-4 may mediate the differential regulation of target genes such as 
CHOP (Zong et al., 2012) and xCT (Ye et al., 2014). 
Bioinformatics analysis of the GlyT-1a flanking sequence revealed a putative composite 
regulatory module (CRM8) consisting of TFBS sites for Nrf-2 (Illustrated in Figure 3.45). 
CRM8, located between 558 and 531 bases upstream from the GlyT-1a TSS, also contains 
binding sites for Atf-4 and small Maf proteins both of which are known Nrf-2 interacting 
partners (He et al., 2001, Motohashi et al., 2004).  
As reviewed in Section 1.7.3, Nrf-2 activation is generally considered to contribute to 
regulatory networks induced by oxidative, chemical and xenobiotic insults. Our 
hypothesis posited that the expression of GlyT-1a may be regulated in a similar manner 
to xCT. Both GlyT-1 and xCT are equally important requirements for the supply of 
glycine and cysteine respectively, for the synthesis of the antioxidant glutathione (GSH). 
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Studies have demonstrated the regulation of xCT by Nrf-2 via antioxidant response 
elements (ARE) in its promoter (Sasaki et al., 2002, Lewerenz et al., 2009, Bell et al., 2011). 
The same is true for transcriptional regulation of EAAT-3 (the principal glutamate 
transporter in the CNS which provides cysteine to neuronal cells that lack system Xc
- 
(Escartin et al., 2011)). 
In the last 20 years significant advancements have been made in understanding how Nrf-
2 is activated. The general consensus is that Nrf-2 mRNA is constitutively transcribed in 
the cell, and the resulting protein, if unneeded, is degraded by a Keap-1 dependent 
pathway (Nguyen et al., 2005, Misra et al., 2013). Exactly how Nrf-2 escapes sequestration 
and degradation downstream of stress is still being investigated. That the translation of 
the always expressed Nrf-2 mRNA is itself redox sensitive has been suggested (Li et al., 
2010). Li et al, in another study, suggest that upon dissociation of the expressed protein 
from Keap-1, its dimerisation with other BZIP factors such as the small Maf proteins, 
mask the nuclear export signal (NES) motif within its leucine zipper domain (Li et al., 
2008). Such interactions effectively renders Nrf-2 nuclear bound, away from the 
cytoplasmic cytoskeleton bound Keap-1.  
 
Figure 3.45: Hypothetical interaction of Nrf-2 and other factors at CRM 8.    
Little is known about the transcriptional regulation (if any) of Nrf-2 following stress. 
Although the primary mode of Nrf-2 ‘activation’ downstream of stress is in its post-
translational dissociation from Keap-1 followed by nuclear stabilisation, some researchers 
report increases in Nrf-2 mRNA expression following stress (Miao et al., 2005). There is 
a suggestion that Nrf-2 may in fact regulate its own expression via the presence of ARE-
like sequences in its promoter (Kwak et al., 2002, Chorley et al., 2012). Thus to completely 
determine if Nrf-2 is involved in the regulation of GlyT-1a, its expression pattern 
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downstream of stress treatment was studied as well as the possible interaction of the 
translated Nrf-2 protein at the putative CRM8 found in the GlyT-1a promoter. 
3.5.1 Basal Nrf2 mRNA expression is unchanged by stress 
To determine if increases in Nrf-2 transcription coincided with its activation for the 
regulation of GlyT-1a downstream of stress treatment, Nrf-2 mRNA was quantified in 
total RNA of Caco-2 cells subject to varied stressors. QPCR was performed to quantify 
a representative 120bp region spanning the third and fourth exons of the Nrf-2 coding 
sequence. QPCR primers used were capable of detecting all three Nrf-2 transcript variants 
in total RNA extracted from stressed treated Caco-2 cells as described in Chapter 2. PCR 
conditions were optimised by endpoint PCR; the size of the resulting amplicon was 
checked on a 2% agarose gel (Figure 3.46). The integrity of the Nrf-2 amplicon (cloned 
in a pGEM-T-Easy plasmid for use as a QPCR standard) was validated by sequencing 
(Figure 3.47)  
 
 
Figure 3.46: Gel image of cloned of pNRF2 standard. The 120bp PCR product seen in 
lanes 8-11 was generated by amplification of Caco-2 cDNA with Nrf-2 specific primers 
shown in Table 2.3. The eluted product was ligated into pGEM-T-easy, cloned in JM109 
cells and characterised by sequencing (see Figure 3.47) and used to generate standard 
curves for use in QPCR.  
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Figure 3.47: Validation of cloned pNrf-2 for use as standards in RT-QPCR. A 120bp 
region of Nrf-2 coding sequence was cloned into a pGEM-T-easy plasmid for use as 
QPCR standard. Sequencing results were aligned to the Nrf-2 (NFE2L2) sequence 
obtained from NCBI. The two PCR errors identified at positions 73 and 82 of the product 
were non critical for QPCR assays. 
Given that in the UPR Nrf-2 may also be activated by PERK along with the observation 
that it is active downstream of prolonged ER stress suggests a pro-survival role for Nrf-
2 (Cullinan and Diehl, 2004). However our data do not suggest Nrf-2 activation by the 
UPR correlates to increases in its transcription. As shown in Figure 3.48, the expression 
patterns observed for Nrf-2 show no significant changes in Nrf-2 mRNA expression in 
Caco-2 cells following either 1 µM tunicamycin, 50 µM thapsigargin for 16 hours, with 
0.2mM DEM for four hours or eight hours of amino acid starvation.  
ER stress induced by thapsigargin (a Ca2+/ATPase inhibitor) has been associated with 
expression of downstream Nrf-2 target genes (Cullinan and Diehl, 2006). The rapid 
increase in intracellular Ca2+ concentration and subsequent accumulation in the 
mitochondria results in the production of ROS. Blocking the transcription of Nrf-2 in 
normal human bronchial epithelial (NHBE) cells with specific siRNA had consequential 
down-regulatory effects on the expression of its target genes following thapsigargin 
treatment (Yolanda et al., 2013). Similar decreases in the expression of target genes was 
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not observed when these NHBE cells were treated with siRNA against PERK. This 
suggests that whilst post-translational events are important to the activation of Nrf-2 
downstream of oxidative stress, its mRNA expression may be equally important. Our data 
however does not suggest that a heightened oxidative stress burden induced by DEM 
results in any changes to Nrf-2 basal mRNA expression 
 
 
Figure 3.48: Nrf2 mRNA abundance is unchanged following stress in Caco-2 cells with 
either 16 hours of tunicamycin (Tu) or thapsigargin (Tg), 8 hours of amino acid starvation 
(No AA) or 4 hours of DEM. Values are pooled from multiple experiments and represent 
a percentage mean of the untreated control sample displayed as mean ± SEM, n=3 (N=2-
3 for each treatment). One-way (non-parametric) analysis of variance (ANOVA) was 
performed. Dunnett’s multiple comparison tests with pooled variance for each treatment 
was used for comparison to the control 
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3.5.2 Atf-4 knockdown increases Nrf-2 mRNA expression only with ER stress by 
thapsigargin and Nutrient stress by amino acid starvation. 
The spatio-temporal and tissue-specific precision with which TFs link external stimuli to 
changes in expression of target genes, often requires an interplay of several other factors. 
Filtz et al suggest the interconnectedness of TFs is governed by a host of several post-
translational modifications (PTMs) (Filtz et al., 2014). It is possible that the PTMs 
regulating the activation of one transcription factor signals directly to the compensatory 
expression of other TFs.  The redundancy of DNA binding site specificity for one TF 
points to the probability of other factors binding to the same TFBS in promoter regions 
of target genes to produce the same or similar regulatory effect (Hummler et al., 1994, 
Mechta-Grigoriou et al., 2001). Takahasi et al show that the binding affinities of TFs to 
their near-perfect required binding sites can be improved by increasing the concentrations 
of the TFs (Takahasi et al., 2011). To establish whether increased Nrf-2 transcription may 
compensate for the down regulation of other BZIP TFs known to be active in the stress 
response, Nrf-2 mRNA level was quantified in total RNA extracted from Caco-2 cells 
pre-treated with specific siRNA to either Atf-4, Atf-6 or Xbp-1. 
Following the transfection of Caco-2 cells with specific siRNA targeting Atf-4, a 
differential pattern of Nrf-2 mRNA expression was observed based on the type of 
stressor. Despite a significant reduction in Atf-4 mRNA expression in the cells (Figure 
3.49), no changes in Nrf-2 mRNA expression were observed following either 16 hours of 
1 µM tunicamycin treatment or 4 hours of 0.2 mM DEM (Figure 3.50). Subjecting the 
transfected Caco-2 cells to 16 hours of 200 µM thapsigargin, or 8 hours of amino acid 
starvation resulted in approximate doubling of Nrf-2 mRNA expression when compared 
to the untransfected controls. That Nrf-2 and Atf-4 can both bind to characteristic 
antioxidant response elements (AREs) has been established (He et al., 2001). Beyond the 
observed protein-protein interaction between Nrf-2 and Atf-4, the transcriptional 
relationship of these proteins remains unclear. There is no evidence for the transcriptional 
regulation of Nrf-2 by Atf-4. Others have suggested that Nrf-2 mediates the 
transcriptional regulation of Atf-4 (Afonyushkin et al., 2010, Miyamoto et al., 2011). Nrf-
2 was reported to bind to characteristic ARE-like sequence 300 bases upstream of the 
Atf-4 TSS (Miyamoto et al., 2011). In that study, Miyamoto and colleagues also 
demonstrated that down regulation of Nrf-2 with specific siRNA completely abolished 
Atf-4 induction by anoxia.  
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Figure 3.49: Specific siRNA knockdown of Atf-4 in Caco-2 cells. Transfection of Caco-2 
cells with Atf-4 specific siRNAs reduced the expression of Atf-4 by about 67% (P < 0.001 
are represented with a ****). Control transfection with siRNA against Atf-6 and Xbp-1 
showed no effect on Atf-4 mRNA abundance. Data are pooled from multiple transfection 
experiments and are represented as a percentage mean ± SEM of the untransfected 
control, n=9 (N = 3 for each treatment). A one-way analysis of variance (ANOVA) was 
performed to compare changes in mRNA abundance for each transfected sample group.  
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Figure 3.50: Effects of Atf-4 knockdown on Nrf-2 mRNA abundance in stressed Caco-2 
cells. Twenty-four hours after plating, cells were either transfected with a specific siRNA 
to Atf-4 (black bars) or mock transfected (open bars). A further 24 hours after 
transfection cells were stressed with either tunicamycin, thapsigargin, DEM or starved of 
amino acids. Values are pooled from multiple transfection experiments and represent a 
percentage mean ± SEM of the un-transfected control. n=3 (N = 2-3 for each treatment). 
A two-way analysis of variance (ANOVA) was performed to compare changes in Nrf-2 
abundance for each stress treatment group. Tukey’s multiple comparison test, revealed 
significant differences only between the un-transfected and transfected expression levels 
of Nrf-2 following 16 hours of 50 µM thapsigargin treatment or four hours of amino acid 
starvation (*** indicates a p-value of < 0.001). 
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3.5.3 Knockdown of Atf-6 or Xbp-1 does not affect Nrf-2 expression. 
Following the transfection of Caco-2 cells with specific siRNA targeting Atf-6 (Figure 
3.51) no changes in Nrf-2 mRNA were observed following 1 µM tunicamycin treatment 
for 16 hours or 0.2 mM DEM for four hours (Figure 3.52). The same was true for Nrf-2 
mRNA levels in these transfected cells following 16 hours of 50 µM of thapsigargin or 8 
hours of amino acid starvation. Unlike with Atf-4 there is no published evidence for Nrf-
2/Atf-6 interactions. Likewise there are no reports of the regulation of Nrf-2 by Atf-6. 
Data shown here indicates that indeed Atf-6 is not necessary for Nrf-2 induction.   
Atf-6, a type II transmembrane ER resident BZIP factor is an important transducer of 
ER stress response signals. All cells possess two Atf-6 isoforms (Atf-6α and Atf-6β) with 
contradicting activator or repressor function. Unlike Atf-4, Atf-6 activation in the UPR is 
independent of PERK. Atf-6 is confined to the ER by its association with the ER 
chaperone BiP/GRP78 (Shen et al., 2002, Sommer and Jarosch, 2002). During ER stress, 
the dissociation from BiP exposes the Atf-6 Golgi localisation signal (GLS) leading to its 
relocation to the Golgi. In the Golgi, Atf-6 is cleaved at two sites by site-1 and site-2 
proteases (S1P, S2P) (Lee et al., 2002). The N-terminal of the cleaved Atf-6 (Atf-6N) 
translocates to the nucleus where it dimerises with other BZIP factors to mediate the 
transcription of ER stress target genes.  
Given that amongst the cascade of Atf-6 target genes are factors which may alter Nrf-2 
activation (Yoshida et al., 2000), the consequences of Atf-6 activation should be 
investigated as a possible link between ER stress, oxidative stress and apoptosis. For 
instance, Xbp-1 is an Atf-6 target (Yoshida et al., 2000, Lee et al., 2002). When activated 
in tissues from liver cirrhosis patients, Xbp-1 causes the transcriptional up-regulation of 
the synovial apoptosis inhibitor (SYVN-1 or Hrd-1) to protect against ER stress induced 
apoptosis (Wu et al., 2014). Hrd-1 mediates enhanced post-translational degradation of 
Nrf-2 and consequent reduction in the expression of Nrf-2 target genes. Given that Atf-
6 up regulates Xbp-1 which in turn down regulates Nrf-2 response pathways, it is possible 
that knocking down Atf-6 stabilises the Nrf-2 protein; hence, no requirement for 
additional Nrf-2 mRNA expression. Whether Xbp-1 activation and the consequent 
degradation in Nrf-2 protein results in increased Nrf-2 mRNA expression is not known.  
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Figure 3.51: Specific siRNA knockdown of Atf-6 in Caco-2 cells. Transfection of these 
cells with specific siRNA to Atf-6 decreased Atf-6 mRNA abundance significantly by 
69% (P < 0.001). Atf-6 expression was unchanged following transfection with siRNA 
specific for Atf-4 or Xbp-1. Data are pooled from three transfection experiments and 
represent a percentage mean ± SEM, n=3 (N = 3 for each treatment). A one-way analysis 
of variance (ANOVA) was performed to compare changes in mRNA abundance for each 
transfected sample group.  
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Figure 3.52: Effect of Atf-6 knockdown on Nrf-2 mRNA abundance in stressed Caco-2. 
Twenty-four hours after plating, cells were either transfected with a specific siRNA to 
Atf-6 (black bars) or mock transfected (open bars). A further 24 hours after transfection 
cells were stressed with either tunicamycin, thapsigargin, DEM or starved of amino acids. 
Relative abundance data was measured by QPCR and are pooled from multiple 
transfection experiments and represent a percentage mean ± SEM of the un-transfected 
control samples. n=3 (N = 3 for each treatment) are plotted. A two-way analysis of 
variance (ANOVA) was performed to compare changes in Nrf-2 abundance for each 
stress treatment group. Tukey’s multiple comparison test, revealed no significant 
difference between stressed and unstressed samples of either the un-transfected and 
transfected groups. 
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Work by Liu et al showing increased oxidative burden and cell death in Xbp-1 deficient 
mouse embryonic fibroblast (MEF) cells somewhat contradicts the conclusions by Wu et 
al. (2014) that Xbp-1 induces degradation of Nrf-2 via Hrd-1 (Liu et al., 2009). Following 
oxidative stress Xbp-1 has been shown to be regulated in an Nrf-2 dependent fashion 
(Kwak et al., 2003). To determine if Xbp-1 knockdown had any effects on Nrf-2 mRNA 
expression Caco-2 cells were transfected with specific siRNA to Xbp-1 and Nrf-2 mRNA 
quantified under both stressed and unstressed conditions.  
A significant knockdown of Xbp-1 mRNA expression was observed following treatment 
with specific siRNA targeting Xbp-1 (Figure 3.53). Xbp-1 mRNA expression was 
unchanged by treatment with other non-specific siRNA. The knockdown of Xbp-1 had 
a doubling effect on Nrf-2 mRNA only in unstressed Caco-2 cells (Figure 3.54). This 
effect was not observed following either 16 hours treatment with 1 µM tunicamycin or 
50 µM of thapsigargin, treatment for 4 hours with 0.2 mM DEM treatment, or 8 hours of 
amino acid starvation.  
Xbp-1, a BZIP factor, was originally detected as a factor bound to the cis-acting x-box 
sequence in the promoter regions of the human major histocompatibility complex (MHC) 
Class II genes (Liou et al., 1990). Signalling via Xbp-1 provides an important link between 
ER function and the regulation of apoptosis. Downstream of ER stress, Xbp-1 mRNA 
induced by Atf-6 is spliced by the inositol-requiring enzyme 1 (IRE-1), an ER trans-
membrane endo-ribonuclease (Yoshida et al., 2001). There is extensive documented 
evidence on the role of the transcriptional activity of the spliced product Xbp-1s 
downstream of stress (Liu et al., 2009, Williams et al., 2014, Xu et al., 2014). However, a 
post-translational role of un-spliced Xbp-1 (Xbp-1u) mRNA is emerging (Zhao et al., 
2013). In the latter study, Zhao and colleagues demonstrated the physical interaction 
between Xbp-1u and other proteins like members of the FOX protein family, with 
subsequent phosphorylation of Xbp-1u by ERK leading to degradation by the 20S 
proteasome. Xbp-1u also sequesters Xbp-1s and Atf-6 (but not Atf-4) for degradation in 
a similar manner (Yoshida et al., 2006, Navon et al., 2010). Does Xbp-1u and Nrf-2 
interaction under unstressed conditions lead to its degradation in a similar manner? If 
true, the divergent roles of Xbp-1u in unstressed conditions and Xbp-1s in stressed 
conditions may explain the differences in Nrf-2 mRNA expression observed following 
Xbp-1 knockdown; however as discussed earlier, Nrf-2 degradation may not necessarily 
result in changes to its basal mRNA expression. 
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Figure 3.53: Specific siRNA knockdown of Xbp-1 In Caco-2 cells. XBP-1 reduction of 
79% (P < 0.001) is achieved following transfection with Xbp-1 siRNA. Xpb-1 mRNA 
expression was unchanged following treatment with Atf-4 siRNA however a significant 
reduction in its mRNA abundance was observed following Atf-6 transfection in Caco-2 
cells. Data are pooled from multiple transfection experiments and represent a percentage 
mean ± SEM, n=3 (N = 3 for each treatment). A one-way analysis of variance (ANOVA) 
was performed to compare changes in mRNA abundance for each transfected sample 
group.  
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Figure 3.54: Effects of Xbp-1 knockdown on Nrf-2 abundance in stressed Caco-2 cells. 
Data are pooled from multiple transfection experiments and represent a percentage mean 
± SEM of the un-transfected control samples displayed as open bars, or closed bars for 
the transfected samples (.n=3, N = 2-3 for each treatment). A two-way analysis of 
variance (ANOVA) was performed to compare changes in Nrf-2 abundance for each 
stress treatment group. Tukey’s multiple comparison test, reveals no significant difference 
between stressed and unstressed samples of either the un-transfected and transfected 
groups. However the transfection with specific Xbp-1 siRNA without any stress showed 
increased expression of Nrf-2 over the un-transfected control. *** indicates a P-value of 
< 0.001 
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3.5.4 Nrf-2 protein abundance is increased by stress  
The absence of any changes in Nrf-2 expression (as discussed above) is possibly due the 
complex mode of activation of Nrf-2 protein following stress (i.e. its escape from 
cytosolic sequestration by KEAP-1 and nuclear translocation; See section 1.7.3). Given 
that Nrf-2 activity is dependent on stabilisation of the protein, Nrf-2 protein abundance 
was quantified and its DNA interactions following stress treatment investigated. Despite 
no changes to Nrf-2 gene transcription (Figure 3.48), Western blot analysis showed an 
approximately 3-fold increase in the Nrf-2 protein abundance in total protein extracted 
from Caco-2 cells after 4 hours of 0.2mM DEM treatment (Figure 3.55a, b).   
 
 1 2 3 4 5 6 7 8 9 10  
 M  Control + DEM -Nrf-2 
-Nrf-2 
+DEM 
 
 
 
 
 
 
 
 
 
 
Figure 3.55a: Effects of DEM and Nrf-2 knockdown on Nrf-2 protein abundance. Caco-
2 cells treated with 0.2mM DEM showed a large increase in Nrf-2 protein abundance 
(lanes 5 and 6) when compared to untransfected and unstressed control cells (lanes 3 and 
4). Nrf-2 siRNA attenuated protein abundance in stress cells (lanes 9 and 10) when 
compared to untransfected yet stressed cells (lanes 5 and 6), however compared to the 
untransfected and unstressed controls (lanes 3 and 4), Nrf-2 protein is increased despite 
siRNA treatment in the transfected and stressed group (lanes 9 and 10).  Abundance of 
Atf-4 protein remained at very low/undetectable level in the cells regardless of treatment. 
Actin loading control was used to ensure the same amount of protein was added to each 
well. Independent samples (n=2) were used for each treatment group. Blot is 
representative of four experiments conducted by Dr Alison Howard.  
 
Nrf-2  
Atf-4  
Actin  
100kDa 
48kDa 
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Figure 3.55b: Densitometry of total Nrf-2 protein following DEM treatment. Caco-2 cells 
treated with 0.2mM DEM showed significantly increased Nrf-2 protein abundance of 
about 3 fold. Pre-treating the cells with Nrf-2 siRNA attenuates the protein in both 
unstressed (untreated) and stressed. Despite siRNA transfection in these cells, DEM 
treatment increased Nrf-2 protein in a manner consistent with the untransfected controls. 
Data is from three independent experiments, n=2-3 per experiment. **** indicates value 
significantly different from control (p<0.001).   
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3.5.5 Nrf-2 does not bind to an ARE identified in the GlyT-1a promoter  
To determine if an outcome of the increases in Nrf-2 protein following DEM treatment 
was increased binding to the putative ARE-like (TGACCAAGCC) sequence identified in 
CRM8 of the human GlyT-1a gene, electrophoretic mobility shift assays (EMSA) using a 
50bp DNA probe sequence from the GlyT-1a promoter were performed. As shown in 
Figure 3.56, the /5IRD800/G1Prom probe was designed to span between 559 and 509 
bases upstream of the GlyT1a TSS. Sense and anti-sense strands were synthetically 
generated and annealed to form a duplex tagged at its 5’-end with an IRD-800 dye 
(/5IRD800/G1Prom). This probe was incubated with nuclear extracts from either 
unstressed or DEM treated Caco-2 cells and the resulting protein DNA compounds 
analysed by PAGE. 
 
 
 
Figure 3.56: Illustration showing the /5IRD800/GlProm EMSA probe sequence for Nrf-
2 interaction analysis. Sense and anti-sense oligonucleotides were synthesised to include 
sequence between 509 and 559 bases upstream from the GlyT-1a transcription start site 
(TSS). The arrangement of a predicted protein complex at the contained CRM is shown.  
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Although no unique bands of low mobility protein-DNA complexes were seen on 
representative gel images capturing the mobility of the /5IRD800/G1Prom probe, 
inspection of the ‘flow through’ of unbound probe in these images highlights some 
important differences (Figure 3.57). In unstressed cells, there is a clear difference in the 
amount of unbound probe (highest mobility) passing through the gel when the incubation 
included nuclear protein (NP; lane 8) than when it included cytosolic protein (CP; lane 9); 
the level of flow through obtained with NP in unstressed cells is similar to that seen in a 
reaction were excess competitor probe was included (lane 10).  
The amount of unbound probe in unstressed NP is almost identical to competitive 
binding reactions containing excess unlabelled probe sequence (lane 10). Conversely, 
when cells are stressed, there is less flow-through with NP than CP (lane 2 – NP from 
DEM treated cells; lane 5 - NP from amino acid starved cells).  One possible explanation 
is that stress results in nuclear translocation of cytosolic proteins which are then able to 
bind to the /5IRD800/G1Prom probe.  
To improve the resolution of detection of protein-DNA interactions by EMSA, the 
incubation period for binding reactions was increased from 1 hour at room temperature 
to overnight (16 hours) at 4oC. As can be seen in Figure 3.58, whilst no retarded bands 
were detected in reactions containing only the /5IRD800/G1Prom probe (lane 1) 
multiple faint bands, possibly indicative of protein-DNA interactions are evident when 
the probe is incubated with crude NP extracts from unstressed Caco-2 cells (lane 2), those 
treated with 0.2 mM DEM for four hours (lane 3) or amino acid starvation for eight hours 
(lane 4). 
To determine if any of these bands represented complexes of Nrf-2 bound to the 
/5IRD800/G1Prom probe, super-shift assays were performed using an anti-Nrf-2 
antibody to further retard the migration of any Nrf-2 bound complex. As shown in Figure 
3.59, no significant band shifts were detected in super-shift experiments using the 
/5IRD800/G1Prom probe with NP extracts from unstressed control cells, cells starved 
of amino acids for 8 hours, or cells treated with 0.2mM DEM for four hours. This 
suggests that Nrf-2 does not bind to the ARE-like sequence in the postulated CRM8 of 
GlyT-1a. 
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1 2 3 4 5 6 7 8 9 10  
 0.2mM DEM  AA starvation. Unstressed  
 
 
+ + + + + + + + + + /5IRD800/G1Prom 
- + - + + - + + - + Nuclear proteins (NP) 
- - + - - + - - +  Cytosolic proteins (CP) 
- - - + - - + - - + Unlabelled competitor 
 
Figure 3.57: Gel image showing the binding to the /5IRD800/G1Prom  in crude cytosolic 
(CP) and nuclear (NP) extracts from stressed and unstressed Caco-2 cells. The 
/5IRD800/G1Prom probe is representative of bases -559 to -509 relative to the TSS of 
the human Glyt-1a gene and labelled with IRD800. A low mobility band, suggestive of 
probe-DNA binding is observed in all lanes, but its appearance in lane 1 (no protein 
control) suggests this is an artefact of the probe. The amount of unbound probe in each 
reaction varies dependent on the nature of the protein with which the probe was 
incubated; in stressed cells, nuclear protein binds a greater proportion of the probe 
whereas in unstressed cells, cytosolic protein is more effective at binding the probe. 
Competition assays which included an excess of unlabelled probe (lanes 4, 7 and 10) 
showed no effect of the competitor on the binding profile, do not change the binding 
profile observed. Samples were collected in a single experiment but the depicted gel is 
representative of a total of three independent experiments.  
 
 
 
Possible protein/DNA 
complexes but also seen 
in Lane 1 
Note the differences in 
amount of unbound 
probes between sample 
groups 
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Figure 3.58: Gel image showing the binding to the /5IRD800/G1Prom probe. Binding 
reactions were incubated overnight at 4oC. Lane 1 does not include any protein whilst 
lane 2, 3 and 4 include NP respectively from unstressed cells, cells treated with 0.2mM 
DEM for 4 hours and cells starved of amino acids for 8 hours.  
 
 
 
 
 
 
 
Possible protein/DNA complexes seen in lane 4 only 
Protein/DNA complexes seen in lane 4 and lane 3 but not in lane 2. 
Possible protein/DNA complexes (seen in lanes 2, 3 and 4 but not 
in the probe only lane 1). 
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Figure 3.59: Gel image of super-shift assays with the /5IRD800/G1Prom probe and 
nuclear (NP) extracts from stressed and unstressed Caco-2 cells. Lane 1 does not include 
any NP or antibody. No band shifts are seen in super-shift experiments with NP from 
unstressed cells (lanes 2-6), DEM treated cells (lanes 7-11), cells treated with tunicamycin  
(lanes 12-16), cells starved of amino acids for 8 hours (lanes 17-21), and thapsigargin 
treated cells (lanes 21-26)  
Taken together, that Nrf-2 mRNA levels are unchanged by stress and that despite 
increases in Nrf-2 protein following DEM stress (even in cells treated with siRNA to Nrf-
2) it does not bind to a predicted GlyT-1a ARE, suggests that Nrf-2 is not necessary for 
transcriptional regulation of GlyT-1a. In a study to measure expression of Nrf-2 target 
genes in human lymphoid cells downstream of oxidative stress, Chorley et al sequenced 
Nrf-2 bound genomic regions captured by ChIP (Chorley et al. (2012) data in 
supplementary file). 96% of the 845 sequences to which Nrf-2 bound contained an ARE-
like sequence. Whilst sequences upstream of GlyT-1 were not enriched by ChIP, Nrf-2 
was detected bound to an ARE-like sequence 56 bases upstream from the transcriptional 
start site of xCT/SLC7A11. This reinforces the many reports on Nrf-2 regulation of xCT. 
Possible 
protein/DNA 
complexes but seen 
throughout lanes 17, 
18, 19, 20 21. No 
band shifts are 
observed 
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3.5.6 Nrf-2 knockdown does not affect GlyT-1a expression  
Despite a significant reduction in Nrf-2 total cell protein following the treatment of Caco-
2 cells with Nrf-2 siRNA, there was no effect on the expression of GlyT-1a in these cells 
(Figure 3.60). 
 
 
Figure 3.60: Nrf-2 knockdown has no effect on GlyT-1a mRNA. Although Nrf-2 
expression is significantly decreased in Caco-2 cells transfected with specific Nrf-2 
siRNA, this reduction has no effect on Atf-4, GlyT-1a or xCT expression. Bars represent 
mean percentage of the control ± SEM, n=2-3. One-way analysis of variance (ANOVA) 
was performed to compare changes in mRNA expression between transfected (solid bars) 
and untransfected (open bars) samples. **** indicates a P-value of < 0.001
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3.6 Regulation of GlyT-1a transcription by Atf-4 
Atf-4, a member of the large CREB/ATF subfamily of BZIP factors is an established 
transcriptional activator of the integrated stress response (ISR). As discussed earlier, in 
response to stress, the ISR connects a series of adaptive response pathways to the 
transcriptional regulation of proteins enabling eradication of the stressor or cell death in 
cases of prolonged stress. The convergence of these adaptive processes at 
phosphorylation of eIF-2α at the ser51 residue by several ER resident kinases results in 
the blocking of protein translation and the preferential up regulation of ATF4 mRNA 
translation via upstream open reading frames (uORF). Such translation regulation was 
first described in the Atf-4 yeast homolog GCN4 (Hinnebusch, 1984) and later shown to 
exist in mammalian cells (Harding et al., 2000). 
Atf-4 was first identified as a protein bound to the tax responsive elements (TRE) of the 
human T-cell leukaemia virus type 1 (HTLV-1) and was historically referred to as the tax 
responsive enhancer element B67 or TaxREB67 (Tsujimoto et al., 1991). In the year after 
its identification, Karpinski et al. (1992) cloned and characterised a protein as a cAMP 
response elements (CRE) binding protein CREB-2 (note that a different protein from 
that described by Karpinski et al., and now known to be Atf-2 was also historically referred 
to as CREB-2 or CRE-BP1 Ozawa et al. (1991)).  Owing to the fact that CREB-2 (Atf-4) 
repressed the expression of the human pro-encephalin (PENK) gene when bound to 
CRE elements in its promoter it was originally described as a negative regulator of 
transcription (Karpinski et al., 1992, Bartsch et al., 1995). Whilst it is likely that by virtue 
of its dimerisation partners Atf-4 may repress gene expression (Soda et al., 2013), Atf-4 is 
widely regarded as a transcriptional activator (Rutkowski and Kaufman, 2003). Upon 
activation, Atf-4 co-ordinates the transcriptional regulation of genes in response to several 
stress types, including nutrient deprivation, ER stress, hypoxia, viral infection etc. 
Although the primary mode of Atf-4 activation is by post-translational modification, its 
transcript is also up regulated by the ISR (Harding et al., 2000, Harding et al., 2003, Dey et 
al., 2010). We therefore investigated the effect of stress on both ATF4 mRNA and protein 
abundance in Caco-2 cells to determine if it may be involved in the stress induced increase 
in Glyt1a mRNA abundance demonstrated in Section 3.1. As shown in Figure 3.61, 
treating Caco-2 cells with either 1µM tunicamycin or 50nM thapsigargin for 16 hours 
resulted in significant doubling of Atf-4 mRNA in these cells (P < 0.001).  
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Figure 3.61: Atf-4 mRNA abundance is increased following stress. Treatment of Caco-2 
cells with tunicamycin or thapsigargin results in a similar increase in Atf-4 mRNA 
abundance for both conditions as measured by QPCR. Pre-treating cells with specific 
siRNA to ATF-4 whilst effectively knocking down Atf-4 expression in unstressed cells 
(open bars) also significantly blunts the observed increases in Atf-4 expression following 
stress treatment (closed bars) by either tunicamycin or thapsigargin. Bars represent data 
expressed as a percent of the no stress, no siRNA control ± SEM (n=4-8. N=2-3). One-
way analysis of variance (ANOVA) was performed to compare changes in Atf-4 
expression between transfected and un-transfected samples within each treatment group. 
**** represents P-value of less than 0.001  
As expected, the magnitude of this response and of basal level of Atf-4 mRNA were 
attenuated in cells transfected with siRNA targeted to Atf-4 prior to the initiation of 
stress. Experiments investigating the effect of Atf-4 knockdown used one of either two 
specific siRNA targeting different regions of the Atf-4 mRNA or a mixture containing 
three different Atf-4-specific siRNAs (See Section 2.4.1, page54 for further details). All 
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transfections, regardless of the siRNA used, gave the same result as that shown in Figure 
3.61. These data suggests that there is either increased transcription of the Atf-4 gene 
during stress or that stress enhances the stability of pre-existing mRNA to prolong its 
lifespan. However the data described in Section 3.1 which shows that GlyT-1 mRNA is 
increased under the same conditions as that used here would support the former i.e. that 
increased transcription of Atf-4 may be required for additional activation of GlyT-1 
mRNA during stress. 
To determine if transcriptional changes in Atf-4 mRNA were consistent with changes at 
the protein level, Atf-4 protein abundance in Caco-2 cells treated with tunicamycin and 
transfected with ATF4 specific siRNAs was examined by Western blotting (Figure 3.62).  
In Caco-2 cells a band of 48kDa and at low intensity in control untransfected, untreated 
cells, was increased in density in cells treated with either tunicamycin or thapsigargin. This 
was diminished to control level in cells transfected with either ATF4 specific siRNA prior 
to treatment.  
Amongst the many Atf-4 target genes are molecular chaperones such as GRP78, DNA 
damage proteins including the CCAAT/enhancer protein homology protein (CHOP or 
C/EBP-ζ) and amino acid transporters such as SNAT-2 (Palii et al., 2006), xCT (Sato et 
al., 2004) and Cat-1 (Fernandez et al., 2003). Previous work showed increases in GlyT-1a 
mRNA in Caco-2 cells following stress treatment (Figure 3.1 page72). The knockdown 
of Atf-4 in Caco-2 cells by specific siRNA against Atf-4 significantly reduced Atf-4 
mRNA expression (Figure 3.61) and total protein abundance (Figure 3.62). The effect of 
the reduced Atf-4 knockdown on GlyT-1a mRNA was investigated. Measurement of 
GlyT-1a mRNA abundance in the same samples indicated that the knockdown of Atf-4 
also reduced the expression of GlyT-1a in both stressed and unstressed cells (Figure 3.63). 
This suggests that Atf-4 is required for both the basal and stress-induced GlyT-1a 
expression. As seen in lane 2 of the blot image in Figure 3.62, Atf-4 itself is protein 
abundance is increased when Caco-2 cells are stress when compared to unstressed control 
cells. Although the low protein abundance in unstressed cells (evident from the high 
differential between stress and unstressed cells, and the fact that the control band intensity 
is much lower than that in the knockdowns) may in part reflect the quality of the antibody 
used in this work, it may be a true indication of the abundance of the protein in the 
absence of stress. If so, this suggests that only a low Atf-4 titre is required to drive the 
basal transcription of the GlyT-1 gene.  
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Figure 3.62: Treating cells with Atf-4 siRNA results in decreased Atf-4 protein. Caco-2 
cells treated with tunicamycin (lane 3) or thapsigargin (lane 5), increased the intensity of 
the 48kDa band corresponding to Atf-4 when compared to the unstressed control (lane 
2). Pre-transfecting the cells prior to stress with Atf-4 siRNA (lanes 4 and 6) diminished 
protein titres as shown by the reduced band intensity. Note that the commercially 
available Atf-4 antibodies detect multiple non-specific bands as well as the specific Atf-4 
band which runs at the apparent molecular weight of 48kDA. All other additional bands 
shown on this blot are of unknown identify. The blot image shown here is representative 
of data from at least four similar experiment. Western blot experiment was conducted by 
Dr Alison Howard.  
Atf-4 Protein 
50kDa 
38kDa 
 182 
It is worth noting at this point that several attempts at using Western blots to follow 
changes in GlyT-1a abundance in stressed Caco-2 cells have been carried out. However, 
neither commercially available nor self-generated antibodies have been successful at 
detecting GlyT-1 in these cells. Control experiments using these antibodies on tissues 
with expected high GlyT-1 expression (such as brain tissue, spinal cord and neuronal 
derived cells) have given ambiguous results, suggesting that this is an issue of reagent 
quality rather than the absence of the GlyT-1 protein. Nonetheless, GlyT-1 expression at 
an mRNA and protein level has been confirmed in Caco-2, HCT-8 cells and human 
intestinal samples by immunohistochemistry using antibodies that are no longer 
commercially available (Christie et al., 2001, Howard et al., 2010).  
That GlyT-1a expression is reduced following Atf-4 knockdown is consistent with 
microarray data from work carried out by Lange et al that shows a decrease in GlyT-1 
differential expression in cortical neurones of Atf-4 knockout mouse when compared to 
wild-type controls (See Table S3 in Lange et al., 2008). The reduction in GlyT-1a mRNA 
following the knockdown of Atf-4 was consistent in both unstressed and stressed 
(tunicamycin or thapsigargin treated) Caco-2 cells. A similar reduction in GlyT-1a mRNA 
was not seen following either Xbp-1, Atf-6 knockdown (in unpublished data from this 
lab) or Nrf-2 (see Section 3.5.6); suggesting that Atf-4 and none of these other 
transcription factors are crucial to transcriptional regulation of GlyT-1.  
To determine if this regulation was part of a non-specific up-regulation of transporters 
driven simply by an increased requirement for amino acids, the effect of Atf-4 knock 
down on the mRNAs for transporters, xCT – which as described previously is thought 
like GlyT-1 to provide amino acids for glutathione synthesis; and PepT1 – which has no 
specific role in glutathione synthesis; was investigated. As shown in Figure 3.64, Atf-4 
knockdown had the same effect on xCT mRNA as it did on GlyT-1a mRNA i.e. it is 
reduced in both stressed and unstressed Caco-2 cells. In contrast, expression of the 
peptide transporter was not influenced by Atf-4 knockdown in either basal or stressed 
conditions (Figure 3.65). That the knockdown of Atf-4 in these cells, had no real effect 
on the PepT1 mRNA following stress, but did on GlyT-1 and xCT supports the 
hypothesis that a specific coordinated transcription regulatory network controls the 
import of amino acids such as glycine and cysteine for function in roles beyond general 
protein synthesis. 
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Figure 3.63: Atf-4 knockdown in Caco-2 cells decreases GlyT-1a expression. Whilst 
GlyT-1a expression is significantly increased in total RNA extracted from tunicamycin or 
thapsigargin treated Caco-2 cells (as measured by QPCR), transfecting these cells with 
specific siRNA to ATF-4 significantly decreases GlyT-1a mRNA abundance in unstressed 
cells (open bars) but also significantly attenuates the increased expression in stressed cells 
(closed bars). Data is presented as percent of no stress, no transfection control ± SEM 
(n=3-6, N=2). One-way analysis of variance (ANOVA) was performed to compare 
changes in GlyT-1a expression between transfected and untransfected samples within 
each treatment group (i.e. unstressed, tunicamycin and thapsigargin). **** indicates a P-
value of < 0.001. 
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Figure 3.64: Atf-4 knockdown in Caco-2 cells decreases xCT expression. In untransfected 
cells xCT expression is increased in total RNA extracted from tunicamycin or thapsigargin 
treated Caco-2 cells (as measured by QPCR). Transfecting these cells with specific siRNA 
to ATF-4 significantly decreases xCT mRNA abundance in unstressed cells (open bars) 
but also significantly attenuates the increased expression in stressed cells (closed bars) in 
a pattern similar to those observed with GlyT-1a (Figure 3.63). Data is presented as a 
percent of the untransfected and unstressed control ± SEM, (n=3-6, N=2). One-way 
analysis of variance (ANOVA) was performed to compare changes in xCT expression 
between transfected and untransfected samples within each treatment group (i.e. 
unstressed, tunicamycin and thapsigargin). **** indicates a P-value of < 0.001. 
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Figure 3.65: Atf-4 knockdown has no effect on PepT1 expression in Caco-2. Transfecting 
these cells with specific siRNA to ATF-4 had no effect on PepT1 mRNA abundance in 
unstressed cells (open bars) or stressed cells (closed bars) contrary to the effects of Atf-4 
knockdown on GlyT-1a mRNA (Figure 3.63). Data is shown as percent of the 
untransfected and unstressed control ± SEM (n=3-5, N=3). One-way analysis of variance 
(ANOVA) was performed to compare changes in PepT1 mRNA abundance between 
transfected and untransfected samples within each treatment group (i.e. unstressed, 
tunicamycin and thapsigargin). No statically significant differences were noted. 
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Similar effects of Atf-4 knockdown have been described on other genes important to the 
response to several type of stress. In HeLa cells transfected with Atf-4 specific siRNA, 
CHOP mRNA was significantly reduced (See figure 4 in Averous et al., 2004). In that 
study, the reporter activity of constructs containing the CHOP AARE required for Atf-4 
mediated transcription was reduced in HeLa cells pre-transfected with Atf-4 siRNA and 
subject to amino acid starvation. Likewise, and consistent with the findings of this study, 
a reduction in activity of reporter constructs representing the xCT promoter was evident 
when these constructs where co-transfected with Atf-4 siRNA into mouse embryonic 
fibroblast cells (See figure 2G in Lewerenz and Maher, 2009). Subsequent work by 
Lewerenz et al., also agrees with the results reported here, in that they found that Atf-4 
siRNA treatment of Caco-2 cells reduced the mRNA expression of xCT in both stressed 
and unstressed cells (Figure 3.64). Atf-4 knockdown in HT-22 cells by two independent 
siRNA effectively reduced xCT mRNA expression (See supplementary figure 3 in 
Lewerenz et al., 2012). Given that downstream of stress treatment xCT mRNA was up 
regulated co-ordinately with that of GlyT-1a (Section 3.1), and that as shown here Atf-4 
knockdown resulted in the down regulation of both GlyT-1a and xCT, it is probable that 
both GlyT-1 and xCT are co-regulated by Atf-4. This is supported by similar data from  
Ait-Ghezala et al. who showed that increased Atf-4 activation associated with depletion 
of the eukaryotic release factor 3a (eRF-3α) in HCT-116 cells resulted in a 2.35 fold 
increase in GlyT-1 expression and a 3.08 fold increase in xCT expression (See table 2 in 
Ait Ghezala et al., 2012).  
Treating BV-2 cells with the cannabinoids tetrahydrocannabinol (THC) and cannabidiol 
(CBD) both known to deplete cellular glutathione (McKallip et al., 2006) leads to the up 
regulation of both xCT and GlyT1 (See table 2 in Juknat et al., 2012). In addition to 
depleting glutathione levels and induction of oxidative stress, cannabinoids are known to 
induce ER stress and subsequent apoptosis in an Atf-4 dependent way (Carracedo et al., 
2006, Salazar et al., 2009). These observations point to the possibility of a common Atf-4 
dependent regulatory programme for both xCT and GlyT-1 downstream of both 
oxidative, nutrient and ER stress.  
The transcriptional control of xCT by Atf-4 has been studied. Sato et al. documented the 
tandem repeat of two characteristic AAREs in forward and reverse orientations upstream 
from the TSS of the mouse xCT gene (Sato et al., 2004). EMSA assays showed that Atf-4 
bound to probes containing either the most 5’ AARE or both AAREs whilst the mutation 
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of one or both AAREs (which are separated by just nine bp) significantly diminished the 
activity observed in promoter constructs. Similar forward and reverse AAREs have been 
shown in the human xCT gene, between 64 and 90 bases upstream from the TSS (Ye et 
al., 2014). 113 bases upstream from the human xCT TSS is a reverse anti-oxidant response 
element (ARE) to which Ye et al propose (without providing any experiment evidence) 
that Atf-4 as well as Nrf-2 may bind. 
The GlyT-1a flanking sequence was analysed to computationally detect the occurrence of 
composite regulatory modules (CRMs), consisting of TFBS sites for Atf-4 like those 
found upstream of the xCT TSS. As discussed in Section 3.2, ten CRMs were identified 
within 2000 bases upstream from the GlyT1a sequence. Whilst each of these CRMs may 
warrant individual experimental validation, the characteristics and arrangement of 
potential binding sites in CRM10 (Figure 3.11c, page101) make it interesting for several 
reasons. Firstly, the Atf-4 binding site of sequence (ACTACGTTG) within this module 
is identical to the reverse complement of AARE sequences described in several other 
stress target genes (Table 3.2), including those in the promoter sequences of the 
asparagine synthetase (ASNS) and CHOP genes, and that in the first intron of the SNAT-
2 gene. Secondly, this highly conserved putative regulatory module (CRM10), located in 
the first exon of GlyT-1a (between 104 and 134 bases downstream from the GlyT-1a 
TSS) also contains a TFBS validated by the ENCODE project to bind C/EBPβ 
(Consortium, 2012). Similarly positioned CRMs downstream of the TSS have been 
described in other Atf-4 regulated genes. Fernandez et al. (2003) reported on the 
transcriptional activity of Atf-4 bound at an AARE of sequence TGATGAAAC located 
in the first exon of the arginine/lysine transporter – Cat-1 gene.  Dimerisation between 
Atf-4, C/EBP-β and Atf-3 at the AARE of Cat-1 gene are known to regulate its spatio 
and temporal transcription following physiological stress (Fernandez et al., 2003, Lopez et 
al., 2007, Huang et al., 2009). A further example is the human tribbles homolog TRB3, a 
suspected pro-apoptotic protein kinase up-regulated by Atf-4 and known to mediate the 
degradation of C/EBP-β proteins (Hattori et al., 2003). Three tandem repeats of C/EBP 
and Atf-4 composite sites of identical sequences (TGATGCAAA) were identified in the 
first exon of TRB3 gene (Ohoka et al., 2005). Finally, sites for Atf-4, Atf-6 and C/EBPβ 
binding have also been identified in the first exon of the microtubule-associated protein 
1 light chain 3β (MAP1LC3B) (Rzymski et al., 2010). 
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Table 3.2: Amino acid response elements in stress target genes. Start stop locations are with respect to the transcriptional start site. Binding factors 
shown are those confirmed to interact with the respective sites. Table adapted from (Brasse-Lagnel et al., 2009). 
AARE Sequence 
Regulated 
Gene 
Featured 
Location  
Start Stop Orientation Binding factors Cell Model 
TGATGAAAC ASNS 5’-flanking -68 -60 Forward C/EBPβ, Atf-4 HeLa 
CATGATG ASNS 5’-flanking -70 -64 Reverse ? HepG2 
TGATGCAAC Atf-3 5’-flanking -23 -15 Forward C/EBPβ, Atf-4, Atf-3 HepG2 
ATTGCATCA CHOP 5’-flanking -310 -302 Reverse C/EBPβ, Atf-4, Atf-2 HeLa 
TGATGCAAA xCT 5’-flanking -94 -86 Forward Atf-4 NIH/3T3 
TTTGCATCA xCT 5’-flanking -78 -68 Reverse Atf-4 NIH/3T3 
TGATGAAAC Cat-1 Exon 1 +45 +53 Forward C/EBPβ, Atf-4, Atf-3 Rat C6 
TGATGCAAA TRB3 Exon 1 +228 +236 Forward CHOP, Atf-4  
TGATGCAAA TRB3 Exon 1 +262 +269 Forward CHOP, Atf-4  
TGATGCAAA TRB3 Exon 1 +294 +302 Forward CHOP, Atf-4  
ATTGCATCA SNAT-2 Intron 1 +712 +724 Reverse CHOP, C/EBPβ, Atf-4 HepG2 
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Figure 3.66: Hypothetical interaction of Atf4 and other factors at CRM10. The Atf-4 
TFBS site of sequence ACTACGTTG is 85.9% similar to the consensus Atf-4 binding 
site described in the TRANSFAC database. Similar sequences have been described in 
other Atf-4 target genes. Downstream from the Atf-4 binding site in this module is a 
TFBS able to bind C/EBP. C/EBP-β protein was positively identified bound to the 
GlyT-1a sequence (AAGAAAGCCACC) in ChIP-seq experiments conducted by the 
ENCODE project. Dimers of Atf-4 and various C/EBP proteins have been shown to 
regulate expression of several genes downstream of amino acid stress, ER stress, oxidative 
stress and nutrient stress (Kilberg et al., 2012, Kilberg et al., 2009). As to whether the 
arrangement of the individual TFBS in this composite regulatory module (CRM) allows 
for such dimerisation between Atf-4 and C/EBP proteins needs to be experimentally 
tested.  
3.6.1 Stress induced protein factors complex to a GlyT-1a probe 
To determine if downstream of stress, the Atf-4 protein effectively bound to the putative 
AARE-like (TGACCAAGCC) sequence identified in CRM10 of the first exon of GlyT-
1a (Section 3.2.4.3, page108), electrophoretic mobility shift assays (EMSA) were 
performed using an 88bp DNA probe sequence from the GlyT-1a promoter. As shown 
in Figure 3.67, the probe, name /5IRD700/G1Exon1, was designed to span between 97 
and 187 bases downstream from the GlyT1a TSS. Sense and anti-sense strands tagged at 
the 5’ end with IRD-700 dye where synthetically generated and annealed to form a duplex. 
This was incubated with extracts of nuclear protein from Caco-2 cells and the formation 
of protein-DNA complexes confirmed in gel shift assays by virtue of their relative 
migration on a polyacrylamide gel. From PAGE results of independent samples shown 
in Figure 3.68, incubating the /5IRD700/G1Exon1 probe with nuclear protein extracts 
(NP) from Caco-2 cells stressed for 16 hours with 1µM tunicamycin resulted in at least 
two bands. This is in line with expectations; if only the two predicted factors (Atf-4 and 
C/EBP-β) bind to the CRM in the probe, a maximum of four bands including that 
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representative of the unbound probe are possible based on the differing molecular sizes 
of the binding protein (Figure 3.67).  
 
 
Figure 3.67: Illustration of the /5IRD700/GlExon1 probe sequence showing possible 
binding patterns for Atf-4 and C/EBP-β. Based on the hypothetical model of interaction, 
should just Atf-4 and C/EBP bind to the CRM contained in the probe four complexes 
of different mobility are predicted.  Band 1, with maximal occupancy of the TFBS in the 
CRM should have lowest mobility, by virtue of the summarily high molecular weight. 
Monomeric interactions between both Atf-4 and C/EBP should result in two additional 
bands (Band 2 and 3), whilst Band 4 would represent the high mobility migration or ‘flow 
through’ of the unbound probe.  
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A band with the lowest relative mobility (RF) is expected, if both Atf-4 and C/EBP-β 
bind to their respective halves in the regulatory composite module. Should either Atf-4 
or C/EBP-β monomers bind separately to the probe, two further bands of relatively 
higher mobility are expected as the only variability is in the molecular size of Atf-4 
(~40kDa) and C/EBP-β (~36kDa) given that the molecular weight of the probe is 
constant and small in comparison to that of either protein. However it is possible that the 
7.5% PAGE gel used here is unable to resolve the 4kDa difference in molecular weight 
between Atf-4 and C/EBP; so the bands may appear as one. Finally, a high mobility band 
of unbound probe should be visible at the bottom of the gel image. 
As can be seen in Figure 3.68, a band of high mobility (identified as the unbound probe 
by comparison to the signal obtained in lane 1 from a reaction where no NP was added) 
is seen in all lanes but with varying band intensity. In all other lanes a further 2 bands of 
retarded mobility are observed. Lanes 3, 5 and 7 in Figure 3.68, represent competition 
reactions that include an unlabelled probe representative of the validated AARE 
contained in the CHOP gene. A 10-fold molar excess of the competitor was added to 
binding reactions containing the labelled /5IRD700/G1Exon1 and nuclear extracts from 
1µM tunicamycin treated Caco-2 cells. This resulted in a visible difference in intensity of 
the higher mobility unbound probe at the bottom of the gel, but did not appear to affect 
the intensity of either of the two lower mobility bands. Looking only at lanes 2 and 3, the 
data would suggest that the competitor is able to displace the labelled probe from the 
bound protein resulting in a diminished intensity for band 1 and enhanced flow through 
of the free probe (band 3). However when lanes 4-7 (which contained the products of 
identical reactions to lanes 2 and 3 but with different NP samples), are considered this 
does not appear to be the case. In these samples, the competitor caused an increase in 
flow through of the unlabelled probe, suggesting it has been displaced from a binding 
protein, but there is no apparent reduction in the intensity of either of the shifted bands. 
Thus, although the gel image does show that factors in NP from tunicamycin stressed 
cells bind to the probe, interpretation from these data on the effect of the competitor is 
ambiguous.  
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1 2 3 4 5 6 7 8 9 10  
 Reactions with NP from cells treated with 1µM Tunicamycin  
 
 
+ + + + + + + + - + /5IRD700/G1Exon1 
- + + + + + + + - + Nuclear proteins (NP) 
- - + - + - + - - - Unlabelled competitor 
 
Figure 3.68: Transcription factors in nuclear extract from tunicamycin treated Caco-2 cells 
bind to the GlyT-1a CRM10  probe (/5IRD700/G1Exon1). The figure shows the result 
of PAGE imaged with a LICOR Odyssey infrared scanner. Lane 1 shows free probe, 
lanes 2, 4, 6, 8 and 10 the result of incubating nuclear extracts with the labelled probe and 
lanes 3, 5 and 7 the effect of including excess unlabelled competitor probe in the reaction. 
Note the nuclear extracts used for the reactions in lanes 2, 4, 6, 8 and 10 are from different 
cell samples; reactions for lanes 2 and 3, 4 and 5, and 6 and 7, were paired in that for 
example lanes 2 and 3 contained the same nuclear extract.  For lanes 2-10 5μg of protein 
was loaded; for lane 1 the same amount of free probe as used in all other lanes was loaded. 
Well 9 of the gel was damaged and left empty. The image shows the migration of three 
bands corresponding to two DNA/protein complexes formed with each binding 
condition, and the excess unbound probe (indicated as bands 1-3 respectively in the right 
hand side panel). Note the differences in intensities of the unbound probe (band 3) in 
lanes to which the unlabelled competing CHOP AARE sequence was added. This gel is 
representative of two separate experiments (N = 2). 
 
 
 
Band 1 of protein/DNA 
complexes. Seen in lanes 
2-8 and lane 10. 
Band 2 of protein/DNA 
complexes. Seen in lanes 
2-8 and lane 10. 
Band 3, unbound probes  
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Comparing the mean of band 1 intensities for lanes 2, 4 and 6 with that of lanes 3, 5 and 
7 showed no difference (Figure 3.69), suggesting that the competitor had no effect on 
probe binding. Experiments subsequent to this have given results similar to those in lanes 
4-7 rather than in lanes 2 and 3. Similary attempts at optimisation, including altering the 
ratio of probe:NP or NP:competitor have not provided an explanation for this result. It 
is clear that the inclusion of the competitor in the binding reaction has an effect on probe 
binding but the nature of that effects remains to be determined. 
. 
 
 
 
Figure 3.69: Plots of average intensities of EMSA gel bands from Figure 3.68. The average 
band intensity provides an approximation of how much of the probe is retained in the 
protein-DNA complex. The relative mobility (RF) score gives a percentage migration 
through the gel, where 0 is for bands with no migration at the top of the gel and 1 
represents complete migration to the bottom of the gel. (A) The average intensity of each 
detected band peak (represented by each point on the graph) from each lane (represented 
using symbols of the same colour on the graph) of the gel image plotted against the RF 
representing the migration from the top of the gel [RF=0] as a function of molecular 
weight. Clustering reveals three distinct peak groups (indicative of bands) corresponding 
to the two DNA/Protein complexes with average RF of 0.2 and 0.35, and the excess 
DNA probe with average RF of 0.9. (B) Comparison of the average intensity of the bands 
with average RF of 0.35 in binding reactions to which the probe (/5IRD700/G1Exon1) 
and competitor were added (lanes 3, 5, 7 of Figure 3.68) or those to which only the probe 
was added (lanes 2, 4, 6, 8). The Student’s t-test comparing the two groups revealed no 
statistical significance between the average intensities, suggesting similar binding affinities 
(n=3-4, P > 0.05)  
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In summary, these data suggests that a protein or other factors within the nuclear extracts 
of tunicamycin treated Caco-2 cells bind to sites contained in the /5IRD700/G1Exon1 
probe, possibly at the AARE in the predicted composite regulatory module.  
To determine if the bands observed are not just specific to tunicamycin treated Caco-2 
cells, gel shift assays were then carried out using nuclear protein extracts from these cells 
following treatment with thapsigargin, DEM or amino acid starvation. Nuclear extracts 
from cells treated with 50nM thapsigargin for 16 hours were incubated with the probe as 
described above. As shown in Figure 3.70, unlike binding reactions with nuclear extracts 
from tunicamycin treated cells, where two distinct low mobility bands were present 
(Figure 3.68), nuclear extracts from thapsigargin treated cells only formed a single low 
mobility protein-DNA complex. It is therefore likely that the interaction of transcription 
factors at their response binding sites is dependent on the nature of the stress. In binding 
reactions of the /5IRD700/GlExon1 probe and nuclear extracts from Caco-2 cells 
treated for four hours with 0.2mM DEM, the intensity of the low mobility protein-DNA 
complex band is very low (Figure 3.71). This suggests that although transcription factors 
in the nuclear extracts from DEM treated cells may bind to TFBS in the probe, the affinity 
of interaction is not as high as with tunicamycin or thapsigargin. From these data it is 
impossible to determine if this is due to low titres of the bound TFs in the nuclear extract. 
The inclusion of excess unlabelled competitor probe into these binding reactions had no 
added effect on the intensities of either the retarded bands or the free probe, suggesting 
that protein binding to the /5IRD700/GlExon1 probe is at a site distinct from that 
contained in the competitor probe.  
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1 2 3 4 5 6 7 8 9 10  
 Reactions with NP from 50nM Thapsigargin treated cells  
 
 
+ + + + + + + + - + /5IRD700/G1Exon1 
- + + + + + + + - + Nuclear proteins (NP) 
- - + - + - + - - - Unlabelled competitor 
 
Figure 3.70: Transcription factors in nuclear extracts from thapsigargin treated Caco-2 
cells bind to CRM10 of GlyT-1a. (/5IRD700/G1Exon1). PAGE gel imaged with a 
LICOR Odyssey infrared scanner showing the migration of two bands corresponding to 
a protein-DNA complex with low relative mobility and the excess unbound probe. Note 
that the addition of the unlabelled competitor had no effect on the binding intensities of 
the low mobility protein DNA/Complex. Different samples were used for each binding 
reaction and competition assay pair. Similar lane profiles were noted in two separate 
experiments (N = 2). 
 
 
 
 
 
 
 
 
Band 1 of protein/DNA 
complexes in lanes 2-8 
and lane 10. 
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1 2 3 4 5 6 7 8 9 10  
 Reactions with NP from 0.2mM DEM treated cells  
 
 
+ + + + + + + + - - /5IRD700/G1Exon1 
- + + + + + + + - - Nuclear proteins (NP) 
- - + - + - + - - - Unlabelled competitor 
 
Figure 3.71: Transcription factors in DEM treated Caco-2 cells bind to GlyT-1a CMR 10 
with very low intensity. PAGE gel imaged with a LICOR Odyssey infrared scanner 
showing the migration of two bands corresponding to a protein-DNA complexes with 
low relative mobility and the excess unbound probe. Note that the addition of the 
unlabelled competitor had no effect on the binding intensities of the low mobility protein 
DNA/Complex. Gel is representative of two experiments (N = 2) 
 
 
 
 
 
 
 
 
Note the low intensity 
diffuse band/s present in 
lanes 2-8 not visible in 
the probe only lane 1 
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1 2 3 4 5 6 7 8 9 10  
 
Reactions with NP from cells incubated in Amino acid free 
medium for 4 hours. 
 
 
 
+ + + + + + + ++ ++ - /5IRD700/G1Exon1 
- + + + + + + ++ ++ - Nuclear proteins (NP) 
- - + - + - + - + - Unlabelled competitor 
 
Figure 3.72: Transcription factors in nuclear extract from Caco-2 cells (incubated in amino 
acid free medium for 4 hours) bind to a GlyT1a probe  (/5IRD700/G1Exon1). PAGE 
gel imaged with a LICOR Odyssey infrared scanner showing the migration of two bands 
corresponding to protein-DNA complex with low relative mobility and the excess 
unbound probe. Note that the addition of the unlabelled competitor had limited effect 
on the binding intensities of the low mobility protein DNA/Complex. Similar lane 
profiles were noted in three separate experiments (N = 3). NB: twice the amount of 
nuclear protein NP (++), or probe (++) was added to lanes 8 and 9. 
Despite the fact that protein-DNA complex bands were seen in all EMSA assays of 
binding reactions using nuclear extracts from stressed Caco-2 cells, the data presented in 
Figure 3.68 - Figure 3.72 does not determine if any or all of the complexes identified result 
from interaction at the postulated AARE contained in the probe. To determine its role, 
if any, an 88 base pair probe (/5IRD700/G1Exon1/Mut) was generated. This probe 
spans the identical region of GlyT-1a as the /5IRD700/G1Exon1. The only difference 
between the two probes is in the double mutation of the predicted AARE from 
TGATGCAAC; or reverse complement ACTACGTTG to TGTTGCAGC; or reverse 
Band 1  
Band 2 ? but also seen  
in the probe only lane  
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complement ACAACGTCG. The decision of which bases to change was guided by base-
wise conservation scores in the Atf-4 binding consensus from the TRANSFAC database 
which showed these bases to be highly conserved.  
As shown in Figure 3.73, binding reactions using either /5IRD700/G1Exon1 or 
/5IRD700/G1exon1/Mut resulted in varying numbers of shifted bands with differing 
intensities (Quantification traces are shown in Figure 3.74). Lanes 1 and 2 in Figure 3.73, 
represent incubations of just the wild type and the mutated probes respectively, and 
demonstrate that only a high mobility band representative of the unbound probe is seen 
for each. Using nuclear extracts from unstressed cells (lanes 3 and 4), generates two 
shifted bands (band 1 and 2 discussed above) which are evident for both the mutated and 
the wild type probe. This suggests that even in the basal state, nuclear proteins bind to 
this region of the GlyT-1a gene and stress may not be a pre-requisite for interaction at 
this site. The intensities of the shifted bands generated by both stressed and unstressed 
conditions is much reduced when the mutated probe was used, suggesting that the 
mutation reduces the ability of the probe to bind to, whatever DNA binding proteins. 
When nuclear extracts from tunicamycin cells were including in binding assays with the 
wild-type probe (lane 5) four low mobility bands were evident. This differs from the 
previous result (Figure 3.68) were tunicamycin treatment resulted in two shifted bands, 
but was consistent between the present data and one further experiment. Of the four 
shifted bands, three (those with the lowest mobility) were reduced to very low intensities 
when the mutated probe was used (lane 6). This suggests that the mutation blocks the 
ability of the probe to bind the TFs responsible for the shift and that the AARE is crucial 
for binding of factors induced by tunicamycin treatment. The fourth highest mobility shift 
band (band 2, lane 6) had an apparent increase in intensity when compared to lane 5. A 
possible explanation for this observation is that the mutated AARE prevents certain TFs 
from binding and frees up more of the probe for binding to factors which interact at 
another site, thus increasing the intensity of this band. It is also possible that the mutation 
introduces a biologically functional site for other TFs which may be responsible for the 
band. Interestingly, as noted previously, this band is evident throughout all reactions using 
nuclear extracts from both stressed and unstressed samples (lanes 3-10). A similar increase 
in intensity of band 2 when the mutated probe was used, was seen only with nuclear 
extracts from DEM treated cells (lane 8). In untreated cells and those starved of amino 
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acids (lanes 3, 4 and 9, 10 respectively) the intensity of band 2 was reduced when the 
mutated probe was used in binding reactions. 
The appearance of shifted bands generated with nuclear extracts from DEM treated cells 
and the wild-type probe (/5IRD700/G1Exon1) is similar to that obtained previously 
(Figure 3.71) in that there is a faint, diffuse band of very low mobility (band 1 in this 
figure). However, as previously noted, there is an additional band (band 2) that is 
increased in intensity when the wild-type probe is substituted for the mutated probe (lane 
8). Furthermore, another band of intermediate mobility is evident with the mutated probe 
that is not present when using the wild-type probe. This suggests that the mutated AARE 
introduces an additional binding site for a protein factor active downstream of DEM 
treatment. The intensity of the diffuse, lower mobility band (band 1 in the figure) is not 
visibly altered between the two probes, suggesting that the mutation, unlike in nuclear 
extracts from tunicamycin treated cells, has no real effect on the binding of the factors 
involved here. 
When cells were subjected to amino acid starvation, binding of nuclear extracts to the 
wild-type probe (lane 9) resulted in two shifted bands (bands 1 and 2, discussed above); 
with band 1 most likely equivalent to the lowest mobility, diffuse band evident in lanes 2 
to 9 in Figure 3.72. The intensity of either of these two bands was not altered by mutating 
the probe (lane 10). As with DEM treatment, the mutated probe allows the formation of 
new DNA-protein complexes not evident with the wild-type probe. These differ in size 
from the additional bands seen with nuclear extracts of DEM treated cells, indicating that 
the array of TFs activated following amino acid starvation differs from that generated by 
oxidative stress. 
Overall, the data described in this section demonstrates that the AARE is indeed required 
for both the basal and tunicamycin stimulated GlyT-1a expression, but appears to be of 
little significance in DNA-protein interaction following either DEM induced oxidative 
stress or the stress induced by amino acid starvation. In this way it highlights that the cells 
respond in different ways to the different stressors used in these experiments, however it 
does not show definitively whether binding of Atf-4 by the AARE is involved in any or 
all of them. The experiments described in the next section set out to determine this.  
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1 2 3 4 5 6 7 8 9 10  
 Control Tunica. DEM No-AA.  
 
 
+ - + - + - + - + - /5IRD700/G1Exon1 
- + - + - + - + - + /5IRD700/G1Exon1/Mut 
- - + + + + + + + + Nuclear proteins (NP) 
 
Figure 3.73: Gel image showing binding of nuclear proteins to the 
5IRD700/G1Exon1/Mut probe. Nuclear protein (NP) extracts from control cells 
(untreated; lanes 3 and 4), tunicamycin treated cells (lanes 5 and 6), DEM treated cells 
(lanes 7 and 8) and amino acid starved cells (lanes 9 and 10) were incubated with either 
the mutated or the un-mutated probe (/5IRD700/G1Exon1). Gel image is representative 
of two separate experiments.  
Band 1  
Band 2  
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Control lanes Tunicamycin  DEM Amino acid starvation 
 
Figure 3.74: Lane profile analysis of gel shift assays in Figure 3.73 using either a probe with mutated AARE sequence 
(/5IRD700/G1Exon1/Mut; green trace) or  wild-type probe (/5IRD700/G1Exon1; red trace). The polyacrylamide gel shown in Figure 3.73 
was analysed using the LICOR Odyssey analysis software to determine the average intensity per pixel location of the gel. 
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3.6.2 Atf-4 binds to GlyT-1a AARE after tunicamycin and thapsigargin stress  
To provide confirmatory evidence that Atf-4 interacts at the GlyT-1a AARE, gel super-
shift assays and ChIP-PCR analysis were performed and are described in this section. Gel 
super-shift assays work on the principle that the binding of an antibody to a TF bound to 
its recognition site on the probe increases the molecular weight of the complex, thus 
decreasing its relative mobility through a PAGE gel. As can be seen in Figure 3.75, when 
nuclear protein extracts from tunicamycin (panel A), thapsigargin (panel B) and DEM 
(panel C) treated cells are incubated with the probe, protein-DNA complex bands 2 and 
3 are evident. However when the anti-Atf-4 antibody is added to the binding reactions, 
an extra band (band 1) of even lower mobility is seen in lanes 3 and 4 (panel A), which is 
absent from lane 1 (panel A). This observation confirms that Atf-4 binds to the 
/5IRD700/G1Exon1 probe following tunicamycin treatment. Similarly, with nuclear 
extracts from thapsigargin treated cells an extra band (band 1) is seen in lane 5 (panel B) 
further retarded on the PAGE gel, than the low mobility bands (band 2 and 3) seen in 
lane 2 (panel B). Significantly, no further band shifts were seen following the incubation 
of nuclear extracts from DEM treated Caco-2 cells, the probe and the anti-Atf-4 antibody 
(panel C) suggesting that the transcription factors binding to the probe and producing 
bands 1 and 2 following DEM stress are not Atf-4.  
Having confirmed the AARE in the GlyT1a first exon was a functional binding site for 
BZIP dimers of at least one Atf-44 subunit, the next experimental aim was to determine 
if this AARE was transcriptionally active following stress. To investigate this, ChIP 
analysis was performed in Caco-2 cells stressed by tunicamycin, amino acid limitation, or 
DEM as described in the Chapter 2, Section 2.7. DNA isolated from the ChIP assays 
using an antibody for Atf-4 were analysed by QPCR to determine the relative enrichment 
of a 100bp sequence spanning the GlyT-1a AARE.  
QPCR assays show that following tunicamycin stress, the GlyT1a AARE sequence in 
ChIP DNA isolated using an Atf-4 antibody is enriched nine times compared to that in 
unstressed cells (Figure 3.76). With amino acid starvation and DEM treatment, this 
enrichment is respectively five and two times that in controls. This is consistent with the 
lower intensity of the protein-DNA complex bands seen in gel shift assays of binding 
reactions with protein extract from DEM treated or amino acid starved Caco-2 cells 
(Figure 3.71 and Figure 3.72). 
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A B C  
Tunicamycin  Thapsigargin DEM  
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5  
   
 
+ + + + + + + + + + + + + + + /5IRD700/G1Exon1 
+ - + + - - + + - + - + + - + Nuclear proteins (NP) 
- + + + - - + - + + - - + + + Anti-Atf-4 antibody  
- + - - - - -  + - - - - + - BSA control 
 
Figure 3.75: Super shift assay showing Atf-4 binds the /5IRD700/G1Exon1 probe 
sequence between positions +97 to +185 of human GlyT-1a exon 1 sequence and 
containing the potential AARE. When incubated with Caco-2 nuclear protein extract and 
in the absence of the antibody, two shifted bands are visible (bands 2 and 3); a third super-
shifted band (band 1) with low mobility is visible above band 2 when an anti-Atf-4 
antibody was included in binding reactions between the probe and extracts from 
tunicamycin (lanes 3 and 4 or panel A) and thapsigargin (lanes 2 and 5 or panel B) treated 
cells. No super-shifted bands are visible in panel C corresponding to binding reactions of 
nuclear extracts from DEM treated cells. Images are representative of observations seen 
in three separate experiments.  
 
 
Band 1  
Band 2  
Band 3  
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Figure 3.76: ChIP-QPCR analysis showing enrichment of GlyT-1a AARE in immune-
precipitated DNA/protein complexes captured with a specific Atf-4 antibody. Bars 
represent the relative mean amounts ± SEM of a representative 100bp sequence spanning 
the GlyT-1a AARE in “input” vs “no-input” samples. “Input” samples represent aliquots 
of ChIP protein-DNA extracts from ~1x106 Caco-2 cells incubated overnight using 
0.5µg/mL of Atf-4 antibody linked to protein-A magnetic Dynabeads. The “Input 
controls” data is from chromatin samples of unstressed cells. “No input” control samples 
represent DNA isolated from ChIP samples not treated with the Atf-4 antibody. Stress 
protocols were maintained as used throughout the text. One way ANOVA was used for 
statistical comparisons between the sample groups. P-values of less than 0.001 are 
indicated with ****. 
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CHAPTER 4.  
CONCLUDING DISCUSSIONS 
 
Outline: In this chapter, I discuss the main highlights from the work described in this 
thesis. This general discussion focuses on the merits and short comings of the observations 
described in Chapter 3. It provides a brief commentary on the theoretical implications of 
these results with respect to existing knowledge of GlyT-1a regulation. It goes on to 
describe avenues for further investigation into the spatio-temporal regulation of GlyT-1a; 
reflecting on a possible role for other transcription factors known to dimerise with Atf-4.  
4.1 Atf-4 is involved in the regulation of GlyT-1a mRNA expression ........... 206 
4.2 Nrf-2 does not directly regulate GlyT-1a .................................................. 210 
4.3 Significance and future perspectives ........................................................ 211 
 
 
Based on the understanding that the intracellular accumulation of glycine (as a function 
of the GlyT-1 transporter) is important to resist stress in epithelial cells of the human 
intestine, the primary aim of the work described in this thesis was to investigate how 
amino acid starvation, oxidative stress, the unfolded protein response and ER stress 
resulted in increases in GlyT-1a mRNA expression. To achieve this aim, Caco-2 cells 
treated with tunicamycin, thapsigargin, DEM and tBHQ or subjected to altered amino 
acid availability were used as models of stress in the intestinal epithelium. 
Gene activation in response to extracellular signals requires a highly complex integrated 
network of molecular interaction which directs the transcriptional machinery for the 
appropriate gene. In the work described here, particular attention was paid to the 
pathways of the integrated stress response, and transcription factors known to be active 
in the stress response, notably the BZIP factors Atf-4 and Nrf-2.  
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4.1 Atf-4 is involved in the regulation of GlyT-1a mRNA expression 
Results from this work (discussed in Chapter 3) shows that the knockdown of Atf-4 in 
Caco-2 cells by specific siRNA decreased its mRNA by ~70%. This decrease in mRNA 
was consistent with a reduction in the protein titres detected by Western blot. A 
consequence of Atf-4 knockdown in these cells was an overall reduction in GlyT-1a 
mRNA expression relative to control transfected cells. A putative GlyT-1a AARE was 
identified in the GlyT-1a first exon by computational analysis (CRM 10). Reporter 
constructs containing this AARE showed significant reporter activity upon stress 
treatment. An 88bp probe containing the same AARE showed DNA/protein complex 
bands in gel shift assays while super shift assays using an anti-Atf-4 antibody confirmed 
the presence of Atf-4 in the protein-DNA complexes formed. Double mutation of the 
AARE sequence resulted in a ~75% reduction in transcriptional induction. Consistent 
with these findings, a high signal enrichment of a 100bp sequence spanning the predicted 
GlyT-1a AARE was obtained in QPCR analysis of DNA isolated from chromatin 
immune-precipitates of stress treated Caco-2 cells using an anti-Atf-4 antibody. 
As the activation of Atf-4 represents a central convergence point in the integrated stress 
response (Harding et al., 2000, Harding et al., 2003), studies into the regulation of several 
other amino acid transporters by stress have largely focused on a possible role for Atf-4. 
Having shown that the knockdown of Atf-4 in Caco-2 and HCT-8 cells repressed GlyT-
1a mRNA expression, and that Atf-4 mRNA was up-regulated by stress in these cells, the 
challenge was to map the direct molecular interactions between Atf-4 and enhancer 
elements in the GlyT-1a sequence. Importantly, the effects seen with Atf-4 knockdown 
on GlyT-1a mRNA were not evident with either Xbp-1 or Atf-6 knockdown. 
For the identification of transcriptional regulatory elements associated with a gene, it is 
typical to perform in silico analysis of its core, proximal and distal promoter regions 
(Wasserman and Sandelin, 2004). There are an ever increasing number of computational 
strategies for such analysis. However, there exists significant variation in sensitivity in 
detection of biologically relevant transcription factor binding sites (TFBS) amongst these 
methods. The strategy employed here was designed to minimise false negatives as well as 
false positives from computational analysis. In this work, multiple sources of evidences 
and classification techniques were used to improve the significance of predicted TFBS. 
The promoter regions of genes potentially co-regulated with GlyT-1a were analysed for 
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the over-representation of TFBS when compared to a control subset of housekeeping 
genes. Caselle et al argue that the statistical relationship between motif over-representation 
in a subset of co-regulated genes to the biological activity of that motif is significant 
(Caselle et al., 2002). Haverty et al have used such statistical relationships in developing an 
algorithm for computational inference of gene regulatory networks from expression 
profiles from micro-array studies (Haverty et al., 2004).  
In the absence of micro-array data from stressed Caco-2 cells it is impossible to accurately 
catalogue genes that have similar spatio-temporal patterns of expression to GlyT-1a when 
treated with the stress agents used in this work. Thus deciphering a transcriptional 
regulatory network for GlyT-1 in these cells is particularly challenging. It is also not 
directly possible to determine such information from publicly available micro-array data 
sets. To overcome this challenge, a subset of genes was identified in public micro-array 
datasets which had condition dependent correlation in their expression profiles to that of 
GlyT-1a. Based on the assumption that similar regulatory factors resulted in these patterns 
of expression, it was concluded that over-represented TFBS in the promoter regions of 
these genes would be important to condition specific regulation. Over a hundred enriched 
motifs were returned from the promoter analysis of co-regulated genes. It would be 
laborious to study the individual biological validity of every one of the returned motifs. 
Given that BZIP factors such as Atf-4 are known to function as dimers, assumptions 
were made on the nearness of individual TFBS within composite regulatory modules 
(CRM) for each monomer in a BZIP dimer. Such an approach has also been suggested as 
a way of improving the significance of predicted transcription factor binding sites (Syed 
et al., 2009).   
In the work presented here, ten CRMs were identified in the sequence region spanning 
1159 bases upstream from the GlyT-1a start site, the first exon and the untranslated 
region (UTR) of the second exon. These modules each contained an arrangement of 
TFBS which may allow for the binding of BZIP dimers which include at least one Atf-4 
subunit. The binding of Atf-4 to the amino acid response element (AARE; sequence 
TGATGCAAC) in the first exon of GlyT-1a has been confirmed by gel shift assays. It is 
highly likely that this AARE regulates the transcription of GlyT-1a given that nuclear 
extracts from tunicamycin, thapsigargin, DEM, and amino acid starved Caco-2 cells 
bound to probes containing it. The mutation of this AARE sequence both in the EMSA 
probe and β-galactosidase reporter constructs showed diminished binding and reporter 
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activity respectively, suggesting that it is an important motif for the regulation of the 
transcript following stress. 
As discussed earlier (Section 3.2.3.1 page 95), owing to the fact that the first half of this 
AARE sequence resembles the original CRE binding motif, and that it was subsequently 
described as a binding site for several CREB/ATF proteins, it is commonly referred to 
as a CREB/ATF or simply CRE/ATF composite site. With the understanding that during 
the amino acid stress response protein members of the C/EBP subfamily may also bind 
to one half of the characteristic CREB/ATF motifs like the one shown here, they are 
often referred to as CARE motifs (short for C/EBP/ATF regulatory motifs) (Wolfgang 
et al., 1997, Fawcett et al., 1999). Kilberg et al. (2009) aligned the CARE motifs from 14 
Atf-4 target genes and concluded that the high conservation of the Atf-4 binding half 
(TGATG) and a fairly divergent C/EBP half (HAAH; where H is either a C, A or T 
according to the IUPAC nucleotide code) suggests that different Atf-4 dimerisation 
partners provide transcriptional specificity to the stress signal. It is also possible that 
interplay of factors at this site may control the spatio-temporal regulation of GlyT-1a by 
specific stress signals. It has been shown that the binding of Atf-3 to a similarly placed 
binding motif in the first exon of the Cat-1 gene negatively regulates its transcription in 
response to amino acid starvation, with Atf-3 replacing Atf-4 at the Atf-4 half-site when 
the duration of stress was extensive (Lopez et al., 2007). The negative isoform of Atf-3, a 
stress induced gene (Hai et al., 1999, Hai and Hartman, 2001, Okamoto et al., 2001), also 
repressed Atf-4 mediated induction of arsenate-induced activation of the Gadd153 
promoter (Fawcett et al., 1999). Could Atf-3 negatively regulate GlyT-1a via this site in a 
similar manner?  
To fully understand the topology and dynamics of a spatial and temporal GlyT-1a 
regulatory network involving Atf-4, there is need to understand how Atf-4 expression and 
interactions with other factors such as C/EBPβ or Atf-3 might change with time. Such 
temporal changes in the expression of Atf-4, Atf-3 and C/EBPβ have been documented 
for the regulation of the SNAT-2 gene by histidine limitation (Palii et al., 2004, Palii et al., 
2006, Thiaville et al., 2008b). In these studies, ChIP analysis show the binding of Atf-4 to 
the SNAT-2 intronic AARE rises sharply after histidine starvation in HepG2 cells. The 
peak in Atf-4 interaction at between 2 and 12 hours after stress overlaps with a peak in 
C/EBPβ interaction at the same site. Interestingly, a drop in both Atf-4 and C/EBPβ 
interaction at the SNAT-2 AARE after 12 hours of stress overlaps a peak in Atf-3 protein 
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enrichment at the same AARE.  Whilst it is impossible to directly infer such changes in 
TF interactions at the GlyT-1a AARE, it is highly likely given the sequence similarity of 
the GlyT-1a AARE to that of SNAT-2 and the fact that similar transcription factors are 
at play following stress in Caco-2 cells.  A project to investigate this was undertaken in 
this laboratory earlier this year by Manasvi Bhasvar (MRes student, titled: Co-ordination 
of cell stress responses: Identification of Atf-4 binding partners in response to different 
stresses). From this work it appears Atf-3 may be an important player in regulating GlyT-
1, however early data from this project are inconclusive and will require further 
investigations, by QPCR, ChIP or EMSA to confirm its involvement.   
In contrast to the intronic AARE of SNAT-2 and the AARE located in the CHOP 
promoter (Bruhat et al., 2002, Palii et al., 2004), mutation of the GlyT-1a AARE did not 
completely abolish basal transcription despite a reduction in protein complexes detected 
by gel shift assays. However, the rate of basal GlyT-1a promoter induction was reduced 
by about ~75%. This observation suggested that although the GlyT-1a AARE is required 
for transcriptional induction following stress, other as of yet unidentified motifs may be 
needed for optimal transcriptional induction of GlyT-1. This is characteristic of flexible 
‘billboard’ enhancer motifs (Arnosti and Kulkarni, 2005), where combinatorial effects of 
transcription factors binding to near and distant motifs control the activation or 
repression of transcription.  
With genome-wide DNase I hypersensitivity data and ChIP-Seq data from projects such 
as ENCODE, there is further evidence of the importance of long-range regulatory 
elements such as enhancers, insulators and silencers in transcriptional regulation (Gerstein 
et al., 2012). It has been suggested that the transcriptional pre-initiation complexes (PIC) 
formed at proximal, but also distal enhancers may be important in regulating the timing 
and onset of transcription (Szutorisz et al., 2005). It has long been known that the binding 
of some BZIP and other transcription factors to DNA, results in the bending and 
wrapping of the DNA strand around the polymerase, increasing the proximity of 
previously distant motifs (Gustafson et al., 1989, Horikoshi et al., 1992, Coulombe and 
Burton, 1999). The DNA-looping model has been suggested as a transcriptional 
mechanism allowing for the regulation of a genes by very distant regulatory motifs (Vilar 
and Saiz, 2005). The high mobility group of nuclear proteins (HMGN) which are known 
to regulate unraveling of the chromatin for transcription of GlyT-1 (West et al., 2004), 
have also been shown to result in DNA bending in favor of specific transcription factor 
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assembly at functional enhancers (Lorenz et al., 1999). Could the binding of factors at the 
postulated GlyT-1a CRMs or other motifs, result in  ‘DNA-loops’, bringing distant motifs 
in closer proximity to the core-promoter in an arrangement conducive to either repression 
or activation of the gene? From the work discussed here, it remains unclear exactly which 
other TFBS in the many predicted CRMs of the TATA-less GlyT-1a gene, together with 
the AARE in exon 1 cooperatively coordinate GlyT-1a transcriptional induction. 
However a systematic strategy of site directed mutagenesis of these CRMs, together with 
reporter experiments as used in these work, should confirm the relevance of the other 
predicted motifs.  High throughput chromatin confirmation capture (3C) methods 
(Simonis et al., 2007), could also be used to confirm the exact arrangement of these 
transcriptional regulatory regions downstream of stress. 
4.2 Nrf-2 does not directly regulate GlyT-1a 
One of the founding hypotheses for the work described in this thesis, was the suggestion 
that similar regulatory modules may regulate both GlyT-1a and xCT following stress. The 
occurrence of AARE in both xCT and GlyT-1a genes, and the demonstration that Atf-4 
mediates the regulation of both xCT and Glyt-1a following oxidative and ER stress as 
well as amino acid starvation, largely confirms this hypothesis. That this regulation is not 
common to PepT1 also confirms that this is not just a general consequence of the 
requirement for increased amino acids for protein synthesis. Owing to the fact that Nrf-
2 is known to regulate other amino acid transporters including xCT downstream of redox 
perturbations, it was expected that Nrf-2 may be directly involved in mediating the 
increase in GlyT-1a mRNA following oxidative stress. The data presented here however 
do not suggest this is the case. Although Nrf-2 mRNA was not increased in Caco-2 cells 
following stress, there was a large increase in total Nrf-2 protein in these cells after DEM 
treatment. However, Nrf-2 protein was not detected bound to a predicted antioxidant 
element (ARE) upstream of the GlyT-1a TSS, and the knockdown of Nrf-2 did not have 
any repressive effects on GlyT-1a mRNA. 
Nrf-2 protein activation is controlled by a very complex epigenetic, transcriptional and 
post-transcriptional network. Whilst the data shown here does not implicate Nrf-2 in the 
direct transcriptional regulation of GlyT-1a, there may still be as yet unknown effects of 
Nrf-2 protein activation on other factors involved in the post-transcriptional regulation 
of GlyT-1a. There are indications that Nrf-2 may directly regulate, and interact with Atf-
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4 (He et al., 2001). The co-regulation of both Nrf-2 and Atf-4 by the flavonoid fisetien is 
known to mediate enhancement of glutathione levels following stress (Ehren and Maher, 
2013). Ye and colleagues using T24 Bladder carcinoma cells showed an increase in Atf-4 
and Nrf-2 mRNA and protein levels following treatment of these cells with sulfasalazine 
(Ye et al., 2014). In the study by Ye et al, Atf-4 and Nrf-2 both mediated up-regulation of 
xCT via separate AARE and ARE binding sites in its promoter. Interestingly, in luciferase 
reporter experiments with xCT promoter constructs containing the mutated ARE 
sequence, Nrf-2 further increased xCT transcription mediated by Atf4; however when the 
two xCT AAREs were mutated reporter activity was completely abolished. In another 
study, Zong and colleagues showed that Nrf-2, by virtue of its interactions with Atf-4 
may regulate its binding to the two AAREs in the CHOP promoter (Zong et al., 2012). 
Like xCT, the CHOP promoter also contains two AAREs and one ARE in the reverse 
orientation. In contrast to the study by Ye et al, Zong and colleagues observed a significant 
reduction in reporter activity using constructs of the CHOP promoter containing a 
mutated ARE element. They conclude that in the absence of an effective Nrf-2 binding 
site, Nrf-2 interaction with Atf-4 sequesters it from binding to the AAREs, hence the 
diminished CHOP induction.  
The fact that Nrf-2 may block Atf-4 mediated transcription of genes lacking a functional 
TFBS for Nrf-2 has led to exploration of a possible dual role for Nrf-2 in controlling a 
switch between protective/survival and apoptotic signalling (Cullinan and Diehl, 2006). 
Mozzini and colleagues suggest that as to whether Nrf-2 is repressive or activating may 
be related to a dose-dependent increase in ROS accumulation (Mozzini et al., 2014). 
Although the data collected here appears to be indicative that Nrf-2 is not involved in 
GlyT-1a transcription, it remains unclear if there is any role for an Atf-4 and Nrf-2 
interaction either as a transcriptional activating or repressive module for GlyT-1a or 
indeed xCT regulation. 
4.3 Significance and future perspectives 
Despite detailed understanding of the kinetics of GlyT-1 transport, very little is known 
about its transcriptional regulation. The work described in this thesis shows for the first 
time that Atf-4, a factor important to the transcriptional induction of several other stress 
response genes, binds to a novel amino acid response element (AARE) in the first exon 
of GlyT-1a. These findings lay the foundation for further investigation into whether 
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interplays of other Atf-4 interacting BZIP factors such as Atf-3, C/EBPβ and Nrf-2 
oversee the spatial and temporal regulation of GlyT-1 from its AARE sequence. 
That the transcription of GlyT-1 is up-regulated in an Atf-4 dependent manner despite 
an overall repression of protein synthesis following stress, is testament that the 
transporter is important for resistance to stress. Beyond its role in the synthesis of the 
antioxidant glutathione, the supply and metabolism of glycine is also pivotal to cancer 
progression (Jain et al., 2012, di Salvo et al., 2013, Locasale, 2013). It is possible that several 
cancers may hijack protective pathways such as the Atf-4 dependent up-regulation of 
glycine transport by GlyT-1 (or other glycine transporters) to evade the damaging effects 
of prolonged stress (Amelio et al., 2014). As such understanding precisely the 
transcriptional modules important to GlyT-1a induction or repression could provide a 
new avenue for precise control of pro-survival or pro-apoptotic outcomes in these cells. 
It is evident from this work that knocking-down Atf-4 in Caco-2 cells diminishes 
expression of GlyT-1a. On the flip side, Atf-4 activation by ER resident kinases such as 
PERK up-regulate GlyT-1a mRNA. The activation of Atf-4 by such ER kinases has been 
shown to protect colonic epithelium in mice against UPR-induced colitis (Cao et al., 2012). 
Could the up-regulation of the PERK-Atf-4 pathway and consequently increase in GlyT-
1 have protective effects against colitis and other forms of stress induced bowel disease? 
The role of stress signalling in the pathogenesis of several degenerative diseases and 
cancer is an active area of research. Last year, it was reported that the knockdown of 
PERK by a proprietary compound prevented the clinical presentation of Prion disease in 
mice, although there was no prevention or decrease in further accumulation of unfolded 
proteins in the ER (Moreno et al., 2013). The work by Moreno and colleagues set out on 
the foundation that the UPR induced phosphorylation of PERK and resulted in disrupted 
proteostasis and neuronal death. The authors hypothesised that PERK knockdown 
represented an important therapeutic target to halt the progression of prion disease owing 
to PERK mediated repression of proteins important for effective synaptic function. 
However, these mice developed significant hypoglycaemia and weight loss ‘side effects’. 
These may in fact be a major consequence of blocking key protective outcomes 
downstream of PERK phosphorylation such as the activation of Atf-4 and transcriptional 
induction of GlyT-1.  
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A detailed understanding of the regulation of pro-survival and pro-apoptotic mechanisms 
downstream of stress induction may provide better therapeutic targets, whilst minimising 
debilitating side effects. It will be of interest to further investigate the involvement of 
other transcription factors in regulating the temporal aspects of GlyT-1 expression as well 
as the switch between pro-survival and pro-apoptosis. If resources become permitting 
ChIP-seq experiments could effectively confirm factors bound to the other predicted 
CRMs in the GlyT-1a sequence under investigation following stress treatment. Coupling 
such data to pathway analysis of expression or protein profiles of factors following stress 
treatment, would provide important insights into the possible use of therapeutic 
modulation of glycine supply.  
In conclusion, the work described in this thesis – whilst complete in itself and providing 
many novel insights into regulation of the human GlyT-1a gene, has by virtue of 
confirming its role as a significant target of the ISR validated the need for further 
investigation of this transporter and its substrate. This with the aim of better understand 
their role in the processes of significant clinical relevance such as in stress induced 
degenerative diseases. 
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Appendix A  
BIOINFORMATICS SUPPLEMENTS 
 
A.1 Classification of GlyT-1a co-regulated genes returned by CORD 
To identify genes potentially co-regulated with GlyT-1 the gene CO-regulation database 
(CORD) was searched. As described in the text (page85, Section 3.2.2), 185 genes with 
correlation co-efficient of greater than 84% were returned. To determine if these genes 
had similar function to that of GlyT-1 they were classified using gene ontology (GO) 
terms representing their function. As can be seen in the table below most of these terms 
overlap GlyT-1a function. 
GO 
Identifier 
Gene symbol GO Term 
GO:0071705 ADORA3, DRD2, SLC14A1, SLC1A2, SLC1A3, 
SLC22A4, SLC35E4, SLC38A3, SLC6A12, SLC6A8, 
SLC6A9, SLC7A10, SNAP25 
nitrogen compound 
transport 
GO:0015837 ADORA3, DRD2, SLC1A2, SLC1A3, SLC22A4, 
SLC38A3, SLC6A12, SLC6A8, SLC6A9, SLC7A10, 
SNAP25 
amine transport 
GO:0006836 DRD2, SLC1A2, SLC1A3, SLC6A12, SLC6A8, 
SLC6A9, SNAP25, SV2B 
neurotransmitter 
transport 
GO:0046942 BSG, GOT2, PLA2G4C, SLC1A2, SLC1A3, 
SLC22A4, SLC38A3, SLC6A12, SLC6A8, SLC6A9, 
SLC7A10 
carboxylic acid 
transport 
GO:0071702 ABCD1, ABCG4, ADORA3, BSG, DRD2, GOT2, 
PLA2G4C, SLC1A2, SLC1A3, SLC22A4, SLC2A1, 
SLC35E4, SLC38A3, SLC6A12, SLC6A8, SLC6A9, 
SLC7A10, SNAP25 
organic substance 
transport 
GO:0006811 AQP1, ATP1A2, ATP1B2, BSG, C3AR1, CHP, 
CLCN4, CYBRD1, DRD2, EHD3, ELN, FXYD1, 
HTR3B, KCNC3, KCNK12, KCNN2, SCN1B, 
SLC1A2, SLC1A3, SLC22A4, SLC2A1, SLC35E4, 
SLC6A12, SLC6A8, SLC6A9, TRPM3 
ion transport 
GO:0006865 SLC1A2, SLC1A3, SLC22A4, SLC38A3, SLC6A12, 
SLC6A8, SLC6A9, SLC7A10 
amino acid 
transport 
GO:0015849 BSG, GOT2, PLA2G4C, SLC1A2, SLC1A3, 
SLC22A4, SLC38A3, SLC6A12, SLC6A8, SLC6A9, 
SLC7A10 
organic acid 
transport 
GO:0006778 ALAD, BLVRB, CPOX, HMBS, UROD porphyrin metabolic 
process 
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GO 
Identifier 
Gene symbol GO Term 
GO:0033013 ALAD, BLVRB, CPOX, HMBS, UROD tetrapyrrole 
metabolic process 
GO:0015672 ATP1A2, ATP1B2, CHP, DRD2, KCNC3, KCNK12, 
KCNN2, SCN1B, SLC22A4, SLC6A12, SLC6A8, 
SLC6A9, TRPM3 
monovalent 
inorganic cation 
transport 
GO:0006783 ALAD, CPOX, HMBS, UROD heme biosynthetic 
process 
GO:0006438 VARS, VARS2 valyl-tRNA 
aminoacylation 
GO:0006779 ALAD, CPOX, HMBS, UROD porphyrin 
biosynthetic process 
GO:0033014 ALAD, CPOX, HMBS, UROD tetrapyrrole 
biosynthetic process 
GO:0003008 ADORA3, AOC2, AQP1, ATP1A2, C1QTNF5, 
C3AR1, CA14, CRYAB, CRYBB2, DIP2A, DMPK, 
DRD2, ELN, FXYD1, HTR3B, KCNC3, NPBWR2, 
NPPC, OR10H5, OR1C1, OR6B3, PPP1R12B, PYY, 
RD3, RDH5, ROM1, SCG2, SCN1B, SIX6, SLC1A2, 
SLC1A3, SLC22A4, SLC6A8, SLC6A9, SNAP25, 
SNCB, SV2B, TRH, TRPM3, ZNF385A 
system process 
GO:0042168 ALAD, CPOX, HMBS, UROD heme metabolic 
process 
GO:0007601 AOC2, C1QTNF5, CRYAB, CRYBB2, RD3, RDH5, 
ROM1, SCG2, SIX6, ZNF385A 
visual perception 
GO:0050953 AOC2, C1QTNF5, CRYAB, CRYBB2, RD3, RDH5, 
ROM1, SCG2, SIX6, ZNF385A 
sensory perception 
of light stimulus 
GO:0001504 SLC1A2, SLC1A3, SLC6A8 neurotransmitter 
uptake 
GO:0045967 GABARAPL1, TENC1 negative regulation 
of growth rate 
GO:0007268 CA14, DRD2, HTR3B, KCNC3, NPBWR2, PYY, 
SCN1B, SLC1A2, SLC1A3, SLC6A8, SLC6A9, 
SNAP25, SNCB, SV2B 
synaptic 
transmission 
GO:0045768 DRD2, GSN, NPBWR2, SNCB positive regulation 
of anti-apoptosis 
GO:0006814 ATP1A2, CHP, SCN1B, SLC6A12, SLC6A8, 
SLC6A9, TRPM3 
sodium ion 
transport 
GO:0019226 CA14, DRD2, HTR3B, KCNC3, NPBWR2, PYY, 
SCN1B, SLC1A2, SLC1A3, SLC6A8, SLC6A9, 
SNAP25, SNCB, SV2B 
transmission of 
nerve impulse 
GO:0035637 CA14, DRD2, HTR3B, KCNC3, NPBWR2, PYY, 
SCN1B, SLC1A2, SLC1A3, SLC6A8, SLC6A9, 
SNAP25, SNCB, SV2B 
multicellular 
organismal signalling 
GO:0001505 DRD2, SLC1A2, SLC1A3, SLC6A8, SNAP25, SV2B regulation of 
neurotransmitter 
levels 
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GO 
Identifier 
Gene symbol GO Term 
GO:0050877 ADORA3, AOC2, C1QTNF5, CA14, CRYAB, 
CRYBB2, DRD2, HTR3B, KCNC3, NPBWR2, 
OR10H5, OR1C1, OR6B3, PYY, RD3, RDH5, 
ROM1, SCG2, SCN1B, SIX6, SLC1A2, SLC1A3, 
SLC6A8, SLC6A9, SNAP25, SNCB, SV2B, TRH, 
ZNF385A 
neurological system 
process 
GO:0006812 AQP1, ATP1A2, ATP1B2, C3AR1, CHP, CYBRD1, 
DRD2, EHD3, ELN, KCNC3, KCNK12, KCNN2, 
SCN1B, SLC22A4, SLC6A12, SLC6A8, SLC6A9, 
TRPM3 
cation transport 
GO:0051234 ABCD1, ABCG4, ADORA3, AGFG2, AQP1, 
ATP1A2, ATP1B2, ATP5D, BSG, C3AR1, CADM2, 
CHP, CLCN4, CTSD, CYBRD1, DGKG, DRD2, 
EHD3, ELN, FGF1, FXYD1, GABARAPL1, GOT2, 
GSN, HBD, HTR3B, KCNC3, KCNK12, KCNN2, 
KLF4, NPPC, PACSIN3, PLA2G4C, PPARA, 
PPP1R3C, S100B, SCG2, SCN1B, SLC14A1, 
SLC1A2, SLC1A3, SLC22A4, SLC2A1, SLC35E4, 
SLC38A3, SLC6A12, SLC6A8, SLC6A9, SLC7A10, 
SNAP25, SNCB, SNCG, SV2B, TENC1, TRAK2, 
TRH, TRPM3, VPS18 
establishment of 
localization 
GO:0046329 DUSP3, EPB49, SNCG negative regulation 
of JNK cascade 
GO:0015838 SLC22A4, SLC6A12 betaine transport 
GO:0042462 NXNL1, ROM1 eye photoreceptor 
cell development 
GO:0006386 NFIC, NFIX termination of RNA 
polymerase III 
transcription 
GO:0040009 GABARAPL1, TENC1 regulation of growth 
rate 
GO:0006810 ABCD1, ABCG4, ADORA3, AGFG2, AQP1, 
ATP1A2, ATP1B2, ATP5D, BSG, C3AR1, CADM2, 
CHP, CLCN4, CTSD, CYBRD1, DGKG, DRD2, 
EHD3, ELN, FGF1, FXYD1, GABARAPL1, GOT2, 
GSN, HBD, HTR3B, KCNC3, KCNK12, KCNN2, 
NPPC, PACSIN3, PLA2G4C, PPARA, PPP1R3C, 
SCG2, SCN1B, SLC14A1, SLC1A2, SLC1A3, 
SLC22A4, SLC2A1, SLC35E4, SLC38A3, SLC6A12, 
SLC6A8, SLC6A9, SLC7A10, SNAP25, SNCB, 
SNCG, SV2B, TRAK2, TRH, TRPM3, VPS18 
transport 
GO:0045767 DRD2, GSN, NPBWR2, SNCB regulation of anti-
apoptosis 
GO:0030001 ATP1A2, C3AR1, CHP, CYBRD1, DRD2, EHD3, 
ELN, KCNC3, KCNK12, KCNN2, SCN1B, 
SLC6A12, SLC6A8, SLC6A9, TRPM3 
metal ion transport 
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GO 
Identifier 
Gene symbol GO Term 
GO:0070303 DUSP3, EPB49, SNCG negative regulation 
of stress-activated 
protein kinase 
GO:0001754 NXNL1, ROM1 eye photoreceptor 
cell differentiation 
GO:0046148 ALAD, CPOX, HMBS, UROD pigment 
biosynthetic process 
GO:0006956 C1QC, C3AR1, C4B, C4B complement 
activation 
GO:0015804 SLC38A3, SLC6A9, SLC7A10 neutral amino acid 
transport 
GO:0060284 BSG, FGF1, KLF4, MGAT5B, ROM1, S100B, SCG2 regulation of cell 
development 
GO:0048592 NXNL1, ROM1 eye morphogenesis 
GO:0042440 ALAD, CPOX, HMBS, UROD pigment metabolic 
process 
GO:0072376 C1QC, C3AR1, C4B, C4B protein activation 
cascade 
GO:0042461 NXNL1, ROM1 photoreceptor cell 
development 
GO:0006813 ATP1A2, CHP, DRD2, KCNC3, KCNK12, KCNN2 potassium ion 
transport 
GO:0044092 ADORA3, BSG, CRYAB, DRD2, DUSP3, EPB49, 
GAB1, GNG7, NPBWR2, PRELP, PYY, S100B, 
SEC14L2, SNCB, SNCG, TENC1 
negative regulation 
of molecular 
function 
GO:0015697 SLC22A4, SLC6A12 quaternary 
ammonium group 
transport 
GO:0009268 AMELY, CLCN4, FMO2 response to pH 
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A.2 Enriched TFBS in the promoter of GlyT-1 co-regulated genes  
Stress associated factors used in composite module analysis are shown in bold. Using the TRANSFAC F-MATCH algorithm, analysis of the promoter 
regions (spanning 2000 bases upstream to 1000 bases downstream of the TSS) of co-regulated genes identified by CORD was performed. F-MATCH 
compares the occurrence of these over-represented TFBS in the ‘test’ or ‘YES’ list of differentially expressed gene promoters to a ‘control’ or ‘NO’ 
list of housekeeping genes to correct for multiplicity (errors in inference, i.e. where the frequency of a given TFBS is higher in the NO set than the 
YES set it is omitted from the result). FDR: false discovery rate. 
Positional Weight Matrices 
Yes (sites 
per 1kbp) 
Yes/ No P-value 
Matched 
promoters 
p-value 
From To FDR 
Matched 
promoters 
FDR 
V$AHR_Q5 0.1896 1.3837 0.0097 0.0902 -1700 -900 0.0156 0.1530 
V$AHRHIF_Q6 0.0462 2.1646 0.0073 0.0691 -1800 -1000 0.0135 0.1202 
V$AP1_Q2_01 0.1064 1.6042 0.0070 0.0069 -1900 -1600 0.0131 0.0194 
V$AP1_Q4_01 0.0486 2.1262 0.0070 0.0042 -600 100 0.0132 0.0156 
V$AP2_Q6 0.0717 2.5605 0.0001 0.0096 -1600 -1300 0.0011 0.0241 
V$AP2_Q6_01 0.0578 2.6156 0.0005 0.0143 -1500 -1200 0.0022 0.0321 
V$AP2ALPHA_01 0.0902 3.0603 0.0000 0.0000 -300 0 0.0001 0.0018 
V$AP4_01 0.0624 2.2301 0.0015 0.0262 -2000 -1700 0.0047 0.0489 
V$AR_Q2 0.0994 1.9009 0.0009 0.0023 -1200 -900 0.0033 0.0101 
V$AREB6_03 0.0601 1.8978 0.0085 0.0166 -900 -200 0.0142 0.0352 
V$BCL6_Q3 0.0439 2.1299 0.0100 0.0079 -1600 -700 0.0159 0.0214 
V$BRCA_01 0.0624 2.0178 0.0041 0.0082 0 300 0.0091 0.0220 
V$CACD_01 0.1734 1.4899 0.0034 0.0113 -1300 -1000 0.0081 0.0267 
V$CDP_02 0.0532 2.1233 0.0050 0.0691 100 500 0.0106 0.1202 
 220 
Positional Weight Matrices 
Yes (sites 
per 1kbp) 
Yes/ No P-value 
Matched 
promoters 
p-value 
From To FDR 
Matched 
promoters 
FDR 
V$CDPCR1_01 0.0416 2.5681 0.0031 0.3995 -400 -100 0.0080 0.6361 
V$CDPCR3_01 0.1017 1.8172 0.0015 0.0013 200 500 0.0047 0.0081 
V$CDXA_02 0.0439 6.6262 0.0000 0.0006 100 400 0.0001 0.0055 
V$C/EBP_Q2_01 0.1873 1.589 0.0006 0.0126 -500 -200 0.0026 0.0287 
V$C/EBPA_01 0.148 1.5334 0.0039 0.1174 100 400 0.0088 0.1944 
V$C/EBPG_Q6 0.074 2.2827 0.0004 0.0183 -300 0 0.0024 0.0374 
V$CIZ_01 0.0509 2.0925 0.0067 0.0030 -1300 500 0.0129 0.0116 
V$CKROX_Q2 0.0462 2.511 0.0023 0.0125 -1000 -700 0.0063 0.0287 
V$CMAF_01 0.0439 2.2937 0.0058 0.0044 -1600 -1200 0.0119 0.0158 
V$COREBINDINGFACTOR_Q6 0.0786 1.7212 0.0088 0.0253 -800 -500 0.0145 0.0484 
V$COUP_DR1_Q6 0.0671 1.8963 0.0057 0.0028 -900 -600 0.0119 0.0113 
V$CP2_02 0.0786 1.7495 0.0074 0.0214 -300 0 0.0131 0.0418 
V$CREB_02 0.1064 1.6596 0.0044 0.0045 -900 -600 0.0096 0.0158 
V$CREBATF_Q6 0.0971 1.7346 0.0035 0.0028 -900 -600 0.0083 0.0115 
V$DBP_Q6 0.0578 2.5312 0.0006 0.0021 -700 -400 0.0027 0.0101 
V$DR1_Q3 0.104 1.6424 0.0056 0.0065 -1900 -1600 0.0118 0.0191 
V$DR3_Q4 0.0462 2.1646 0.0073 0.0143 -1400 -1000 0.0135 0.0321 
V$DR4_Q2 0.0462 2.9893 0.0005 0.0069 -600 0 0.0025 0.0194 
V$E12_Q6 0.0416 2.5681 0.0031 0.0017 -800 -100 0.0080 0.0091 
V$E2A_Q2 0.0439 3.3131 0.0003 0.0003 -700 -400 0.0020 0.0043 
V$E2F_03 0.0786 1.8722 0.0034 0.0564 -1800 -1500 0.0081 0.0989 
V$E2F_Q6_01 0.0671 2.4601 0.0003 0.0194 -1800 -1500 0.0020 0.0389 
V$EBF_Q6 0.0416 3.5311 0.0003 0.0034 -2000 -1700 0.0020 0.0129 
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Positional Weight Matrices 
Yes (sites 
per 1kbp) 
Yes/ No P-value 
Matched 
promoters 
p-value 
From To FDR 
Matched 
promoters 
FDR 
V$EBOX_Q6_01 0.1064 1.6986 0.0032 0.0017 -700 -400 0.0078 0.0089 
V$EFC_Q6 0.074 1.7621 0.0085 0.0077 -1400 -1100 0.0142 0.0213 
V$EGR1_01 0.0416 3.3234 0.0004 0.0050 -1600 -1000 0.0024 0.0157 
V$ER_Q6 0.0532 2.4893 0.0012 0.0022 -1900 -1200 0.0039 0.0103 
V$ETF_Q6 0.0532 2.1876 0.0038 0.0342 -1500 -800 0.0088 0.0609 
V$ETS_Q6 0.178 1.5011 0.0026 0.0150 -1400 -1100 0.0070 0.0323 
V$FAC1_01 0.0948 1.9207 0.0010 0.0260 -100 200 0.0036 0.0495 
V$FOXJ2_02 0.0416 2.5681 0.0031 0.0020 200 500 0.0080 0.0103 
V$FXR_Q3 0.0416 3.7665 0.0002 0.0001 -100 200 0.0013 0.0035 
V$GATA_C 0.0532 2.6737 0.0006 0.0005 -500 0 0.0026 0.0057 
V$GATA_Q6 0.0486 2.6365 0.0012 0.0213 -300 100 0.0039 0.0419 
V$GEN_INI3_B 0.3052 1.307 0.0064 0.0066 -1900 -1600 0.0126 0.0190 
V$GFI1_Q6 0.0486 2.7464 0.0008 0.0002 -200 200 0.0032 0.0042 
V$GRE_C 0.0416 4.3459 0.0001 0.0001 -600 500 0.0007 0.0031 
V$HIC1_03 0.0439 2.2937 0.0058 0.0066 -1800 -1400 0.0119 0.0192 
V$HIF1_Q3 0.0509 2.5575 0.0012 0.0048 -2000 -1700 0.0039 0.0166 
V$HMGIY_Q6 0.296 1.3044 0.0075 0.1106 -1900 -1600 0.0132 0.1846 
V$HNF3_Q6_01 0.0439 2.2937 0.0058 0.0474 200 500 0.0119 0.0838 
V$HNF6_Q6 0.0416 3.5311 0.0003 0.0007 -1700 -1200 0.0020 0.0063 
V$HSF2_01 0.0763 1.9181 0.0029 0.0182 -1200 -900 0.0077 0.0377 
V$IK_Q5 0.2035 1.4537 0.0028 0.0172 -700 -400 0.0073 0.0360 
V$IPF1_Q4_01 0.0555 2.354 0.0016 0.0053 -1000 500 0.0046 0.0163 
V$KAISO_01 0.0439 3.1387 0.0005 0.0017 -2000 -900 0.0023 0.0095 
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Positional Weight Matrices 
Yes (sites 
per 1kbp) 
Yes/ No P-value 
Matched 
promoters 
p-value 
From To FDR 
Matched 
promoters 
FDR 
V$KID3_01 0.8023 1.189 0.0036 0.5211 -1000 -700 0.0085 0.8234 
V$KROX_Q6 0.0416 3.5311 0.0003 0.0049 -1700 -1100 0.0020 0.0161 
V$LEF1_Q2_01 0.1064 1.5866 0.0082 0.0049 -700 100 0.0138 0.0163 
V$LRF_Q2 0.1156 2.4144 0.0000 0.0056 -1600 -1300 0.0001 0.0170 
V$LRH1_Q5 0.0416 2.354 0.0059 0.0089 -700 300 0.0118 0.0230 
V$LXR_Q3 0.0486 2.8658 0.0006 0.0011 -600 -300 0.0026 0.0074 
V$MAF_Q6_01 0.0416 2.6903 0.0022 0.0008 -700 0 0.0062 0.0063 
V$MAZ_Q6 0.0671 2.3953 0.0005 0.0082 -1000 -700 0.0022 0.0220 
V$MEF2_Q6_01 0.0416 2.2599 0.0079 0.0024 -1800 -800 0.0138 0.0101 
V$MEIS1BHOXA9_02 0.074 2.5754 0.0001 0.0023 100 400 0.0009 0.0101 
V$MINI19_B 0.0809 2.0344 0.0011 0.0103 -500 -200 0.0038 0.0255 
V$MRF2_01 0.0486 2.354 0.0031 0.0042 -1200 500 0.0079 0.0156 
V$MYOGNF1_01 0.0671 1.8205 0.0086 0.0059 -1800 -1000 0.0142 0.0176 
V$NFAT_Q4_01 0.0532 2.5782 0.0009 0.0022 -100 300 0.0033 0.0103 
V$NFY_01 0.0439 2.8398 0.0011 0.0008 -1500 -1100 0.0038 0.0063 
V$NKX22_01 0.0439 2.2937 0.0058 0.0153 0 400 0.0119 0.0327 
V$OCT_Q6 0.0439 3.9757 0.0001 0.0007 -300 400 0.0008 0.0063 
V$OCT1_02 0.0439 9.9393 0.0000 0.0001 0 300 0.0000 0.0030 
V$OCT1_03 0.1457 1.6208 0.0016 0.0091 100 400 0.0047 0.0233 
V$OCT1_07 0.0994 2.6464 0.0000 0.0004 200 500 0.0001 0.0052 
V$OCT1_Q5_01 0.0439 3.7272 0.0001 0.0010 -300 300 0.0011 0.0078 
V$OCT4_01 0.0416 4.0355 0.0001 0.0003 -300 500 0.0009 0.0045 
V$OCT4_02 0.0624 2.1186 0.0025 0.0113 200 500 0.0069 0.0269 
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Positional Weight Matrices 
Yes (sites 
per 1kbp) 
Yes/ No P-value 
Matched 
promoters 
p-value 
From To FDR 
Matched 
promoters 
FDR 
V$OG2_01 0.0416 2.2599 0.0079 0.0048 -100 500 0.0138 0.0166 
V$OSF2_Q6 0.0694 1.9217 0.0043 0.0113 -800 -500 0.0095 0.0271 
V$P300_01 0.0462 5.2312 0.0000 0.0000 -1400 -700 0.0001 0.0020 
V$P53_02 0.1595 1.4535 0.0073 0.0309 -1100 -800 0.0135 0.0561 
V$PAX2_01 0.1133 1.5855 0.0066 0.0301 -900 400 0.0127 0.0551 
V$PAX3_01 0.0509 3.6343 0.0000 0.0001 -1400 -1100 0.0006 0.0031 
V$PAX4_03 0.0486 3.8773 0.0000 0.0711 0 300 0.0006 0.1217 
V$PAX5_01 0.0439 2.7107 0.0016 0.0034 -700 -400 0.0047 0.0129 
V$PAX6_Q2 0.3098 1.4968 0.0001 0.0012 -300 0 0.0010 0.0073 
V$PAX8_01 0.0486 2.2729 0.0041 0.0022 -2000 -1500 0.0091 0.0103 
V$PBX_Q3 0.0416 7.0621 0.0000 0.1836 -400 500 0.0001 0.2969 
V$PBX1_02 0.0416 4.7081 0.0000 0.0020 -200 500 0.0005 0.0103 
V$PLZF_02 0.0555 3.9647 0.0000 0.0016 -300 0 0.0002 0.0095 
V$POU1F1_Q6 0.074 3.24 0.0000 0.0011 100 400 0.0001 0.0076 
V$POU3F2_01 0.0902 4.221 0.0000 0.0000 200 500 0.0000 0.0018 
V$POU3F2_02 0.0948 3.4781 0.0000 0.0001 100 400 0.0000 0.0031 
V$POU6F1_01 0.0416 2.9735 0.0010 0.0196 -200 500 0.0037 0.0391 
V$PPAR_DR1_Q2 0.0717 2.5605 0.0001 0.0001 -1900 -1600 0.0011 0.0028 
V$PPARA_02 0.0624 1.8423 0.0098 0.1423 -300 200 0.0157 0.2337 
V$PPARG_02 0.0509 2.2275 0.0040 0.0262 -300 0 0.0090 0.0492 
V$R_01 0.0416 2.5681 0.0031 0.0049 -900 400 0.0080 0.0157 
V$RUSH1A_02 0.0416 2.8249 0.0015 0.0011 -1800 -1100 0.0048 0.0076 
V$S8_01 0.0416 2.8249 0.0015 0.0186 -800 400 0.0048 0.0378 
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Positional Weight Matrices 
Yes (sites 
per 1kbp) 
Yes/ No P-value 
Matched 
promoters 
p-value 
From To FDR 
Matched 
promoters 
FDR 
V$SMAD3_Q6 0.0462 2.7293 0.0011 0.0017 -800 -300 0.0039 0.0093 
V$SOX9_B1 0.2543 1.5143 0.0003 0.0904 100 500 0.0020 0.1522 
V$SP1_Q6 0.0486 2.5351 0.0016 0.2564 -2000 -1700 0.0047 0.4114 
V$SP3_Q3 0.0486 3.1387 0.0003 0.0002 -1100 -400 0.0019 0.0044 
V$SPZ1_01 0.0439 4.9697 0.0000 0.0001 -1900 -1600 0.0002 0.0031 
V$SREBP_Q3 0.1017 1.5874 0.0094 0.0220 -800 -300 0.0154 0.0425 
V$SREBP1_01 0.1249 1.5408 0.0070 0.0311 -700 -400 0.0132 0.0560 
V$STAF_02 0.0439 2.9818 0.0007 0.0005 -1100 -300 0.0030 0.0060 
V$STAT_Q6 0.1711 1.4426 0.0065 0.0120 -700 -300 0.0126 0.0280 
V$STAT1_01 0.0416 3.3234 0.0004 0.0049 -1600 -1300 0.0024 0.0161 
V$SZF11_01 0.0532 2.7766 0.0004 0.0008 -1900 -1400 0.0025 0.0061 
V$TAL1BETAE47_01 0.0578 3.1387 0.0001 0.0003 200 500 0.0007 0.0041 
V$TAXCREB_02 0.0416 2.2599 0.0079 0.0294 -1600 -1200 0.0138 0.0543 
V$TBP_Q6 0.0717 2.7028 0.0001 0.0005 200 500 0.0008 0.0058 
V$TBX5_01 0.0439 2.1299 0.0100 0.0110 -600 500 0.0159 0.0268 
V$TCF11_01 0.0578 3.2695 0.0000 0.0003 -1100 -700 0.0006 0.0041 
V$TEL2_Q6 0.1225 1.7511 0.0010 0.0019 -1100 -800 0.0036 0.0101 
V$TST1_01 0.0439 2.7107 0.0016 0.0098 0 300 0.0047 0.0243 
V$VDR_Q3 0.0416 3.3234 0.0004 0.0007 -1000 -700 0.0024 0.0062 
V$WT1_Q6 0.0439 3.3131 0.0003 0.1668 -1900 -1500 0.0020 0.2719 
V$XFD2_01 0.0416 3.3234 0.0004 0.0010 -600 500 0.0024 0.0078 
V$XVENT1_01 0.0462 2.1646 0.0073 0.0143 -2000 -1300 0.0135 0.0321 
V$YY1_Q6 0.0763 1.7556 0.0079 0.0085 -1700 -1400 0.0138 0.0223 
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Positional Weight Matrices 
Yes (sites 
per 1kbp) 
Yes/ No P-value 
Matched 
promoters 
p-value 
From To FDR 
Matched 
promoters 
FDR 
V$ZF5_B 0.0416 3.1387 0.0007 0.0144 -2000 -1300 0.0029 0.0314 
V$ZIC3_01 0.0416 3.1387 0.0007 0.0024 -500 -200 0.0029 0.0099 
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A.3 GlyT-1a/SLC6A9 orthologous transcripts. 
GlyT-1a/SLC6A9 orthologous sequences were obtained from OrthoDB 7 – A database cataloguing orthologous groups of 64 vertebrates, 57 
arthropods , 175 fungi, 14 basal metazoans and 1115 bacteria species (as of the 22nd of July 2013).  For complete documentation of this database and 
current release. see (Waterhouse et al., 2013). OrthoDB does not differentiate between the two Cow GlyT-1a/SLC6A9 paralogous genes, both of 
which were used in the phylogenetic analysis. Transcripts of the Zebra Finch and Platypus have no GlyT-1a/SLC6A9 5’UTR defined in their respective 
genome assembly whilst care was taken to minimize the impact of the ‘frameshifts’ introduced by Ensembl’s genome build program to the upstream 
sequences of transcripts from Dolphin, Zebra Finch, Turkey, Chicken, Kangaroo Rat, Lesser Hedgehog Tenrec, Platypus and Tarsier. 
 
Common Name Scientific Name SLC6A9 Ensembl Gene ID Orthologous Ensembl 
Transcript ID 
Protein 
Length 
Ensembl Database 
Human Homo sapiens ENSG00000196517 ENST00000372310 633 hsapiens_gene_ensembl 
Panda Ailuropoda melanoleuca ENSAMEG00000001028 ENSAMET00000001148 696 amelanoleuca_gene_ensembl 
Anole lizard Anolis carolinensis ENSACAG00000014488 ENSACAT00000014677 636 acarolinensis_gene_ensembl 
Cave fish Astyanax mexicanus ENSAMXG00000012229 ENSAMXT00000012594 649 amexicanus_gene_ensembl 
Cow** Bos taurus ENSBTAG00000006043 ENSBTAT00000011456 757 btaurus_gene_ensembl 
Cow Bos taurus ENSBTAG00000008690 ENSBTAT00000011454 633 btaurus_gene_ensembl 
Marmoset Callithrix jacchus ENSCJAG00000003879 ENSCJAT00000007493 573 cjacchus_gene_ensembl 
Dog Canis lupus familiaris ENSCAFG00000004826 ENSCAFT00000007773 632 cfamiliaris_gene_ensembl 
Guinea Pig Cavia porcellus ENSCPOG00000013598 ENSCPOT00000013734 647 cporcellus_gene_ensembl 
Zebrafish Danio rerio ENSDARG00000018534 ENSDART00000077462 653 drerio_gene_ensembl 
Armadillo Dasypus novemcinctus ENSDNOG00000037887 ENSDNOT00000043792 411 dnovemcinctus_gene_ensembl 
Kangaroo rat Dipodomys ordii ENSDORG00000005475 ENSDORT00000005474 687 dordii_gene_ensembl 
Lesser hedgehog tenrec Echinops telfairi ENSETEG00000018374 ENSETET00000018377 705 etelfairi_gene_ensembl 
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Common Name Scientific Name SLC6A9 Ensembl Gene ID Orthologous Ensembl 
Transcript ID 
Protein 
Length 
Ensembl Database 
Horse Equus caballus ENSECAG00000002225 ENSECAT00000005457 623 ecaballus_gene_ensembl 
Hedgehog Erinaceus europaeus ENSEEUG00000002019 ENSEEUT00000002027 693 eeuropaeus_gene_ensembl 
Cat Felis catus ENSFCAG00000006493 ENSFCAT00000006495 761 fcatus_gene_ensembl 
Flycatcher Ficedula albicollis ENSFALG00000005298 ENSFALT00000005539 633 falbicollis_gene_ensembl 
Chicken Gallus gallus ENSGALG00000010098 ENSGALT00000038518 633 ggallus_gene_ensembl 
Stickleback Gasterosteus aculeatus ENSGACG00000014462 ENSGACT00000019111 628 gaculeatus_gene_ensembl 
Gorilla Gorilla gorilla gorilla ENSGGOG00000003651 ENSGGOT00000003674 706 ggorilla_gene_ensembl 
Squirrel Ictidomys tridecemlineatus ENSSTOG00000004456 ENSSTOT00000004456 689 itridecemlineatus_gene_ensembl 
Coelacanth Latimeria chalumnae ENSLACG00000004060 ENSLACT00000004601 565 lchalumnae_gene_ensembl 
Spotted gar Lepisosteus oculatus ENSLOCG00000002674 ENSLOCT00000003165 639 loculatus_gene_ensembl 
Elephant Loxodonta africana ENSLAFG00000000144 ENSLAFT00000000144 633 lafricana_gene_ensembl 
Macaque Macaca mulatta ENSMMUG00000015158 ENSMMUT00000021254 709 mmulatta_gene_ensembl 
Wallaby Macropus eugenii ENSMEUG00000015649 ENSMEUT00000015696 659 meugenii_gene_ensembl 
Turkey Meleagris gallopavo ENSMGAG00000010003 ENSMGAT00000011249 635 mgallopavo_gene_ensembl 
Mouse Lemur Microcebus murinus ENSMICG00000011037 ENSMICT00000011036 707 mmurinus_gene_ensembl 
Opossum Monodelphis domestica ENSMODG00000002931 ENSMODT00000039267 573 mdomestica_gene_ensembl 
Mouse Mus musculus ENSMUSG00000028542 ENSMUST00000030269 633 mmusculus_gene_ensembl 
Ferret Mustela putorius furo ENSMPUG00000013573 ENSMPUT00000013686 633 mfuro_gene_ensembl 
Gibbon Nomascus leucogenys ENSNLEG00000013923 ENSNLET00000017767 712 nleucogenys_gene_ensembl 
Pika Ochotona princeps ENSOPRG00000013803 ENSOPRT00000013813 698 oprinceps_gene_ensembl 
Tilapia Oreochromis niloticus ENSONIG00000009062 ENSONIT00000011406 659 oniloticus_gene_ensembl 
Platypus Ornithorhynchus anatinus ENSOANG00000013788 ENSOANT00000021747 432 oanatinus_gene_ensembl 
Rabbit Oryctolagus cuniculus ENSOCUG00000023733 ENSOCUT00000031972 706 ocuniculus_gene_ensembl 
Medaka Oryzias latipes ENSORLG00000012525 ENSORLT00000015683 638 olatipes_gene_ensembl 
Bushbaby Otolemur garnettii ENSOGAG00000001182 ENSOGAT00000001183 706 ogarnettii_gene_ensembl 
Sheep Ovis aries ENSOARG00000000739 ENSOART00000000788 441 oaries_gene_ensembl 
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Common Name Scientific Name SLC6A9 Ensembl Gene ID Orthologous Ensembl 
Transcript ID 
Protein 
Length 
Ensembl Database 
Chimpanzee Pan troglodytes ENSPTRG00000022644 ENSPTRT00000047245 706 ptroglodytes_gene_ensembl 
Orangutan Pongo abelii ENSPPYG00000001435 ENSPPYT00000001719 652 pabelii_gene_ensembl 
Hyrax Procavia capensis ENSPCAG00000012744 ENSPCAT00000012781 699 pcapensis_gene_ensembl 
Megabat Pteropus vampyrus ENSPVAG00000009510 ENSPVAT00000009510 706 pvampyrus_gene_ensembl 
Rat Rattus norvegicus ENSRNOG00000019484 ENSRNOT00000048770 633 rnorvegicus_gene_ensembl 
Tasmanian devil Sarcophilus harrisii ENSSHAG00000006607 ENSSHAT00000007664 443 sharrisii_gene_ensembl 
Zebra Finch Taeniopygia guttata ENSTGUG00000007574 ENSTGUT00000007899 492 tguttata_gene_ensembl 
Fugu Takifugu rubripes ENSTRUG00000000570 ENSTRUT00000001360 649 trubripes_gene_ensembl 
Tarsier Tarsius syrichta ENSTSYG00000012739 ENSTSYT00000012738 624 tsyrichta_gene_ensembl 
Tetraodon Tetraodon nigroviridis ENSTNIG00000007959 ENSTNIT00000002211 692 tnigroviridis_gene_ensembl 
Tree Shrew Tupaia belangeri ENSTBEG00000004257 ENSTBET00000004291 674 tbelangeri_gene_ensembl 
Dolphin Tursiops truncatus ENSTTRG00000001295 ENSTTRT00000001295 705 ttruncatus_gene_ensembl 
Xenopus Xenopus tropicalis ENSXETG00000003268 ENSXETT00000007095 633 xtropicalis_gene_ensembl 
Platyfish Xiphophorus maculatus ENSXMAG00000019099 ENSXMAT00000019205 660 xmaculatus_gene_ensembl 
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